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A b s t r a c t
The neural crest is an embryonic cell type derived from the ectoderm that gives rise to 
a number of diverse cell types. Factors required for correct differentiation of these 
derivatives from the initial multipotent neural crest cell population have been described, 
however the interactions and roles of these factors in the neural crest are not fully 
understood. Zebrafish colourless (els) mutants display disrupted development of non- 
ectomesenchymal neural crest derivatives including chromatophores and neurons and glia 
of the peripheral nervous system, and correspond to mutations in the transcription factor, 
soxlO. Reported els alleles appear to be nulls with lesions including missense and nonsense 
point mutations. Mutations in human SoxlO are associated with Waardenburg-Shah 
syndrome and Hirschsprung’s Disease, whilst mouse SoxlO mutants correspond to the 
Dominant megacolon mutant.
Here the isolation and mapping of PAC genomic clones containing zebrafish soxlO is 
described, the partial sequence of which has allowed the deduction of soxlO gene structure. 
Injection experiments have shown the ability of these clones to partially rescue pigment 
and neuronal aspects of the els phenotype. This indicated that the PACs contain sufficient 
promoter sequence required for functional sox 10 expression.
To assist in vivo analysis of the role of sox 10 and other genes in neural crest 
development, three GFP reporter constructs have been made, including both an engineered 
soxlO PAC and constructs containing 6.1 or 4.9 kb upstream promoter fragments. These all 
drive GFP expression in appropriate sites, including the neural crest and CNS, but also 
ectopically in muscle fibres in transient assays. Germline transgenics have been generated 
for all three reporter constructs, and show expression in premigratory neural crest, and later 
in certain migrating neural crest populations, in particular neural crest cells in the branchial 
arches and PNS glial cells. Other expression sites include cartilage cells, otic epithelia, 
oligodendrocytes and the olfactory bulb. Similarities and differences between the 
transgenic lines produced are discussed, as are some potential uses.
Two interesting els alleles have been characterised. One spontaneous mutant has been 
shown here to be due to a transposable element, previously implicated in another 
spontaneous zebrafish mutant. Finally, an allele screen afforded an apparently weaker 
zebrafish els allele with an unusual DRG-associated neurogenic phenotype. This may 
provide a unique insight into the mechanisms involved in DRG formation and the role of 
sox 10 therein.
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C h a p t e r  1 
In t r o d u c t io n
1.1. The  N eural  Crest
1.1.1. Overview
The neural crest is an embryological stem cell population, and comprises the precursors 
to a wide diversity of cell types. Formed from the ectoderm, it exists only transiently 
during development as mesenchymal tissue, which arises upon delamination from the 
nascent neural tube during neurulation. Subsequent migration, specification and fate 
restriction appear to be intimately interrelated processes, which have attracted much 
attention, due to both the relevance to human disease aetiology and as a model of stem cell 
ontogeny. Upon differentiation, the varieties of cell types generated include peripheral 
neurons and glia (including those associated with cranial, enteric, sympathetic and sensory 
(dorsal root) ganglia), Schwann cells, adrenal medullary cells, pigment cells and 
craniofacial cartilage (Le Douarin and Kalcheim, 1999). The critical stages of neural crest 
cell development will be briefly discussed here.
1.1.2. Formation and induction of Neural Crest
1.1.2.1. Morphological changes involved with Neural Crest formation
Neural crest forms at the lateral edges of the neural plate at the interface with the 
surface ectoderm (the future epidermis). The precise timing of neural crest induction is 
unclear, but it probably results from a multistep mechanism, initiated during gastrulation 
and continuing until neural tube closure (Aybar and Mayor, 2002). In species which 
undergo mostly primary neurulation (amphibians, mouse and chick), induced neural crest 
cells delaminate from the neural folds either before they meet in the mid-line or after 
neural tube closure, depending on the organism and the axial position. Zebrafish instead 
undergo secondary neurulation, forming a neural keel, without neural folds. Subsequent to 
the formation of the neural keel, at approximately 15hpf, the neuroepithelium separates 
from the overlying the ectoderm, and concomitantly, neural crest cells can be seen 
segregating from the dorsal aspect of the neural keel. As in other vertebrates, the 
segregation and future development of neural crest cells occurs in a rostrocaudal 
progression (Raible et al., 1992).
1.1.2.2. Molecules implicated in Neural Crest induction
There is a growing understanding as to the molecular mechanisms involved in neural 
crest induction, driven by a combination of techniques including confrontation of tissues in 
vivo and in vitro, exposure of explants to growth factors and perturbation of signalling 
pathways using overexpression assays and mutagenesis approaches. A critical component 
of these experiments is the detection of induced neural crest cells, which almost always 
relies on the use of early neural crest markers such as Snail, Slug, Zic and FoxD3. It has 
been long appreciated that interaction between the neural plate and the lateral ectoderm can 
induce neural crest markers (Selleck and Bronner-Fraser, 1995). One model invokes the 
ventral to dorsal gradient of BMP activity across the neural plate, established by a ventral 
source of BMP expression (in particular BMP-2/-4/-7) and a dorsal sink of BMP 
antagonists (such as noggin, chordin and follistatin) in the organiser region. The model 
proposes that regions of low BMP activity form neural keel, regions of high BMP activity 
form epidermis, whilst at intermediate levels between the two cell types, neural crest forms 
(Mullins et al., 1998). Evidence for this comes from introducing various activators or 
repressors of BMP signalling directly into embryos or to explants. For example, addition of 
mesodermally derived BMP antagonists to Xenopus animal caps induces neural crest 
marker expression (Marchant et al., 1998; Morgan and Sargent, 1997) and addition of 
BMP-4 expressing cells to chick neural plate explants induces neural crest markers (Liem 
et al., 1995). Zebrafish BMP mutants support this BMP gradient model, with mutants 
abolishing all BMP signalling having no induced neural crest, whilst those with diminished 
BMP signalling show a ventral expansion of neural crest markers (Mullins et al., 1998; 
Nguyen et al., 1998).
There is clear evidence that other signalling mechanisms and factors are essential to the 
process of neural crest induction. For example, addition of FGFs, which constitute 
posteriorising signals in the neural plate, can restore the ability of noggin to induce neural 
crest markers in Xenopus neural plate explants (LaBonne and Bronner-Fraser, 1998), and 
overexpression of an FGF inhibitor in Xenopus embryos can inhibit crest markers (Mayor 
et al., 1997). In chick, analysis of misexpression and grafting studies has led to the 
proposal that FGFs have a role in establishing the neural plate border (Streit and Stem, 
1999). Wnts also act as a posteriorising signal which, like FGFs, can act with noggin to 
induce neural crest markers in neural plate explants. Inhibition of Wnt signalling prevents 
neural crest marker expression (LaBonne and Bronner-Fraser, 1998). However, there may 
be other mechanisms through which Wnts act to induce neural crest. Recently, for 
example, Wnt6 was shown to induce neural crest in naive chick neural plates alone, and 
that its inhibition blocks neural crest formation in vivo. This indicated that in chick, Wnt6
is necessary and sufficient for neural crest induction. Furthermore, its expression domain is 
consistent with its identity as the ectodermal neural crest inducer (Garcia-Castro et al., 
2002). As with BMPs, later roles for Wnts in the maintenance of neural crest identity can 
be proposed based on functional studies and new expression domains in the dorsal 
ectoderm of the neural tube and neural crest (Aybar and Mayor, 2002).
An additional mechanism, which is likely to act during neural crest induction, has been 
demonstrated in zebrafish, where neural crest cells arise from an equivalence group with 
Rohon-Beard sensory neurons, narrowminded mutants lack both these cell types (Artinger 
et a l, 1999), and Delta-Notch signalling clearly acts to segregate one of these cell types 
from the other (Cornell and Eisen, 2000; see Section 5.1). Rohon-Beards or analogous cells 
also exist in Xenopus and mammals, and thus similar lateral inhibition mechanisms might 
also be functioning within the neural plate of these species to generate neural crest cells 
(Cornell and Eisen, 2000).
It is most probable that multiple signals will be involved in the steps of neural crest 
induction. Additional complexity is provided by the differences in the mechanisms 
involved and the relative importance of each signalling system between species (Aybar and 
Mayor, 2002; LaBonne and Bronner-Fraser, 1999).
1.1.3. Segregation of Neural Crest cells
Following their induction, neural crest cells segregate as individual cells at the dorsal 
midline of the neuroepithelium via an epithelial to mesenchymal transition (Le Douarin 
and Kalcheim, 1999). Following its early role as a ventralising signal, BMPs are later 
expressed in the dorsal neural tube (Sela-Donenfeld and Kalcheim, 1999). The dorsal 
neuroepithelial expression of BMP4 (see above), and a caudo-rostral gradient of its 
antagonist, noggin, appears to coordinate emigration of neural crest cells, via BMP4- 
dependant activation of rhoB and alteration of the expression profile of cadherins in the 
neural crest (Sela-Donenfeld and Kalcheim, 1999). rhoB encodes a GTP-binding protein 
which transduces extracellular signals and drives cytoskeletal changes. Inhibition of its 
function has been reported to disrupt neural crest emigration (Liu and Jessell, 1998). The 
expression profile of cadherins changes as neural crest cells leave the neuroepithelium, 
consistant with the known importance of cadherin mediated cell signalling in maintenance 
of tissue integrity (Akitaya and Bronner-Fraser, 1992; Inoue et al., 1997). Neural crest 
cells themselves secrete proteases to digest the overlying basal lamina, thus permitting 
their own emigration (Le Douarin and Kalcheim, 1999). The zinc finger transcription 
factors Snail and Slug, are very early markers of the neural crest in the neuroepithelium, 
and appear to be required for the epithelial to mesenchymal transition, possibly through
repression of certain cadherins such as E-cadherin (Cano et al., 2000; LaBonne and 
Bronner-Fraser, 2000). Another transcription factor involved in the induction of the neural 
crest and/or the segregation of the neural crest from the neuroepithelium is the winged- 
helix transcription factor, FoxD3. Chick and mouse studies have indicated that ectopic 
FoxD3 promotes formation of neural crest cells at the expense of surrounding 
neuroepithelial derived cells, such as intemeurons. However FoxD3 must be 
downregulated for later neural crest cell differentiation. Although independent from the 
Slug cascade, which promotes delamination as well as specification of neural crest, FoxD3 
requires Pax3 for its expression. In the mouse Pax3 mutant, Splotch, neural crest cells are 
not formed and this might be due to a specification failure due to lack of FoxD3 (Dottori et 
al., 2001; Kos et al., 2001).
1.1.4. Migration of Neural Crest cells
1.1.4.1. Pathways of Neural Crest migration
Cranial Neural Crest migration
Once delaminated from the neuroepithelium, cranial neural crest cells migrate laterally 
through the ECM underlying the ectoderm, and either enter the pharyngeal arches, 
contribute to the cranial ganglia, or migrate dorsally to produce pigment cells (Le Douarin 
and Kalcheim, 1999). There has been much study into the migration of the cranial neural 
crest, in particular, that of the neural crest at the level of the hindbrain. The hindbrain of 
vertebrates is segmented into rhombomeres, and the migration pattern of neural crest cells 
here is also segmented. Neural crest cells migrate ventrally from the dorsal hindbrain in 
three main streams adjacent to rhombomeres 1/2, 4 and 6-8, however they are excluded 
from migrating adjacent to rhombomeres 3 and 5. Neural crest cells arising from these 
latter regions often die, but remaining cells migrate rostrally or caudally first before 
entering one of the three main streams (Bronner-Fraser, 1994; Le Douarin and Kalcheim, 
1999). There is good evidence that directing the neural crest cells appropriately into the 
streams relies on anterior-posterior identity of both the neural crest and the surrounding 
environment, and that this identity is established by the Hox code (reviewed in Le Douarin 
and Kalcheim, 1999).
Pathways o f Trunk Neural Crest migration
After emigration from the dorsal neural tube, trunk neural crest cells are known to 
pause in a cell-free and ECM-rich migration staging area sited dorsolateral to the neural 
tube, from where they subsequently migrate away to take up the various positions in the
5
embryo. From this position, neural crest cells extend processes and probe the surface of the 
somite before migrating (Jesuthasan, 1996). In the trunk, neural crest cells migrate on 
either of two pathways, a dorsolateral pathway (in zebrafish termed the lateral pathway), 
which forms underneath the ectoderm and overlying the lateral surface of the somite, and a 
ventral pathway (termed the medial pathway in zebrafish), which forms between the neural 
tube and the medial somite surface (Le Douarin and Kalcheim, 1999; Raible et a l, 1992). 
Onset of migration occurs in a rostrocaudal sequence, with neural crest cell invasion of the 
ventromedial pathway preceeding that of the dorsolaterally pathway. In zebrafish the lag 
between medial and lateral pathway migration is approximately 4 hours (Raible et a l, 
1992), whilst in the mouse and chick, it can be up to 1 day (Weston, 1991). Furthermore, 
the mechanism of migration differs such that the dorsolateral migration pathway is 
unsegmented, and neural crest cells will cross somite boundaries, whilst neural crest cells 
migrating on the medial pathway do so in a segmental pattern and at a specific rostro­
caudal position relative to each somite (Bronner-Fraser, 1994; Le Douarin and Kalcheim, 
1999). In chick, this is in the rostal half of each somite, whilst in zebrafish neural crest 
cells will migrate along the middle of the somite (Raible et al., 1992). The medial pathway 
is also used independently by other cells and axons, namely dorsally migrating sclerotome 
cells and outgrowing spinal nerves (Morin-Kensicki and Eisen, 1997).
1.1.4.2. Molecules involved in controlling Neural Crest migration
Recent work has been directed towards determining the molecules underlying the 
control of neural crest migration. Firstly, delay of migration onto the lateral pathway 
correlates with deposition of inhibitory molecules in this location, namely peanut 
agglutinin (PNA)-binding glycoproteins and chondroitin-6-sulfate. Neural crest migration 
on this pathway begins after these factors are downregulated (Oakley et a l, 1994). Other 
factors are likely to play a role in migration on this pathway. c-Kit is a receptor tyrosine 
kinase expressed in melanoblasts and crucial to melanoblast survival, proliferation and 
migration (Steel et al., 1992). It is bound by a soluble and membrane-bound form of its 
cognate ligand Steel-factor (SCF), with different roles ascribed to the different forms. The 
soluble form of SCF appears to be crucial in initial migration of melanoblasts onto the 
lateral pathway (Wehrle-Haller and Weston, 1995).
A number of factors control the segmental migration of neural crest cells on the medial 
pathway. Visualizing neural crest migration in chick embryos where some somites have 
been rotated 180°, led to the deduction that the information directing segmental migration 
is provided by the somites (Bronner-Fraser and Stem, 1991). The factors secreted by the 
somites form components of the extracellular matrix and act through integrin receptors
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expressed on the neural crest cell surface to either promote or inhibit migration. This 
ultimately leads to funnelling of neural crest cells onto the correct path. Thus sites where 
neural crest cells do not migrate have been shown to contain a number of inhibitory ECM 
or cell adhesion molecules, including F-spondin, collagen EX, T-cadherin and versican. As 
with the lateral migration pathway, PNA-binding glycoproteins and chondroitin-6-sulfate 
also play an inhibitory role in the medial pathway (Krull, 2001).
Promoters of neural crest migration are often not localised specifically, but act as a 
permissive substrate for neural crest migration. Some of the molecules acting in this 
fashion are also required for the emigration of nascent neural crest cells from the 
neuroepithelium, and include fibronectin, laminin, thrombospondin and tenascin (Krull, 
2001; Le Douarin and Kalcheim, 1999). Finally, the Eph family of receptor tyrosine 
kinases and their ligands, ephrins, play a role in segmental migration of trunk neural crest 
cells, along with many other roles in cell migration during development. As both receptor 
and ligands are located on the cell surface, their effects are mediated by direct contact 
between neural crest and somite cells. Analysis of expression patterns of Eph receptors and 
their ligands indicated that some were localised to regions of the somite corresponding to 
regions inhibitory to neural crest migration. For example, the EphB3 receptor was found to 
be expressed in the caudal half of somites, whilst its ligand ephrin-Bl was expressed on the 
surface of migrating neural crest cells (Krull et al., 1997). Functional assays have shown 
that the interaction is a repulsive one, and is likely to prevent neural crest migration over 
the caudal half of the somites (Wang and Anderson, 1997). There is growing evidence for 
the role of other ephrin and Eph receptor family members in the control of neural crest 
migration in the trunk as well as in the hindbrain (Krull, 2001; Robinson et al., 1997).
As to the precise mechanisms that pattern neural crest correctly and bring them to 
adopt the correct locations, little is known.
1.1.5. Specification of neural crest cells
The question as to whether neural crest cells emigrating from the neural tube are 
committed to a lineage as soon as they form, or whether they are initially multipotent and 
commit later is a fundamental question in neural crest biology. This has been addressed 
with four main approaches: determining heterogeneity in molecular marker expression in 
the neural crest at various stages, fate mapping neural crest cells by labelling in vivo, 
challenging NCSC cultures in vitro and altering neural crest cells’ environments by in vivo 
transplantation experiments (Le Douarin and Kalcheim, 1999). Note that only the latter 
two approaches really test a cell’s commitment, which is a function of the cell’s potential. 
Marker analysis only comments on developmental diversity or specification of a
population of cells, whilst fate mapping makes no comment on what a cell can become, 
only on what cell types it contributes to under normal embryonic conditions. However a 
progenitor cell contributing to multiple fates, by definition, must be pluripotent for those 
fates at least. Conversely, a labelled progenitor cell producing only a single fate is said to 
be specified to that fate, but if challenged, it could potentially produce other cell types 
(Raible and Eisen, 1994).
A number of different experiments conducted using chick, mouse and zebrafish neural 
crest cells in vivo and in vitro, indicate that early neural crest cells are heterogeneous with 
respect to fate, some being lineage restricted, with others giving rise to a greater range of 
derivatives. How this heterogeneity arises is unknown, but might involve stochastic events, 
in combination with regulative interactions between neural crest cells (Raible and Eisen,
1996). The mechanism of restriction of potency in stem cells is also of interest, and might 
be brought about by either environmental signals instructing uncommitted cells to lose 
potency, or by intrinsic cellular events, such as asynchronous cell divisions, that alter 
potency and in doing so alter response to permissive environmental signals (Anderson et 
a l , 1997).
In higher vertebrates, the specification of neural crest cells migrating on the two 
pathways differs, such that those migrating on the lateral pathway will become pigment 
cells, whilst those migrating medially are fated to become neurons and glia of the PNS. 
This migration pattern is mostly true in zebrafish. Cells migrating laterally will only give 
rise to pigment cells as in chick and mammals, whilst, unlike chick and mammals, those on 
the medial pathway will become pigment cells as well as neurons and glia (Eisen and 
Weston, 1993). There is evidence in chick that melanocytes are specified prior to 
embarking on the lateral pathway (Wakamatsu et al., 1998). Furthermore, neural crest- 
derived melanocyte precursors in the chick preferentially migrate to the lateral pathway, 
even if placed ectopically on the medial pathway. Conversely neurogenic precursors 
transplanted onto the lateral pathway undergo apoptosis. Thus there are environmental 
differences between the two pathways, which direct specified neural crest cells to migrate 
appropriately and which remove aberrantly migrating neural crest progenitors (Wakamatsu 
et al., 1998).
There is evidence from analysis of molecular markers that the early neural crest does 
not have a homogeneous expression profile. A number of antibodies label subpopulations 
of early neural crest cells, which show developmental restrictions (Weston, 1991). For 
example the Hu antibody stains mature neurons, however at an earlier stage, it labels a 
subset of neural crest cells with neuronal potential (Marusich et al., 1994). Similarly, only 
a subset of avian neural crest cells expresses the neurotrophin receptor trkC, putatively
those shown to have neurogenic potential in vitro (Henion et al., 1995), although recently, 
more detailed analysis in vitro has shown that very young trkC expressing neural crest cells 
can also give rise to glia (Luo et al., 2003). Such heterogeneity in expression profiles may 
underlie differences in neural crest specification to different lineages at this early stage. 
However the functional meaning of neural crest marker heterogeneity is not easy to 
demonstrate in vivo. So far establishing that the fate of a neural crest cell is different from 
that of a sibling cell that does not express a given marker has been limited to in vitro 
analyses of isolated cells, or immunodepletion (Le Douarin and Kalcheim, 1999). Using a 
GFP transgenic line to reveal heterogeneity of gene expression in live embryos would 
allow vital-dye labelling of the different subsets of cells in vivo to reveal any difference in 
specificity.
There is good evidence that neural crest cells in the migration staging area in all 
species studied to date are a mixed population of both fate restricted and multi-derivative 
precursor cells (Henion and Weston, 1997; Weston, 1991). Contributing to this evidence is 
in vivo fate mapping of single cells, which demonstrated that early neural crest cells are 
heterogeneous with respect to developmental restrictions. In chick, labelling neural crest 
cells demonstrated that the majority of them gave rise to more than one cell type, including 
DRG neurons, glia, ENS cells and pigment. This indicated multipotency of early neural 
crest cells. Intriguingly, not all neural crest cells labelled in this experiment gave rise to 
multiple-phenotype clones, indicating heterogeneity of migratory neural crest cells with 
respect to fate restriction (Fraser and Bronner-Fraser, 1991). Henion and Weston (1997) 
extended this by labelling premigratory neural crest cells in explanted chick neural tubes. 
This also demonstrated heterogeneity in this population, and later indicated progressive 
restriction of fate during neural crest development. Distinct melanogenic and neurogenic 
sublineages were identified, within both of which existed bipotent precursors with the 
added capacity to generate glia. Later, the ability of some cells to produce two alternate 
fates was lost and only single cell-type restricted lineage precursors could be identified.
A similar lineage analysis was performed in zebrafish in vivo. Comprehensive fate 
mapping of zebrafish cranial neural crest has been conducted and has demonstrated that the 
cranial premigratory crest is segmentally restricted, and crest cells are restricted at an early 
stage to contribute to cells of a single arch segment (Schilling and Kimmel, 1994). Thus a 
premigratory neural crest cell in an anterior position will form a clone in a single anterior 
arch element. In addition, there appears to be a medial-lateral gradient of fate-choice 
within the premigratory crest, such that laterally positioned crest generates mostly neurons 
and glia of cranial ganglia, the most medially positioned neural crest cells contribute 
mostly to cartilage and connective tissue, whilst intermediately positioned neural crest cells
will produce pigment cells, however all premigratory cranial neural crest cells gave rise to 
only a single cell type, and thus are fate-restricted (Schilling and Kimmel, 1994).
In contrast to the fate-restricted cranial neural crest cells, similar single cell labelling 
experiments indicated that some, but not all, premigratory trunk neural crest cells in 
zebrafish gave rise to multiple phenotypes. However the frequency of precursors 
generating multiple cell types decreased with time such that cells migrating later were all 
type-restricted. Additionally there was a shift in fates produced with time, with only early 
migrating neural crest (EMC) cells giving rise almost all neural crest trunk derivatives, 
whilst late migrating crest (LMC) cells only gave rise to pigment and glial cells, and not 
neuronal derivatives (Raible and Eisen, 1994). Thus there is compelling evidence that early 
neural crest cells are heterogeneous for both expression profiles and potency, and that 
neural crest cells become progressively more restricted in fate during development.
Zebrafish fate mapping experiments have been extended by transplantation 
experiments to uncover if the restrictions in fate are associated with restrictions in potency, 
and if environmental changes underlie changes in neural crest cell commitment, or if some 
intrinsic mechanism changes cell potency (Raible and Eisen, 1996). The authors 
demonstrated by heterochronic transplantation that EMC cells could still generate neurons 
if placed into an older embryo, but that LMC cells could not produce neurons when 
transplanted into younger embryos. This directly contrasted with similar heterochronic 
experiments in chick, which argued that LMC transplanted into young hosts, were still 
multipotent (Weston and Butler, 1966). However zebrafish LMC cells could generate 
neurons if EMC cells were ablated during migration or before (Raible and Eisen, 1996). It 
was proposed that interactions between neural crest cells establish intrinsic differences in 
developmental bias, although this might be conditional depending on the environment.
A fate map of the neural crest along the avian axis has been produced using isotopic 
grafts from quail as a marker, supported by tracer injection work described above 
(reviewed in Le Douarin and Kalcheim, 1999). Using heterotropic grafts where cell are 
placed into a different rostro-caudal site in the host has allowed production of a map of 
developmental potentials. To summarise, these analyses indicated that early neural crest 
cells grafted to different axial positions are able to generate cell derivatives appropriate for 
their new position. Thus although there is heterogeneity with respect to fate restriction, the 
neural crest appears to be highly plastic along the almost the entire length of the embryo. 
For example, Le Douarin et al., (1978) showed that thoracic quail neural crest grafted to a 
vagal position in chick could contribute to the ENS, appropriate behaviour for the new 
location. One exception is the inability of trunk neural crest cells to contribute to cranial 
cartilage tissue when transplanted into the cranial region of hosts. The existence of
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precursors restricted to either an ectomesenchymal (cartilage) or non-ectomesenchymal 
(pigment and PNS) fate has been proposed based on this and other evidence (Weston,
1991). The discovery of a zebrafish mutant with defects in only one of these sublineages 
{els -  see later) supports this notion (Kelsh and Eisen, 2000).
A final technique elucidating neural crest cell behaviour is the use of in vitro clonal 
analysis of isolated neural crest cells. This has allowed the extent of potency possessed by 
neural crest cells to be tested, and also the timing and mechanism of commitment and 
lineage segregation. So far, in vitro experiments have been mostly performed using 
cultures of isolated avian (Baroffio et al., 1988) and murine (Stemple and Anderson, 1992) 
neural crest cells. Work in chick identified a proliferative cell population containing clones 
with extremely diverse potency, being able to generate neuronal, glial, pigment and 
cartilage precursors, with many clones able to generate more than one cell-type. As 
demonstrated in vivo, there was inherent heterogeneity in the isolated population, with a 
proportion of cells being monopotent, whilst others displayed intermediate developmental 
potentials. Development of a method for isolating and culturing of mammalian neural crest 
cells has revealed that some have stem cell properties such as self-renewal, and capable of 
generating autonomic neurons, glia and smooth muscle cells upon exposure to instructive 
signals from BMP2, NRG1 and TGFp respectively (Shah et al., 1996).
1.1.6. Factors involved in the specification and differentiation of neural 
crest cells
1.1.6.1. Soluble Factors
The factors used in the above in vitro neural crest culture experiments are also 
expressed in the embryo at sites appropriate for the type of derivatives they promote in 
vitro. For example, autonomic neurons form near the dorsal aorta, where BMPs are 
expressed (Schneider et al., 1999), TGFp is present in the blood vessels where smooth 
muscle forms and nascent neurons in ganglia express NRG1 on axons, thus directing 
neighbouring neural crest cells to adopt a Schwann cell fate (Leimeroth et al., 2002; Shah 
et al., 1994). In addition to the roles for these signalling molecules identified by in vitro 
analysis, other factors are likely to be involved in neural crest specification. For example, 
Wnt signalling has been identified as a promoter of pigment-cell formation in the zebrafish 
neural crest (Dorsky et al., 1998). Thus fate restriction may be brought about by instructive 
cues present in the environment in which neural crest cells migrate. Heterogeneity in 
expression of certain signalling systems within the cell might then dictate whether a neural 
crest cell can respond to the signal or how it might interpret a combination of signals.
1.1.6.2. Transcription Factors
To effect the alteration in cell specification, signalling pathways of the above factors 
are likely to activate expression of certain transcription factors involved in differentiation 
of the various neural crest drivatives. A number of transcription factors have been 
identified with such roles. Many of these belong to the basic Helix-Loop-Helix (bHLH) 
family of transcription factors, and are implicated in the development of melanophores, 
sensory and autonomic neurons.
Mitf is required for melanogenesis
Firstly, there is currently strong evidence that the Microphthalmia associated 
transcription factor (Mitf) is a key regulator of the melanocyte lineage. Mutations in this 
gene are associated with the mouse mutant, Microphthalmia, which displays defects in eye 
development and has a severe deficits in neural crest-derived melanocytes (Opdecamp et 
al., 1997). There are two zebrafish orthologues of mitf, with mitf a corresponding to the 
nacre (nac) locus, nac mutants show a complete lack of melanophores, but unlike mouse 
mutants, there is no eye defect (Lister et al., 1999). This is due to the presence of a second 
orthologue in zebrafish, mitfb, which has assumed the role of mammalian Mitf in the eye. 
Mutation and overexpression studies in both mouse and zebrafish have indicated that Mitf 
is both necessary and sufficient for melanogenesis, and thus might act as a melanocyte 
master switch gene (Dorsky et al., 2000; Lister et al., 1999). It has been shown that the 
mediators of Wnt signalling, the Tcf/Lef transcriptional activators, directly activate the 
mitfa gene along with other transcription factors, demonstrating a combinatorial 
mechanism acting to specify pigment cells (see Section 1.2). Mitf carries out the 
melanocyte developmental program by activating survival and differentiation genes, such 
as c-Kit, ednrB and Dct (Opdecamp et al., 1997).
Transcription factors involved in autonomic nervous system development
As mentioned above, BMPs provide an environmental signal promoting sympathetic 
neuron specification, in the same manner as Wnts promote the melanocyte lineage. 
MASH1 is a critical bHLH transcription factor required for autonomic neuron 
development, possibly to direct neuronal differentiation following commitment (Sommer 
et al., 1995), but there is also evidence that it maintains neural crest cell competence to 
respond to BMP signals (Lo et al., 1997). The Mashl knock-out mouse displays extensive 
loss of sympathetic, parasympathetic and certain enteric neurons (Guillemot et al., 1993).
It appears that BMPs themselves can induce MASH1 in vitro (Shah et al., 1996) and are 
required for its expression in vivo (Schneider et al., 1999). It is not known if MASH1 is a
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direct target of BMP signalling. Other transcription factors implicated in this pathway 
include the Phox2 protein family. Phox2b knock-out mice show a more complete absence 
of autonomic neurons than Mashl knock-out mice, and Mashl expression is lost in these 
mutants (Pattyn et a l, 1999). Mice lacking Phox2a also show defects in the autonomic 
nervous system, however less severe than that of Phox2b knock-out mice, and Phox2a 
appears to be downstream of MASH1 (Stanke et al., 1999). Both Phox2a and Phox2b are 
upregulated by BMPs and both are sufficient to promote sympathetic neuron development 
in chick (Stanke et al., 1999). Thus it appears that Phox2b is a critical transcription factor 
in the ontogeny of the autonomic nervous system, and may link extracellular BMP 
signalling with a cascade of transcription factors necessary for its neurogenesis. MASH1 
and the Phox2 proteins are all potential direct activators of other factors required during 
this process.
Neurogenenins are required for sensory neuron development
The bHLH proneural transcription factors neurogeninl and 2 (ngnl, ngn2) play a 
central role in sensory neurogenesis. The factors involved in this process, including the 
neurogenins, are discussed in more detail in Chapter 5. Neurogenins are expressed in 
precursors of sensory neurons in mouse neural crest, and targeted mutations result in loss 
of DRG sensory neurons (Ma et a l, 1999). This study demonstrated slight temporal 
differences in expression between NGN1 and NGN2 in the developing DRG, as well as 
partial functional redundancy between them. Ectopic neurogenin expression in chick 
neural crest biases them to behave as sensory neurons, indicating that neurogenin acts to 
specify neural crest cells to a sensory neuron fate (Perez et a l, 1999). Reduced 
responsiveness of ngn2 expressing neural crest cells to BMP signalling in vitro indicates 
these cells are committed to a sensory fate (Greenwood et a l, 1999), however lineage 
tracing ngn2+ neural crest cells at a very early stage indicated that this restriction occurs 
later, and early ngn2+ cells can contribute to the autonomic nervous system (Zirlinger et al, 
2002). The mechanisms controlling the size of dorsal root ganglia and the proportions of 
neurons to glia therein are not well understood, but there is growing evidence for intimate 
involvement of neurogenin in Notch-Delta mediated lateral inhibition within the DRG (see 
Chapter 5).
1.1.7. Receptors expressed by Neural Crest cells required for survival
Instructive signalling pathways are likely to act via transcription factors to effect 
correct differentiation, migration and survival. There is evidence in vivo that neural crest 
cells require exposure to survival and proliferation factors during migration. Sublineages or
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type-restricted precursors often express specific receptors for such factors. In particular, 
the receptor tyrosine kinase family play a pivotal role in many of the neural crest lineages.
Receptor tyrosine kinases o f the pigment cell lineage
c-Kit is a receptor tyrosine kinase required for survival and proliferation of 
melanoblasts. Mutations in the c-Kit gene have been identified in mouse (Dominant 
spotting, W), zebrafish (sparse, spa) and humans (Piebaldism). In all cases, there is a 
reduction or lack of melanocytes, which has been attributed to defects in migration, 
survival and proliferation (Parichy et al., 1999; Spritz, 1998). Luo et al. (2003) have shown 
that neural crest cells expressing c-Kit are restricted to the melanophore fate. The ligand 
for c-Kit has been shown to be Steel Factor, which is expressed in the environment through 
which melanogenic neural crest cells migrate, and mouse mutations in Steel (Steel, SI) 
produce similar phenotypes to W (Steel et al., 1992; Wehrle-Haller and Weston, 1995). 
Zebrafish mutagenesis screens have identified other tyrosine kinase receptors in other 
pigment cells types. For example, the salz mutant corresponds to a mutation in a receptor 
tyrosine kinase, fms, and shows defects in migration and survival of xanthophores, similar 
to the defect caused by c-Kit mutation (Parichy et al., 2000).
The Schwann cell lineage requires signalling through the erbB3 receptor tyrosine kinase
Other receptor tyrosine kinase families are required for neural crest survival, migration 
and/or differentiation. The erbB3 receptor binds the NRG1 ligand, and is required for 
Schwann cell precursor survival and migration along axons (Britsch et a l, 2001). A mouse 
knock-out displays severe neuropathies due to paucity of Schwann cells, and in vitro,
NRG1 can restrict neural crest cells to a glial fate (Shah et a l, 1994). In vitro analysis of 
neural crest cells has also implicated NRG1 signalling in undifferentiated, multipotent 
neural crest cell survival (Paratore et a l, 2001).
Neuronal lineage associated receptor tyrosine kinases
The trk receptor tyrosine kinase family, (including trkA, trkB and trkC), also plays a 
survival role in all neural crest derived neuronal lineages, including enteric and 
sympathetic ganglia (Le Douarin and Kalcheim, 1999). Associated ligands are the 
neurotrophin family of secreted factors. In particular, neurotrophin-3 (NT3) binds to the 
trkC receptor, which is expressed in a subset of neural crest cells fated to the sensory 
neuron lineage, and which require NT3 signalling for migration and survival (Henion et 
al, 1995).
The role of the c-Ret tyrosine kinase receptor and its ligand GDNF has been shown to 
be critical for enteric neuron development from the neural crest. Humans with mutations in
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c-Ret display Hirschsprungs disease, a condition characterized by absence of enteric 
ganglia leading to a distended colon (Hofstra et al., 2000). Mice with a targeted knock-out 
also show similar ENS defects (Schuchardt et a l, 1994). c-Ret is expressed by neural crest 
cells in the vagal neural crest region prior to migration, a site mapped as being the origin of 
the ENS. They also express c-Ret as they migrate along the gut. GDNF is expressed in a 
complimentary fashion in the gut mesenchyme (Pachnis et al., 1993). Expression of 
zebrafish c-Ret in the ENS has been described, although there is as yet no reported mutant 
(MarcosGutierrez et al., 1997). The exact role of c-Ret signalling in the ENS is unclear, 
and it might be required for multiple processes in neural crest derived enteric precursor 
cells, including migration, survival, proliferation and/or differentiation (Lo and Anderson, 
1995; Taraviras and Pachnis, 1999).
1.1.8. Waardenburg syndromes and Hirschprung’s disease
Neurochristopathies are the group of diseases caused by defects of neural crest 
derivative. One of the most common families of these diseases is that of the Waardenburg 
syndromes, which often display defects in multiple neural crest cell fates, and are 
associated with mutations in some of the critical factors associated with neural crest 
ontogeny. They are classified into four subtypes depending on the combination of 
phenotypes presented.
1.1.8.1. Waardenburg syndrome type I (WSH
Features of this disease include pigment anomalies (often a white forelock and 
heterochromatic irises), broadening of the nose due to displacement of the inner canthii of 
the eye (dystopia canthorum) and deafness. It shows autosomal dominant inheritance with 
variable severity. All cases reported so far have been due to disruptions in the Pax3 gene, 
which thus makes the Pax3 mouse mutant Splotch a model for WS1 (Tassabehji et al.,
1992). As alluded to elsewhere in this chapter, the neural crest phenotypes might thus be 
due to lack of Pax3 mediated neural crest cell specification within the neuroepithelium or a 
later defect in regulation of downstream lineage regulating factors such as Mitf.
1.1.8.2. Waardenburg syndrome type II (WS2)
This autosomal dominant syndrome presents as per WS1, however without the dystopia 
canthorum. Thus patients present pigment anomalies, and deafness. All cases for which a 
lesion has been found are due to a mutation in the bHLH transcription factor, M itf 
(Tassabehji et al., 1994). Deafness has been attributed to loss of melanocytes in the ear 
(Nobukuni et al., 1996). As mentioned earlier, mutations in this master regulator of
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melanocyte differentiation are associated with the mouse mutant microphthalmia (mi) and 
the zebrafish mutant nacre (Lister et al., 1999; Opdecamp et al., 1997).
1.1.8.3. Waardenburg syndrome type IP (WS3: Klein-Waardenburg Syndrome)
Like WS1, this disease is also caused by mutations in the PAX3 gene, and is also
inherited in a dominant manner. In addition to the hypopigmentation, facial abnormalities 
and deafness associated with WS1 it also presents upper limb anomalies, including 
hypoplasia of the musculoskeletal system, flexion contractures, fusion of the carpal bones, 
and syndactyly (Zlotogora et a l , 1995). This may be due to a secondary defect arising 
from lack of skeletal muscle (Tremblay et al., 1998).
1.1.8.4. Waardenburg syndrome type IV (WS4: Waardenburg-Shah Syndrome)
WS4 is a multigenic condition, inherited in either a recessive or dominant manner, 
depending on the gene affected. Also called Hirschsprung disease with pigmentary 
anomaly, it combines the enteric aganglionosis of Hirschprung’s disease with the pigment 
defects of WS2. The recessive condition has been identified as due to mutations in the 
endothelin-3 (Edn3) signalling molecule (Edery et al., 1996; Hofstra et a l , 1996), or its G- 
protein coupled receptor endothelin receptor B (EDNRB) (Puffenberger et a l , 1994; Syrris 
et a l , 1999). Homozygosity for mutations in either of these genes has been shown to cause 
WS4, with a range of severity, presenting with some degree of hypopigmentation and 
aganglionosis of the gut (Edery et a l , 1996). Unlike WS1, deafness is relatively rare in 
recessive WS4, but has been reported (Puffenberger et a l , 1994). These phenotypes have 
striking similarity to those of the recessive mouse mutants piebald-lethal (sl-  mutant for 
the Ednrb gene) and lethal spotting (Is -  mutant for the Edn3 gene) (Kapur et a l , 1995), 
indicative of a conserved role for EDNRB-mediated signaling in both melanoblasts and 
ENS precursors. Recent work in mouse knockout lines clearly indicated that this role 
involves the correct terminal migration of these precursor cell types (Lee et a l , 2003). 
Humans heterozygous for mutations in either of these two genes have been shown to 
display Hirschprung’s disease alone, with no pigment anomalies (Amiel et a l , 1996; 
Auricchio et a l , 1999; Pingault et a l , 2001b).
Heterozygosity at the SOXIO locus also causes WS4, with combined pigment defects 
and Hirschprung’s disease. Deafness is also common in this disorder. As with WS2, this is 
often attributed to loss of melanocytes, but as SOXIO is expressed in the ear, a SOXIO 
mutation might have a direct role here. In addition to WS4 symptoms, some SOXIO 
mutations produce variable dysmyelination of the CNS and PNS leading to neurological 
disorders (Touraine et a l , 2000). SOX10 mutations will be dealt with in more detail later 
(see Section 1.2). Although mutations in the three genes mentioned here all result in WS4,
the aetiology is proving to be different, and the cellular defects caused by the mutation of 
SOXIO are much earlier than those caused by disruption to the EDN3 signalling pathway 
(Lee et al., 2003).
1.1.9. Zebrafish screens for neural crest mutants
Recently, the zebrafish has been employed to genetically dissect processes of 
vertebrate development. Mutagenesis screens have isolated numerous loci important in 
development of various tissues, including the neural crest (Haffter et al., 1996; Henion et 
al., 1996). As the first vertebrate species on which such large-scale mutagenesis screening 
has been conducted, and as positional cloning efforts are now identifying many of these 
mutant loci at a molecular level, the zebrafish promises to permit rapid characterization of 
the genes involved in formation of certain structures. Some of the mutants isolated clearly 
correspond to those known in humans, mice and other experimental model systems.
Neural crest derived pigment cells in zebrafish form a stereotypical pattern, and are 
easy to visualise and score for disrupted number, distribution or differentiation. The 
pigment pattern of a wild-type larva is composed of three pigment cell types, black 
melanophores, yellow xanthophores and the reflective iridophores and is shown in Figure
1.1. Melanophores are found in four longitudinal stripes in early larvae, namely the dorsal 
stripe, lateral stripe, ventral stripe and a yolk-sac stripe. Note that the only other cells to 
melanise in the embryo, found in the pigmented retinal epithelium, are not neural crest 
derived. Iridophores co-localise with melanophores in the dorsal, ventral and yolk sac 
stripes and migrate to cover the eye. Iridophores are also found in the lateral patch, a 
region lying dorsolateral to the yolk sac. Finally, xanthophores are predominantly found on 
the dorsal half of the embryo (Figure 1.1; Kelsh et a l ,  1996). Due to the ease of visualising 
aberrations in the embryonic pigment pattern, screens readily identified a large number of 
mutants, each defective in some aspect of pigmentation. These mutants were classified into 
having reduced pigment cell number, abnormal pigment cell distribution, reduced levels of 
pigment in particular chromatophore(s), or abnormal pigment cell morphology (Kelsh et 
al., 1996). In addition to pigment, the jaw cartilage also represents a readily visualised 
neural crest derivative. As such, screens were also able to identify a number of mutants 
which affect the ectomesenchymal derivatives of neural crest, in particular the jaw 
(Piotrowski et al., 1996; Schilling et al., 1996a). Subsequent screens have also been 
performed using PNS neuron markers to find mutants with defects in neural crest derived 
neuron structures (Henion et al., 1996). Insertional mutation screens have also yielded 
interesting neural crest mutants, such as alyron, which show a severe deficit in
colourless
Figure 1.1 Wild-Type and colourless larvae pigmentation
Upper panel shows a lateral view of a 6dpf wild-type larva, viewed with transmitted 
light. Black melanophores are present in four longitudinal stripes, a dorsal, lateral, ventral 
and yolk-sac stripe. They begin to migrate to these locations at about 20 hours post 
fertilisation, having emerged dorsal to the neural tube. A cast of yellow xanthophores is 
evident dorsally, and iridophores are found with melanophores in all but the lateral stripe. 
In the ventral stripe, iridophores are also seen in large patches above the yolk sac termed 
the lateral patches, and overlying the eye.
Lower panel shows a els larvae at the same stage, which displays total absence of 
morphologically normal body melanophores. This absence is complete for all els alleles 
described. Note that the non-neural crest derived melanophores of the pigmented retinal 
epithelium are unaffected. Xanthophores and iridophores of both the body and eye are 
significantly reduced in els individuals, however occasionally individual cells of these 
types are seen in els larvae (Kelsh et al, 1996). Other cell types not evident here are 
affected as well (see Section 1.2).
premigratory neural crest leading to lack of pigmentation and heart flow defects (Cretekos 
and Grunwald, 1999).
These screens have led to the identification of mutants disrupted for a number of the 
processes required during neural crest cell development. Preliminary analyses of some of 
the mutants’ phenotypes suggested defects in neural crest induction, specification, 
proliferation, survival, migration or differentiation. Mutants include those with lack of or 
having a reduction in one type of neural crest cell derivative, for example melanophores 
(nacre!mitf a), xanthophores (salz/fms), iridophores (shady), DRG neurons (nosedive) and 
craniofacial cartilage (chinless) (Henion et al., 1996; Kelsh et a l , 1996; Lister et a l , 1999; 
Schilling et a l , 1996b). Additionally, mutants affecting neural crest survival have also 
been identified, such as sparse/c-kit (Parichy et a l , 1999). Of particular interest is the 
colourless (els) mutant, which shows loss of multiple neural crest derivatives. An example 
of a homozygous els mutant is shown in Figure 1.1. Evident is the loss of all body pigment 
cells. Other neural crest derivatives are severely diminished as well, but not 
ectomesenchymal derivatives such as facial cartilage (see Section 1.2).
Thus the ability to perform mutagenesis screens in zebrafish provides a unique and 
novel approach to dissecting the genes responsible for the processes of neural crest 
development.
1.2. SOXlQ
1.2.1. Overview of the SOX family of transcription factors
Vertebrate embryonic development relies on the complex interactions of transcriptional 
regulators of gene expression. As disruptions in the activity or distribution of these factors 
are a cause of many human congenital diseases, understanding the associated molecular 
mechanisms is important, not only developmentally, but also medically. Examples 
demonstrating this can be found in the SOX group of transcription factors, which form a 
subclass of the HMG box protein superfamily (reviewed in Soullier et a l, 1999). Several 
members of the SOX family of transcription factors have essential roles in pathways 
governing cell behaviour and identity (Prior and Walter, 1996), and diseases exist in both 
humans and animals ascribed to disruption of certain Sox genes (Pevny and Lovell-Badge,
1997). Unlike the ubiquitously expressed HMG family, Sox proteins display tissue specific 
domains of expression (Pevny and Lovell-Badge, 1997).
1.2.1.1. Domains found in Sox proteins
SOX transcription factors are characterised by the presence of a conserved DNA 
binding domain encoded by the SRY-related HMG box, first identified in the mammalian 
sex-determining gene SRY (Pevny and Lovell-Badge, 1997). The HMG domain has 
multiple identified roles other than its DNA binding capability. There are identified motifs 
responsible for nuclear import (Forwood et a l, 2001; Sudbeck and Scherer, 1997) and 
export (Rehberg et a l, 2002) of the protein, and an ability to engage in protein-protein 
interactions has been noted (Melnikova et a l, 2000). HMG domains of some Sox proteins 
have also been demonstrated to have RNA splicing activity (Ohe et a l, 2002).
The Sox family comprises approximately 20 genes and are classified into ten subgroups 
(A- J) based on sequence similarities (Bowles et a l, 2000). Intriguingly, in vertebrates 
group A, B, C and G Sox proteins are encoded by one exon (e.g. Schilham et a l, 1993), 
whilst the few genes of the other groups characterised so far do contain intron-exon 
structure (eg Sox5, 9, 10 and 17). Generally, intron-exon boundaries are conserved within 
each subgroup across vertebrate species, although these cannot be extrapolated to 
invertebrates (Kanai et a l, 1996; Pusch et a l, 1998; Wright et a l, 1995; Wunderle et a l, 
1996). Although there is a high degree of HMG domain sequence similarity between Sox 
proteins, there is much less conservation elsewhere in the protein. However within a 
subgroup certain other functional domains are conserved. These other domains include 
transactivation domains, mostly found in the C-terminus and shown for many Sox proteins 
to be able to activate transcription of target genes, as well as protein-protein binding and 
homodimerisation domains such as the leucine zipper motif of subgroup D (Lefebvre et al, 
1998; Peirano and Wegner, 2000; Wegner, 1999; Yamashita et a l, 1998). Repression 
domains have been identified in some group B Sox proteins (Uchikawa et a l, 1999).
1.2.1.2. DNA binding specificity of Sox proteins
All HMG domain containing proteins are able to bind to DNA, however only the 
subfamily containing the Sox proteins can do so with sequence specificity. This occurs 
through their HMG-domain, which binds DNA at the consensus sequence 
(a/t )(a/t)CAA(a/t )G (Pevny and Lovell-Badge, 1997). The structure of this DNA binding 
domain has been solved, indicating that it consists of three a-helices that form an L-shape. 
Uncommon to transcription factors, DNA binding by Sox proteins is targeted to the minor 
groove (Wegner, 1999). Upon binding, the DNA molecule is bent (Kamachi et a l, 1999; 
van de Wetering and Clevers, 1992), a process proposed to remodel the chromatin 
surrounding the gene and to bring other DNA-bound transcription factors into close
proximity to the promoter. The conformational change in the DNA might also exclude the 
binding of other factors to the major groove of DNA (Pevny and Lovell-Badge, 1997).
Sox proteins thus bind to a small consensus DNA recognition sequence, through a 
highly conserved HMG domain. Several Sox factors are expressed in more than one cell 
type, and many Sox genes are co-expressed in the same cells. This has implications for 
redundancy of function between Sox protein family members and also implies that there 
must be some mechanism to generate specificity of Sox protein recognition for, and 
binding to, promoters. Firstly, a degree of specificity might be produced by slight DNA 
recognition sequence variation. For example, Mertin et al. (1999) showed specificity of 
SOX protein binding could be altered by dinucleotide sequences flanking this target 
sequence. However the current favoured model relies on formation of multi-protein 
complexes to provide the specificity of Sox protein action. It has been well established that 
Sox proteins partner with other transcription factors, and this provides, to a large extent, 
the specificity of binding. Such interactions for Sox proteins are summarised by Wilson 
and Koopman (2002), and are mediated through the HMG domain itself, or other protein- 
protein synergy domains. For example, the Sox2 protein has multiple roles during 
embryogenesis, including an early role in the induction of FGF4 in mouse blastocysts, 
which requires the binding of both Sox-2 and the POU transcription factor Oct-3/4 to 
adjacent sites in an enhancer on the FGF4 gene (Ambrosetti et al., 1997). Later in 
development, Sox2 (like Soxl and 3) has a role in the developing CNS and lens. In this 
latter site, any one of Soxl, 2 or 3 can activate the h-crystallin gene, but require protein- 
protein interaction with the partner transcription factor Pax6, which also binds to the 8- 
crystallin promoter (Kamachi et al., 1995; Kamachi et al., 1998). Further, domain swap 
experiments between SOX2 and SOX9 demonstrated that specificity of activation of the 8- 
crystallin promoter by SOX2 was mediated through a proximal portion of the C-terminal 
domain, a putative protein-protein binding domain (Kamachi et al., 1999). Other examples 
of protein-protein interactions important in Sox function include the cooperative activation 
by Sox5, Sox6 and Sox9 of the type II collagen gene during chondrogenesis (Lefebvre et 
al., 1998), and the synergistic transactivation by Soxl 1 and the POU protein Bml when 
adjacent binding sites were included on an artificial promoter linked to a reporter gene. 
Soxl 1 and Bml are co-expressed in the oligodendrocyte lineage, suggesting a real 
biological role in this cell type. The inability of Bml to act in synergy with Sox 10 on the 
other hand suggested the presence of a combinatorial code regulating specificity of Sox 
protein transcriptional activation (Kuhlbrodt et a l , 1998a). Additionally, transcription 
factor partners of Sox 10 have been recently identified (see below).
1.2.1.3. Sox genes are found throughout the animal kingdom
Sox genes can be found outside the vertebrates, and a number have been identified in 
C. elegans and in Drosophila, where thay also act as tissue specific transcription factors 
during development (reviewed in Bowles et al., 2000; Cremazy et al., 2001). These include 
the well-characterised Dichaete (=fishhook), which shows strongest sequence similarity to 
vertebrate Sox2 (Russell et al., 1996). Indeed the mouse Sox2 gene can rescue Dichaete 
mutant phenotypes indicating functional conservation (Sanchez-Soriano and Russell,
1998). Less well characterised is the Drosophila SoxlOOB gene. Based on sequence 
comparison, SoxlOOB has been described as an invertebrate homologue of the group-E 
genes Sox9 and SoxlO, and like its vertebrate counter parts it is expressed in the developing 
gut, gonads and kidney (Loh and Russell, 2000). However the function of SoxlOOB 
remains unclear, as no mutant has yet been identified.
Of the diverse roles that Sox proteins play in different aspects of development, some 
have been alluded to here, and include sex determination, endoderm formation, 
chondrogenesis, early neural development, lens development and haematopoiesis. Of most 
interest to the field of neural crest biology is the group E Sox genes, Sox8, 9 and 10. All are 
expressed in the neural crest and/or derivatives (Wegner, 1999).
1.2.1.4. Sox8 and Sox9
Along with SoxlO, Sox8 and 9 comprise the only members of Group E family of Sox 
proteins. All genes show a highly similar intron-exon structure and their encoded proteins 
have similar structure with a conserved HMG domain, and a C-terminal transactivation 
domain, which has been demonstrated to be functional in vitro (Schepers et al., 2000).
Sox8 is the least well characterised member, partly because it is not associated with a 
human disease, although it appears to map closely to the ATR-16 mental retardation 
syndrome locus. Consistent with this linkage, SOX8 is expressed in human brain (Pfeifer 
et al., 2000). In addition to the shared C-terminal domain, Sox8 has an additional potent 
transactivating domain immediately C-terminal to the HMG domain. In situ analysis in 
chick and mouse demonstrated Sox8 expression beginning at E9.5 in the nasal region, and 
later seen in the branchial arches, limbs, eye, testes, kidney, DRGs and glia of the CNS and 
PNS (Cheng et al., 2001; Montero et al., 2002; Schepers et al., 2000). A mouse lacZ 
knock-in reporter line confirmed much of this expression pattern and additionally 
described expression in the neural crest, muscle, ear, sympathetic and enteric ganglia. 
Although expected to generate a null allele, homozygous knock-in mice developed 
normally and were viable, but displayed a reduction in weight (Sock et al., 2001). Possible
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functional redundancy with other group E Sox proteins was proposed as a reason for the 
mild phenotype. Chick Sox8 is additionally seen in the forming neural crest (Bell et al., 
2000). No full-length zebrafish Sox8 has yet been cloned although a partial sequence was 
reported by Chiang et al. (2001). A putative rainbow trout Sox8 homologue, SoxPl, has 
also been identified (Ito et al., 1995).
The functions of Sox9 are better understood as it is implicated in the disease 
Campomelic Dysplasia (CD; reviewed in Marshall and Harley, 2000). This autosomal 
dominant disease displays skeletal defects, in particular bowing of the long bones, 
sometimes with craniofacial defects and often presenting with male to female sex reversal 
(Foster et a l , 1994). A number of translocations or rearrangements affecting chromosome 
17 have been identified in patients (e.g. Maraia et al., 1991) as have specific mutations 
affecting the SOX9 coding region (Foster et al., 1994). Consistent with the defects caused 
by SOX9 mutation, expression domains in human and mouse includes chondrogenic 
mesenchymal condensations, particularly in the chondrocyte preursor cells and 
chondrocytes of the bones and pharyngeal arches (Lefebvre et al., 1997; Wright et al., 
1995), and in the developing genital ridges where expression is rapidly downregulated in 
females, but later specifically expressed Sertoli cells in males (Wagner et al., 1994). A 
pivotal role for Sox9 in initiation of the chondrocyte differentiation program and 
maintenance of protein expression in differentiated chondocytes has been proposed (Bi et 
a l, 1999). This is consistent with the discovery that Sox9 is directly regulated by FGF and 
BMP-2 signalling, and also directly regulates collagen genes (reviewed in Marshall and 
Harley, 2000). Sox9 also plays a crucial role in the sex determination pathway, although 
the precise mechanism might vary between vertebrate species. SOX9 appears to be 
immediately downstream of SRY in mammals, and functions as a critical Sertoli cell 
differentiation factor, probably in all vertebrates (daSilva et al., 1996).
Regulation of SOX9 appears to occur over a long range, with some Campomelic 
Dysplasia patients having breakpoints mapping up to 950kb from the SOX9 gene (Wirth et 
al., 1996). Evidence supporting this long distance regulation was provided by the 
comparative analysis of different sized SOX9 YAC reporters in transgenic mice (Wunderle 
e ta l, 1998).
Animal models of CD exist, including a targeted Sox9 knock-out which reproduces 
many aspects of the skeletal defects in CD patients (Bi et al., 2001). In addition, two sox9 
genes exist in zebrafish, sox9a and sox9b. Both are expressed in chondrocytes of the head 
and fin skeleton, but whereas sox9a mimics mammalian Sox9 expression in testes, sox9b is 
expressed in the ovaries. sox9b is also expressed in the neural crest (Li et a l, 2002), and 
overlaps with soxlO (Pauliny, 2002). A sox9a mutant, jellyfish, has been isolated and
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shows craniofacial defects similar to CD. Cell analysis indicated that specification and 
migration of the neural crest contributing to the pharyngeal arches was normal, but 
subsequent differentiation and morphogenesis was impaired (Yan et al., 2002).
1.2.2. SoxlO has been cloned from a number of species
The final group E family member, SoxlO, is of interest due to its pivotal role in 
development of derivatives of the neural crest. Phenotypes due to soxlO mutations have 
been described in humans, mice and zebrafish, and allow mutational analysis of SoxlO 
function (Kelsh et al., 1996; Pingault et al., 1998; Southard-Smith et al., 1998). Studies in 
the zebrafish have suggested sox 10 may specify neural crest cell fate (Kelsh and Eisen, 
2000).
SoxlO was first identified by virtue of its conserved DNA-binding motif - the HMG 
domain, characteristic of all Sox genes (Wright et al., 1993). A full-length clone was 
isolated from rat primary Schwann cell cultures, and demonstrated a high degree of 
sequence similarity (>90%) in the HMG domain to both mouse Sox8 and 9. Regions of 
homology existed outside this domain, including a putative C-terminal transactivation 
domain. Although the HMG domain could bind DNA, no detectable autonomous 
activation or repression could be elicited from SoxlO protein in transcriptional assays using 
an artificial promoter with consensus Sox protein binding sites. Crucially, however, SoxlO 
could efficiently transactivate in a synergistic manner with the POU transciption factor 
Oct6. This synergy required both proteins to bind to adjacent sites in the promoter, with 
synergy mediated by the N-termini of both proteins. Similar synergy was demonstrated 
with the Pax3 transcription factor (Kuhlbrodt et a l, 1998b).
SoxlO cDNAs have been cloned from a number of other species, including mouse 
(Southard-Smith et al., 1998), human (Pingault et al., 1998), chick (Cheng et a l, 2000), 
xenopus (Aoki et al., 2003; Honore et a l, 2003) and zebrafish (Dutton et al., 2001), 
although zoo blot analysis has demonstrated that many other vertebrate species contain a 
SoxlO gene (Southard-Smith et a l, 1999a). All SoxlO proteins show a high degree of 
sequence conservation between species, mostly confined to the HMG, synergy and 
transactivation domains. Only the mouse and human SoxlO genes have been cloned to 
date, analysis of which has shown that gene structure (such as intron-exon boundaries) are 
also highly conserved (Southard-Smith et al., 1999a; Southard-Smith et al., 1999b). 
Futhermore, SoxlO in all species analysed to date have remarkably similar expression 
patterns. Detailed comparison of these patterns will be dealt with in a later chapter (see 
Section 4.1), but briefly, in situ analyses conducted in the species mentioned above have 
shown expression in the premigratory neural crest, and maintenance in a subset of neural
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crest derivatives, mostly PNS glia. Ear expression during development is common to all 
species as is CNS expression, both at embryonic and adult stages. A lacZ knock-in mouse 
line has been produced, and the analysis of SoxlOtacZ/+ embryos has largely confirmed the 
in situ results, albeit in a SoxlO heterozygous background (Britsch et al., 2001). Mutant 
lesions have been identified in three species, mouse, human and zebrafish, and have 
provided understanding of the role of SoxlO in the neural crest.
1.2.3. Mouse, human and zebrafish SoxlO mutations
1.2.3.1. Mouse SoxlO mutants
Using a forward genetic approach, both Southard-Smith et al. (1998) and Herbarth et 
al (1998) showed that a mutation in SoxlO was responsible for the Dominant megacolon 
(Dom) mouse mutant. This strain arose spontaneously and displays, in heterozygotes, a 
white belly spot with white feet and concomitant megacolon, presenting as a distended 
abdomen. Histological analysis has demonstrated that this colon distension is due to severe 
reduction in enteric ganglia cells in the distal gut (Lane and Liu, 1984), caused by 
defective colonization by neural crest-derived neuroblasts (Kapur et al., 1996). A circling 
behaviour, sometimes seen in Dom heterozygotes on certain backgrounds, suggests lack of 
functional SoxlO can additionally cause an inner ear defect (Pingault et a l, 1998). 
Heterozygotes do survive, with variability in survival time, depending on the background 
strain used. This, combined with the fact that Dom heterozygotes exhibit variable 
penetrance and expressivity of phenotypes has been attributed to modifier loci, some of 
which may encode co-factors that modulate SoxlO action (Southard-Smith et a l, 1999a). 
Further characterisation of these loci may afford insight into the molecular interactions and 
epistatic relationships of SoxlO.
Homozygous Dom/Dom embryos were far more severely affected, and die around 
birth. Unlike heterozygous embryos, almost all cranial ganglia were disrupted with fewer 
erbB3+ glia and NF+ neurons present and there was a total lack of D c t, K i t  melanoblasts. 
Using a combination of neuronal markers including peripherin, DpH+, NF and tyrosine 
hydroxylase to analyse Dom/Dom embryos, showed a rostro-caudal gradient of severity of 
DRG and sympathetic neurons (being completely absent caudally), and no enteric ganglia 
or their precursors were evident at any position along the gut at any stage (Herbarth et al, 
1998; Kapur, 1999). Apoptosis of Dom/Dom neural crest cells was evident, a proportion of 
which might be accounted by a lack of maintenance of erbB3 expression, a receptor 
required for neural crest survival/migration (Britsch et a l, 2001; Kapur, 1999; Paratore et 
al, 2001). There was no detectable defect in ectomesenchymal neural crest fates such as
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the facial anatomy and the cardiac outflow tract (Kapur, 1999). This suggests that only a 
subset of neural crest fates are affected in Dom.
Preliminary (Lane and Liu, 1984) and more detailed (Puliti et a l , 1995) mapping 
analysis placed Dom to within 0.8cM on Chromosome 15, from which chromosome 
walking strategies were commenced (Herbarth et al., 1998; Southard-Smith et a l , 1998). 
SoxlO was assessed as a candidate gene, and the lesion corresponding to Dom was 
identified as an extra guanine inserted after the HMG box, and predicted to insert 99 novel 
amino acids before terminating (Figure 1.2). Functional analysis indicated that although 
the frameshift mutation did not disrupt DNA binding, it did severely abolish the ability of 
the SoxlO protein to synergistically enhance transactivation through Pax3 and Oct6 
(Herbarth et al., 1998).
A targeted mutation of mouse SoxlO has been produced in which the SoxlO coding 
region has been replaced with the lacZ reporter gene (Britsch et a l , 2001). Embryos 
homozygous and heterozygous for the Soxl0facZ allele reproduce the respective phenotypes 
of Soxl(PomISoxl(Pom and Soxl(Pornl+ mice. As the SoxlOlacZ is a null, it argues that 
dominance of SoxlO mutant alleles is due to haploinsufficiency, as opposed to a dominant 
negative function previously proposed for Soxl(Pom due to its retained DNA binding 
ability (Britsch et a l , 2001; Pingault et al., 1998). As mentioned earlier, the lacZ reporter 
was expressed in appropriate sites, including premigratory neural crest, neural crest 
migrating into the gut, in PNS glia found associated with ganglia and axons in the head and 
trunk, and the otic vesicle. This line has been much used to analyse various aspects of 
SoxlO function in various cell types. For example, during melanocyte development, cells 
expressing melanoblast markers such as mitf, c-kit and dct, were decreased to 50% in 
heterozygous embryos, and almost totally absent in homozygous embryos, in accordance 
with the extent of pigmentation seen in the two genotypes and consistent with results from 
the Dom allele (Britsch et a l , 2001). Analysis of the glial differentiation marker B-FABP, 
in Soxl0lacZ embryos demonstrated that lacZ+ cells in the DRGs of heterozygous embryos 
were glial in nature (in particular PNS associated satellite glia and Schwann cells). These 
cells were diminished in the homozygotes, and did not appear to have differentiated into 
either neurons or glia (Britsch et a l , 2001). Decreased proliferation and increased 
apoptosis of undifferentiated progenitor neural crest cells in the DRG periphery is the 
likely cause (Sonnenberg-Riethmacher et a l , 2001). Similarity of mutant phenotypes 
between Soxl 0lacZ/Soxl 0lacZ and erbB3'f~ embryos, combined with loss of erbB3 expression 
in homozygous SoxlO mutants suggested that SoxlO is normally required for multipotent 
neural crest cell survival through maintaining erbB3 expression (Britsch et a l , 2001; 
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Figure 1.2: Distribution of SOX10 mutations in human and mouse
Schematic of the SoxlO protein with synergy, HMG and transactivation domains marked. Mutations in human SOXIO resulting in WS4 only are 
given above the protein schematic, whilst mutations that additionally produced dysmyelination of the PNS and/or the CNS are presented below. 
Numbers above or below each lesion refers to the reference listed below. Open arrow marks the lesion in the mouse SoxlO mutant, Dom. 
Black-filled arrowheads refer to patients displaying deafness, hypopigmentation and Hirschprung’s.
Open arrowheads indicate patients which display deafness and enteric abnormalities, but not hypopigmentation.
The filled arrow indicates a patient with hypopigmentation and deafness, but no enteric aganglionosis (Yesemite deaf-blind hypopigmentation 
syndrome).
References: 1: Pingault et a l , 1998, 2: Southard-Smith et al., 1999a, 3: Bondurand et al., 1999, 4: Touraine et al., 2000, 5: Pingault et al., 2001, 
6: Inoue et al., 1999, 7: Inoue et al., 2002.
Soxl (facZISoxl d acZ embryos was proposed to be the cause of the degeneration of DRG and 
motomeurons (Britsch et al., 2001). No overt DRG phenotype has been seen in either 
Soxl(facZ or SoxlODom heterozygotes.
Localisation and morphology of lacZ+ cells in the CNS of SoxlCfacZl+ embryos was 
consistent with expression in oligodendrocytes and oligodendrocyte precursors, confirmed 
by double labelling analysis with oligodendrocyte lineage markers such as myelin basic 
protein (MBP) and PDGF receptor a. SoxlO CNS expression was restricted to these cells, 
and no neuronal or astrocytic expression was noted. Whereas PNS glial progenitors appear 
diminished and disorganised, oligodendrocyte progenitors appear unaffected in 
Soxl OlacZ/Soxl d acZ embryos. However these mutant oligodendrocytes fail to ever express 
terminal differentiation products such as MBP when assessed in various in vivo contexts, 
indicating that SoxlO is required for terminal differentiation in the oligodendrocyte 
lineage, but not oligodendrocyte progenitor formation (Stolt et al., 2002).
Paratore et al. (2002) demonstrated aganglionosis of the distal, but not proximal, gut in 
Soxl(?acZ/+ embryos. This was accounted for by reduction in the multipotent enteric 
progenitor pool populating the gut. Unlike Soxl0facZ/Soxl(facZ embryos, this was not due to 
apoptosis of trunk neural crest cells. Instead, through use of progenitor and neuronal 
markers, combined with fate mapping of initially SoxlO+ neural crest cells using 
perdurance of p-gal activity, this defect in colonising the distal gut was shown to be due to 
precocious adoption of neuronal traits by previously Soxl0+ enteric progenitors. A model 
for the effect of SoxlO mutation on the enteric neurons was proposed. Neural crest cells 
require SoxlO for correct specification and migration to the gut; this very early step is 
defective in Soxl0facZISoxlCtacZ embryos. However in SoxltfacZ/+ embryos, neural crest 
cells survive and migrate to the gut to form the enteric progenitor pool. Due to altered 
SoxlO levels in heterozygotes, these cells are unable to properly interpret their 
environment, and thus fail to maintain their proliferative, progenitor status, and 
subsequently aberrantly adopt a neuronal fate. This dramatically reduces the migratory, 
progenitor pool, leading to insufficient numbers available to colonise the disal gut. This 
link between altered SoxlO levels, and responsiveness of the cell to external signals is a 
growing theme in describing the cellular role of SoxlO, as is the link between SoxlO and 
maintenance of multipotency (see below).
In vitro cultures of neural crest stem cells derived from both wild-type and SoxlO 
mutant mice have recently been employed to better understand the role of SoxlO in mouse 
neural crest ontogeny. These undifferentiated cells can be challenged with soluble growth 
factors to produce neurons, Schwann cells or smooth muscle (Anderson, 1997). Consistent 
with in vivo expression patterns, only the uncommitted stem cells, and cells of the glial
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lineage express SoxlO in this system (Paratore et al., 2001). Survival of these explanted 
cells, and subsequent direction to a glial fate depended on presence of NRG 1 (=Glial 
growth factor n, GGFII) in the medium, response to which requires cellular expression of 
wild-type SoxlO, presumably through SoxlO dependant expression of the NRG1 receptor 
ErbB3. Absence of SoxlO not only led to increased apoptosis of these stem cells, but the 
surviving clones were unable to adopt a glial fate. Wild-type clones however survived, 
proliferated and differentiated into arrays of glia. Paratore et al. (2001) then demonstrated 
that SoxlO haploinsufficiency does not affect this NRG1 mediated survival, but did disrupt 
the fate choice of the neural crest stem cells. Thus, although the majority of wild-type 
clones always differentiated as glial cells in response to NRG1, clones heterozygous for 
SoxlO did not, and instead produced non-neural/smooth muscle cells. At higher culture 
densities, which allowed cell-cell interactions, heterozygous clones become mostly 
neuronal in the absence of NRG1, but supplying NRG1 restores these clones ability to 
become glia. Thus not only does SoxlO promote neural crest stem cell survival and 
acquisition of a glial fate through the NRG1 signalling pathway, but its gene dose (and 
presumably level of functional protein) is critical in determining how a cell interprets a 
combination of signals, mirroring conclusions drawn from analysis of enteric progenitors 
in SoxlO heterozygous embryos (Paratore et al., 2001; Paratore et al., 2002). The authors 
predict that an increase in neurogenesis in DRGs might be expected in SoxlO 
heterozygotes. That this is not the case argues for some compensation or redundancy in the 
combinatorial signalling mechanism employed in forming correct cell numbers in DRGs. 
This area is revisited later in further detail (see Chapter 5). This model would be 
strengthened greatly by the identification of a SoxlO mutant showing enhanced 
neurogenesis in DRGs.
Kim et al. (2003) have extended this in vitro analysis of the cellular role SoxlO plays. 
Using a neural crest stem cell system, in which autonomic neurons, glia and smooth 
muscle can be produced, they showed that transient exposure of wild-type neural crest 
stem cells to factors promoting neuronal differentiation (such as BMP2), abolished the 
ability to subsequently direct these cells to glial fates using NRG1. Similar loss of 
neurogenic potential after exposing the neural crest stem cells to the smooth muscle 
promoting factor, TGFp, was noted. Forced expression of SOXIO in the stem cells, 
however, protected them from this loss of potential, through permitting subsequent 
induction of MASH 1 and PHOX2B by BMP2. However, although SOXIO maintained 
neurogenic potential, it inhibited neurogenic differentiation by repressing PHOX2A, thus 
keeping the cells in a multipotent, proliferative state. Thus, in Dom/Dom embryos, 
although the early differentiation transcription factor PHOX2A is derepressed in neural
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crest cells, early specification transcription factors (MASH1 and PHOX2B) are not, 
blocking neurogenesis. Curiously in the heterozygous state, derepression of PHOX2A still 
occurs, but unlike in the homozygotes, the early transcription factors are expressed 
normally. This caused inappropriate and precocious neuronal marker expression 
exclusively in Dom/+ embryos. The authors conclude that, consistent with other studies 
(Paratore et al., 2001; Paratore et a l , 2002), a higher level of SOXIO is required for 
delaying neuronal differentiation than to maintain neurogenic potential, and thus 
haploinsufficiency alters a cells response to combinatorial signalling (Kim et al., 2003). It 
is dangerous to extrapolate the results from this study using these limited NCSCs to other 
neuronal cell types affected in SoxlO mutants, however it might indicate a theme 
underlying the role of SoxlO in PNS development.
I.2.3.2. Human SOXIO syndromes
Due to striking phenotypic similarities, the Dom mouse mutant has been proposed as a 
model for the human syndromes, Waardenburg-Shah syndrome (WS4) and Hirschsprung’s 
disease (Herbarth et al., 1998; Southard-Smith et al., 1999a). Both diseases display 
aganglionosis of the distal colon, with Waardenburg-Shah syndrome additionally 
presenting hypopigmentation, and in some cases deafness (Pingault et al., 1998). 
Deficiency in glial cell mediated myelination, leading to severe neuropathy of the PNS 
(Charot-Marie-Tooth disease) in a Waardenburg-Shah case has also been reported (Inoue 
et a l , 1999), as has CNS dysmyelination which may account for the added mental 
retardation and neurological phenotypes seen in some patients (Inoue et a l , 2002; Pingault 
et a l, 2001a; Touraine et a l, 2000). SOXIO mutations have been associated with these 
syndromes (Pingault et a l, 1998). Additionally, Yemenite deaf-blind hypopigmentation 
syndrome, which combines pigment, inner ear and cornea anomalies, has been attributed to 
SoxlO dysfunction (Bondurand et a l, 1999a). Lesions in other genes have also been 
described for WS4 and Hirchprung’s disease, including RET, EDNRB and ET-3 
(Auricchio et a l, 1999; Bidaud et a l, 1997; Edery et a l, 1996; Kapur et a l, 1995; Syrris et 
a l, 1999). The multigenic nature of Waardenburg-Shah syndrome and Hirschsprung’s 
disease supports the hypothesis that SoxlO acts in concert with other factors to correctly 
form each non-ectomesenchymal derivative. Mice homozygous for mutations in either Et-3 
or EdnrB are phenotypically similar to Dom heterozygotes (Kapur et a l, 1995; Zhan et a l,
1999).
All human SOXIO mutations have so far appeared in the heterozygous state, and a 
patient homozygous for a SOXIO mutation has never been reported. As described above, 
the associated phenotypes present in SOXIO mutations include deafness, pigmentary
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abnormalities, aganglionosis leading to bowel dysfunction, and dysmyelination of the PNS 
and/or CNS. So far, 13 SOXIO lesions in WS4 cases have been identified. The penetrance 
of each phenotype varies such that some patients only displayed a subset of defects. As in 
the Dom model, this suggests the involvement of modifying loci. However each described 
lesion probably disrupt SOXIO function to differing extents, so an alternative model might 
invoke altered transactivation of downstream targets by SOXIO. In support of the former 
proposal, the same mutation (Q377X) occurs in siblings displaying vastly different 
aganglionosis severity (Southard-Smith et al., 1999a). All described lesions discovered to 
date are presented in Figure 1.2, with presence or absence of associated myelin deficiency 
noted. Lesions include 7 nonsense mutations (at amino acids 83, 189, 207, 250, 251, 313 
and 377), three frameshifts leading to addition of novel amino acids and premature 
termination, one substitution (S135T), a duplication of two amino acids within the HMG 
domain, and a deletion of the last 12 nucleotides of the coding region, which caused the 
normal stop codon to be skipped, and extended the protein by 82 novel amino acids. This 
last mutation does not affect the coding region, so loss of function might be due to 
abnormal folding of the protein or steric hindrance caused by the extra amino acids 
(Bondurand et al., 1999b; Inoue et a l , 2002; Inoue et al., 1999; Pingault et al., 1998; 
Pingault et al., 2001a; Southard-Smith et al., 1999a; Touraine et al., 2000). The variable 
expressivity of the same mutation within a family, argues that it is difficult to correlate 
position and nature of a lesion within the protein with the severity of phenotypes presented.
The transactivational potency of human wild-type SOXIO was tested using an artificial 
SOX-responsive reporter. The wild-type protein displayed weak transcriptional activity, in 
contrast to the rat SoxlO, which showed none. Analysis of the human Y83X, 482ins6, 
E189X and 1076delGA mutant SOXIO proteins, and domain swap experiments localised 
this activity to the very C-terminus of the protein (Kuhlbrodt et al., 1998c; see also Pusch 
et al., 1998). Similar analyses with the SOXIO substitution mutation S135T, indicated that 
the substitution disrupted DNA binding due to steric hindrance, and that transcriptional 
potency of the protein was decreased (Bondurand et al., 1999b). In addition, similar 
approaches clearly demonstrated that SoxlO can function synergistically with other 
transcription factors such as Oct6 and Pax3 to transactivate the reporter. This synergy 
however required adjacent sites on the promoter, and a synergy/dimerisation domain 
located in the N-terminal region of SoxlO (Kuhlbrodt et a l , 1998b; Kuhlbrodt et a l , 
1998c).
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1.2.3.3. The zebrafish SoxlO locus, colourless
The first zebrafish colourless (els) mutant allele first arose as a spontaneous mutation 
in a stock background. In addition to this first allele, clstS, subsequent mutagenesis 
screening has yielded 4 other alleles, namely els*™2, clsty22f, clste275 and clsm618. Embryos 
displayed a lack of all three types of neural crest derived pigment cells (melanophores, 
xanthophores and iridophores), due to an early reduction of pigment cell precursors (Figure 
1.1). An early effect on ear development was also evident as a very reduced ear size (Kelsh 
et a l, 1996; Malicki et a l, 1996; Whitfield et al., 1996). The non-neural crest derived 
pigmentation in the retinal epithelium was, however, not affected suggesting the pigment 
phenotype was due to some neural crest defect.
More detailed analysis of the els phenotype revealed a stark reduction in the number of 
other cell types, including loss of Hu+ neurons of the enteric, dorsal root and sympathetic, 
but not cranial, ganglia and a severe loss offoxD3+ Schwann cells, cranial ganglion 
associated glia and GFAP+ enteric glia (Kelsh et al., 2000a; Kelsh and Eisen, 2000). 
Although the loss of neurons of the enteric and sympathetic chain is strong, loss of DRG 
neurons displays a rostro-caudal gradient of severity, as described ior Dom (Kapur, 1999), 
with posterior neurons almost absent, whilst anterior DRG neurons were reduced and 
misplaced. The cause of these ‘escaper neurons’ is currently under investigation, but might 
be attributable to incomplete loss of support glia (Britsch et a l, 2001), or possibly due to 
partial functional redundancy with other zebrafish group E Sox genes, such as sox9b or 
sox8. Importantly the ectomesenchymal neural crest derivatives such as craniofacial 
cartilage and fin mesenchyme are mostly unaffected, except that older els embryos showed 
slight retardation in branchial arch development (Kelsh and Eisen, 2000). That only non- 
ectomesenchymal crest derivatives are affected in soxlO mutants suggested the hypothesis 
that neural crest cells are fate restricted early to either ectomesenchyme or non- 
ectomesenchyme, and implied a role for sox 10 in the generation, survival and/or 
subsequent differentiation of a population of progenitors restricted to non- 
ectomesenchymal fates.
Furthermore, detection of premigratory neural crest with the foxD3 and snail-2 
markers indicated that els does not affect formation of nascent neural crest (Kelsh and 
Eisen, 2000). There was, however, an absence of melanoblast markers such as dct, 
nac/mitfa and spa/kit (Dutton et al, 2001; Kelsh et al., 2000b). Neural crest cell lineage 
analysis indicated that generally, non-ectomesenchymal crest fates do not form in els, and 
the neural crest cells instead fail to migrate and differentiate and subsequently die by an 
apoptotic mechanism. Thus in els, multipotent neural crest cells initially appear normally 
but the non-ectomesenchymal subset of derivatives fail to be specified correctly.
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Based on phenotypic similarities, els has been proposed to model Waardenburg-Shah 
syndrome (Kelsh and Eisen, 2000). A candidate gene approach identified els as encoding a 
zebrafish soxlO orthologue (Dutton et a l , 2001). This has been corroborated with evidence 
from rescue experiments with an inducible soxl 0-cUNA construct, identification of mutant 
lesions and physical mapping data (Dutton et al., 2001). The expression pattern of sox 10 in 
zebrafish is consistent with the els phenotype and is similar to that described for SoxlO in 
other species, namely in premigratory neural crest, migrating neural crest, glial derivatives, 
the ear and oligodendrocytes. The zebrafish soxlO expression pattern is described in more 
detail in Chapter 4. That els corresponds to mutations in a transcription factor is also 
consistent with previous demonstration of the cell-autonomous nature of the mutation 
(Kelsh and Eisen, 2000).
All of the five els alleles listed above are recessive and with seemingly identical 
phenotypic severity. In contrast to mammalian SoxlO mutants, there is no reported 
heterozygous phenotype, els embryos fail to inflate a swim bladder and die at 
approximately 1 ldpf. A weaker allele, clsm24] was discovered, and showed some surviving 
melanophores (Malicki et al., 1996). Unfortunately, this allele is no longer extant. 
Sequencing of soxlO cDNA prepared from two of these alleles has identified a nonsense 
mutation leading to truncation of the protein directly before the putative transactivation 
domain (K376X -  els*™2) and a missense mutation within the HMG-box leading to 
substitution of a highly conserved residue essential for DNA binding (L142Q - clsm618\ see 
also Section 5.1). Analysis of the other alleles, and generation of new, possibly weaker, 
alleles would allow a protein domain map to be developed, and may give further 
understanding of sox 10 biology. The relative ease with which mutagenesis screens can be 
carried out in the zebrafish, facilitates this end.
Analysis of els (soxlO) mutant neural crest cells show that they undergo apoptosis 
before migration or differentiation. The loss of expression of factors required for 
melanophore specification and survival such as mitfa and c-kit prior to this in els mutants 
suggests that apoptosis might be due to failure to activate genes required (directly or 
indirectly) for cell specification and survival. Perhaps soxlO has a general role in 
specifying non-ectomesenchymal lineages, and does so by activation of master genes 
controlling cell fate and differentiation through downstream targets (Dutton et a l , 2001). 
The bHLH transcription factor mitfa plays such a role in the melanophore lineage, and has 
been shown to be directly activated by soxlO in zebrafish (Elworthy et a l , 2003). In fact, 
comparative rescue analysis has demonstrated that the only essential role of SoxlO in the 
melanophore lineage is simply to activate the melanophore master switch gene mifta 
(Elworthy et a l , 2003). mitfa is thus regulated directly by at least two different
mechanisms acting in conceit, namely soxlO (Elworthy et a l, 2003) and Wnt signalling 
(Dorsky et al, 2000). This combination may confine specific expression of mitfa to only a 
subset of neural crest cells in a particular location at a particular time.
It would be interesting to know if similar master switch genes, regulated by soxlO, 
exist in the other non-ectomesenchymal cell fates, such as glia, enteric neurons, DRG 
neurons, xanthophores and iridophores. There is evidence that phox2b is lost in els 
embryos (Elworthy et a l, in prep.) It is also likely that in some lineages, SoxlO promotes 
expression of growth factor receptors or receptors necessary for survival, such as c-Ret 
(see below). The function of SoxlO in the ear is unknown, but is a field of current study in 
the laboratory.
1.2.4. Target genes and mechanism of SoxlO function
The roles of SoxlO in various cell lineages are only beginning to be understood. As a 
transcription factor, SoxlO is likely to perform these roles through its ability to directly 
regulate downstream targets. To date, few target genes of SoxlO have been identified. 
Those described so far are the a3 and p4 subunits of the neuronal nicotinic acetylcholine 
receptor (nACh) of the PNS (Liu et a l, 1999), MITF (Bondurand et a l, 2000; Elworthy et 
al, 2003; Potterf et a l, 2000), c-Ret (Lang et a l, 2000; Lang and Epstein, 2003), the 
Connexin 32 junction protein (Cx32) of Schwann cells (Bondurand et a l, 2001) and the Po 
protein found in the myelin sheath of Schwann cells (Peirano et a l, 2000). In all cases, the 
promoters have been analysed and show critical SoxlO response elements, necessary for 
SoxlO binding. As mentioned previously, specificity of Sox protein activity on promoters 
is conferred by synergistic activation through a combinatorial code, and SoxlO requires 
synergy with other factors for enhanced transactivation potency. This has been 
demonstrated in all cases above (except for the Po promoter -  see below), with the 
promoters always containing at least one Sox element adjacent to the recognition site for 
the second transcription factor in question. Thus Pax3 has been shown to act in synergy 
with SoxlO on the c-Ret and M itf promoters, both of which contain SoxlO and Pax3 
binding sites in close proximity (Bondurand et a l, 2000; Lang and Epstein, 2003). Other 
transcription factors have been implicated in interactions with SoxlO, including EGR2, 
shown to enhance activation of Connexin 32 by SoxlO, and the Spl transcription factor 
acts synergistically with SoxlO to activate nACh subunit genes (Bondurand et a l, 2001; 
Melnikova et a l, 2000). The Po promoter is activated by SoxlO directly. However attempts 
to uncover a second transcription factor acting with SoxlO in this process have so far been 
fruitless (Peirano et a l, 2000). Instead, SoxlO acts on this promoter as both a homodimer 
and a monomer. Dimerisation has two effects, namely decreasing the off-rate of the
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protein, and increased the angle of DNA bending induced by SoxlO binding (Peirano and 
Wegner, 2000). As to why the Po promoter is only active in a subset of SoxlO expressing 
cells, cannot be explained by this, but might involve as yet undiscovered cell type-specific 
activating or repressing co-factors acting with SoxlO.
Specific mutants of the SoxlO domains abort transactivation of the promoters listed 
above by disruption to DNA binding (the HMG domain), transactivation (the C-terminus) 
and/or synergistic protein-protein interaction (N-terminus and the HMG domain). In 
addition, a mutation in the Sox-binding element of the Cx32 promoter has been described 
in a patient with peripheral myelin defects (Bondurand et a l , 2001). One human SOXIO 
lesion, S135T, shows disparate effects on the synergistic activation of the c-Ret and Mitf 
promoters with PAX3. This mutation affects DNA binding by the HMG domain, such that 
the Mitf promoter fails to be activated; in contrast activation of the c-Ret promoter is 
indistinguishable from wild-type. This is probably due to the mechanism of assembly of 
the SOX10-PAX3 heterodimer and DNA complex. Medically, this is relevant as this is the 
only known human SOXIO lesion which does not show enteric aganglionosis, (this patient 
did however show hypopigmentation), and thus suggests that different SoxlO lesions can 
produce a different range of phenotypes depending on the particular domain affected by 
the lesion (Lang and Epstein, 2003). SOXIO mutations clearly produce heterogeneous 
phenotypes in different individuals. There is evidence in both human and mouse that this is 
caused by modifier loci (e.g. Southard-Smith et a l , 1999a). The above observation also 
demonstrates that the different lesions in SOXIO can produce different phenotypes due to 
divergent effects on downstream targets.
As the Soxl(facZ homozygous mice display a severe reduction in the expression of 
erbB3, it has been proposed that SoxlO might regulate erbB3. Although induction of 
SoxlO in an in vitro system can also induce erbB3, this has not yet been shown to be direct 
(Britsch et al., 2001). Similarly, activation of the DCT promoter by SoxlO protein in cell 
culture assays, combined with loss of DCT expression in mouse SoxlO mutants, have been 
interpreted as evidence of direct transactivation of DCT by SoxlO (Britsch et al., 2001; 
Potterf et al., 2001). However direct binding of the promoter by SOXIO has not been 
demonstrated, and this proposal remains questionable (Elworthy et al., 2003).
Soxl O’s pivotal role in multiple neural crest lineages makes it likely that there are 
many other target genes. Its ability to activate both transcription factors, tyrosine kinase 
receptors and cell surface differentiation markers may indicate that sox 10 functions in a 
variety of contexts to direct cell specification through activation of master switch 
transcription factors, to promote migration and survival as well as to maintain levels of 
certain proteins in terminally differentiated derivatives, such as glia. Furthermore,
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identification of interacting transcription factors is clearly important for identifying 
potential target genes and understanding SoxlO function. Perhaps a screen such as a yeast 
2-hybrid experiment could be used to isolate other transcription factors important for 
SoxlO function. This has been successfully implemented to isolate modulators of sox23 
activity in the rainbow trout (Yamashita et al., 1998).
It is worthwhile mentioning that the target genes of SoxlO described previously were 
all identified through a candidate approach. Candidate target genes were selected based on 
overlapping expression of SoxlO and either Pax3 or Tst-l/Oct6/SCIP with the putative 
target. This approach is severely limited, as it requires some prior characterisation of the 
target gene. Clearly some form of screening method to isolate downstream targets would 
be a far more attractive approach, and will allow identification of novel factors.
As to the question of factors upstream of SoxlO, little is known. Recently however, 
work on Xenopus SoxlO has revealed that SoxlO is expressed very early in the neural crest 
lineage, and is activated by factors involved in neural crest induction and the early neural 
crest transcription factor, Snail. Thus addition of beads soaked with inhibitors of the 
canonical Wnt pathway or FGF signalling both inhibited SoxlO expression in the neural 
plate. Additionally, loss of the Slug and Snail transcription factors found in the early neural 
crest also diminishes SoxlO expression (Aoki et al., 2003; Honore et al., 2003). In the 
developing chick limb digits, SoxlO expression can be enhanced by addition of BMP-7 
(Chimal-Monroy et al., 2003). Thus a number of different signalling pathways are 
probably involved at different stages in the regulation of SoxlO, however there is, as yet, 
no evidence for a direct effect of specific factors.
1 .3 . A i m s  o f  t h e  p r o j e c t
Many aspects of SoxlO biology remain unresolved, including its precise role in the 
non-ectomesenchymal lineage, the mechanisms it uses to achieve specification and the full 
array of genes it regulates. Clearly, SoxlO functions through activation of downstream 
effectors, of which very few have been described. Other candidates can be proposed based 
on known functions in certain crest sub-lineages. Identification of these and other novel 
factors is an important step in defining the precise role of sox 10 as well as understanding 
mechanisms of neural crest fate restriction. Characterising the molecular 
pathways/interactions associated with SoxlO will elucidate many aspects of neural crest 
cell development.
Generation of a variety of particular tools is critical in the approaching these problems.
The main aim of this work involves the generation of a soxlO-gfp reporter transgenic line.
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This will prove useful for understanding the sites and times of SoxlO expression, and allow 
manipulation to determine the key regulators of soxl 0. Further, this transgenic line will 
label live neural crest cells in vivo, allowing visualisation of cells’ behaviour in time, and a 
better understanding of neural crest migration. Additionally, it offers the ability to isolate 
pure neural crest cells at various stages. Cloning of the sox 10 promoter will also allow 
examination of the regulation of soxlO and factors involved.
Towards this, the initial aims were:
1. Isolation of genomic clones containing the zebrafish sox 10 gene and 
characterisation of structure, such as intron-exon boundaries and transcription start 
site.
2. Demonstration that the genomic clones isolated contain a functional soxlO gene
by attempting to rescue aspects of the els phenotype with genomic clone injection
3. Sub-cloning the promoter region of sox 10 and generation of GFP reporter 
constructs
4. Assaying the reporter constructs in vivo for ability to drive GFP expression in
the neural crest and other appropriate sites.
The ultimate aim was the generation of stable transgenic lines carrying these reporter 
constructs, and preliminary characterisation of the GFP expression pattern. Thus a major 
aim was to then compare the GFP expression sites with those previously described through 
soxlO in situ analysis. This might extend the pattern of expression described by in situ. 
Additionally it was hoped to isolate neural crest cells by FACS analysis, but this aim was 
not met due to lack of time.
In addition, identification of new els alleles promises to afford a better understanding 
of the functional domains of the SoxlO protein, as well as to establish the roles and 
mechanisms of SoxlO activity. Thus one final aim was to help perform an allele screen to 
identify new els alleles. Subsequent characterisation of any alleles found was hoped to 
reveal new information as to the mechanism of SoxlO action.
C h a p t e r  2 
M a t e r ia l s  a n d  M e t h o d s
2.1. M a t e r ia l s
Materials used and sources are listed below in the following categories.
2.1.1. Chemical Reagents
General laboratory chemicals were of analytical research grade and were purchased 
from a range of manufacturers, mostly Sigma Chemical Co., St Louis, MO, USA or Acros 
Organics, Geel, Belgium. Specialist reagents and their sources are listed below:
Agarose USB Co., Cleveland, OH, USA
Bacto Tryptone Oxoid, Basingstoke, Hampshire, UK
Bacto Agar Difco Laboratories, Detroit, MI, USA
Chlorotetracycline Acros Organics, Geel, Belgium
Fusaric acid Acros Organics, Geel, Belgium
EPTG Melford Labs Ltd., Suffolk, UK
Luria Agar/Broth Base Invitrogen, Groningen, The Netherlands
Methylcelluose Sigma Chemical Co, St Louis, MO, USA
Phenol/chloroform/isoamyl alcohol Sigma Chemical Co, St Louis, MO, USA
l-phenyl-2-thiourea (PTU) Sigma Chemical Co, St Louis, MO, USA
Tricaine (methylsulfonate) Sigma Chemical Co, St Louis, MO, USA
TriReagent™ Sigma Chemical Co, St Louis, MO, USA
Yeast Extract Difco Laboratories, Detroit, MI, USA
Antibiotics. Indicators and Dyes
Ampicillin Sigma Chemical Co, St Louis, MO, USA
Bromophenol Blue BDH Laboratory Supplies, Poole, UK
Chloramphenicol Sigma Chemical Co, St Louis, MO, USA
Ethidium bromide Sigma Chemical Co, St Louis, MO, USA
Kanamycin Sigma Chemical Co, St Louis, MO, USA
Methylene Blue Acros Organics, Geel, Belgium
Phenol Red Sigma Chemical Co, St Louis, MO, USA
seeDNA™ Amersham Pharmacia Biotech, NJ , USA
Tetracycline Sigma Chemical Co, St Louis, MO, USA
X-gal Sigma Chemical Co, St Louis, MO, USA
Xylene Cyanol BDH Laboratory Supplies, Poole, UK
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2.1.3. Enzymes
Most restriction endonucleases (and 10 x restriction buffers) were purchased from 








Shrimp Alkaline Phosphatase 
T4 DNA ligase 
Taq DNA polymerase
Sigma Chemical Co, St Louis, MO, USA 
Sigma Chemical Co, St Louis, MO, USA 
Sigma Chemical Co, St Louis, MO, USA 
Roche GmbH, Mannheim, Germany 
Invitrogen, Groningen, The Netherlands 
New England Biolabs, Beverly MA, USA 
Epicentre Technologies, Madison WI, USA 
USB Co., Cleveland, OH, USA 
Promega, Madison, WI, USA 
Gibco Life Technologies, Paisley, UK
Reaction buffers (10 x) were supplied with the latter four enzymes and 50 mM MgCL 
was supplied with Taq DNA polymerase. The Reverse Transcriptase was supplied with a 
5x Reaction Buffer and DTT.
2.1.4. Nucleic Acids and Radioactive Isotopes
[a -32P] dCTP (3000 Ci/mmole) 
ATP
Salmon sperm DNA 
Unlabelled deoxyribonucleotides 
DNA ladder, 100 bp 
DNA ladder, lkb 
lkb DNA ladder 
lOObp DNA ladder 
High Molecular Weight ladder 
Primers (listed in Table 2.4) 
Random Hexamers
Amersham Pharmacia Biotech, UK 
Sigma Chemical Co, St Louis, MO, USA 
Sigma Chemical Co, St Louis, MO, USA 
Gibco Life Technologies, Paisley, UK 
New England Biolabs, Beverly MA, USA 
New England Biolabs, Beverly MA, USA 
Promega, Madison, WI, USA 
Promega, Madison, WI, USA 
Gibco Life Technologies, Paisley, UK 
Invitrogen, Groningen, The Netherlands 
Promega, Madison, WI, USA
2.1.5. Bacterial Strains And Cloning Vectors
The plasmid vectors and bacterial strains used in this project are summarised in Tables 
2.1 and 2.2 respectively. Figures 2.1 and Figure 2.2 show vector maps for pSV.RecA and 
XLT.GFPlt.CS2+.
T able 2.1: P lasm id  vectors
Vector Source Use Reference
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Figure 2.1: Map of pSVI.RecA
A Plasmid map showing features of the vector including the RecA gene, temperature 
sensitive origin of replication, Tetracycline resistance gene and important restriction sites. 
Taken from “Protocol for Targeted Modification of Bacterial artificial Chromosomes 
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Figure 2.2: Maps of XLT.GFPlt CS2+
Upper part shows a plasmid map with features of the vector including CMV promoter, 
gfp gene, Ampicillin resistance gene and restriction sites. The sequence directly 5’ to the 
gfp gene is given below. Adapted from http://faculty.washington.edu/rtmoon/vectors.html
Table 2.2: Bacterial strains (Escherichia coli)
E. coli Strain Source Use Genotype and Reference
DH-5aF' CLONTECH Host for cloning recAl, endAl,gyrA96, thi-1, h sd R ll (rK\  mK+),
Labs, CA into pGEM®-T 
and general 
cloning




PAC clone host F- mcr A A(mrr-hsdRMS-mcrBC) deoR recAl 
endAl araD139 (ara,leu)1691 galU galK  1- rpsL 
nupG [F’80dlacZ AM15 AlacX74]
2.1.6. Kits and Miscellaneous Materials
Kits and other materials used in this project were obtained from the following
manufacturers:
Bio-Gel P60 resin (G50 mesh) 
GPS™ -1 Genome Priming System 
HighPrime™ DNA labelling kit 
Microcon™ filter units 
MSI nylon membrane 
QIAGEN Large Construct kit 
QIAquick™ purification kit 
X-ray film
Wizard™ plasmid mini/midi kits
Bio-Rad Laboratories, Richmond CA, USA 
New England Biolabs, Beverly MA, USA 
Roche GmbH, Mannheim, Germany 
Millipore, Billerica, MA, USA 
Osmonics, Minnetonka, MN, USA 
QIAGEN, Valencia, CA, USA 
QIAGEN, Valencia, CA, USA 
Fuji X-ray Film, Fuji Co, Ltd, Japan 
Promega, Madison, WI, USA
2.1.7. Antibodies
All antibodies used were purchased from Molecular Probes, Eugene, OR, USA, and are 
listed in Table 2.3.
Table 2.3: Antibodies
Antibody Type Use Reference
Anti-Hu mAb 16A ll Monoclonal Pan-neuronal antibody (Marusich et aL, 1994)
Primary Antibody Mouse IgG
Alexa Fluor 546 goat anti­ Polyclonal Secondary antibody for Hu http://www.probes.com/
mouse Goat IgG primary products/
Rabbit Anti-GFP Polyclonal Detection of GFP in fixed http://www.probes.com/
Primary Antibody Rabbit IgG embryos products/
Alexa Fluor 488 goat anti­ Polyclonal Secondary antibody for http://www.probes.com/
rabbit Goat IgG GFP primary products/
2.2. So lutions . Buffers a nd  M edia
Solutions, buffers and media were sterilised by autoclaving or filtration through a 
0.22fim filter where appropriate.
2.2.1. Solutions and Buffers
1 x Denhardt’s
0.02% (w/v) Ficoll 
0.02% (w/v) PVP 
0.02% (w/v) gelatin
1 xSSC
0.15 M sodium chloride
0.015 M sodium citrate
Adjusted to pH 7.2 with sodium hydroxide
1 x SSPE
0.18 M sodium chloride
10 mM sodium dihydrogen orthophosphate
1 mM EDTA (pH 7.2)
1 xTAE
40 mM Tris HC1 
20 mM sodium actetate
2 mM EDTA
Adjusted to pH 7.8 with glacial acetic acid
1 xTE
10 mM Tris-HCl (pH 8.0)
1 mM EDTA (pH 8.0)
1 x TNE
10 mM Tris-HCl (pH 8.0)
1 mM EDTA (pH 8.0) 
lOmMNaCl
6 x Loading Buffer
0.25% (w/v) Bromophenol Blue 
0.25% (w/v) Xylene Cyanol 
40% (w/v) Ficoll
Antibody Blocking Solution (Block)
0.5% TritonX-100 
1% DMSO 
5% Horse serum 
in PBS
Fix
PBS with 4% Paraformaldehyde
Genomic DNA extraction buffer
1 x TE with 1.7mg/ml Proteinase K
Lvsing Solution
10 mM glucose




1.5 M sodium chloride 
0.5 M sodium hydroxide
Southern Neutralising Solution
1.5 M sodium chloride 




5 x Denhardt’s 
0.5% (w/v) SDS
100 mg/ml denatured sonicated salmon sperm DNA
STET Buffer
O.lMNaCl
10 mM Tris-HCl (pH 8.0)
1 mM EDTA 
5% Triton X-100
Stop Buffer
0.25%(w/v) Bromophenol Blue 
10 mM Tris-HCl (pH 8.0)
1 mM EDTA (pH 8.0)
0.2% (w/v) SDS
PBS
2.7 mM KC1 
137 mM NaCl
0.01 M Phosphate Buffer (Na2HP0 4  + KH2PO4 ) (pH 7.4)
PBTX
PBS with 0.5% Triton X-100
2.2.2. Media
Fusaric Acid and Kanamvcin TB Agar
1% (w/v) Bacto tryptone 
0.1% (w/v) Yeast Extract 
0.1% (w/v) Glucose 
0.8% (w/v) NaCl 
1.5% (w/v) Bacto Agar 
50pM ZnCl2
50mg/L Chlorotetracycline
Autoclaved then supplemented with sterile: 
72mMNaH2P04*H20  
12mg/L Fusaric Acid 
20mg/L Kanamycin
Luria Agar (L-agar)
3.7% (w/v) Luria agar base
Luria broth CL-brothl
2.5% (w/v) Luria broth base
Zebrafish Embryo medium
0.50 pM sodium chloride 
0.17 pM potassium chloride 
0.33 pM calcium chloride 
0.33 pM magnesium sulphate 
0.1% methylene blue
2.3. General  M ethods
2.3.1. Preparation of DNA samples
2.3.1.1. Bacterial Growth
Glycerol stocks or agar stabs of bacterial cell stocks were propagated by streaking on 
LB-agar plates containing appropriate selective antibiotics and incubated overnight at 37°C 
or appropriate temperature.
Bacterial cultures were grown in LB-medium supplemented with required antibiotics. 
Antibiotic concentrations used were as follows: Ampicillin: 50pg/ml; Chloramphenicol: 
20pg/ml; Kanamycin: 25pg/ml; Tetracycline: lOpg/ml. After inoculation with a single 
colony, the culture was incubated overnight at appropriate temperature in a shaking 
incubator.
2.3.1.2. Plasmid Preparation 
Rapid Boiling Lysis
Plasmid DNA for screening of putative clones was prepared using the boiling lysis 
method described by Holmes and Quigley (1981). Briefly, 2ml bacterial cultures were 
pelleted by centrifugation, resuspended in 200pl of STET buffer supplemented with 
1 jig/ml lysozyme and then lysed by heating at 100°C for 45 seconds. Cell debris was then 
pelleted by centrifugation and removed with a toothpick. The plasmid was purified from 
the supernatant by ethanol precipitation.
Plasmid preparation kits
High quality DNA for cloning, sequencing, embryo injection or large-scale 
applications was prepared using Promega mini or midi Wizard™ kits, as per manufacturer 
instructions. Briefly, bacterial suspensions were lysed by alkali and loaded onto the 
provided column. Following extensive washing of the column, the plasmid DNA was 
eluted with water.
2.3.1.3. Preparation of DNA from PACs
PAC DNA for embryo injection or PFGE was prepared with a QIAGEN Large 
Construct Kit as per manufacturer’s directions.
PAC DNA for all other applications was prepared by a modified alkaline lysis method. 
After lysis, neutralisation and ethanol precipitation, the PAC DNA was incubated with
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Plasmid-Safe™ DNAse in the supplied buffer with ImM ATP for 3 hours. This was 
followed by a phenol/chloroform extraction and a final ethanol precipitation.
2.3.2. Isolation of DNA/RNA from zebrafish embryos
2.3.2.1. Isolation of genomic DNA
Genomic DNA was isolated from single zebrafish embryos by first euthanasing in 
Tricaine and dehydration in methanol. Embryos were desiccated by heating at 70°C for 10 
minutes, and genomic DNA extracted by addition of 25pi genomic DNA extraction buffer 
with incubation at 55°C for 4 hours then 75°C for 10 minutes. Samples were then made up 
to lOOpl with MilliQ water before analysis of a 5pi sample by PCR.
2.3.2.2. Isolation of total RNA
Total RNA from pooled zebrafish embryos was isolated by homogenisation in 
TriReagent™ following Sigma instructions and using 2ml per 60 embryos. Following 
phase separation by centrifugation, RNA was precipitated from the aqueous phase using 
isopropanol, and resuspended in water.
2.3.3. Molecular Techniques
2.3.3.1. Restriction Digests
Digestion of DNA by restriction enzymes was performed in a minimal volume, using 
conditions recommended by the enzyme manufacturer, for a minimum of one hour. Five 
units of restriction enzyme were added per pg of DNA, ensuring that the volume of 
enzyme never exceeded 10% of the total reaction volume. When required, RNase A and/or 
BSA were added to final concentrations of 20 pg/ml and 100 pg /ml respectively.
Heat inactivation of restriction enzymes was carried out by incubating the reaction at 
65°C for 15 minutes.
2.3.3.2. Electrophoretic Separation of DNA
Size fractionation of DNA was performed by submarine electrophoresis on 0.8-2.0% 
(w/v) agarose gels in 1 x TAE supplemented with ethidium bromide to lOOng/ml, 
submerged in 1 x TAE running buffer. Samples were loaded with 1 x loading buffer, and 
electrophoresed at 15-100 V. The DNA was visualised and photographed under UV light.
2.3.3.3. Pulsed Field Gel Electrophoresis
Pulsed Field Gel Electrophoresis was performed in a CHEF-DR™ II system (Bio-Rad, 
Richmond, CA) through a 1% agarose gel in 0.5 x TBE. The chamber was filled with 0.5 x 
TBE maintained at 14°C by circulating the buffer through hosing submerged in a 9°C 
water bath. After loading of the samples, electrophoresis was performed at 12V/cm for 25 
hours with switch times linearly ramped from 0.5s-3.0s. The gel was post-stained in 
ethidium bromide and DNA visualised under UV light.
2.3.3.4. Recovery of DNA from Agarose Gels
The band of interest was cut from the gel and DNA isolated using the QIAquick™ kit 
according to supplier instructions. Briefly, the agarose block was dissolved by heating for 
10 mins at 50°C in the provided buffer, and the resulting mixture diluted with isopropanol 
and then loaded onto the supplied column. Following washing of the column, DNA was 
eluted in water or Tris buffer.
2.3.3.5. Purification of DNA
Using Phenol/Chloroform Extraction
DNA solutions were made up to a minimum volume of 100 pi with the addition of 1 x 
TE, and purified by mixing with an equal volume of phenol/chloroform/isoamyl alcohol. 
The emulsion was centrifuged at 12000 x g for 2 minutes and the upper, aqueous layer 
transferred to a new tube. Contaminating phenol was removed by washing with an equal 
volume of chloroform followed by centrifugation as above. The DNA solution was 
transferred to a new tube, and concentrated using a Microcon filter unit or by ethanol 
precipitation.
Using QIAquick™purification kit
For purification of DNA from some enzymatic reactions, the QIAquick™ purification 
kit was employed as per manufacturer instructions. The reaction mix was diluted in the 
provided buffer, bound to the purification column and then washed with the provided 
buffer. DNA was subsequently eluted with water or Tris buffer.
Using Microcon™filter units
Microcon filter units were used to concentrate, desalt and purify DNA solutions 
following Millipore instructions.
Precipitation o f  DNA and RNA
DNA and RNA samples were precipitated by addition of ammonium acetate or sodium 
acetate pH 5.2 to a final concentration of 0.1M and either 2.5 volumes of cold redistilled 
ethanol or an equal volume of isopropanol. Sometimes seeDNA™ was added to visualize 
the pellet. The DNA or RNA was then recovered by centrifugation at 12000 x g for 15 
minutes at 4°C. The pellet was washed with cold 70% (w/v) ethanol, dried at room 
temperature and resuspended in a minimal volume of MilliQ water or 1 x TE.
2.3.3.6. Determination of DNA Concentration
DNA concentration was determined by comparison to DNA markers run in conjunction 
with the sample on an agarose gel, or by UV spectrophotometry at a wavelength of 260 
nm.
2.3.4. Reverse Transcription
cDNA was synthesised from 5pg of zebrafish embryo total RNA using random 
hexamers and reverse transcriptase following Invitrogen instructions. Briefly, RNA was 
incubated with 250ng random hexamers in 1 1  pi volume at 65°C for 5 minutes then cooled 
to 4°C before addition of reverse transcriptase buffer (to final concentration of lx), lOmM 
DTT, 0.5mM dNTPs and 200U of Superscript II in a 20pl reaction volume. After 
incubation at 42°C for 50 minutes, the enzyme was heat inactivated at 70°C for 15 
minutes. Resulting cDNA was diluted 5-fold with MilliQ water before use in PCR.
2.3.5. Polymerase Chain Reaction (PCR)
PCRs were performed in 25 pi mixtures containing 0.2 mM each of dATP, dCTP, 
dGTP and dTTP, 1 x PCR reaction buffer, 2 or 3mM MgCb, 1.0 pM of each forward and 
reverse primer, 2.5 U of Taq DNA polymerase and template DNA. Amplification was 
performed in a programmable temperature controller (Techne, Cambridge, UK). Programs 
consisted of an initial template denaturation at 95°C for 2  minutes, followed by 35-40 PCR 
cycles consisting of denaturation at 94°C for 30 seconds, a 1 minute primer annealing step 
at temperature appropriate for the primers and final extension at 72°C for 30 -90 seconds.







PAC6F TCG CGT AGT CGA TAG TG 47°C Sequencing of PAC vector
PAC6R CAC TCA ATG ACC TGA CC 47°C Sequencing of PAC vector
Sall5 GCG TCG ACG CGC GAC ACA GAG - 
CAG GCA TTC AGA GC 55°C
Cloning of p2.5GFP
T7 GTA ATA CGA CTC ACT ATA GGG C 55°C Cloning of p2.5GFP
S ll ACC GTG ACA CAC TCT ACC AAG - 
ATG ACC 66"C
PCR based genomic library 
screen
S13 CAT GAT AAA ATT TGC ACC CTG - 
AAA AGG 66°C
PCR based genomic library 
screen
S15 GCG CGA CAC AGA GCA GGC ATT - 
CAG AGC 66°C
PCR of soxlO cDNA or gDNA
S17 TAT ATT CTG AGG AAG ACG GCG 66°C PCR of sox 10 cDNA or gDNA
S19 GCA GCA AGA GCA AAC CGC ACG 68°C PCR of soxlO cDNA or gDNA
S20 TGG TAG GGG GCG TTG GAG GGC 68°C PCR of soxlO cDNA or gDNA
S21 ACC TAC CGA AGT CAC CTG TGG 58°C PCR of soxlO cDNA or gDNA
S22 GAT ATT GAT CCG CCA GTT TCC 58°C PCR of soxlO cDNA or gDNA
S24 AAT CGC ATT ACA AGA GCC TGC 56°C PCR of soxlO cDNA or gDNA
S25 CCA GGG AAG TGT GTT TCA CTC 56°C PCR of soxlO cDNA or gDNA
S26 TAT ACA TAC GGC ATC TCC AGC 56°C PCR of soxlO cDNA or gDNA
S27 AGT TTG TGT CGA TTG TGG TGC 56°C PCR of soxlO cDNA or gDNA
2.3.6. Cloning Strategies
2.3.6.I. Preparation of Insert DNA and Plasmid Vector
DNA fragments for ligation were generated by complete restriction, followed by heat 
inactivation of the restriction enzyme where possible. Dephosphorylation of DNA ends, 
when required, was achieved by addition of 2 units of Shrimp Alkaline Phospotase directly 
to the restriction enzyme reaction. If required, the desired fragment was purified by 
recoveiy from an agarose gel.
Vector DNA for use in ligations was digested with the appropriate restriction enzymes, 
and purified through a QIAquick™ column.
2.3.6.2. Ligations
Ligations were performed using 50-100 ng of vector DNA and a three molar excess of 
insert DNA, catalysed by 10 units of T4 DNA ligase in a 10 pi reaction. Ligations were 
incubated at 16°C overnight or room temperature for 2 hours.
PCR products were cloned into pGEM-T Easy vector following Promega instructions.
2.3.6.3. Preparation and Transformation of Competent E. coli
Introduction of plasmid DNA into E. coli was performed by the two methods outlined 
below. Following transformation, cells were incubated in Luria Broth for one hour before 
spreading on LB-agar plates containing required antibiotic and overnight incubation at 
appropriate temperature. Where colour selection of colonies containing recombinant 
plasmids was desired, 200 pg/ml X-gal and 160 pg/ml IPTG were added to the plate.
Calcium chloride method
Preparation of DH5aF' competent cells for transformation was performed using the 
calcium chloride method as per Sambrook (1989). Transformation of competent E. coli 
cells with plasmids was achieved using a 2 minute heat shock at either 42°C or 37°C.
Electroporation method
Preparation of electrocompetent E. coli was performed by culturing a sufficient volume 
of E. coli to mid-log phase, followed by extensive washes in cold 10% glycerol. After a 
final wash, cell pellets were resuspended in an appropriate volume of 1 0 % glycerol and 
aliquoted for storage. Transformation of lOOpl of thawed E. coli with 5ng plasmid was 
performed in 1mm cuvettes using a Bio-Rad Electroporator set at 1.25kV.
2.3.7. DNA Sequencing and sequence analysis
General DNA sequencing runs were performed at the Sequencing Facility, University 
of Bath with an ABI DNA sequencer module. Sequencing of the t3 mutant lesion was 
performed commercially (Oswell Research Products Ltd, Southhampton).
Analysis of raw sequences and chromatograms, compilation of contigs and sequence 
comparisons were performed with the BioEdit Software package, which can be found at 
www.mbio.ncsu.edu/BioEdit/bioedit.html.
2.3.8. Analysis of DNA by Hybridisation
2.3.8.1. Transfer of DNA to Nylon Membranes 
Southern Blotting
Following electrophoresis, DNA was transferred and UV-fixed onto a nylon 
membrane, following the method of Sambrook (1989). For transfer of large DNA 
fragments (>10kb), the gel was washed in 0.2M HC1 for 15 minutes immediately before 
commencing the protocol.
Colony Hybridisation
Colony hybridisations were performed largely as described by (Grunstein and Hogness, 
1975). Bacterial colonies were patch plated onto an L-agar plate supplemented with 100 
pg/ml ampicillin and replica plated onto a Hybond-N™+ membrane which overlayed 
another ampicillin supplemented L-agar plate. Following overnight growth at 37°C, the 
filter was placed colony side up on a pad of Whatman® 3MM paper soaked in lysing 
solution for 20 minutes. The filter was transferred to a fresh pad of 3MM paper soaked in 
Southern Denaturing Solution plus 1% (w/v) SDS for a total of 20 minutes, and then on 
3MM soaked in Southern Neutralising Solution, before the filter was partially air-dried and 
washed in 2 x SSC, during which bacterial debris was removed using absorbent cotton 
wool. The DNA was UV-fixed onto the filters as per Amersham instructions using a UVP 
CL-1000 unit (UVP, Upland CA).
2.3.8.2. Radiolabelling of DNA probes
PCR products or DNA fragments purified from an agarose gel were labelled by primer 
extension of random oligonucleotides using the HighPrime™ system and [a-32P] dCTP. 
The reaction was stopped by addition of 30pl of Stop Buffer and unincorporated 
nucleotides were removed by column chromatography through Bio-Gel P60 resin columns 
made with G50 beads. Columns were packed and equilibrated with 100 pi 1 x TNE buffer 
by gravity flow. Labelled DNA fragments were eluted by adding the labelling reaction plus 
stop buffer to the top of the column and collecting the first dye fraction.
2.3.8.3. Prehvbridisation. Hybridisation and Washing of filters 
Prehybridisation
Filters were prehybridised in Southern prehybridisation buffer at 65°C for a minimum 
of one hour. The volume of Southern prehybridisation solution was approximately 0.1 
ml/cm2 of filter.
Probe Denaturation and Hybridisation
Before dilution in fresh Southern prehybridisation buffer and addition to the 
prehybridised filters, the radiolabelled probe was denatured by boiling for 2 minutes. 
Hybridisation was conducted for a minimum of 16 hours at 65°C.
Washing o f  Filters
Filters were normally washed twice in a solution of 2 x SSC, 0.1% SDS at 65°C for 30 
minutes and then twice in 0.2 x SSC, 0.1% SDS at 65°C for 30 minutes.
Autoradiography and Stripping o f  Filters
Filters were covered in plastic wrap and exposed to X-ray film at -70°C for appropriate 
periods of time, backed by an intensifying screen (DuPont Hi-Plus).
Southern blots and colony filters were stripped of probe by boiling for 10 minutes in 
0.1 x SSC, 1% SDS, then rinsed in 2 x SSC and stored in plastic wrap at 4°C.
2.4. Zebr afish  M ethods
2.4.1. Fish husbandry
Embryos were obtained through crosses of wild-type, mutant and transgenic zebrafish 
kept in the University of Bath zebrafish facility, and were raised and staged according to 
Kimmel et al. (1995). Dechorionation was performed with Watchmakers’ No. 5 forceps, 
and embryos older than 15hpf, which were to be manipulated, fixed or live mounted, were 
anaesthetised by addition of tricaine (to approximately 0.2% final concentration v/v) to 
embryo medium.
2.4.2. Injection of zebrafish embryos
Needles for injection were made by pulling 3 Vi” Drummond glass capillaries 
(Drummond Scientific Co., Broomall, PA) on a Micropipette puller (Sutter Instrument 
Co., Novato, CA). Zebrafish embryos were pipetted onto a 2% agarose plate in zebrafish 
embryo medium. Injections were performed under a dissecting microscope using a 
Drummond Nanoject II apparatus (Drummond Scientific Co., Broomall, PA). Phenol Red 
was added to DNA solutions before loading into needles backfilled with mineral oil.
2.4.3. Antibody staining
Staining of embryos with antibodies against GFP or the pan-neuronal marker Hu were 
performed as follows, using incubations performed at room temperature with gentle 
agitation. Embryos were treated with fix for 2 hours before being washed three times in 
PBTX for five minutes. Following three one-hour washes in MilliQ water, the embryos 
were pre-blocked for 2 hours by incubation in antibody blocking solution. This was 
replaced with primary antibody diluted 1:750 in antibody blocking solution and incubated 
overnight. The following day, the antibody solution was discarded and the embryos 
washed three times in PBTX for one hour each, then incubated overnight with appropriate 
secondary antibody diluted 1:800 in antibody blocking solution. The antibody was 
discarded and embryos washed three times in PBTX for 30 minutes each before clearing in 
glycerol and mounting for visualisation by microscopy.
2.4.4. Embryo mounting and microscope techniques
Mild inhibition of melanisation was performed by addition of PTU to the embryo 
medium to a final concentration of 0.0015%. Anaesthetised or fixed embryos were 
mounted either between No.l coverslips or in 3% methylcellulose for microscopic 
examination on an Eclipse E800 (Nikon) microscope using Nomarski optics or 
fluorescence with appropriate filter.
Low power microscopic analysis and general embryo manipulation was performed on 
an MZ12-FL dissecting microscope (Leica) with fluorescent attachment.
GFP was visualised by epifluoresence with FITC filters, whilst the fluorescently 
conjugated secondary antibody for Hu staining was detected using a TRITC fluorescence 
filter. Photography was performed with a SPOT digital camera (Diagnostic Instruments) 
and images analysed and enhanced with Photoshop™ (Adobe). Confocal images were 
taken with a Zeiss Confocal Microscope (LSM510).
C h a p t e r  3
I so l a t io n  a n d  a n a l y sis  o f
ZEBRAFISH SOX 1 0  GENOMIC CLONES
3.1. Ba c k g r o u n d : Zebrafish  genom ic  libraries  and
RESCUE OF ZEBRAFISH MUTANTS
3.1.1. Zebrafish genomic library resources
The advent of high throughput genome sequencing projects and the need for detailed 
analysis of gene structure, including identification of distant regulatory elements, have 
required the generation of large insert genomic libraries providing full genome sequence 
coverage. Additionally, large-scale mutagenesis screens in many model organisms have led 
to acceleration of positional cloning efforts, which depend ultimately on availability of 
such libraries. To this end, genomic libraries of numerous organisms, including zebrafish, 
have been made commercially available and are produced mostly using three vectors 
systems: bacterial artificial chromosomes (BACs), PI-derived artificial chromosomes 
(PACs) and yeast artificial chromosomes (YACs) (Amemiya et al., 1999). Each of these 
systems show differences in insert size and culturing methods, however all offer relative 
ease of handling, increased cloning size capability compared to older vectors, improved 
stability and amenability to simple and established laboratory protocols. However each 
vector probably displays unique cloning biases meaning that the use of all resources is 
required to reduce the chance of missing regions of the genome under represented in any 
one system (Amemiya et a l, 1999).
Zebrafish YAC, BAC and PAC libraries available at the time of the commencement of 
this work are summarised in Table 3.1, however many more are available currently 
(Geisler, 2002). These four original large-insert libraries all provide approximately 4 to 5- 
fold coverage of the genome and were produced from the AB wild-type strain. Screening 
of the libraries can be performed by two methods, filter hybridisation or use of PCR pools. 
By arraying colony DNA of the entire library onto filters, the hybridisation approach 
allows rapid screening, with one round sufficient to identify positive clones. The PCR 
screening procedure however occurs in two rounds using gene specific PCR to detect 
presence or absence of the gene of interest in pools of DNA. Primary pools are prepared 
from DNA of genomic clones representing sections of the library, and secondary pools, 
corresponding to any positive primary pools, are subsequently screened to obtain plate, 
column and row information within the library (Geisler, 2002). The PCR approach does 
have the advantage of being more robust and sensitive, with little optimisation required 
(Amemiya et a l, 1999).
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Resources for screening and the libraries themselves are available commercially and 
from public organisations such as RZPD (http://www.rzpd.de: Vente et al., 1999), and 
have numerous important applications to zebrafish genomic analysis. These include 
candidate and positional cloning projects (examples include one-eyed pinhead (Zhang et 
al., 1998a), sauternes (Brownlie et al., 1998) and mind bomb (Itoh et al.t 2003)), isolation 
of zebrafish homologues or promoters of certain genes (e.g. the Cx43alpha 1 gene; 
(Chatteijee et a l , 2001) and the annexin A13 gene; (Iglesias et al., 2002)), the zebrafish 
genome sequencing project at the Sanger centre
(http://www.sanger.ac.uk/Projects/D_rerio) and rescue experiments (see below).
Table 3.1: Summary of zebrafish genomic libraries
Library name Vector Host Strain Average insert size Reference
BCH-YAC pYAC4 AB1380 240kb www.incvte.com
MGH-YAC pRMLl/2 J57D 470kb (Zhong etal., 1998)
BAC pBeloBacll DH10B™ 90kb www.incvte.com
PAC PCYPAC6 DH10B™ 115kb (Amemiya and Zon, 1999)
3.1.2. Rescue of zebrafish mutants
Molecular genetic characterisation of zebrafish mutants begins through either a 
candidate or positional cloning approach. Attempts at phenotypic rescue by introduction of 
cloned genes, DNA constructs or synthetic mRNA into embryos is a valuable tool for both 
methodologies, and often allows quick dismissal of candidate genes or narrows a 
chromosome walk to overlapping genomic clones. Ultimately, rescue of mutant phenotype 
is an important criterion in the proof of gene identity of given mutants and is now routine 
in zebrafish gene studies.
Although first demonstrated using injection of mRNA into mutant embryos (Currie and 
Ingham, 1996), rescue can also be performed with genomic DNA or cDNAs driven by 
ubiquitous, inducible or tissue specific promoters (e.g. Liao et al., 1998; Miller et al., 
2000). It should be noted that mosaic expression of injected DNA is far more severe than 
that of RNA (Gilmour et a l, 2002a). Thus RNA injection often provides a greater degree 
of rescue and is additionally a useful tool for misexpression studies and in epistasis tests. 
One drawback of mRNA injection (or cDNAs under ubiquitous promoters) is that 
expression is ectopic. This can lead to developmental defects, which may complicate 
interpretation of rescue success Additionally, exogenous RNA is less stable than DNA and 
thus rescue of later defects might prove difficult due to degradation of the mRNA (Gilmour 
et al, 2002a). Finally, rescue by ectopic expression of a protein does not imply that it
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directly corresponds to the mutation in question; it may simply be supplementing a 
downstream component of the pathway, indirectly disrupted by the mutation. However this 
cannot be the case with rescue by wild-type genomic clones as wild-type protein is 
produced only in the correct time and place, and only if the pathway both upstream and 
downstream is functional. Accordingly, rescue experiments fall into two types, those where 
the injected nucleic acid used for rescue corresponds to the mutated gene and those which 
rescue with a component downstream of the mutation. A summary of some rescue 
experiments conducted using nucleic acid injection in zebrafish is presented in Table 3.2.





Method Assessment criteria; reference
A: Rescue uses injection of nucleic acid corresponding to gene affected in mutant
swirl bmp2 mRNA Morphology; (Kishimoto et a l ,  1997)
one-eyed pinhead EGF-CFC mRNA Morphology; (Zhang eta l., 1998a)
floating head znot BAC col2al expression in notochord cells; (Yan et al., 1998)
cyclops ndr2 mRNA twhh.shh, and pax2.1 expression; (Rebagliati et al., 1998)
sucker e tl PAC, cDNA Alcian Blue cartilage stain; (Miller et al., 2000)
nacre m itf cDNA Melanin; (Lister et a l ,  1999)
colourless sox 10 cDNA Melanin; (Dutton et al., 2001)
lost-a-fln alk8 mRNA Morphology; (Mintzer et a l ,  2001)
spiel ohne 
grenzen pou2 mRNA pax2.1 expression in MHB; (Belting et al., 2001)
vlad tepes gata l mRNA, cDNA, BAC band3 expression; (Lyons et a l ,  2002)
after eight deltaD Germline transgenic Somite morphology and markers; (Hans and Campos-Ortega, 2002)
B: Rescue of Mutant uses different (downstream) gene
cyclops Shh mRNA Netrinl expression; (Strahle e t a l ,  1997)
one-eyed pinhead mixer mRNA Sox 17 expression; (Alexander and Stainier, 1999)
nil Jlh ehh mRNA Muscle Pioneers (MyoD); (Currie and Ingham, 1996)
casanova mezzo mRNA Sox 17 expression; (Poulain and Lepage, 2002)
cloche SCL cDNA Red Blood cells; (Liao et al., 1998)
bozozok noggin mRNA Otxl expression; (Fekany-Lee e t a l ,  2000)
colourless m itf cDNA Melanin; (Elworthy et al., 2003)
Adapted and extended from Ekker, (1999).
3.1.3. Alms
Cloning and analysis of the SoxlO genomic loci from humans and mice have been 
reported (Pusch et al., 1998). The aims of this section of work included isolation, coarse 
mapping and initial sequence analysis of genomic clones containing the zebrafish soxlO
gene, as well as demonstration that they can rescue the els mutation and thus contain 
critical promoter elements required for sox 10 expression.
3.2. R e su l t s
3.2.1. Isolation of zebrafish soxlO PAC clones
A PCR based library screen was used to isolate PAC clones containing the sox 10 gene 
from an arrayed zebrafish genomic library (RZPD, Berlin, Germany). Primers SI 1 and S I3 
(Table 2.4) amplify 940bp of the 3’ UTR of the zebrafish soxlO gene and were used to 
detect presence or absence of this fragment in 33 primary pools. Single bands of correct 
size were detected in seven primary pools (Figure 3.1a) as can be seen in lanes 13, 15, 18 
and 30 and faintly in lanes 7, 9 and 20. Of these positive primary pools, four gave 
informative patterns in the secondary screen allowing identification of a row, column and 
plate number in the arrayed library for each clone (an example for primary pool 13 is given 
in Figure 3.1b). The remaining three secondary screens were not informative, as they did 
not give all three positive lanes required to identify position of the clone in the library 
(Table 3.3). The four PAC clones obtained from the screen were designated PAC G, PAC 
I, PAC L and PAC N, and corresponding full RZPD clone codes are presented in Table
3.3. Presence of soxl0-like sequence was confirmed by both PCR (Figure 3.1c) and 
Southern analysis (Figure 3.2b, c).
3.2.2. Restriction mapping of soxlO PAC clones
A coarse restriction map of each PAC was generated by analysing Not\ /Sail single and 
double digests with Pulsed Field Gel (PFG) Electrophoresis, as shown on Figure 3.2a. 
Maps were deduced (Figure 3.3) and confirmed by probing a Southern blot of the PFG 
with the sox 10 5’ RACE product and a probe to the 3’ UTR (provided by A. Pauliny; 
Pauliny, 2002; Figure 3.2b,c). The hybridisation patterns also indicated position and 
orientation of the coding region on each PAC shown in Figure 3.3. Note that the 3kb SaR- 
Notl fragment present on all PACs (Figure 3.3) was too small to be present on the PFG or 
blots, however its presence has been verified on a standard agarose gel (not shown). 
Probing the blot with vector sequence (not shown) provided further verification of the 
maps.
Summing fragment sizes also allowed estimation of total insert size for each PAC, as 
shown on Figure 3.3 and in Table 3.3. All are smaller than the average insert size of the
Figure 3.1: PCR based genomic library screen
a. Agarose gel of the Primary PCR based screen, showing products obtained from PCR 
on primary pool DNA template using Primer pair SI 1-S13.
PCRs were performed on Primary Pools of the RZPD BUSMP706 zebrafish PAC 
genomic library. Numbers at top of lanes refer to Primary Pool numbers.
PCR products of the expected size (940bp) are present in 7 of the 33 pool lanes, 
namely lanes numbered 7, 9,13, 15, 18, 20 and 30 (indicated by arrowheads).
Lane M: Promega 1 kbp DNA ladder with selected fragment sizes indicated.
b. An example of an agarose gel of one informative secondary screen (corresponding to 
Primary Pool #13) in which 3 PCR products were obtained using Primer pair SI 1-S13 
(again indicated with arrowhead and positive lanes highlighted with arrows). A positive 
control was included (lane labelled G) which used zebrafish genomic DNA as a 
template. In addition, a negative control PCR was included in which Secondary Pool 
DNA was replaced with water. This reaction gave no product (lane labelled W).
Lane M: Promega lOObp DNA ladder with fragment sizes indicated.
c. PCR of DNA template from the four PAC clones using Primer pairSll-S13. All four 
PACs (labelled at top of respective lanes) show a PCR fragment of correct size. A 
negative control PCR which used water in place of DNA template gave no product (not 
shown).
Lane M: NEB lOObp DNA ladder with fragment sizes indicated.
M 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33
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Figure 3.2 Physical mapping of soxlO PAC clones
a. Pulsed field gel of single and double restrictions of PAC G, I, L and N with Notl and 
Sail.
Lanes M: High Molecular Weight Marker. Some fragment sizes are indicated to the left 
for clarity. Sizes in kb are from top to bottom: 48.5, 38.4, 33.5, 29.9, 24.8, 22.6, 19.4, 
17.1,15.0,12.2,10.1,8.6,8.3.
Restriction digests are indicated as follows: Notl (N), Sail (S) and Notl + Sail (N/S). 
PAC clones represented in each lane are indicated above the restriction digest title.
b. Southern blot of above gel probed with zebrafish soxlO 5’RACE probe. Lanes as in (a.) 
above.
c. Southern blot of above gel probed with a region of the 3’UTR. Lanes as in (a.) above.
N S N/S N S N/S M \ N S N/S N S N/s\
Figure 3.3 Restriction Maps of the four zebrafish sox10 PACs
Notl (N), Sail (S) restriction maps of each PAC G, L, I and N are shown, as deduced 
from PFGE data and subsequent southern analysis (Figure 3.2). Estimated sizes are in 
kb. Sites in brackets correspond to those present on the cloning vector. The 
approximate position and orientation of the sox 10 gene is shown as an arrow above the 
maps (based on Figure 3.2b,c).
The asterisk under one fragment in PAC N indicates that this fragment appears to be 
approximately lkb shorter than in the other 3 PACs (see text).
Note that the restriction digest information at the far right hand end of PAC L was 
uninformative. Although total size (32kb) could be accurately determined, the order of 
the three SaH-SaK fragments could not.
Also note that hybridisation of the approximately 3 kb Sali-Notl fragment within the 
soxlO gene could not be seen on either of the PFG southerns as it had run off the 
Pulsed Field Gel, however this has been confirmed on other gels (not shown).

library (~115kb; Amemiya and Zon, 1999), with PAC N being significantly so. The three 
largest PACs all show hybridisation of a 27kb Notl-Sall fragment to the 5’ RACE product. 
Further, hybridisation of a 9kb Notl-Sall fragment to the 3’ probe occurred in all three 
PACs, and this combined information, allowed positioning and orientation of the sox 10 
coding region on the maps, also shown in Figure 3.3.
Table 3,3: Zebrafish soxlO PACs
Positive Primary Pools 
(PCR signal strength)
Number Positive 





BUSMP706PP7 (+) 1 -
BUSMP706PP9 (+) 2 -
BUSMP706PP13 (+++) 3 BUSMP706N1498Q2 PAC N 30 kb
BUSMP706PP15 (+++) 3 BUSMP706G03116Q2 PAC G 92 kb
BUSMP706PP18 (++) 3 BUSMP70611613 7Q2 PAC I 84 kb
BUSMP706PP20 (+) 3 BUSMP706L06154Q2 PAC L 111 kb
BUSMP706PP30 (+++) 2 -
It appears that the smallest PAC (PAC N) had undergone some deletion or 
rearrangement during cloning, as one of the fragments 3’ to the sox 10 gene in this PAC 
was approximately lkb shorter than expected from the maps of the other PACs (compare 
band in N/S lane of PAC N with those in N/S lanes of the other PACs, Figure 3.2c). 
Alternatively, it could represent a polymorphism within the zebrafish sample used to 
construct the library, such as a small deletion or insertion, or an RFLP such as an extra Sail 
site in the region, however this could not be detected by more detailed agarose gel 
electrophoresis of Sail and No til Sail digested PAC N, so is unlikely (not shown).
Note also that precise mapping at one end of PAC L was not possible due to 
uninformative restriction pattern here. Restriction mapping using a different enzyme may 
better resolve this region.
3.2.3. Sequence of PAC I
In collaboration with W. J. Pavan at the National Institute of Health (NIH) in Bethesda, 
MD, U.S.A., one of the sox 10 PACs (PAC I) was partially sequenced (unpublished). High 
quality sequence from an 18.5kb contig containing the putative zebrafish sox 10 gene was 
obtained, and used for all subsequent sequence analysis. It contained sequence with high 
homology to the published zebrafish sox 10 cDNA sequence (Figure 3.4), demonstrating 
that it probably corresponds to the gene encoding the zebrafish SoxlO protein. The overall 
identity between the predicted exons and the cDNA sequence is 98.6%, with the predicted
Figure 3.4 59
Figure 3.4 Intron-Exon structure and cDNA alignment
Alignment of a contig from the PAC I sequence to the published zebrafish soxlO 
cDNA sequence using the Spidey program (found at http://www.ncbi.nlm.nih.gov/).
a. Intron-exon structure of the zebrafish sox 10 gene deduced from alignment to the cDNA 
sequence. Exons are represented as orange boxes with introns shown as blue lines. The 
numbers at either end refer to the position of the start of exon 1 and the end of exon 4 
in the 18.5kb genomic contig sequence. Note that this 4 exon -  3 intron structure is 
conserved with mouse and human SoxlO genes.
b. Table summarising the alignment by Spidey including the sites in each sequence of 
overlap, length of exon, percent identity within each exon, numbers of mismatches or 
gaps and presence of donor (d) and acceptor (a) splice sites. Overall homology is 
98.6%.
c. Alignment of predicted exons with the zebrafish sox 10 cDNA sequence, with 10 bp of 
intron sequence either sde of each exon also shown. Intron sizes are shown at the end of 
exons 1-3. Note that only eight substitutions occur in the coding sequence and all are 
synonymous substitutions. Further, a G is present at the start of the cDNA sequence 
which is not present in the gene sequence, however this is likely to represent reverse 
transcription of the 7-methyl-guanosine cap of the sox 10 mRNA, added during mRNA 
processing.
Intron -  exon structure and boundaries are conserved between zebrafish, human and 




EXON Genomiccoordinates mRNA coordinates length identity mismatches gaps Donor site Acc. site
Exon 1 5526-5658 1-133 133 98.5% 2 0 d
Exon 2 7764-8445 134-815 682 97.9% 14 0 d a
Exon 3 10321-10583 816-1078 263 99.6% 1 0 d a
Exon 4 12470-14603 1079-3202 2124 98.4% 33 14 a
c.
Exon 1: 5526-5658 (genomic); 1-133 (mRNA)
5526 CATGAATTGATTTTTTTCTCGCTCTTCACACAACGGGGCTCTTTAAGCCTCGACGCGCGACACAGAGCAGGCATTCAGAGCGCGAGCGAGGGGGCTGAAC
I I I I I I I I I I I I I I I I I I I I I I I III I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I
1 GTTTTTTCTCGCTCTTCACACAACGGGGCTCTTTAAGCCTCGACGCGCGACACAGAGCAGGCATTCAGAGCGCGAGCGAGGGGGCTGAAC
5616 CGACGGACTCTCGTGCTGGGCGGGCGACCTGCTGCACTGTAAAGTAAGTGCAT Intron 1 (2106bp) 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
91 CGACGGACTCTCGCGCTGGGCGGGCGACCTGCTGCACTGTAAA
Exon 2: 7764-8445 (genomic); 134-815 (mRNA)
7764 ATTTTTGTAGGTTTCCATCAGATCTATATCCAGAGGAAGACGGCGGAAGGATTCCTTCTTACAAACTCGAATTATATAAAAAGAACTGTTAAGGTTTCAC
I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I III I l l l l  I I I I I I I I I I I I I I I I I l l l l l l l  
134 GTTTCCATCAGATCTATATTCTGAGGAAGACGGCGGAAGGATTCCTTCTGACAGAGTCGAGTCGTTTGAAAAGAACTGTTAAAGTTTCAC
7854 TGGATGATCTTAAATAATAAACAAAAGCACAATTATTTTACAAGAAAAAAACATTTGTAAAGTATAAATTAATACATTTATATTTAAAATAAAATTTAAG
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 11111111111111111111111111111111111111111 
224 TGGATGATCTTAAATAATAAACAAAAGCACAATTATTTTACAAGAAAAAAACATTTGAGAAGTATAAATTAATACATTTATATTTAAAATAAAATTTAAG
7954 TGAGGAAATTAAACCTACCGAAGTCACCTGTGGCCGCAGAACTAGTGGACCGATGTCGGCGGAGGAGCACAGCATGTCGGAGGTGGAAATGAGTCCCGGG
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
324 TGAGGAAATTAAACCTACCGAAGTCACCTGTGGCCGCAGAACTAGTGGACCGATGTCGGCGGAGGAGCACAGCATGTCGGAGGTGGAAATGAGTCCCGGG
M S A E E H S M S E V E M S  P G
8054 GTGTCGGACGATGGGCACTCCATGTCCCCTGGTCACTCGTCGGGCGCTCCCGGTGGCGCGGACTCCCCTCTGCCCGGTCAGCAGTCTCAGATGTCCGGGAI I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
4 2 4 GTGTCGGACGATGGGCACTCCATGTCCCCTGGTCACTCGTCGGGCGCTCCCGGTGGCGCGGACTCCCCTCTGCCCGGTCAGCAGTCTCAGATGTCCGGGA
V S D D G H S M S P G H S S G A P G G A D S P L P G Q Q S Q M S G
8154 TCGGGGATGATGGAGCCGGTGTCTCCGGCGGGGTCTCAGTGAAGTCCGACGAGGAAGATGACCGGTTCCCCATCGGCATCCGCGAGGCGGTCAGTCAGGT
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
524 TCGGGGATGATGGAGCCGGTGTCTCCGGCGGGGTCTCGGTGAAGTCCGACGAGGAAGATGACCGGTTCCCCATCGGCATCCGCGAGGCGGTCAGTCAGGT
I G D D G A G V S G G V S V K S  D E E D D R F P I G I R E A V S Q V
8254 GCTGAACGGGTACGACTGGACGCTCGTGCCCATGCCCGTGCGCGTGAACTCGGGCAGCAAGAGCAAACCGCACGTCAAGCGGCCGATGAACGCGTTCATG
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
624 GCTGAACGGGTACGACTGGACGCTCGTGCCCATGCCCGTGCGCGTGAACTCGGGCAGCAAGAGCAAACCGCACGTCAAGCGGCCGATGAACGCGTTCATG
L N G Y D W T L V P M P V R V N S G S K . S K P H V K R P M N A F M
8354 GTGTGGGCGCAGGCCGCGCGCAGGAAACTGGCGGATCAATATCCGCACCTGCACAACGCCGAGCTCAGCAAAACACTGGGGAAGCTGTGGAGGTGAGCGCGC
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I  I I I I I I I I I I I I I I I I I I I I I I I I I I I I , . ,
724 GTGTGGGCGCAGGCCGCGCGCAGGAAACTGGCGGATCAATATCCGCACCTGCACAACGCCGAGCTCAGCAAAACACTGGGGAAGCTGTGGAG “ rrX"
V W A Q A A R R K L A D Q Y P H L H N A E L S K T L G K L W R  (18/Obp)
Exon 3:10321-10583 (genomic); 816-1078 (mRNA)
10321 CATGTTTCAGACTGCTGAACGAGACGGATAAGCGGCCGTTTATCGAGGAGGCCGAGCGCTTGAGGAAGCAGCATAAGAAAGATTATCCCGAGTACAAGTA 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
816 ACTGCTGAACGAGACGGATAAGCGGCCGTTTATCGAGGAGGCCGAGCGCTTGAGGAAGCAGCATAAGAAAGATTATCCCGAGTACAAGTA
L L N E T D K R P F I E E A E R L R K Q H K K D Y P E Y K Y
10411 CCAGCCACGTCGACGCAAGAACGGCAAACCGGGTTCCAGCTCAGAGGCCGACGCCCACTCTGAGGGCGAGGTCAGCCACAGCCAATCGCATTACAAGAGC 
I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I I  I  I  I  I  I  I  I  I  I  I  I  I I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I I  I  I  I  I  I  I  I I  I  I  I  I  I  I  I  I  I  I  I  I  I  
906 CCAGCCACGTCGACGCAAGAACGGCAAACCGGGTTCCAGCTCAGAGGCCGACGCCCACTCTGAGGGTGAGGTCAGCCACAGCCAATCGCATTACAAGAGC
Q P R R R K N G K P G S S S E A D A H S E G E V S H S Q S H Y K S
10511 CTGCACCTGGAGGTGGCGCACGGCGGGGCTGCAGGGTCACCATTGGGTGATGGACACCACCCTCACGCTACAGGTGAGATACA Intron 3 (1887bp)
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
956 CTGCACCTGGAGGTGGCGCACGGCGGGGCTGCAGGGTCACCATTGGGTGATGGACACCACCCTCACGCTACAG 
L H L E V A H G G A A G S P L G D G H H P H A T
ctd..
Exon 4: 12470-14603 (genomic); 1079-3202 (mRNA)
12470 GTTTGCTCAGGTCAGAGTCACAGCCCTCCAACGCCCCCTACCACCCCCAAGACGGAACTGCAGGGAGGAAAATCAGGCGAGGGCAAGCGTGAGGGCGGAG
I  I  I  I  I I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I I  I  I  I  I  I  I  I  I  I  I  I  I I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I
1079 GTCAGAGTCACAGCCCTCCAACGCCCCCTACCACCCCCAAGACGGAACTGCAGGGAGGAAAATCAGGCGAGGGCAAGCGTGAGGGCGGAG
G Q S H S p T p p X T K T E L G G K S G E G K R E G G
12560 CCTCTCGGAGTGGACTGGGGGTGGGAGCAGATGGAAGCTCCGCCTCATCGTCTGCCAGCGGGAAACCGCACATCGACTTCGGTAACGTGGACATTGGCGA
I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
1169 CCTCTCGGAGTGGACTGGGGGTGGGAGCAGATGGAAGCTCCGCCTCATCGTCTGCCAGCGGGAAACCGCACATCGACTTCGGTAACGTGGACATTGGCGA
A S R S G L G V G A D G S A S S S A S P H D F G N V D I G E
12660 AATCAGCCATGACGTGATGGCCAACATGGAGCCGTTCGACGTGAACGAGTTCGACCAGTATCTCCCACCCAATGGCCACCCGCAGGCGTCCGCCACTGCC 
I I I I I I I I I I I I I I I I I I I I I I I I II I II I I I I I I I ! I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I 
1269 AATCAGCCATGACGTGATGGCCAACATGGAGCCGTTCGACGTGAACGAGTTCGACCAGTATCTCCCACCCAATGGCCACCCGCAGGCGTCCGCCACTGCC
S H D V M A N M E P F D V N E F D Q Y P N G H P Q A S A T A
12760 AGCGCAGGATCTGCAGCGCCATCGTATACATACGGCATCTCCAGCGCGCTAGCGGCCGCTAGTGGCCACTCCACCGCATGGCTGTCCAAGCAGCAACTGC 
I  I  I I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  
1369 AGCGCAGGATCTGCAGCGCCATCGTATACATACGGCATCTCCAGCGCGCTAGCGGCCGCTAGTGGCCACTCCACCGCATGGCTGTCCAAGCAGCAACTGC 
S A G S A A P S Y T Y G I S S A L A A A S G H S T A W ' L S K Q Q L
12860 CGTCCCAGCAGCATTTGGGCGCAGATGGCGGAAAAACGCAGATAAAGAGTGAAACACACTTCCCCGGGGATACAGCGGCGAGCGGTTCACACGTCACATA
I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I  I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
1469 CGTCCCAGCAGCATTTGGGCGCAGATGGCGGGAAAACGCAGATAAAGAGTGAAACACACTTCCCTGGGGATACAGCGGCGAGCGGTTCACACGTCACATA 
P S Q Q H L G A D G G K T Q I K S E T H F P G D T A A S G S H V T Y
12960 CACGCCGCTAACACTGCCGCACTACAGCTCCGCCTTCCCCTCGCTGGCGTCCCGCGCACAGTTCGCCGAATACGCCGAGCACCAGGCCTCGGGATCCTAC
I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I I  I  I  I  I I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I
1569 CACGCCGCTAACACTGCCGCACTACAGCTCCGCCTTCCCCTCGCTGGCGTCCCGCGCACAATTCGCCGAATACGCCGAGCACCAGGCCTCGGGATCCTAC 
T P L T L P H Y S S A F P S L A S R A Q F A E Y A E H Q A S G S Y
13060 TACGCCCACTCCAGCCAGACCTCAGGCCTCTACTCCGCCTTCTCCTACATGGGCCCCTCACAGCGGCCCCTGTACACCGCCATTCCGGATCCGGGATCCG 
I  I  I  I  I  I I  I I  I  I  I  I  I  I  I  I  I I  I  I  I  I  I  I  I  I  I  I  I I  I  I  I  I  I  I  I I  I  I  I  I  I  I  I  I  I  I  I I  I  I  I  I  I I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  
1669 TACGCCCACTCCAGCCAGACCTCAGGCCTCTACTCCGCCTTCTCCTACATGGGCCCCTCACAGCGGCCCCTGTACACCGCCATTCCGGATCCGGGATCCG 
Y A H S S Q T S G L Y S A F S Y M G P S Q R P L Y T A I P D P G S
13160 TGCCGCAGTCGCACAGCCCCACGCACTGGGAGCAGCCCGTATACACCACACTGTCTCGACCGTGACACACTCTACCAAGATGACCAGTCACGGAAGGTCC 
I I I I I I I I I I l l l l t l l l  l l l l i  1111 1111 I 111 11 I I I 11 I 1111 1111 11 11 1111 111II111 1111 111 I 1111 1111 11 11 I I I I II I I 
1769 TGCCGCAGTCACACAGCCCTACGCATTGGGAGCAGCCCGTATACACCACACTGTCTCGACCGTGACACACTCTACCAAGATGACCAGTCACTAAAGGTCC 
V P Q S H S P T H W E Q P V  Y X T L S R P *
13260 AACCGTAAAGTGTGTGTGTGTGTGTGTGTGCTAAAAATCATCGAAACACTCGCCTGCACCACAATCGACACAAACTGAGATCTGAGAAACGAGTGTGTGT
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
1869 AACCGTAAGGTGTGTGTGTGTGTG---------- CTAAAAATCATCGAAACACTCGCCTGCACCACAATCGACACAAACTGAGATCTGAGAAACGAGTGTGTGT
13360 GTGTGTGTGGAGATCTGCAGGGAAATATTCTCACGTGCCTCAGACGACCACCGTCCAGACCTGCTCCCTCAACGCCAATTTGAACACCAGTAGTATTTTC 
I I I  I  I I  I I  I  I I I  I  I  I  I  I I  I I I  I  I  I  I  I  I  I  I I  I I  I I  I I I  I I  I I  I  I  I I  I  I  I  I I  I I  I  I I  I I  I  I I I  I  I I I  I I  I I  I  I  I I  I I  I I I  I I  I I  I I  I I  I  I I  I I I I  I  I  I I  I  
1963 GTGTGTGTG-AGATCTGCAGGGAAATATTCTCACGTGCCTCAGACGACCACCGTCCAGACCTGCTCCCTCAACGCCAATTTGA-CACCAGTAGTATTTTC
134 60 GAAAAAGACGTATTACCAAAGTACCGAGACCAAAACATTACAGAAATACGAGAGTGCATCCATCCTTCCTGAACTCCGGATATCAGATCACACACAGACT
I I  I I I I I  I  I I  I I I I I  I  I I I  I  I I  I  I I  I I  I  I I  I I I  I I  I I  I I I I I I I I I  I  I  I  I I  I  I I  I I I  I I  I  I I  I I  I  I  I  I  I I  I  I II I I I  I I I  I I  I  I I I I I I  I I I I  I I  I I I I
2061 GAAAAAGACGTAGTACCAAAGTACCGAGACCAAAACATTACAGAAATACGAGAGTGCATCCATCCTTCCTGAACTCCGGATATCAGATCACACACAGACT 
13560 TCAACACATGATGCTAGTACCAGTGCATCCGCATTTTTTATCTGTATTTGTATGAATGAATAATCTTTTTATTAACCAAAATAAGGCCATATTGTTTTTA
I  I  I  I  I  I  I  I  I  I  I  I  I  I I  I  I  I  I  I  I  I  I  I  I  I  I  I  I I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I
2161 TCAACACATGATGCTAGTACCAGTGCATCCGCATTTTTTATCTGTATTTGTATGAATGAATAATCTTTTTATTAACCAAAATAAGGCCATATTGTTTTTA 
13660 AAAAAATAATGAGGTGTTTTTCGTTGTTGTAATCTCTTGTGTTGTCGTTACTGTTGTTATTTGTGTTGCCATAACTACACTGAAAAGTCTTCACCACTGT
I  I I I  I I I I I  I I  I I I  I  I  I I I I I I I  I I I  I I I I I I I  I I I  I  I  I I I  I  I  I  I  I  I  I  I I  I I  I  I  I  I I  I I I I I I I I I I  I  I  I I I I I I I  I  I  I I  I  I I I I II I  I  I I  I  I I I I I  I  I  I
2261 AAAAAATAATGAGGTGTTTTTCGTTGTTGTAATCTCTTGTGTTGTCGTTACTGTTGTTATTTGTGTTGCCATAACTACACTGAAAAGTCTTCACCACTGT
13760 CTAGTGTTTGTTAATGACATTTGTGTTTTATGACTTTCAGCGTGTGTAAATATCAGTGCCAGGACGCCATACACACATGTCTCCACCCAATTAAGGTGCG 
I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I I  I  I  I  I  I  I  I  I I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  
2361 CTAGTGTTTGTTAATGACATTTGTGTTTTATGACTTTCAGCGTGTGTAAATATCAGTGCCAGGACGCCATACACACATGTCTCCACCCAATTAAGGTGCG
13860 CTCACAGTGACGTTAATTAAATTGAGGAATTCCCAATCATGCAGATTCCTCTAGAAATGGCTATATTTCGTGAAAGCAGTAAATGTGAGCGCACCTTTAT 
I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  
2461 CTCACAGTGACGTTAATTAAATTGAGGAATTCCCAACCATGCAAATTCCTCTAGAAATGGCTATATTTCGTGAAAGCAGTAAATGTGAGCGCACCTTTAT
13960 TTCACACAAGCAGTACTGTAAAGGTAATATATTTTTACCAGATTGGAAATAGTGGACGTAATTACGAATTTTTAATAATAAATGACTATTTTTAGAGAAT
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2661 ACCGCTAGTGCCTCAAGTCCATCACAAACGAATTGTCGTTTCTGATAAATTCAATTTTGATGATGTAAAATCCTTTTCAGGGTGCAAATTTTATCATGCG
14160 TTAAGCGATGTGATTATACATCGAATATGCATATGCAAATTAATAAGTGCCATTTTTATAATTAAAAATACATCTATCAACTATCTGAAGACCTTCCTAA
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3157 AGCAGTGACTAACTTTCCTCACTCTAAATAAAGCTGCAGTCTTTAC
proteins having identical sequence. Note the cDNA begins with a G, not present in the 
gene sequence. This is consistent with reverse transcription of the 7-methyl-guanosine cap 
of the soxlO mRNA previously reported during cDNA synthesis (Hirzmann et al., 1993). 
The presence of this cap additionally supports the notion that the reported sox 10 cDNA 
sequence represents a full-length transcript. This alignment to the zebrafish sox 10 cDNA 
sequence also allowed identification of intron-exon size, structure and boundary locations 
as shown in Figure 3.4, and also in the zebrafish sox 10 cDNA sequence in Appendix 1.
Percentage Identity Plots performed at the NIH, between the zebrafish sox 10 gene 
region and the mouse sox 10 gene showed homology between coding regions (not shown), 
as expected from previous analysis using the zebrafish sox 10 cDNA sequence (Pauliny, 
2002). With a view to revealing transcription factors important for controlling SoxlO 
expression, it was hoped that conserved sox 10 regulatory regions would be identified, 
however no homology was noted outside the coding region (J.R. Dutton, W. Pavan pers. 
comm.).
To identify conserved enhancer or promoter regions, which might have key binding 
sites for transcription factors controlling sox 10 expression, a comparison with the sox 10 
gene from a closer species was made. The Fugu genome sequencing project is nearing 
completion and a putative sox 10 containing scaffold was identified by blast search against 
the zebrafish sox 10 gene sequence. Scaffold number S002943 shows good homology to 
sox 10 sequence from zebrafish, mouse, chick and human, and is annotated in the Fugu 
genome database as containing a sox 10 orthologue based on a number of criteria including 
gene prediction software and a TBLASTX search. An alignment of the predicted Fugu and 
zebrafish SoxlO proteins is given in Figure 3.5a, demonstrating a 74% identity and 90% 
similarity between the two proteins. The similarity was greater than for any other protein 
sequence in the database, including the closely related zebrafish sox9 genes. Although it 
cannot yet be proven, it is highly likely that this gene represents the Fugu sox 10 
orthologue, as annotated by the gene prediction software.
A Percentage Identity Plot was produced between the putative 30.3kb Fugu sox 10 
genomic sequence and the 18.5kb sox/fl-containing contig of PAC I. This is shown in 
Figure 3.5b, and indicates 7 sites of homology (numbered 1 to 7 for clarity), plotted in a 
position relative to the PAC I contig and the degree of identity. A Dot Plot is also given in 
Figure 3.5c showing the position of these sites with respect to both sequences. Homology 
is seen in the exons and extremities of the introns, as well as 3 CA-repeats (numbered 4 in 
Figure 3.5b and c) and interestingly two sites found outside the exons. One of these sites 
occurs upstream of the start of transcription, whilst the other occurs downstream of the 
final exon.
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Figure 3.5 Percentage Identity Plots of the soxlO genomic regions 
from zebrafish and Fugu
a. Alignment of the predicted proteins from the zebrafish (upper) and the Fugu (lower) 
soxlO genes. Percentage Identity between the two proteins is 74%, whilst the 
percentage similarity is 90%, with identical residues shaded in black and similar 
residues in grey. This indicates that this gene is most likely a true sox 10 orthologue.
b. Percentage Identity Plot (produced by the PIPMaker software 
(http://bio.cse.psu.edu/pipmaker/). comparing the zebrafish soxlO gene contig with 
Fugu Scaffold S002943. Regions of identity are plotted with respect to position to the 
zebrafish PAC I contig sequence (x-axis; shown below) and degree of identity shown at 
the right on the y-axis. Boxes above outline predicted CpG islands. Note that homology 
exists at 7 loci in the zebrafish gene region, numbered 1 to 7 below plot. This includes 
the four soxlO exons (#s 2, 3, 5 and 6), CA repeats (#4) and two flanking sites (#s 1 and 
7) (see text and Figure 3.6).
c. Dot Plot from same output as in (b.) showing relative positions of the homology sites in 
(a.) with respect to both sequences. The Fugu sequence is presented on the y-axis and 
the PAC I contig sequence on the x-axis, with total sizes of sequences given on axes. 
Numbers within figure correspond to sites in (b.).
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Zebrafish sox 10 PAC I
The sequence alignments for all sites (except the CA-repeats) are shown inFigure.3.6. 
Again, intron-exon structure and boundary position is conserved for these sox 10 genes, 
however notice that the Fugu introns are often much smaller, consistent with its compacted 
genome. Homology within introns is confined to short stretches at the extremities near the 
splice sites, and probably represents conservation of splice signal sequences. Both 
extragenic sites (#s 1 and 7) show no homology to sequences in the BLAST database, and 
the annotated Fugu genome browser indicates that they lie outside any recognised gene in 
this region (not shown). It is possible they might represent a conserved, non-coding region 
or conserved enhancer for the sox 10 gene in teleosts, however it is possible one or both are 
associated with regulation of another gene such as the pol2rf gene, which is found 3’ to the 
sox 10 gene. Further functional and in silico analysis of these sites and the sox 10 gene 
region in general remains to be undertaken.
3.2.4. Rescue o f els by PAC clone injection
Hybridisation, PCR and sequence data imply all four PACs contain sequence highly 
homologous to zebrafish sox 10 cDNA, and thus were highly likely to contain the sox 10 
gene. To test this, a rescue experiment was used to ask if the soxlO sequence on each PAC 
represented a functional gene in vivo and if it corresponds to the gene affected in els. 
Additionally, comparing abilities of each PAC to rescue all the cell types affected in els 
allowed inferences to be made as to the size of promoter required for necessary expression 
in each lineage, as well as rough positioning of any enhancers for such lineages.
3.2.4.1. Chromatophore rescue
Strong colourless alleles never show migrating, stellate melanophores, only very small 
black melanised cells in the dorsal stripe, which never migrate (Kelsh et al., 1996; Kelsh 
and Eisen, 2000). Furthermore, they show an almost complete absence of xanthophores 
and generally do not have any iridophores, although some embryos display a small number 
of iridophores in the dorsal stripe or present as a patch in the eye or lateral patch. Initial 
assessment of whether PAC injection could partially rescue the colourless phenotype 
focussed on melanophores, as the presence of healthy melanophores is easy to visualise 
and score. 1-8 cell stage embryos from els +/m618 or els +/ty22f incrosses were injected with 
approximately 30-60pg of DNA from each of the four PACs. These embryos were raised at 
28.5°C and inspected over the next 3 days for signs of melanophore rescue.
Figure 3.7a and b show examples of 48hr putative els embryos rescued with all four 
PACs. By comparing to uninjected siblings (both wild-type and els; see top two panels in 
both Figure 3.7a and Figure 3.7b), it is clear that these embryos contain an intermediate
Figure 3.6 Sequence alignments of homologous regions between 
zebrafish and fugu soxlO genes
Regions of homology associated with the sox 10 gene were predicted and aligned by the 
PIPMaker software. Each site of homology is presented as boxed sequence alignment, 
with numbers corresponding to those designating the sites in Figure 3.5. These consist 
of almost all the exons of zebrafish soxlO as well as a region upstream of the start of 
transcription of both genes, and a region downstream of the fourth exon, between the 
soxlO gene and thepol2rf gene.
In each alignment box, the zebrafish sequence is given on the upper strand, with the 
Fugu sequence given below. Dots indicate identity and dashes indicate gaps. Exons are 
written in capitals and intronic sequence or putative promoter sequence written in 
lowercase. Predicted intron sizes are shown. The BamYlX site present in the first region 
of homology is boxed.
Numbers on the left of each line of sequence give position number relative to the 
predicted start of transcription, which is shown as a large arrow. Translation start and 
stop codons are indicated in bold.
Note that due to lack of a full length fugu sox 10 cDNA sequence, the exact size of the 
first intron and 5’UTR were difficult to predict.
The other regions showing homology found by the PIPMaker software are CA repeats 
and are not presented here.
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24 07 ATATTTAAAATAAAATTTAAGTGAGGAAATTAAACCTACCGAAGTCACCTGTGGCCGCAGAACTAGTGGACCGATGTCGGCGGAGGAGCA 
2535 a a ............. CAGA...................
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Figure 3.7: Rescue of melanophores in c/s by PAC injection
a. Dorsal views of approximately 48hpf embryos showing the ability of sox 10 PACs to 
rescue melanophores. Upper two panels show uninjected siblings with the top panel 
displaying a wild-type embryo with a large number of melanophores evident. The 
second panel shows a els embryo completely devoid of melanophores. Partial rescue of 
this phenotype is clear in the lower two panels showing els embryos rescued by 
injection of PAC I (third panel) and PAC N (bottom panel). An intermediate number of 
melanophores are evident as is the variation of the degree of rescue seen. These 
melanophores appear to have normal morphology and are able to migrate to ventral 
parts of the embryo. This is evident in lateral views of rescued embryos.
b. Lateral views of approximately 48hpf embryos showing the ability of sox 10 PACs to 
rescue melanophores. Upper two panels show uninjected siblings with the top panel 
displaying a wild-type embryo with a large number of melanophores evident. The 
second panel shows a els embryo completely devoid of melanophores. Again, partial 
rescue of this phenotype is apparent upon injection of all PACs, in this case PAC G 
(third panel) and PAC L (bottom panel). Examples of melanophores which have 










number of melanophores which display a wild-type morphology and behaviour, namely are 
stellate, darkly melanised and are able to migrate to ventral regions of the embryo (arrow 
in Figure 3.7b).
The intermediate number of melanophores seen in some injected embryos can be 
attributed to two different causes. Firstly, injection of the PAC DNA might have somehow 
reduced the number of healthy melanophores in originally wild-type embryos due to 
cytotoxic effects. Secondly, they could in fact represent mosaic rescue of els embryos. The 
latter scenario predicts a decrease in the number of embryos in a batch showing zero 
melanophores (ie truly els) from the number expected by Mendelian inheritance.
To test this, the number of strictly els embryos (i.e. containing absolutely no stellate, 
wild-type melanophores) was compared to the numbers showing wild-type melanophores 
and numbers of putative rescued els embryos in a batch o f injected embryos at 48hpf. The 
proportions obtained for each PAC injection are shown graphically in Figure 3.8 as a pie 
chart, and compared to an uninjected batch. Whilst the latter shows, as expected, a 3:1 
'WT'.cls ratio, injection of all PACs result in significant divergence from this expected 
Mendelian ratio (Chi-squared test results are shown in Figure 3.8), and all cause a decrease 
in the number of embryos with a full els phenotype from the expected.. This demonstrates 
that the embryos showing intermediate numbers of melanophores almost certainly 
represent els embryos partially rescued by injection of sox 10 PAC DNA.
To assess if all PACs were able to rescue to the same degree, the average number of 
melanophores per rescued els embryo was counted. As shown in Figure 3.9, no apparent 
statistically significant difference between the four PACs was seen (one-way ANOVA; 
Figure 3.9b), and averages ranged from approximately 18 to 26 melanophores. This 
compares with figures reported for a heat-shock>5ojc70 construct injected at similar 
amounts (50pg), which gave an average of 15 rescued melanophores per embryo (Dutton et 
al., 2001). The heat-shock construct is approximately 6 to 16 times smaller than the PACs, 
indicating that there were far fewer copies of PAC injected per embryo, yet similar rescue 
numbers were seen. This probably reflects the greater efficiency of the endogenous sox 10 
promoter over the heat-shock promoter.
As with melanophores, all four PACs are able to rescue the other chromatophores 
affected in els. Xanthophores are severely disrupted in strong els embryos. Almost all els 
embryos have no visible xanthophores at 5dpf (Kelsh et al., 1996), however occasionally 
one or two xanthophores can be seen, although these appear apoptotic. The PAC injected 
embryos analysed for melanophore rescue at 2 days were later assessed for xanthophore 
rescue at 3 and 5dpf. Xanthophores can be readily visualised under transmitted light as 
they stain blue when the embryo is incubated in dilute Methylene Blue solution (as found
Figure 3.8: Comparison of the melanophore rescue abilities of 
each PAC
Embryos from incrosses of els heterozygous fish were injected with each PAC and 
scored at 48hpf as either having a wild-type number of melanophores, no 
melanophores or an intermediate number of melanophores (putative rescued embryos). 
These counts are displayed graphically in the left column, represented as black, white 
or grey segments respectively. It is evident that the injected batches have a smaller 
proportion of embryos with no melanophores, and that these appear to now display an 
intermediate number of melanophores. The sum of embryos with no or an intermediate 
number of melanophores fully accounts for the expected number of els embryos, 
arguing against an effect of injection on wild-type embryos.
The numbers of embryos in each treatment with any melanophores (i.e. wild-type + 
rescued embryos) were then compared to the number with no melanophores (i.e. 
embryos with a full els phenotype). These are presented in column two with the 
numbers expected by Mendelian inheritance given below in brackets. The uninjected 
controls show a 3:1 wild-type: els proportion as expected from Mendelian ratios and 
consistent with the recessive mode of inheritance known for the els alleles used, whilst 
there is a deviation from this in the injected embryos. To more formally demonstrate 
significant rescue by PAC clone injection, a x2 value was calculated for each (column 
3) and a probability (based on one degree of freedom) is indicated in the final column 
to test the null hypothesis: That divergence of the observed ratio from the expected is 
due to chance alone.
For the uninjected control batch, this probability is greater that 0.05, and thus there is 
no reason to reject the null hypothesis. Thus uninjected batches behave in a Mendelian 
fashion with variations due to chance.
As the probability that this is true is very small for all injection experiments (p<0.001), 
then the null hypothesis is rejected in these cases and implies that injection of the PACs 



















110 37 0.002 P>0.05
(110.25) (36.75)
172 13 31.872 P<0.001
(138.75) (46.25)
144 16 19.200 P<0.001
(120) (40)
208 6 56.231 P<0.001
(160.5) (53.5)
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rank sum P value Summary
PAC G vs PAC I 15.23 P > 0.05 ns
PAC G vs PAC L -15.85 P > 0.05 ns
PAC G vs PAC N -0.8194 P > 0.05 ns
PAC I vs PAC L -31.09 P > 0.05 ns
PAC I vs PAC N -16.05 P > 0.05 ns





Do the medians vary signif. (P < 0.05) 







F ig u re  3.9: A v e ra g e  n u m b e r  o f  m e l a n o p h o r e s  p e r  r e s c u e d  c / s  
e m b ry o
a. Graph showing the mean number of melanophores found per rescued els embryo after 
injection with each PAC. Error bars show standard deviation. The large standard 
deviations indicate the mosaic nature of the rescue. Uninjected els embryos never 
show any melanophores (not shown).
b. All PACs rescue to a statistically indistinguishable degree. One-way ANOVA 
analysis (using the Kruskal-Wallis nonparametric test) of melanophore counts of the 
four PACs showing that there is no difference in degree of rescue between any of 
them. Probabilities shown test the null hypothesis that each PAC rescues to the same 
degree (Left-hand table). All pairwise tests between PACs (using Dunn’s Multiple 
Comparison test; right-hand table) indicate that there is no reason to reject this 
hypothesis.
in Embryo Medium). The presence of healthy stellate xanthophores in a lateral position on 
the trunk was clearly visible in mosaically rescued els embryos as shown in Figure 3.10. 
Such trunk xanthophores are never seen in uninjected els embryos. As xanthophores often 
form a sheet of cells covering the dorsal aspect of the embryo, it is difficult to distinguish 
individual cells, and counts of cell numbers are often impossible. Instead, quantification of 
xanthophore rescue by each PAC was made by simple comparison of the number of 
embryos with less than 5 xanthophores (considered to be unrescued els) to the number 
showing 5 or more xanthophores (considered to be rescued els or wild-type) within 
injected or uninjected batches. As with melanophores counts, these comparisons are 
represented as pie charts in Figure 3.11, and batches injected with all four soxlO PACs 
show a significant deviation from the expected number of embryos showing less than 5 
xanthophores (i.e. embryos with an unrescued els xanthophore phenotype), demonstrated 
by x2 analysis. Thus the xanthophore phenotype of els can also be rescued by injection of 
any of the four PACs.
Finally 5dpf injected embryos were viewed under incident light to assess rescue of the 
third pigment cell type, iridophores. els embryos do not always have a complete lack of 
this cell type, and occasionally show isolated patches in an eye or the lateral patch, or cells 
in the dorsal stripe. Thus, in contrast to other chromatophores, rescue of this cell type was 
not evident on simple inspection as with other chromatophores. Figure 3.12a shows an 
example of a putative rescued els embryo injected with PAC N and viewed under incident 
light at 5dpf, showing good iridophore coverage of the eye and the presence in the lateral 
patch. The identification of injected els individuals with almost complete coverage of 
iridophores in one eye strongly suggested rescue of this cell type, as this is never seen in 
uninjected els embryos. To more formally demonstrate the ability of the PACs to rescue 
the iridophore fate, it was necessary to perform quantitative analysis. The number of 
iridophores seen in the dorsal and ventral stripes, and the number of patches of iridophores 
seen in the eyes and lateral patches were counted. Iridophores were never seen in the yolk 
sac stripe in uninjected or injected els embryos. The iridophore counts obtained from each 
injection (Figure 3.12b) show that all four PACs show rescue, to a statistically significant 
degree (one-way ANOVA; Figure 3.12c), given the null hypothesis that uninjected and 
PAC injected els embryos have the same average numbers of iridophore cell and patches, 
with variation due to chance. Similar tests comparing each PAC injected batch indicated 
that no statistically significant difference of rescue between the four PACs was evident 
(Figure 3.12c).
Viewing injected embryos at 5dpf also allowed assessment of the viability of the other 
rescued pigment cells to this stage. Note from the bottom panel in Figure 3.12a that the 
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F ig u re  3.10 R e s c u e  o f  x a n th o p h o r e s  in c / s  by  PAC in je c t io n
Top panel shows a lateral view of an approximately 72hpf els embryo stained with 
Methylene Blue, showing a complete absence of xanthophores. A els sibling injected 
with PAC N, similarly stained, is shown in the lower panel. Rescue o f xanthophores in a 
mosaic manner can be seen as blue-green stellate stained cells, present on the lateral 
migration pathway (arrows in the higher magnification shown inset).
Figure 3.11: Comparison of the xanthophore rescue abilities of 
each PAC
As els does not always display a complete loss of xanthophores, again a statistical 
approach was used to demonstrate rescue of this cell type. After counts of melanophore 
rescue, embryos were assessed for xanthophore rescue. Embryos from incrosses of els 
heterozygous fish were injected with each PAC and scored at 72hpf as either having 
more than 5 xanthophores, or less than 5 xanthophores. The latter class were 
designated as els whilst the others consisted of both wild-type and putative rescued els 
embryos. These counts are displayed graphically in the left column, represented as 
white or black segments respectively. For simplicity, embryos with more than 5 
xanthophores (i.e. wild-type and putative rescued els embryos) are presented as one 
group.
As with melanophores, these number are presented in the table with the numbers 
expected from Mendelian inheritence. It is evident that whilst the uninjected controls 
show a 3:1 wild-type:c/s proportion as expected from mendelian ratios and consistent 
with the recessive mode of inheritance known for the els alleles, the injected batches of 
embryos have a smaller proportion of embryos showing the defined els xanthophore 
phenotype.
X2 analysis was used to demonstrate that this deviation upon injection was significant 
for all PACs. x2 values are given (column 3) and probabilities (based on one degree of 
freedom) is indicated in the final column to test the null hypothesis: That divergance of 
the observed ratio from the expected is due to chance alone.
As the probability that this is true is very small for all injection experiments (p<0.001), 
then the null hypothesis is rejected in these cases and implies that injection of the PACs 
is leading to a decrease in numbers of embryos with a els xanthophore phenotype.
For the uninjected control batch, this probability is greater that 0.05, and thus have no 
reason to reject the null hypothesis. Thus uninjected batches behave in a Mendelian 
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110 37 0.0023 P>0.05
(110.25) (36.75)
146 19 16.002 P0.001
(123.75) (41.25)
188 10 42.027 P<0.001
(148.5) (49.5)
191 23 23.184 P<0.001
(160.5) (53.5)
204 18 33.784 P0.001
(166.5) (55.5)
Figure 3.12: Rescue of Iridophores in c/s by PAC clone injection
a. Lateral views of 5dpf embryos photographed under incident light to examine 
iridophores. Upper panel shows a wild-type embryo with extensive iridophore coverage 
over the eye and in the lateral patch (arrows). The panel below shows a els embryo with 
deficit of iridophores on the eye and in the lateral patch apparent, but escaper 
iridophores are apparent on the dorsal stripe (arrowhead).
The bottom two panels show a putative els embryo rescued with PAC N. The upper of 
these panels is photographed under incident light and shows a good coverage of 
iridophores over the eye, and also visible in the lateral patch (arrows). Iridophores were 
also noted in the dorsal and ventral stripes in this embryos but are not shown here. 
Bottom panel shows the same embryo photographed with transmitted light. Note that 
there are melanophores present in all four stripes, namely the yolk sac stripe, the 
ventral stripe, the medial stripe and the dorsal stripe. This indicates the ability of the 
rescued melanophores to survive and migrate to appropriate locations
b. Graph displaying average number of iridophores and iridophore patches for both 
injected and uninjected els embryos. Error bars indicate standard deviations.
c. One-way ANOVA demonstrates that els embryos injected with all four PACs have a 
significantly greater number of iridophores and iridophore patches than uninjected els 
embryos. Left-hand table shows the results from one-way ANOVA showing there is a 
significant difference between mean iridophore scores of the groups. Results and 
probabilities from pairwise post-test (Tukey’s Multiple Comparison test) is shown in 
the right-hand table, and shows that each PAC injection displays significantly different 
means to the uninjected els (p<0.01). Meanwhile, there is no significant difference in 

















Tukey's Multiple Comparison Test Mean Diff. _ q P value
PAC G vs els 9.688 6.625 P < 0.001
PAC 1 vs els 7.548 7.507 P < 0.001
PAC L vs els 6.658 5.406 P<0.01
PAC N vs els 7.892 6.882 P < 0.001
PAC G vs PAC 1 2.139 1.555 P > 0.05
PAC L vs PAC G -3.029 1.956 P > 0.05
PAC N vs PAC G -1.795 1.212 P > 0.05
PAC L vs PAC 1 -0.8902 0.7899 P > 0.05
PAC N vs PAC 1 0.3438 0.3326 P > 0.05
PAC N vs PAC L 1.234 0.9835 P > 0.05
One-way analysis of variance
P value P<0.0001
P value summary * * *
Are means signif. different? (P < 0.05) Yes
Number of groups 5
F 9.774
R squared 0.1509
other chromatophores have survived, and have migrated to appropriate positions in the 
embryo. For example, melanophores can be seen in all stripes at this stage, and 
xanthophores are still present in the dorsal portion of the embryo. Thus PAC injection not 
only allows chromatophores to form in els mutants, but once formed, these cells behave as 
wild-type cells, namely are viable, healthy and can migrate to appropriate locations.
It is clear that all four PACs are able to rescue all pigment cell types disrupted in 
colourless. This implies they all contain the promoter and enhancer elements required for 
sox 10 expression in the chromatophore lineages. To assess if they can also rescue the other 
neural crest derivatives disrupted in els, such as PNS neurons, an immunofluorescent 
antibody stain against the Hu epitope was performed on 5dpf rescued els embryos to detect 
neurons.
3.2.4.2. PNS rescue
Due to time constraints, only the smallest PAC (PAC N) and one larger PAC (PAC I -  
chosen as it was sequenced) were assayed for ability to rescue PNS neurons. As all PACs 
rescued chromatophores equally, it seemed likely that at least all the 3 larger PACs would 
rescue PNS neurons equally well, and probably all four PACs. Wild-type embryos have an 
iterated series of DRG neurons present in ganglia along the trunk and revealed by 
immunofluorescent labelling with an antibody against the pan-neuronal antigen, Hu 
(Figure 3.13a). In els embryos this series is clearly disrupted, with DRGs almost 
completely absent in the posterior trunk and tail (Figure 3.13a). In the anterior trunk, DRG 
neuron number is reduced, and those that do form (arrows) are more disorganised. The 
lower panel shows a els embryo injected with PAC N and immunostained with an antibody 
against Hu. Rescued melanophores can be seen in the dorsal head in this image. An 
intermediate number DRGs can also be seen, however it is not clear if this represents 
rescue or simply a els individual displaying a less severe DRG phenotype. Other injected 
individuals did appear to show rescue as they formed an iterated series of DRGs in the tail 
with a wild-type organisation (Figure 3.13a bottom panel). To formally test if there was 
PAC mediated rescue of DRGs in els, counts were made of DRG neurons in injected els 
embryos and uninjected embryos, and results are displayed graphically in Figure 3.13d for 
both PACs. Only els embryos showing pigment cell rescue were included in the DRG 
counts of injected embryos. This was done to eliminate any embryos that had been injected 
but not successfully rescued, and to maximise the chance of seeing a statistically 
significant effect of PAC injection on DRG neurons. A two-way students t-test was 
performed on data for both PACs to investigate whether there were significant difference 
in DRG neurons number in injected els embryos compared to uninjected els embryos.
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Figure 3.13 Rescue of PNS neurons in els by PAC clone injection
All figures are lateral views of 5dpf els embryos, uninjected or injected with PAC N 
and subsequently immunofluorescently stained with an antibody against the pan­
neuronal marker Hu.
a. DRGs are apparent as reiterated series of labelled cells situated along the wild-type 
embryo (top panel; some indicated with arrows). Enteric neurons along the gut are 
evident as well and indicated with an arrowhead.
Second panel shows an cism618/m618 embryo at the same stage, showing an absence of 
enteric neurons (arrowhead) and a severe, but incomplete, loss of DRG neurons (some 
surviving neurons indicated with arrows). Note that these latter neurons are often 
abnormally positioned dorsoventrally.
Third panel shows a sibling els embryo injected with PAC N. There appears to be a 
greater number of trunk and tail neurons (arrows) compared to the uninjected els 
sibling. Bottom panel is a close-up view of the most posterior tail DRGs of a els 
embryo rescued with PAC N. Such a regular series at the correct dorsal-ventral 
position is not normally seen at this axial level in uninjected els embryos.
b. Close up images of enteric neurons. The top panel is a close up view of the gut of an 
uninjected els embryo showing no enteric neurons along the gut. The lower two panels 
show sibling els embryos injected with PAC N. Enteric neurons can be clearly seen 
populating the anterior half of the hindgut in the upper example, whilst the bottom 
panel shows an example of a rescued els embryo with enteric neurons along the entire 
hindgut.
c. Putatively rescued neurons of the sympathetic ganglia (arrowhead) in a els embryo 
injected with PAC N. These neurons are normally completely absent in uninjected els 
embryos (not shown).
d. Graph displaying the average number of DRG neurons in WT embryos, uninjected els 
embryos and PAC injected els siblings. Values are given above each bar and error bars 
show standard deviations. * = significant p=0.03, *** = extremely significant, p=0.001, 
for comparison of each PAC injections versus els.
e. Results from two-tailed unpaired t-test with Welch’s correction for each pair of 
analyses. Probabilities (p) test the null hypothesis that differences between two the 
means are due to chance alone (* = significant, p=0.03; *** = extremely significant, 
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Initially a normality test was performed, and showed that all data sets were normally 
distributed about a mean (not shown). This validated use of the t-test to analyse this data. 
As the two different data sets have been treated differently (i.e. one set has been injected), 
it can be expected that the deviation of the two are different. Indeed Bartlett’s test for equal 
variance showed that both injected samples are likely to have significantly different 
deviations compared to uninjected els controls. This then required modification of the t-test 
with Welch’s correction. A null hypothesis for each PAC injection was proposed, namely 
that there was no significant difference between the number of DRG neurons in injected els 
embryos and uninjected els embryos, t-values were derived for both comparisons and are 
given in Figure 3.13e. It can be seen for PAC N that the t-value is greater than the critical 
value of 2.278 at the p=0.03 level (31df), whilst PAC I has a t-value greater than the 
critical value of 3.883 at the p=0.001 level (19df). Thus both null hypotheses were rejected 
and it could be deduced that both PACs are able to rescue the DRG neuron number. 
Although the probability level is different for the two comparisons, this does not mean the 
PACs rescue to different extents. In fact their means do not differ significantly (p>0.05; 
Figure 3.13e), and the better degree of significance seen for PAC I rescue might simply 
reflect stochastic differences in injection success. Alternately the slight difference in 
sample size between the two PAC injection experiments might alter the degree of 
significance seen.
Rescue of other PNS neuron types was also noted in some of the injected els embryos. 
Figure 3.13b shows the hindgut of els embryos injected with PAC N and stained for Hu 
(two lower panels), compared to an uninjected els sibling in the top panel. cls'A embryos 
are always almost totally devoid of enteric neurons, although an occasional Hu+ cell can be 
seen in this location. The two injected embryos presented here show clear evidence of 
enteric neuron rescue (arrowhead), with one individual showing good coverage along 50% 
of the hindgut (middle panel) and another with apparently full coverage along the hindgut 
(lower panel). In fact 5 out of the 23 els embryos rescued with PAC N in this batch showed 
more than 10 enteric neurons. This reflects the success of this particular injection 
experiment. In all cases, rescue of enteric neurons in a posterior position along the gut was 
only seen if those anterior were also rescued.
Meanwhile, some individuals also appeared to have neurons in a position consistent 
with sympathetic ganglia (e.g. Figure 3.13c), which is never seen in els embryos. Although 
rescue of sympathetic and enteric neurons was not noted with PAC I, this might be due to a 
better injection concentration or other variable of PAC N, rather than difference in DNA 
sequence content (see Discussion).
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3.3 . D is c u s s io n
Four overlapping PAC genomic clones corresponding to the zebrafish sox 10 locus have 
been isolated by a PCR based library screen. Based on coarse restriction mapping and size 
estimation, the combined size of the region covered by the PACs is approximately 116kb, 
and it is of note that all PACs are smaller than the average insert size of the library.
A PCR of the 3’UTR of sox 10 was chosen for use in the library screen for several 
reasons. Firstly, it was known not to span an intron (A. Pauliny, pers.comm.). Secondly, a 
PCR within this region was most likely to discriminate sox 10 from other closely related 
Sox genes, as the target sequence was non-coding and therefore probably more divergent 
than coding regions of Sox family genes. This is a particularly important consideration in 
zebrafish as there are a number of examples of duplicated genes in zebrafish compared to 
mammals. This has been attributed to a genome duplication event early in the teleost 
lineage (Postlethwait et al., 1998). For example, there appear to be two soxll orthologues 
of tetrapod Soxll in zebrafish, both with similar function (De Martino et al., 2000). 
Although the possibility of two sox 10 orthologues in the zebrafish cannot yet be fully 
discounted, degenerate PCR, recent genome searches and genomic southern analyses have 
failed to show any evidence of such an occurrence (A. Pauliny, R.N.K., K. Dutton, pers. 
comm.). Based on evidence of rescue and sequence information, it seems highly likely that 
these PACs do contain the gene corresponding to both the els locus and the isolated sox 10 
cDNA.
A crude map of the region using rare cutting enzymes was developed, and the coding 
region positioned and orientated within it. The sox 10 gene was found in the central portion 
of all PACs, meaning it was likely they all contained the full coding sequence and a good 
deal of flanking sequence. The apparent small (~1 kb) deletion in PAC N is the only 
inexplicable result from the mapping data. Although it could represent some form of gel 
artefact causing aberrant band migration, or a polymorphism in the original library DNA 
sample, it may also be some form of internal deletion caused by instability of that PAC 
clone, a phenomenon which has been reported for PACs previously, albeit at a low 
frequency of occurrence (Ioannou et al., 1994). The presence of a 30kb PAC insert is odd 
considering that the library was constructed by size fractionation of partially digested 
genomic DNA to give inserts of 100-200kb. This most likely excluded cloning such a 
small insert and supports the suggestion that it has undergone some form of internal 
deletion. The deletion occurs in an approximately 9kb fragment, which includes 420bp of 
sequence coding for the C-terminal of the Sox 10 protein. Thus there is a low probability 
that the deletion might affect the Sox 10 coding region. However, as this PAC can rescue as
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well as other PACs, it appears that the deletion has in no way compromised the function of 
the soxlO gene within this genomic clone, and thus does not appear to affect the coding 
region. Using the sequence data for this region might allow design of primer pairs to better 
localise the deletion site by PCR.
Identification of a putative Fugu soxlO homologue has uncovered conserved regions 
flanking the soxlO gene in both species. Initial analysis of these sites show that they are not 
recognisable coding regions, and thus might represent conserved regulatory region. This 
requires further analysis; however it cannot be assumed that if they are regulatory regions, 
that they both control sox 10 gene expression and not some other nearby gene.
It was hypothesised that these PACs contained the gene disrupted in els (sox 10). To 
test this, and to establish that the gene was functional, each PAC was injected into els 
embryos, and assayed initially for melanophore rescue. An intermediate number of healthy 
melanophores were seen. It was proposed that this could be attributed to either mosaic 
rescue of els embryos, or some form of cytotoxic effect on the melanophores of wild-type 
embryos. The latter would predict the presence of unhealthy, pale, dying melanophores in 
injected embryos, however this was not seen. Nor did the presence of these embryos with 
intermediate melanophore phenotype correlate with a deviation from the expected number 
of wild-type embryos; instead a decrease in the number of expected els embryos was 
noted. This again argued against a cytotoxic effect of injection, rather that the PACs were 
able to rescue the els melanophore phenotype. At the time, this allowed three conclusions 
to be drawn. Firstly, as all PACs rescued els, they must all be from the same physical 
location in the genome. Secondly all PACs must contain a functional copy of the gene 
disrupted in els, and lastly, as the smallest PAC was 30kb and as all PACs contained the 
soxlO gene, it meant that the sox 10 gene mapped to within 30kb of the els locus, which 
provided further evidence that els does indeed correspond to mutations in soxlO.
The success of the rescue experiments also implied there were elements present in all 
four PACs able to direct sufficient expression of sox 10 in the neural crest to rescue the 
melanophore defect in els. An attempt to identify any enhancers represented in some of the 
PACs, but absent in others, was made by comparing the ability of the four PACs to rescue 
pigments cells and PNS neurons. In addition to melanophores, all PACs appear to be able 
to rescue the xanthophore and iridophore phenotype of els, with no significant difference in 
success of rescue detectable. As expected, the degree of rescue between injected els 
embryos varied within a batch, due to mosaicism obtained from DNA injection and 
possibly other variables such as embryo age, position of injection and precise amount of 
DNA injected. However no difference in rescue ability could be detected between PACs 
for any pigment cell type. Thus it appears that all PACs contain the elements required for
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rescue of all pigment cells. Although speculation, it might be that expression of soxlO in 
all pigment cell-type precursors is regulated by the same element(s).
Furthermore, there was slight but significant rescue of PNS neurons in the DRGs by 
the two PACs tested. That more striking rescue was not seen might be caused by a smaller 
contribution of neural crest cells to this derivative than compared to chromatophores, 
meaning that the probability that neural crest cells normally fated to become DRG neurons 
will contain injected PAC DNA is much lower. There is supporting evidence for this from 
the single neural crest cell labelling studies, which showed that DRGs represented a 
relatively small proportion of premigratory neural crest cell fates. Additionally, the els 
DRG phenotype is not as severe as the els chromatophore phenotype, which might cause 
rescue to appear less dramatic. Finally, loss of DRG neurons in the mouse SoxlO mutants 
has been proposed to be a secondary effect of loss of support glia in the ganglia (Britsch et 
al.t 2001). If this is also true in zebrafish, then PAC rescue of DRG neurons is not acting 
cell autonomously, but through rescue of satellite glia. Thus there may be some community 
effect required for these neurons to survive, possibly including trophic support from 
sufficient numbers neural crest derived glia. In this mechanism a DRG neuron might only 
be rescued by the presence of a minimum number of rescued support cells, thus limiting 
the degree of neuron rescue seen.
Rescue of enteric neurons was also seen with PAC N (5 in 23 embryos). Although this 
rescue was only rarely seen, when present it was striking, with some examples showing 
rescue along half or even the full length of the gut length. This might indicate that only a 
small number of neural crest cells contribute to this cell type, and that they undergo a large 
number of divisions to produce the neurons along the gut. Thus, when one or more 
precursors are successfully targeted, extensive rescue occurs. Further, note that posterior 
enteric neurons were rescued if those anterior to them were also rescued. This is consistent 
with the notion that neural crest cells migrate in an anterior to posterior direction when 
populating the gut (I.T. Shepherd pers. comm.). Thus it seems likely that anterior neurons 
will be rescued first, and if sufficient rescued neural crest cells are present then posterior 
cells will be rescued. This effect is reminiscent of SoxlO haploinsufficiency in humans and 
mice, where enteric ganglia are nearly normal rostrally, but are absent caudally in the 
hindgut. This has been attributed to depletion of the pool of progenitor cells populating the 
gut. It seems likely that the extent of colonisation of the gut might also be proportional to 
the numbers of progenitors able to migrate here from the vagal premigratory neural crest 
position. Thus the extent of gut colonisation by neurons in rescued els embryos probably 
reflects the number of rescued neural crest cells fated to be enteric progenitors.
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Enteric neurons rescue was not seen in any PAC I injected els embryos. However the 
mosaicism of melanophore rescue was more severe in the injection experiment with this 
PAC than with PAC N and it is most likely that the neural crest cells giving rise to enteric 
neurons, by chance, did not inherit any PAC I DNA upon injection in this particular 
experiment. As PAC N is almost 3 times smaller than PAC I, injection of the same mass of 
DNA in fact equates to almost 3 times more copies of PAC N than PAC I. This might 
account for the slightly better melanophore and enteric rescue seen with PAC N. As rescue 
of these cells was seen with the smallest PAC, it is highly likely that all four PACs would 
display this ability. Given that enteric rescue by PAC N was a relatively rare event, it 
might be that the apparent inability of PAC I to rescue could be due to insufficient 
experimental attempts. I predict that PAC I (and the other 2 larger PACs) would be able to 
rescue enteric neurons given sufficient injection experiments and good mosaic coverage of 
the PAC DNA upon injection. This might require increasing the amount of injected PAC I 
DNA so that the copy number introduced, although too much DNA might cause non­
specific defects. As enteric neurons are derived from the vagal neural crest, it might be 
possible to predict likelihood of enteric rescue with the presence of melanophore rescue in 
this region.
Another explanation for the lack of enteric rescue with PAC I is that it might in fact 
contain an additional repressor element, missing in PAC N. This seem unlikely as it would 
require the existence of a further ‘de-repression’ element beyond the limits contained in 
PAC I. Without more definitive evidence that PAC I is incapable of enteric rescue, this 
explanation remains the less favourable.
Whether these PACs contain all the cw-elements controlling sox 10 expression could 
not be easily determined by rescue experiments, which would not be expected to reveal 
repressor elements for other cell types or elements responsible for fine tuning levels of 
expression. There is, as yet, no evidence that these PACs do not all contain the full 
complement of regulatory elements controlling the expression of the sox 10 gene, although 
this is based purely on the rescue of pigment cells and PNS neurons. Thus it is likely that 
most, if not all, of the important regulatory elements are contained within the region cloned 
in the PACs. However this is based on the ability of the PACs to rescue a limited number 
of cell types known to be disrupted in els. Nor do rescue experiments indicate if the 
expression is at the wild-type levels, or if they are at lower levels, which happen to be 
sufficient for rescue. Rescue experiments additionally might not indicate ectopic sites of 
expression. If required, isolation of genomic clones containing more sequence flanking 
soxlO could be achieved by either attempting to re-screen the three secondary pools that 
failed to give an informative PCR pattern, or alternatively screening other genomic
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libraries with bigger average insert sizes, such as YAC and new generation zebrafish BAC 
libraries.
soxlO appears to be expressed only briefly in pigment precursors on the lateral 
pathway, and appears to be downregulated rapidly at around the onset of pigmentation. 
This indicates that the function of sox 10 in the pigment cell lineages is an early one, a 
notion supported by the lack of mitfa expression at 20hpf in els, and the subsequent 
apoptosis of many neural crest cells in els (Dutton et al., 2001). Thus for the PACs to 
rescue pigment cells, they must be able to drive soxlO expression in early neural crest.
That we do see chromatophores rescue means that there are the necessary promoter regions 
for early neural crest expression present on these PACs. In addition, sox 10 expression is 
seen in neural crest cells migrating along the gut at around 30hpf, although its precise role 
here is not known, but assuming its role here is indispensable, then the enteric neuron 
rescue demonstrated that the PACs contain elements required for this later expression.
Furthermore, expression of sox 10 is seen in cells for which there is as yet no known 
phenotype, such as cartilage cells and oligodendrocytes (Pauliny, 2002). Knowledge of a 
detectable defect in these cell types is required before a rescue experiment could be used to 
assess if the PACs direct sox 10 expression here. Other cell types and structures beyond 
those tested here are known to be disrupted in els mutants, namely the ear and glial cells of 
the peripheral nervous system. At the time, detailed understanding of the ear phenotype 
was not available, making assessment of rescue criteria difficult. Similarly, a lack of 
suitable markers for PNS glia made it difficult to evaluate the ability of the PACs to rescue 
this cell type. Thus the presence of other enhancers controlling other expression sites 
cannot be predicted based on these limited rescue experiments. However, subsequent 
experiments demonstrate that all PACs contain sequence necessary to direct soxlO 
expression in these sites, as shown in the next chapter.
C h a p t e r  4
Pr o d u c t io n  a n d  a n a l y sis  o f
SOXlO  REPORTER CONSTRUCTS
4 .1 .  I n t r o d u c t i o n
4.1.1. Zebrafish reporter constructs. GFP and transgenesis
Characterisation of the regulatory regions of a gene requires investigation both in vitro 
and in vivo by use of a reporter gene to provide a read-out of a particular promoter’s ability 
to drive expression in the embryo, tissue or cell type in question. The optical clarity of the 
zebrafish embryo, the ease with which it can be injected and the large clutch size make it 
amenable to such studies. A number of reporter genes have been successfully used in 
zebrafish and include chloramphenicol transferase (CAT; Stuart et al., 1990), lacZ (Lin et 
a l , 1994), luciferase (Collas and Alestrom, 1998) and Green Fluorescent Protein (GFP; 
Amsterdam et al., 1996). Early work relied on exogenous promoters such as the SV40 
early promoter, the CMV promoter and the efla  promoter from Xenopus laevis. Zebrafish 
gene cloning efforts have afforded endogenous promoters, which, not surprisingly, also 
drive reporter gene expression in zebrafish. Production of multiple germline transgenic 
lines has helped delineate critical elements in a number of zebrafish promoters (with some 
summarised in Table 4.1). The use of GFP has become the standard reporter gene in 
zebrafish. This is largely due to its ability to be visualised in live organisms without the 
need for fixation, staining or addition of accessory molecules, allowing a number of 
experiments in addition to the promoter dissection analysis offered by other reporters. GFP 
variants such as RFP are also starting to be used (Blader et al., 2003).
One recent example of multiple GFP germline transgenic lines being used to 
investigate the regulatory elements of a gene focussed on dissection of the deltaD 
promoter. Production and analysis of fourteen different transgenic lines, each carrying a 
different amount of flanking promoter sequence, identified a number of regulatory regions 
directing expression in mesodermal and ectodermal domains and spanning 12.5kb both 5’ 
and 3’ to the start of transcription.
Live cell labelling by reporter genes provide a unique ability to analyse the behaviour 
of a cell population over time and to correlate expression patterns with cell fate (Amacher, 
1999). One example of such in vivo analysis used a transgenic line carrying the foxd3 
promoter driving GFP, which expresses strongly in certain neural crest derivatives, namely 
migrating pigment cells and PNS glia. Timelapse analysis of the latter’s migration along 
the posterior lateral line axon, coupled with laser ablation and genetic mutant studies 
demonstrated that these neural crest derived glia follow cues provided by the axons, rather
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than leading axon pathfinding, and additionally appear to have a role in nerve fasciculation 
(Gilmour et al., 2002b).
Screening for perturbations of reporter expression pattern through mutagenesis may 
also uncover loci involved in controlling a promoter’s activity, or mutants of a cell type 
labelled by the transgene. For example, a mutagenesis screen conducted using a zebrafish 
endoderm specific GFP line has recently identified a number of mutations affecting 
specific endoderm-derived organs (H. Verkade pers. comm.). Additionally, fluorescence- 
activated cell sorting (FACS) can be used to isolate pure cell populations, allowing rapid 
production of a homogeneous cell population for transplantation or generation of 
expression profiles/comparisons by cDNA library analysis (Dickmeis et al., 2001; Long et 
al., 1997).
Most of these techniques described above require the use of a large number of animals, 
each expressing the reporter gene widely. Although microinjection of DNA constructs into 
large numbers of zebrafish embryos is relatively straightforward, such transient analysis is 
limited due to concomitant mosaicism. This means that there is a variable dose of 
transgene in different regions of the embryo and not all cells in an embryo will necessarily 
inherit a copy. Even after numerous repeated injections, a cell type arising from a small 
progenitor population might never be seen, and the end result is that it might not be 
possible to assess the full extent of expression. Additionally, some cells may inherit a dose 
of DNA which far exceeds the normal copy number. It is conceivable that such a dose 
might afford erroneous expression due to titration of transcription factors or repressor 
proteins required for proper gene expression and cell differentiation. Thus it is generally 
desirable for experimental purposes to produce transgenic animals in which the construct 
has integrated into the genome in moderate copy number and is thus passed through the 
germline to offspring in Mendelian fashion. Such inheritance produces a large number of 
embryos in which all cells carry equal amounts of the transgene, hence describing the 
complete expression pattern of the reporter consruct, and labelling the full complement of 
target cells. This approach has the added advantage of simply and quickly producing large 
amounts of labelled cells without having to perform repeated injections each time.
Nevertheless, transient transgenesis is a simple and rapid method for generating 
expression information for a number of different constructs. Such GFP reporter analysis 
has been used successfully to quickly assay for critical promoter and enhancer elements in 
a number of zebrafish genes including six7 (Drivenes et al., 2000), islet-1 (Higashijima et 
al., 2000), insulin (Huang et al., 2001), HuC (Park et al., 2000\pax2.1  (Picker et a l ,
2002) and gata-2 (Meng et al., 1997). Germline and transient reporter analyses are often 
used in combination to dissect a promoter and describe a transgene’s full expression
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pattern. Recently, Koster and Fraser (2001) used a Gal4-UAS system to amplify GFP 
levels from a tissue specific promoter in transient transgenics. A marked improvement in 
mosaicism was noted in these embryos, with enhanced levels of expression seen 
throughout the embryo. Such an approach might facilitate rapid promoter dissections and 
mis-expression studies where germline transmission may be impossible due to dominant 
lethality associated with the expressed protein.
Generation of germline transgenic zebrafish has so far been achieved using simple 
microinjection of linear DNA into 1-cell stage embryos. However this technique shows 
variable efficiency, with rates often below 5% (see Table 4.1). One of the reasons for this 
poor efficiency might be due to large-scale concatemerisation of linear DNA when injected 
into early embryos (Stuart et al., 1988). This could conceivably cause the injected DNA to 
become too large for efficient genome integration, or produce complex tandem arrays at 
integration sites. Such sites are often unstable, and recombination can lead to variation in 
expression levels (Cretekos and Grunwald, 1999). Another explanation for the poor 
germline transmission rate is the inability of the injected DNA to enter the nucleus. 
Complexing nuclear localisation signal peptides to the DNA reporters have been reported 
to improve germline transmission rates, although with variable success (Collas and 
Alestrom, 1998; but see also; Higashijima et al., 1997; Long et al., 1997). Due to its 
simplicity, simple microinjection of linearised reporter DNA remains the method of choice 
for generating transgenic lines. Given the poor efficiency and associated complications 
with this method, production of multiple transgenic lines currently remains a laborious and 
slow task. Numerous groups are attempting to develop more reliable methods.
One method tried is the use of retroviral infection which, when optimised, showed 
enhanced transmission rates, and less variable expression, however the packaging, 
passaging and titering proved a lengthy and time-consuming process, (Chen et al., 2002; 
Linney et al., 1999; Udvadia and Linney, 2003). Addition of adenoviral-derived flanking 
inverted terminal repeats to DNA constructs has been successfully used to improve 
uniformity of expression in transient assays and between transgenic lines, but did not 
improve germline transmission rate (Hsiao et al., 2001). At present, the most active areas 
of development in zebrafish transgenesis include transposons, sperm-mediated transgenesis 
and co-injection with meganucleases. Firstly, a reconstructed transposon (Sleeping Beauty) 
and an active medaka transposon (Toll) have both been used successfully to integrate 
reporter constructs into host cell DNA. Reported experiments demonstrating this are 
limited to in vitro integration into cultured cells for the former transposon (Ivies et al., 
1997), and transposition of both an endogenous medaka Tol2 transposon into zebrafish 
(Kawakami et al., 2000) and an engineered Tol2 transposon carrying a p-actin GFP
reporter into medaka (Koga et al., 2002). Application of this technique to reporter 
transgenesis in zebrafish is yet to be reported, and as such its value to the field remains 
unknown.
A second approach developed for efficient germline transgenesis is an adaptation of 
one used for Xenopus transgenesis. This involves incubation of decondensed sperm nuclei 
with linear DNA prior to in vitro fertilisation of eggs, and has been used to generate 
embryos expressing GFP under both exogenous (Xenopus efla) and endogenous (HuC) 
promoters. These embryos showed exceptionally good coverage of expression, which 
might in future obviate the need for screening potential founders and establishment of 
transgenic lines (Jesuthasan and Subburaju, 2002). In fact all surviving fish raised to 
adulthood did indeed transmit the transgene to offspring indicating this method might also 
prove to be an efficient way of generating transgenic lines, although it might require a 
higher level of technical expertise than for simple microinjection.
Finally, a promising technique recently developed promotes highly efficient 
transgenesis using restriction enzyme mediated integration (REMI). Flanking a reporter 
construct with recognition sites for the meganuclease I-Scel and then co-injecting this into 
one-cell stage medaka embryos with the I-Scel enzyme gave much improved expression 
levels and rates using actin reporter constructs, with subsequent germline transgenesis rates 
of up to 50% (Thermes et al., 2002). Although not yet published, others have reported 
similar success in zebrafish with this method.
There are currently very few GFP lines which have reported expression in the neural 
crest. As mentioned earlier, the FoxD3:GFP transgenic line shows expression in neural 
crest fates including pigment-cell precursors and PNS glia, however the extent of 
expression in premigratory neural crest cells is not reported, although its message is 
detectable here (Gilmour et al., 2002b). Secondly, the fliliEGFP transgenic line shows 
expression in ectomesenchymal cranial neural crest derivatives from 2dpf, including the 
branchial arches, and later in the jaw and pectoral fin cartilage, however no expression was 
reported earlier in neural crest development, nor in any other neural crest derivatives. 
Thirdly, both mouse and zebrafish Cx43alpha 1 promoters drive reporter expression in 
zebrafish neural crest, however this was only demonstrated in transient assays (Chatteijee 
et al., 2001). Finally, the Lefl/f3-Catenin dependent GFP reporter line shows a complex 
expression pattern throughout the embryo, due to it possessing a Wnt signalling responsive 
promoter. Amongst a number of other domains, expression is seen in medially (but not 
laterally) migrating neural crest cells, but does not appear earlier in premigratory neural 
crest (Dorsky et al., 1998).
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Thus a transgenic line showing expression in premigratory neural crest is not yet 
described and would prove a valuable tool to the field of neural crest research. The known 
expression domains of soxlO (Section 4.1.3) make its promoter an excellent candidate for 
driving GFP expression in this cell type and derivatives.
Table 4.1: Summary of zebrafish germline transgenic reporter lines
Promoter Reporter Expressiondomains
Rate of 
transmission Notes and References
SV40 early Hygromycin Not expressed 5% (by Southern)
First demonstration of germline 
transgenesis in zebrafish; (Stuart et al, 
1988)
RSV-LTR CAT Positive (CAT assays) -5%
In vivo expression demonstrated; 
(Stuart el al, 1990)
efla  (.Xenopus) GFP Ubiquitous 5-9% First use of GFP in zebrafish; (Amsterdam et a l , 1995)
GATA-1 (zebrafish) GFP Erythroid lineage -1% First use of an endogenous zebrafish promoter; (Long et al, 1997)
a,fi-actin (zebrafish) GFP Muscle, ubiquitous 21%, 8% (Higashijimae/fl/., 1997)
CMV Luciferase Ubiquitous 43%
Directing DNA to the nucleus via a 
NLS increases transgenic rate; (Collas 
and Alestrom, 1998)
efla  (Xenopus) GFP Ubiquitous 10%
Retroviral vector infection. (Linney et 
al, 1999) compared efficiency using 
this method with injection.
ragl (zebrafish) GFP Lymphoid & olfactory organs
?
An engineered PAC revealed distant 
repression elements; (lessen et al, 
1999)
shh (zebrafish) GFP Retina and other shh expression domains
?
Upstream promoter and intronic 
elements required for expression. 
Demonstrated a wave of shh expression 
across the retina; (Neumann and 
Nuesslein-Volhard, 2000)
HSP70 (zebrafish) GFP Heat Inducible -2%
Can be induced in single cells by laser 
and used for fate mapping; (Halloran et 
al, 2000)
HuC (zebrafish) GFP All neurons ~2% Detected muscle repression elements; (Park et al, 2000)
islet-1 (zebrafish) GFP Cranial motor neurons ~3% (Higashijima et al, 2000)
Histone H2A.F/Z 
(zebrafish) GFP fusion
All nuclei and 
chromosomes 4%
Histone promoter driving a histone- 
GFP fusion; (Pauls et al, 2001)
Rod opsin 
(zebrafish) GFP Rod Photoreceptors 4% (Kennedy et al, 2001)
deltaD (zebrafish) GFP Mesoderm, somites, neural domains ?
Numerous lines allowed detailed 
dissection of the promoter; (Hans and 
Campos-Ortega, 2002)
pax2.7 (zebrafish) lacZ, GFP
MHB, intemeurons, 
pronephros, ear and 
hindbrain
9%
Used transient transgenic analysis to 
identify c/s-elements, and then 
germline transgenics for analysis in 
mutants; (Picker et al, 2002)









<1% Trangene provided a readout of active Wnt signalling; (Dorsky et al, 2002)
f l i l  (zebrafish) GFP Vasculature, jaw arches 15% (Lawson and Weinstein, 2002)
Keratin8 (zebrafish) GFP Skin and certain epithelia 16% (Gong et al, 2002b)
foxd3 (zebrafish) GFP
Pigment cells, PNS 
glia and pineal 
gland
?
The first neural crest expressing line in 
zebrafish. Used to analyse PNS glia 
behaviour (Gilmour et al, 2002b).
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4.1.2. Introduction to PAC/BAC engineering
4.I.2.I. Recombinogenic targeting techniques
The development of large insert genomic vectors and their use in genome studies has 
allowed analysis of large genes, gene clusters and regulatory regions located large 
distances from coding sequences. Crucial to this is the ability to modify or engineer the 
inserts to introduce reporter genes and perform deletions or substitutions. This is 
particularly important in cases where conventional cloning of small promoters has failed to 
yield all the expression domains of a given gene. A number of techniques for modifying 
BACs and YACs have been developed, all based on recombination of DNA sequences 
(reviewed in Giraldo and Montoliu, 2001). A brief description of some of the methods 
developed for recombinogenic engineering of BACs and PACs is presented here.
Unlike YACs, PACs and BACs reside in recombination deficient host cells. Thus one 
initial requirement for recombination based engineering is either conferring homologous 
recombination competence to the host cell transiently, or transfer of the BAC to a new 
recombination competent host. The first and most successful method is detailed in Section 
4.1.2.2., but other approaches have realised similar results. Jessen et al. (1998) have 
developed an approach which utilizes the capacity of short flanking DNA octamer 
sequences (Chi sites), engineered into a targeting vector to stimulate transfer of 
homologous DNA segments through the RecBCD recombination pathway. This requires 
the transformation of both the BAC and the targeting vector into recombination competent 
bacteria, but has the added advantage of only occurring through a single recombination 
event. The authors have used this to insert the gfp reporter gene into a BAC clone 
containing the zebrafish GATA-2 gene (Jessen et al., 1998) and into a PAC clone 
containing the zebrafish ragl gene (Jessen et al., 1999). Both these successfully gave GFP 
expression in transient or germline transgenic analysis.
Targeted insertion of the lacZ reporter into a PAC containing the zebrafish Hoxa-llb 
gene was accomplished with an alternative approach. This employed capture of the PAC 
into yeast by a specialised Shuttle vector. Once in yeast, where homologous recombination 
techniques are well established, the lacZ gene was readily targeted to the Hoxa-llb gene 
from a targeting plasmid. The modified PAC was then shuttled back into bacteria, from 
where DNA was prepared and subsequently transgenic mice produced. These successfully 
expressed the reporter in appropriate locations, demonstrating the conservation of 
regulatory elements between mouse and zebrafish (Chiu et al., 2000).
Other techniques employed for conferring transient recombination competence to BAC 
containing bacteria include the introduction of a defective X prophage containing the X red
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recombination genes under a temperature sensitive promoter. Once the prophage has been 
introduced to a bacterial cell and induced, the targeting cassette can be electroporated in as 
a linear PCR or plasmid fragment, and a one-step recombination event ensues. In this 
manner, a transgenic mouse strain carrying the ere gene under the control of a neuron 
specific promoter was produced (Lee et al., 2001).
Finally, another prophage based recombination pathway, namely RecE/RecT has also 
been used in a recombinogenic strategy termed “ET cloning”. A plasmid carrying these 
genes under inducible promoters is co-transformed into the BAC host cell, along with a 
linear targeting cassette (Zhang et al., 1998b). However this approach has proven to be 
technically challenging and many labs have failed to use it successfully. Attempts to 
improve the technique have been reported, but it does not appear to be the method of 
choice for modifying BACs (Giraldo and Montoliu, 2001; Muyrers et al., 2001).
The most widely used method relies on introduction of RecA, and is described below.
It is relatively simple to use and requires the transformation of a single construct to the 
original BAC host cell and has the advantage of not requiring the transformation of the 
PAC into a new bacterial or yeast strain as recombination is performed in the host strain.. 
The only slight inconvenience is the requirement of molecular detection of two subsequent 
recombination events.
4.1.2.2. RecA-dependant modification
Yang et al. (1997) were the first to report the homologous recombination based 
modification of a BAC, having used it to introduce the reporter gene lacZ into a BAC 
containing the mouse zinc finger gene RU49. Unlike conventional reporter constructs, this 
faithfully reproduced the endogenous expression pattern in transgenic mice. The technique 
has been used subsequently to produce transgenic mice containing other modified BACs, 
including those containing the a9 acetylcholine receptor (Zuo et al., 1999), p S S ^ 2 (John et 
al., 2001), RAG2 (Yu et a l, 1999), Mrf4/Mrf5 (Carvajal et a l,  2001 ),ATP7B (Bockukova 
et a l,  2003), and IL-8 (Wen and Wu, 2001) genes. The technique is the most widely used 
approach for modifying BACs and is clearly a simple and readily transferable protocol.
The technique is outlined in Figure 4.1, and uses a pop-in/pop-out approach via two 
successive homologous recombination events. These require the construction of a 
recombination cassette, which contains the sequence to be inserted into the BAC (such as a 
reporter gene), flanked by arms with sequences homologous to the target region on the 
BAC. This cassette is built in a building vector using standard cloning techniques and then 
transferred to a Shuttle vector (pSVl.itec^). Other essential features present on the latter 
vector include the TetR gene, which can be used as both a selectable and counter-selectable
Figure 4.1: Rec A-mediated strategy for targeted PAC 
modification
A shuttle vector is used to deliver the reporter gene to a precise site in the PAC via two 
homologous recombination steps. The GFP gene is indicated on the shuttle vector and 
is flanked by two homology arms, A* and B’, with homology to sites A and B in the 
PAC. This shuttle vector is created in a building vector before being transferred to the 
temperature sensitive shuttle vector, which contains both positive and negative 
selection markers and the RecA gene to confer recombination capability to the host cell. 
After transformation into the PAC host cell, recombination events occurring at either of 
the homology arms can be selected. Co-integrates thus produced are then resolved via a 
second recombination event and, depending on the homology arm through which this 
occurs, produces either the original PAC or the desired modified PAC.





marker, a temperature-sensitive origin of replication to allow for selection of co-integration 
events and finally the RecA gene, which confers homologous recombination ability to the 
normally recombination deficient BAC/PAC host strain.
The Shuttle vector is transformed into the BAC-containing host strain and selection of 
co-transformants performed using double selection of both Tet and the BAC selection 
(here, Kanamycin). Due to its temperature-sensitive origin of replication, the Shuttle vector 
(and hence Tet resistance) can only be maintained if these bacteria are grown at the 
permissive temperature. However integration of the vector into the BAC, mediated by 
RecA induced recombination, allows replication of these sequences from the BAC origin of 
replication at restrictive temperatures. Thus out of the population of co-transformants, co­
integrants can be selected for by growing on both selections and at the restrictive 
temperature (see Figure 4.1). As integration can occur at one of two homology sites, 
molecular characterisation can confirm the co-integrants and indicate site of integration.
Growing the bacteria on the BAC selection only then allows some to undergo a second 
recombination event to resolve the co-integrants. If this recombination occurs at the same 
site as the first event, then the co-integrants revert to the original target BAC. However 
recombination at the second homologous arm of the cassette will lead to replacement of the 
endogenous sequence with the marker (Figure 4.1). In either case, resolved BACs will 
have lost all regions of the Shuttle vector outside the recombination cassette, such as the 
TetR gene, the temperature-sensitive origin of replication and the RecA gene. Whereas co­
integrants were identified by positive selection for tetracycline resistance, resolution is now 
driven by selection against the TetR marker. This gene encodes a membrane bound protein, 
which acts to promote tetracycline exclusion from the cell and to aid its co-transport out of 
the cell. Present at high levels, this gene alters membrane properties such as structure and 
cation exchange rates (Stavropoulos and Strathdee, 2001). However this also confers 
sensitivity to certain chelating agents such as fusaric acid (Bochner et a l , 1980), and thus it 
is possible to select against tetracycline resistance by incubating the cells with the chelator 
fusaric acid. Colonies can then be tested for tetracycline sensitivity and should represent 
cells in which a second recombination event has resolved the co-integrants. These resolved 
BACs will include both the desired result (containing the reporter gene substituted into the 
BAC), and the original BAC (Figure 4.1). Identification of correctly resolved BACs is 
achieved through molecular analysis.
This method reported by Yang et a l (1997) has been recently improved by the same 
lab, offering an even quicker modification of BACs, and allowing efficient production of 
reporter constructs carrying large regions of a gene promoter sequence (Gong et a l ,
2002a).
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4.1.3. Summary of SoxlO expression patterns
4.1.3.1. Expression in the neural crest and its derivatives
Knowledge of a gene’s expression pattern is, amongst other criteria, critical to 
understanding its role in development. The SoxlO expression pattern has been described in 
a number of species and cell lines using a combination of Northern, in situ, 
immunostaining and transgenic reporter analysis. New sites of expression are being 
continually uncovered, highlighting the fact that many analyses are not complete and that 
many domains are overlooked. A summary of in vivo expression patterns in all species 
analysed to date is given in Table 4.2, including data accrued from in situ analysis and 
information revealed by a mouse lacZ line. Additionally, a summary of SoxlO Northern 
experiments is presented in Table 4.3.
SoxlO expression patterns have been most extensively analysed in the mouse using 
immunostaining, Northerns, in situ hybridisation and a lacZ transgenic knock-in. The latter 
two techniques showed that expression is first seen in edges of the lateral plate and in the 
pre-migratory neural crest at approximately E8.5 (Britsch et al., 2001; Kuhlbrodt et al., 
1998b). Later, expression was confined to migrating neural crest contributing to peripheral 
nerves and ganglia, presumably glia, whilst it was downregulated in other neural crest 
derivatives during migration. Thus at E9.5, expression is described in both dorsal root and 
a number of cranial ganglia. Of the latter, the first to indicate SoxlO expression are the 
trigeminal (V), the facial (VII) and the acoustic (VIII) ganglia, and later (at E l0.5) all 
cranial ganglia and nerves express SoxlO, as do sympathetic ganglia. SoxlO signal in 
enteric ganglia is detected from E12.5, when expression in peripheral nerve fibres of the 
limbs is also prominent (Herbarth et al., 1998; Kuhlbrodt et a l, 1998b; Pusch et a l, 1998; 
Southard-Smith et al., 1998).
This early SoxlO expression pattern is well conserved with that of other species, 
although minor differences are described. Thus human SOXIO expression is seen in neural 
crest cells at 4 weeks, including some cranial ganglia, with expression at 6 weeks seen in 
all cranial ganglia, DRGs, spinal nerves, the sympathetic ganglia chain and enteric ganglia. 
Interestingly, SOXIO expression was also noted in the cephalic neural crest derivatives 
which later form cartilage rudiments of the nasal bone (Bondurand et al., 1998; Touraine et 
al, 2000).
The chick cSoxlO expression pattern reveals similar expression patterns to those of 
mammalian SoxlO genes, namely expression in premigratory neural crest, as well as 
migratory neural crest with expression retained only in the subset of neural crest 
contributing to the cranial ganglia, DRGs, sympathetic ganglia, nerve fibres, and later in
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enteric ganglia. Double labelling studies indicated that the cells labelled at these sites are 
non-neuronal (Cheng et a l, 2000).
Recently, the SoxlO expression pattern in Xenopus was reported, and again shows 
expression in neural crest forming regions of the lateral neural plate as demonstrated by 
overlap with other neural crest markers such as Slug and Sox9. Following neural tube 
closure, SoxlO expression remains in neural crest in a premigratory position in both trunk 
and cranial regions. Interestingly, in contrast to mouse, there is strong expression in 
migrating neural crest cells within the branchial arches (Honore et al., 2003). Expression in 
the head is later confined to the cranial ganglia and otic vesicle, but the authors did not 
report maintenance of SoxlO expression in any other neural crest derivatives such as trunk 
PNS glia (Aoki et al., 2003).
Thus SoxlO expression is seen in the neural crest from an early stage in all species 
studied, and appears to be maintained in glial derivatives thereof, including dorsal root, 
sympathetic, enteric and cranial ganglia, although expression in neuronal precursors at 
early stages cannot be categorically ruled out, based on current reports.
4.1.3.2. Expression outside the neural crest
Expression of SoxlO has been reported in sites outside neural crest. This includes the 
otic vesicle, which maintains strong expression from early stages in all species, and the 
CNS. Northern analysis of human samples at adult stages indicates high levels of 
expression at various sites as listed in Table 4.3 and includes expression in the spinal cord 
and brain, particularly in the medulla and corpus callosum. Weaker expression was also 
detected in all brain regions analysed including the cerebellum, occipital pole, frontal lobe, 
thalamus, hippocampus, substantia nigra, cerebral cortex, and major brain nuclei (Pusch et 
al., 1998). Northern analysis also detected fetal expression in the developing brain, and 
faintly in the lung and kidney (Bondurand et al., 1998; Southard-Smith et a l, 1999a).
Similar northern results were obtained with mouse and rat samples, with transcripts 
detected during embryogenesis and in adult colon, heart, lung, muscle, testes and brain 
(Table 4.3). At the latter site, transcripts were detected in all regions tested, in particular in 
the cerebellum, pons, olfactory bulb, hippocampus, cerebral cortex and midbrain 
(Kuhlbrodt et al., 1998b; Southard-Smith ef a l, 1999a; Southard-Smith et a l, 1998). 
Greater detail of expression patterns was obtained through in situ analysis of sectioned 
adult and embryo rodent brains, and correlated with regions containing a high content of 
myelinated fibres. Strong SoxlO expression in the otic and nasal placodes is seen in mouse 
from E8.5 and E l0.5 onwards respectively (Kuhlbrodt et al., 1998b). Elsewhere in the 
CNS, strong expression was seen in the spinal cord, adjacent to the ventricular zone,
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probably oligodendrocyte precursors (Kuhlbrodt et al., 1998b). X-gal staining of the 
SoxldacZ strain confirmed this CNS expression pattern (Britsch et al., 2001; Stolt et al., 
2002). In situ analysis of human fetal brain also showed expression in the otic vesicle and 
in nonneuronal cells of glial rich regions including the cerebellum, hippocampus (Touraine 
et al., 2000).
Chick in situ analysis demonstrated expression in the ventricular zone of the spinal 
cord as well as in the pineal organ. In addition, strong cSoxlO expression is also described 
in the otic vesicle (Cheng et al., 2000). Subsequent analysis has shown expression of 
cSoxlO in the septa, valves and glia of the innervating nerves of the developing heart 
(Montero et al., 2002), and expression in the condensing mesenchyme within the digits and 
nerves of the limbs (Chimal-Monroy et al., 2003). Expression in condensing mesenchyme 
of the limbs has also been reported in the Soxl(jacZ strain (Britsch et al., 2001).
4.1.3.3. Zebrafish soxlO expression pattern
Analysis of sox 10 expression in zebrafish by in situ hybridisation has revealed a pattern 
which is comparable to that just described for other species. Expression is first detectable 
at 2 somite stage (~1 lhpf) as two stripes in the lateral neural plate, in a position consistent 
with neural crest progenitors. The two stripes meet medially and dorsal to the neural tube 
as the cells converge, to form premigratory neural crest cells, sox 10 expression is 
maintained in these cells and follows an anterior to posterior progression as neural crest 
develops, with the posterior extent of expression expanding towards the tail with time. By 
approximately 18 somite stage (~18hpf), expression in premigratory neural crest extends 
along the entire axis of the embryo. To determine if sox 10 labels all premigratory neural 
crest, double in-situ analysis was used with sox 10 in combination with foxD3, which 
demonstrated that foxD3 expression precedes sox 10 in this domain and that overlap was 
extensive but incomplete (Dutton et al., 2001). Similar analysis with sox9a indicated very 
little overlap of sox 10 and sox9a in the embryo, restricted to the otic vesicle. No expression 
of sox9a was evident in premigratory neural crest. sox9b, in contrast, mostly overlapped 
with sox 10 here (Pauliny, 2002). sox 10 expression is maintained in migrating neural crest 
cells from 14 somite stage (~16hpf) on the medial pathway, and is rapidly downregulated 
in cells on the lateral pathway from this stage onwards. Nonneuronal cells expressing 
sox 10 were also seen associated with the cranial ganglia, presumably neural crest derived 
glia, whilst some expressing cells remained adjacent to the notochord in a medial position 
within each somite segment at 35hpf, in a position consistent with Schwann cells along the 
spinal nerves. There was no expression of soxlO in the neural crest streams in the branchial 
arches, but cranial cartilage cells did express sox 10 at 48 and 60hpf. Enteric nervous
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system precursors expressed sox 10 at 24hrs and can be seen as a stream of cells migrating 
posteriorly along the gut (Elworthy et al., in prep.). At 60hpf, soxlO positive cells can be 
seen around the gut epithelium (Dutton et al., 2001).
Outside the neural crest or its derivatives, strong expression in the otic placode 
commences at around the 12 somite stage, (~15hpf), which remains until at least 60hpf. 
Expression is seen in the pectoral fin endoskeletal disk at 48 and 60hpf, and additionally, is 
reported at 24hpf in the ventricular layer in the hindbrain. Later sox 10 is seen in the spinal 
cord, forebrain and midbrain, although the identity of these cells is not yet clear. There is, 
however, good evidence for sox 10 expression in oligodendrocytes and their precursors 
from 48hpf onwards, first seen where they are bom in the ventral spinal cord (Park et a l , 
2002; Pauliny, 2002).
Table 4.2; Summary of SoxlO in situ and lacZ expression studies
Organism
Mouse Mouse Mouse Chick Human Xenopus Zebrafish Zebrafish
Expression site Stage (in situ) SoxlO lacZ/+ (in situ) (in situ) (in situ) (in situ) Stage
Neural Plate E7.5 - nr + nr - + 1 som
Premigratory neural crest E8.5 + + + + + + 1 som -
Otic Vesicle E8.5- + + + (NN) + + + 12 som -
Migrating neural crest E9.5 + + + + + + 14hpf-
Neural crest in branchial arches E9.5 - - - + + - 20hpf
Dorsal Root Ganglia E9.5- + + + (NN) + nr nr 24hpf-
Cranial Ganglia E9.5- + + + (NN) + + + (NN) 24hpf-
Spinal Nerves E10.5- + + (S) + + nr + 24hpf-
Sympathetic ganglia E10.5- + + + + nr nr 24hpf
Cardiac autonomic ganglia E10.5- nr + + nr nr nr 24hpf
Cardiac septa, valve endothelia E10.5 nr nr + nr nr nr 24hpf
Plexi of fore/hindlimbs El 1.5- + +? + nr nr nr 24hpf
Pineal organ El 1.5- nr nr + nr nr + 24hpf
Olfactory Bulb E12.5 + + nr + nr nr 24hpf
Enteric Nervous system E12.5- + +* + + nr + 24hpf
Melanoblasts E12.5 + + nr nr + + 30hpf
Limbs/Fins mesechyme/cartilage E12.5 +? + + nr nr + 48hpf
Developing facial cartilage E12.5 nr nr nr + - + 48hpf
Spinal cord (ventricular zones) E13.5- + + + nr nr + 48hpf
Brain and/or Oligodendrocytes E14.5- + + + + + + 48hpf
Organism studied and method used to determine expression pattern is given above, (+) indicates
expression noted in this site, (-) indicates no expression seen and (nr) indicates either not reported or not 
examined. (NN) designates expression is in non-neuronal cells at this site as shown by a double staining 
approach, and (S) indicates that this expression has been shown to be in Schwann cells. (*) indicates that this 
cell type is much reduced in heterozygous SoxlCfacZ mice due to haploinsufflciency. (?) marks sites where 
expression has been suspected or is masked by overlying expression. Sites of expression are listed on the left 
in approximate chronological order of commencement of SoxlO expression. Corresponding mouse and 
zebrafish stages are presented on the left and right respectively. See text for more detail and associated 
references.





Whole Embryo Ell-12.5 nr +
Whole Embryo E15-16.5 nr +
Intestine E17-19.5 nr +
Brain CO + nr
Lung 3V + nr
Kidney P h + nr
Brain + +
Cerebellum + + (low)
Oligodendrocytes nr +
Olfactory bulb nr +
Small intestine + nr
Colon + +
Heart + -
Bladder ■*-> + nr
Spinal Cord T3< + nr
Stomach + (low) nr
Pancreas acini + (low) nr
Skeletal muscle + (low) +
Adrenal Gland + nr
Lung - ?
Prostate + nr
Testes + (low) -
Table is presented as per Table 4.2. (?)-Indicates conflicting reports as to presence or absence of expression 
at this site. See text for associated references.
4.I.3.4. SoxlO expression in SoxlO mutants
Analysis of the sox 10 expression pattern in els embryos indicated a severe disruption to 
neural crest migratory ability at 24hpf, with a relative increase in cells seen dorsal to the 
neural tube. Additionally, soxlO positive cells associated with cranial ganglia and nerves 
were reduced in els. Prior to this, no overt differences in expression pattern could be 
detected between els embryos and their siblings. Later, although the lateral migration 
pathway showed a reduction in migrating sox 10 positive cells in els, a comparable number 
of cells were seen migrating on the medial pathway. Maintenance of expression in 
segmental medial clusters of cells (putative Schwann cells) was much reduced in els 
(Dutton et al., 2001). No expression was visible in the enteric nervous system in els 
embryos at 60hpf. Loss of sox 10 expression on the lateral pathway and in the ENS has 
been shown by labelling studies and use of other markers to be due to absence of cells, not 
just SoxlO disregulation (Dutton et al., 2001; Kelsh and Eisen, 2000).
Aside from the neural crest and its derivatives, sox 10 expression was largely unaffected 
in els mutants. Thus expression in the spinal cord, brain and cartilage cells was not 
obviously affected. Ear expression, however is downregulated after 40hpf (Pauliny, 2002).
The disruption to the soxlO expression pattern in els is similar to that seen in mouse 
Sox JO mutant embryos. There appears to be no difference in SoxlO expression in early 
neural crest between homozygous Dom mutants and their siblings. The migration of 
mutant neural crest cells was delayed however, and SoxlO expression was lost from all 
cranial ganglia and nerves, due to absence of neural crest derived cells at these sites. Some 
migrating SoxlO+ neural crest cells were evident in the trunk, in particular in medially 
placed neural crest derivatives associated with the DRGs, although at reduced levels. 
Although most of the wild-type expression pattern is not disrupted in heterozygous Dom 
mice, the overall level of expression appears reduced. There is a dramatic reduction in the 
number of SoxlO+ cells in the gut of heterozygous embryos, consistent with the dominant 
phenotype seen for this cell type. Similarly homozygous Dom embryos have no SoxlO+ 
cells populating the gut (Herbarth et al., 1998; Southard-Smith el al., 1998).
Defects in the SoxldacZ mutant line reflect those found in Dom mutants. Again, early 
neural crest was unaffected in both homozygous and heterozygous embryos, as shown by 
p-gal staining. SoxldacZ/ SoxldacZ embryos subsequently showed vastly reduced numbers 
of p-gal+ cells associated with cranial ganglia and nerves, peripheral nerves, the enteric 
nervous system and sympathetic primordium. In heterozygotes, P~gal+ cells were present 
in the proximal gut (at a reduced level), but absent in the distal gut (Paratore et al., 2002). 
An anterior-posterior gradient of staining in DRGs was notable in homozygotes, with a 
later decrease in overall size of the DRGs (Britsch et al., 2001; Sonnenberg-Riethmacher et 
al., 2001). The otic vesicle, cartilage and oligodendrocyte precursors all express p-gal in 
SoxldacZ/ Soxl(facZ embryos.
4.1.4. Aims
A transgenic line containing a soxlO GFP reporter gene would be an extremely useful 
tool for studying both sox 10 gene regulation and visualising neural crest behaviour in vivo, 
allowing pursuit of many of the experiments outlined above. With the ultimate aim of 
eventually producing such lines, isolation of the sox 10 promoter was commenced.
4.2. R e su l t s
4.2.1. Generation of a fine map of the gene region
To characterise the sox 10 genomic region in more detail and to allow subcloning of the 
promoter, a finer restriction map was derived from a combination of Southern analysis (not 
shown) and the soxlO PAC I sequence. This map is shown in Figure 4.2, where a selection 
of sites found are shown, and indicates that there are a number of useful sites for promoter 
cloning in the upstream region of the gene. For initial sequence verification of the presence 
of sox 10 sequence in the PACs (not shown), a number of subclones were made from PAC 
L, and these are drawn in the lower part of Figure 4.2.
4.2.2. Subcloning o f soxlO upstream sequence
Based on the new map information, attempts were made to clone a fragment upstream 
of the soxlO gene. Note that the position of the SpeI site adjacent to the ATG of soxlO 
(Figure 4.2) is ideal for reporter construct cloning, as it allows inclusion of almost all the 
5’UTR, which has been suggested to be crucial in maximising reporter expression from 
other zebrafish promoters (Long et al., 1997). In order to subclone part of the soxlO 
promoter, the 4.9kb BamHl-Spel fragment (Figure 4.2) was isolated from PAC L by gel 
purification and successfully cloned into pBluescript™ II also cut with BamHl and Spe I. 
The resulting plasmid, pBSp4.9, is represented in Figure 4.2, and was used for subsequent 
generation of a GFP reporter construct. The sox 10 gene contains a 2.1 kb intron in the 
375bp 5’UTR putting the estimated start of transcription 2.5kb upstream of the ATG. Thus 
the amount of sequence 5’ to the transcription start site present in the 4.9kb BamHl-Spel 
fragment is approximately 2.4kb.
4.2.3. Production o f reporter constructs
4.2.3.l . p4.9:GFP
To produce a GFP reporter construct, the 5’ region of the zebrafish sox 10 gene present 
in pBSp4.9 was cloned into the XLT.GFPlt CS2+ plasmid (see Figure 2.2), kindly 
provided by Randall Moon (University of Washington), which contains a gene encoding an 
enhanced GFP. Briefly, both pBSp4.9 and XLT.GFPlt CS2+ were digested with Sail and 
Xbal, and the appropriate bands isolated by gel extraction following gel electrophoresis. 
These fragments were ligated together resulting in replacement of the CMV promoter from 
the latter plasmid with the 5’ soxlO gene sequence. This places the ATG of the GFP gene
Figure 4.2: Map of soxlO genomic region
Upper Section: Depiction of total cloned region surrounding sox 10. Known Sail (S) 
and Notl (N) sites, based on combined PAC restriction maps (see Figure 3.3), are 
shown with sizes in kb (Sail fragments at the far right are unordered, see Figure 3.3). 
Total cloned DNA is approximately 116kb. Dashed lines at ends represent uncloned 
flanking genomic DNA. As previously (Figure 3.3), arrow shows position and 
orientation of the soxlO gene.
Lower Section: Detail of the soxlO gene and upstream region. From sequence 
information and Southern analysis, the position of sites for certain restriction enzymes 
were deduced and are depicted thus: Sail (S), Spel (Sp), Ncol (Nc), EcoRV (RV), 
BamHl (B), EcoRl (E). Above this map is the predicted intron/exon structure, with 
exons depicted as boxes. Of these, grey boxes represent the soxlO open reading frame, 
the black boxes represent regions of the gene encoding the HMG domain, whilst empty 
boxes represent the 5’ and 3’ untranslated regions. Arrow depicts the predicted start of 
transcription, and the relative position of the Sal 15 primer is indicated with an 
arrowhead.
Below restriction map are the positions of the various subclones made from PAC L, 




in an identical position relative to the normal position of the ATG in the soxlO gene, thus 
very closely mimicking the environment found in the endogenous sox 10 promoter, 
however it substituted the sequence preceeding the start codon (GGACCG) with the Xbal 
recognition sequence (TGTACA). As this sequence in the sox 10 gene was non-coding and 
far removed from the transcription start site, it was deemed to be unlikely to have 
significant influence on expression of the reporter. The resulting plasmid was called 
p4.9:GFP and a crude restriction map is shown in Figure 4.3a.
To determine if it contains functional sox 10 promoter sequence, p4.9:GFP was injected 
into early cleavage embryos, and then viewed after neurulation by fluorescent microscopy 
for GFP expression. Figure 4.3b shows an example of a 20hpf embryo injected with 30pg 
of p4.9:GFP before the 1-cell stage. Neural crest cells can be seen dorsally in the head, 
trunk and tail in a premigratory position (arrowheads). Some of the most anterior neural 
crest cells expressing GFP appear to be beginning to migrate ventrally. An example of a 
neural crest cell is given inset in Figure 4.3b, demonstrating the stellate morphology 
associated with this cell type. Thus these transient analyses have shown that the promoter 
fragment used here appears to mimic the sox 10 expression pattern, and can drive GFP 
expression in the neural crest. Note however that expression is seen in muscle fibres 
(arrows), a site not expected based on the in situ pattern and which thus appears to be 
ectopic. This ectopic muscle expression is also shown in Figure 4.3c, d (arrows), in 24hpf 
and 5dpf embryos respectively. The latter embryo also shows expression in the ear as 
expected based on the expression of soxlO (asterisk; Figure 4.3d). These transient analyses 
almost certainly do not describe the complete expression domains of this promoter. As 
there appeared to be ectopic expression, it was assumed that this promoter lacked 
repression elements and hence would render a germline transgenic line derived from this 
construct less useful for neural crest analysis due to masking effects by the muscle 
expression.
4.2.3.2. p6.1:GFP
It was hypothesised that increasing the amount of sox 10 upstream sequence in the 
reporter construct might lead to inclusion of repressors required for silencing promoter 
activity seen in muscle. An attempt to clone a larger sox 10 promoter fragment was made 
using the presence of the EcoRW site, approximately 6.1 kb 5’ to the start of translation (see 
Figure 4.2). PAC L was digested with EcoRV and Spel and an approximately 6kb band 
was gel purified following electrophoretic separation. This was cloned into pBluescript cut 
with the same enzymes to produce pRVSp6.1 (Figure 4.2). A cloning strategy identical to 
that for p4.9:GFP was then employed to introduce this promoter fragment upstream of GFP
Figure 4.3: Map and transient transgenic analysis of p4.9:GFP
a. A map of the reporter transgene present on p4.9:GFP with restriction sites shown 
(abbreviations as per Figure 4.2; X-XbaY). Those sites not derived from the soxlO gene 
but from the vector are shown in brackets. The start of transcription is shown (arrow) 
and the soxlO exons of the 5* UTR depicted as open boxes. From the start of 
transcription to the ATG is approximately 2.5kb including 375bp 5’UTR and a 2.1kb 
intron. This construct thus has approximately 2.4kb of sequence upstream of the start of 
transcription. The gfp gene is shown as a green box and the polyadenylation signal 
sequence is given as a hatched box.
Injection of this construct into early embryos in a transient assay directs expression of 
GFP in a number of cell types throughout development. As expected, this is mosaic in 
nature, with variable degrees of expression noted.
b. Upper panel shows a lateral view of an injected embryo at 20hpf viewed under 
fluorescent light. Premigratory and migrating neural crest cells can be seen in both the 
head and trunk (upper panel, arrowheads). An enlarged picture of a migrating neural 
crest cell is shown inset. However ectopic expression was noted in a few sites including 
muscle fibres (upper panel, arrows). .
c. A further example of muscle (arrow) is shown in lateral views of a 24hpf injected 
embryo under fluorescent light (left panel) and overlaid onto an image of the embryo 
viewed under Normaski optics (right panel). A single muscle fibre can be seen 
expressing GFP.
d. Expression in muscle cells remains until at least 5dpf. A lateral view of an injected 
embryo at 5dpf under fluorescent light, showing expression in muscle fibres (arrows) 







in XLT.GFPlt CS2+. Thus both pRVSp6.1 and XLT-GFPLt-CS2+ were cut with Sail and 
Xbal, and the appropriate bands isolated and ligated together to produce p6.1 :GFP, a map 
of which is shown in Figure 4.4a. This construct contains approximately 50% more 
sequence upstream of the start of transcription compared to p4.9:GFP, with addition of an 
extra 1.2kb (Figure 4.4a).
As before, transient analysis was then conducted to see if  this reporter could direct GFP 
expression in a sox 10 pattern and if it also gave ectopic expression in striated muscle cells. 
As can be seen in Figure 4.4b, GFP expression was again driven in neural crest cells 
(examples at 30hpf are shown in Figure 4.4b arrowheads; also in Figure 4.4c), however 
expression was also noted in muscle fibres (arrows, Figure 4.4b and c). Again, expression 
in the ear was evident from at least 30hpf onwards in epithelial cells of the otic vesicle 
(Figure 4.4c, asterisks). This expression in the ear is shown in a 5dpf embryo (Figure 4.4d, 
asterisk), where jaw cartilage expression was noted as well (see also Figure 4.4e). 
Expression at this site is in accordance with in situ data, which describes sox 10 expression 
beginning at 48hpf in this cell type and remaining until at least 60hpf (Pauliny, 2002). This 
transient GFP analysis thus demonstrated that the sox 10 promoter used here is probably 
active in the ear and jaw until later than previously described. However expression in 
muscle was again noted.
Due to the ectopic expression of this reporter in muscle, it was again assumed that 
repressor elements were not included in either the p6.1:GFP or p4.9:GFP constructs, and 
that the muscle expression would render any germline transgenic line produced with these 
reporters useless. To attempt to produce a larger reporter construct that might include all 
promoter and enhancer elements, a PAC engineering approach was commenced.
4.2.4. Engineering o f a soxlO PAC
Due to the ectopic expression seen in the plasmid-based sox 10 promoter constructs, it 
was decided to attempt to increase further the amount of sequence surrounding the sox 10 
reporter gene in the hope it would include repressor elements and more accurately 
reproduce the endogenous expression pattern. Modifying a PAC using the method outlined 
in Section 4.1.2 .2. above and described in Yang et al. (1997) was attempted. This was 
selected over other approaches due to a personal recommendation and an offer of 
necessary reagents (Dr. Rosalind John, University of Cambridge, pers. comm.).
4.2.4.1. Production of the Building and Shuttle vectors
Recombination of the GFP marker gene into a PAC first required construction of a 
recombination cassette, which was achieved in a building vector. The cassette needed then
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Figure 4.4 Map and transient transgenic analysis of p6.1:GFP
a. Map of the reporter transgene present in p6.1 :GFP, which includes approximately 50% 
more sequence upstream of the start of transcription than p4.9:GFP (now 
approximately 3.6kb). This was hoped to include repressors of the ectopic muscle 
expression seen earlier. Annotations are as per Figure 4.3.
This construct was injected into early embryos in a transient assay to assess expression 
domains of the larger promoter region.
b. A magnified lateral view of the anterior dorsal trunk of an injected embryo at 
approximately 30hpf. Again a migrating neural crest cell shows strong fluorescence 
(arrowhead), however this promoter also appears to direct expression in muscle fibres 
in transient assays (arrows).
c. A lower power image of the head of the same embryo, indicating expression in the otic 
vesicle (in particular, the otic epithelium, asterisks), muscle (arrow) and neural crest 
cell above the eye (arrowhead). Right panel shows the fluorescent image overlaid onto 
a brightfield image of the embryo.
d. Occasional embryos showed expression in jaw elements. This image shows a 5dpf 
embryo injected with p6.1 :GFP in a lateral view. Expression at 5dpf is clear in the ear 
(asterisk), and also in the jaw (arrowhead).
e. Viewed ventrally, it is apparent that in this embryo (in d.), the left jaw elements 
(arrowhead) show good expression and coverage of the transgene, sox 10 in situ 






to be transferred into the Shuttle vector pSVl.itecvf, kindly provided by Dr. Rosalind John 
(University of Cambridge) with permission granted by Nat Heintz (Rockerfeller Institute, 
NY). The recombination cassette contained the gfp gene flanked by recombination arms, 
which needed to be at least 500bp in size and with homology to the region flanking the 
target site on the PAC. It was decided to introduce the gfp gene at the same site as in the 
small constructs. This aided cloning of the cassette, as well as meaning the start of 
translation of the reporter is close to that of the sox 10 protein as previously described. This 
also maximised comparability with the plasmid constructs. The cloning strategy used is 
presented in Figure 4.5.
The 5’ homology arm (“A”) was isolated by PCR from pBSp4.9. A 2.5kb fragment 
was amplified using the Sal 15 primer and the T7 primer of the pBluescript vector, the 
former primer being simply the S15 primer with a 5’ Sail site added for later cloning 
purposes (see Table 2.4; position shown on Figure 4.2). The 2.5kb fragment obtained is 
shown in Figure 4.6a and contains some of exon 1, all of intron 1 and exon 2 up to the Spe I 
site just before the ATG of the soxlO gene. After being cloned into pGEM-T Easy, this 
homology arm was cut out with Sail and Xbal (as shown in Figure 4.6b) and gel purified. 
p2.5GFP was then created by ligating this fragment into the XLT.GFPlt CS2+ vector, also 
digested with Sail -X b a l (Figure 4.6b), such that this homology arm replaced the CMV 
promoter in this vector and lay directly upstream of the gfp gene (Figure 4.5).
The 3’ homology arm (“B”) was a 1.2kb EcoRl -  Sail fragment which consisted of 
most of intron 2 and part of exon 3 up to the Sail site. This was subcloned from pE4.6 by 
gel purification into pBluescript giving the clone pES1.2 (Figure 4.2). Fortuitously, the 
1.2kb EcoRl -  Sail fragment in pES 1.2 was now flanked by the Notl and Apal site of the 
pBluescript multiple cloning site. These were used to cut out the homology arm from 
pES1.2, which was transferred to p2.5GFP, 3’ of the gfp gene, as Notl and Apal sites occur 
here in the correct orientation (Figure 4.6c). Note that this process also introduced a second 
Sail site to the very 3’ end of the recombination cassette, allowing it to be isolated as a Sail 
fragment. The building vector thus derived was called pBV and is shown in Figure 4.5, and 
was checked by restriction with Notl and Sail in comparison with p2.5GFP (Figure 4.6c).
Having produced the recombination cassette in the building vector it was now
necessary to transfer it to the Shuttle vector (pSVl .RecA). This was done by digesting pBV
with Sail and gel purifying the recombination cassette. This was ligated to pSV 1 .RecA
which had been cut with Sail and treated with Shrimp Alkaline Phosphatase to enrich for
recombinants. Transformation was performed with a 37°C 2 minute heat-shock and
bacteria grown on tetracycline selection at 30°C, to allow activity of the temperature-
sensitive origin of replication on the Shuttle vector. The resulting clone, pSVsox was
► 89Figure 4.5; Figure 4.6
Figure 4.5: Cloning strategy for generation of pBV and pSVsox
The first step towards engineering of GFP into a sox 10 containing PAC requires the 
generation of a shuttle vector carrying the GFP reporter gene surrounded by homology 
arms (see text for detail). The upstream homology arm was isolated by PCR using 
pBSp4.9 as a template and the T7 primer (priming from the vector) and a Sail5 primer, 
which represents the S15 primer with a Sail site added, and primes from within exon 1. 
The product produced (Figure 4.6a) was cloned into pGEM T-Easy (resulting plasmid 
p(SX)2.5 is shown in Figure 4.6b).
This product was cloned upstream of a GFP reporter, by isolating the product as a Sail 
-X bal fragment and cloning into XLT-GFPLt.CS2+, which has had the CMV 
promoter removed, also by Sail and Xbal digestion and gel purification of appropriate 
band. The resulting plasmid p2.5GFP is shown in Figure 4.6b, along with the donor 
plasmids. Fortuitously, this introduced Notl and Apal sites in correct orientation for 
cloning the EcoRl -  Sail fragment from pES1.2, which represents the 3’ homology 
arm. This was achieved by digestion of both p2.5GFP and pES1.2 with Notl and Apal 
and subsequent gel purification and ligation of the appropriate bands. This in effect 
introduces the EcoRl -  Sail 3’ homology arm downstream of the gfp gene. The 
resulting plasmid constitutes the Building vector, pBV. Note that the cloning steps 
mentioned leave Sail sites either side of the recombination cassette. This permitted 
cloning of the cassette into the pSV vector (Figure 2.1), which was also cut with Sail 
and treated with Shrimp Alkaline Phosphotase to promote recovery of recobinant 
clones. The resultant clone pSVsorwas analysed along with pBV and pSV by digestion 
with Sail, BamHl single and double digests (Figure 4.6), and indicated presence of all 
appropriate bands.
The GFP gene is represented by a green box, with non-coding exons fragments of the 
sox 10 gene represented as white boxes and the coding exon fragment from exon 3 
represented as a black box. Thick grey lines depict vector regions in all plasmids. On 
the shuttle vectors, the striped box indicates the temperature-sensitive origin of 
replication, the blue box indicated the tetracyline resistance gene and the yellow box 
shows the RecA gene. Thin black lines depict non-coding regions of the soxlO gene 
such as the introns or the promoter region. The CMV promoter present on XLT- 
GFPlt-CS2+ is similarly shown.
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Figure 4.6 Cloning steps of pSVSox
Production of plasmids towards the cloning of pSVsar. Letters of all panels refer to the 
corresponding steps in Figure 4.5. In all parts, M indicates lanes containing lkb ladder, 
with certain size bands indicted.
a. Lane 1: Product obtained by PCR using pBSp4.7 template and Sail5 and T7 primers. 
This product (arrow) contains the 3* half of exon 1, all of intron 1 and half of exon2 up 
to (but not including) the start of translation. This 2.5kb product will constitute the 
upstream (“A”) homology arm.
b. This PCR product was cloned into pGEM-T Easy, producing p(SX)2.5. Digesting this 
plasmid with Sail and Xbal (Lane 3) allowed isolation of the PCR product (arrow) and 
cloning into XLT.GFPlt-CS2+, similarly digested (Lane 1). This replaced the CMV 
promoter from the latter plasmid with the PCR product to produce p2.5GFP (shown in 
lane 2, also digested with Sail and Xbal).
c. Generation of pBV by introduction of the 3* homology arm into p2.5GFP. This arm 
comprises the 3’ half of intron 2 and the 5’ half of exon 3, and was isolated from 
pES1.2 by digestion with Notl and Apal (Lane 3, open arrowhead). This was ligated 
into p2.5GFP similarly cut (not shown) to yield pBV. This latter plasmid is shown in 
Lane 1, digested with Notl and Sail, which releases the 1.2kb 3’ homology arm, the 
2.7kb vector backbone and a 3.4kb fragment containing the 5’ homology arm and the 
gfp gene. p2.5GFP cut with Notl and Sail is shown in lane 2 for comparison.
d. Gel demonstrating the cloning of the approximately 4.6kb recombination cassette from 
pBV into pSV to produce pSVsar- This was achieved by isolating the cassette from 
pBV through Sail digestion and gel purification, and ligating to pSV similarly cut and 
treated with Shrimp Alkaline Phosphotase.
Lanes labelled with corresponding restriction enzyme digest above.
Lane 1: pSVsox- Lane 2: pBV. Lane 3: pSV
Sail digests of all three plasmids are shown in the first three lanes. pSVsox is 
composed of the 4.6kb recombination cassette from the pBV and the 1 lkb backbone of 
pSV. In addition, Xbal and double digests are also shown to demonstrate that all 
appropriate bands found in pBV are also present in pSVsor- In all cases, pSVsox is 
composed of the pSV backbone and bands from the recombination cassette. Note that 
some of the smaller bands of pSVsox are not visible on this gel due to insufficient 
loading, but their presence on the gel has been confirmed on other gels (not shown).

checked by restriction digest (Figure 4.6d). With the Shuttle vector now ready, engineering 
of a sox 10 containing PAC could be attempted.
4.2.4.2. Identification of co-integrants
The first step of engineering a PAC involved introducing the Shuttle vector to the PAC 
host. This was achieved by making the PAC containing bacteria competent through 
standard calcium chloride treatment. The Shuttle vector pSVsox was now transformed in, 
again using a 37°C 2 minute heat shock, and co-transformants grown overnight at 30°C on 
dual selection (Tet and Kan). This gave a large number (-200) of colonies per plate.
To select for co-integrants where the Shuttle vector had integrated into the PAC, six 
co-transformant colonies were plated on dual selection and incubated at the restrictive 
temperature overnight (43°C). To identify correct co-integrants, PAC DNA from twenty of 
the large colonies obtained was prepared by miniprep, and digested with BamUl. After gel 
electrophoresis and Southern blotting, the filter was probed with the 3’ homology arm,
“B” A simple schematic of the two possible co-integrant events are depicted in Figure 4.7 
a, b, and allows prediction of band sizes on the Southern blot. Thus integration events at 
the “A” homology arm will give bands on the southern blot of 11 kb and 7.8kb (Figure 
4.7a), whilst recombination occurring at the other homology arm (“B”) will give bands of 
17kb and 3.9kb (Figure 4.7b). As can be seen on the Southern blot (Figure 4.7c), seven 
clones appear to represent integration at the “A” site (#s 5, 8, 11, 12, 17, 18, and 20) and 
only one clone has a restriction pattern indicative of recombination occurring at the “B” 
site (# 19). The difference in relative frequencies of recombination between the two 
homology arms may be due to their difference in size and/or sequence specific preference 
for RecA-mediated recombination. One lane (14) had two bands that did not match those 
expected from either recombination event, and might represent an erroneous recombination 
event elsewhere in the PAC or bacterial genome. All remaining lanes had a band equal in 
size to the original PAC, and thus probably represent clones where co-integration of the 
Shuttle vector did not occur. That they were tetracycline resistant might be due to the fact 
that pSVsox has remained in the cell, and that it might be able to replicate at a low level in 
the PAC host cell due to incomplete stringency of the temperature sensitive origin of 
replication (as reported by Gong et al. (2002a)). To complete the engineering of the PAC, 
it was necessary to resolve the co-integrants.
4.2.4.3. Resolving co-integrants
All eight correct co-integrants were streaked onto kanamycin plates and incubated at 43 
°C overnight to allow resolution in some bacteria. To reveal resolved colonies, selection
Figure 4.7: Generation and identification of co-integrants
Transformation of pBV into the host cell containing PAC I, followed by plating on 
dual tetracycline and kanamycin and growing at 30°C, selected for co-transformants. 
Co-integrants were selected for by growth of single colonies at 43°C also on dual 
selection. Southern analysis was used to identify successful integration events, as 
follows.
a. Recombination occurring at homology arm “A” will yield a co-integrant clone with 
BamHl (Ba) fragment sizes indicated. Upper plasmid on the left represents the original 
PAC I, whilst the lower plasmid represents pSVsor, with the temperature sensitive 
origin of replication and recA gene indicated. The targeting cassette is shown with 
homology arms (A’, B’) and the gfp gene. The targeted site on the PAC is similarly 
shown, as are two BamHl sites that flank the targeted region. Crossed lines depicts the 
site of recombination at the A homology arm. The distance between the BamHl sites on 
PAC I is approximately lOkb. The co-integrant generated is shown on the right, and 
expected sizes of BamHl fragments are shown. These are, however, only a subset of all 
the bands generated, as the remaining sites in the PAC are not shown. Bands that would 
hybridise to a homology arm “B” probe are indicated with an asterisk.
b. Recombination occurring at homology arm “B” will yield a co-integrant clone with 
BamHl fragments as shown on the right. Note that these differ from the fragments 
shown in a., allowing differentiation of recombination events by Southern analysis.
c. Southern analysis of 20 putative co-integrant colonies. Following DNA purification, 
digestion with BamHl, gel electrophoresis and Southern blotting, correct co-integrants 
were identified by probing the blot with homology arm “B”. Co-integrant colony 
numbers are indicated above lanes and run along side DNA from the original PAC I 
also digested with BamHl. As shown in a. and b., the latter should give a hybridising 
band at approximately lOkb as seen in the final lane. A number of putative co-integrant 
lanes also show a single band of this size indicating that these do not represent clones 
containing the desired recombination event. However lanes 5, 8,11,12,17,18 and 20 
have the two bands expected from a recombination event at site “A” (namely 1 lkb and 
7.8kb), whilst one lane (19), had bands indicative of a recombination event at site “B” 
(17kb and 3.9kb). One lane (14) had two bands that did not match those expected from 
either recombination event, and might represent an erroneous recombination event 
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against the TetR gene was required. As previously discussed, this can be achieved by 
incubation with a chelator such as fusaric acid. Thus a number of putative resolved 
colonies from co-integrant #5 were incubated on Fusaric Acid and Kanamycin TB agar 
plates and derived colonies then tested for resolution (ie loss of tetracycline resistance). As 
all colonies grew on both Kan and Tet plates, it indicated that either the resolution did not 
occur or the fusaric acid mediated selection was ineffective. The latter seemed most likely 
as a control colony (an unresolved co-integrant) also grew on fusaric acid containing 
plates. Numerous attempts to optimise fusaric acid concentration for selection were 
undertaken. However they all proved unsuccessful and this approach was discontinued.
Another method for direct selection of Tetracycline sensitive colonies has been 
reported by Podolsky et al. (1996), who showed that the tetR gene confers sensitivity to 
nickel salts such as NiC^. Thus Kanamycin containing plates supplemented with 7mM 
NiCl2 were made, onto which both putative resolved colonies of co-integrant #19 and an 
original PAC I control colony were streaked out. After overnight incubation at 37°C, both 
plates showed no growth, so a titration series of lower NiCh concentrations was tried to 
test for differential survival based on genotype. Whereas high concentrations of NiCl2 was 
toxic to cells irrespective of genotype, low concentrations did not seem to produce any 
difference in survival between the control and experimental plates. At 2.4mM, there was 
approximately twice the number (30) of colonies on the control plate as on the putative 
resolved co-integrant plate. These sixteen colonies were tested for resolution by assessing 
if they were tetracycline resistant. Although all were Kan+, 5 out of the 16 were 
tetracycline sensitive, indicating possible resolution.
To test if this was the case, and to distinguish correctly resolved PACs from the 
original PAC, Southern analysis of PAC DNA from each clone was conducted. Figure 4.8a 
shows the sizes of some of the expected BamHl and SpeI fragments obtained by digesting 
resolved PAC DNA. It is evident that a correctly resolved PAC should contain the gfp gene 
(in contrast to the original PAC), as well as showing a smaller fragments hybridising with 
homology arm “B”. Accordingly, Southern analysis using a gfp probe indicated that only 
resolved clones #4 and 5 gave gfp hybridising bands of expected size, whilst the three other 
clones showed no hybridisation (Figure 4.8b). Stripping this blot and re-probing with the 
3’ homology arm, “B” (Figure 4.8b), supported the inference that colonies 1, 2 and 3 
appeared to have reverted back to the original PAC I, whilst colonies 4 and 5 were 
correctly resolved. Thus the first three clones had BamHl and Spe I bands of approximately 
lOkb and 8.8kb on this blot as expected, whilst clones #4 and 5 had smaller BamHl and 
Spe I bands of 3.8kb and 7.5kb (Figure 4.8b).
Figure 4.8 91
Figure 4.8: Resolving co-integrants to produce PACIGFP
Resolution of co-integrants was achieved by growth in kanamycin at the restrictive 
temperature (43°C), followed by selection on MCI2  containing agar (see text). Five 
colonies were obtained from selection of bacteria obtained from resolution of co­
integrant number 19 (the single co-integrant formed by recombination at site “B”), all 
proved to be kanamycin resistant and tetracycline sensitive as expected for resolved 
PACs.
a. Resolution of co-integrant #19 can occur, either through homology arm “B” again in 
which case it reverts to the original PAC I, or through the other homology arm “A”, as 
shown as crossed lines between the sites. The latter produces the desired targeted clone, 
shown below, where the first part of the soxlO coding region has been replaced by the 
gfp gene. This gene contains BamHl and Spel sites at its 3* end, such that Southern 
analysis and restriction polymorphisms can be used to distinguish between the two 
possible resolved PACs, which differ by the presence of this gene and these two novel 
sites in the targeted PAC. The original PAC I is also shown for comparison, and sizes 
of certain restriction fragments which hybridise to a gfp probe or the homology arm 
“B” probe are shown.
b. Southern blot of the 5 resolved PAC clones, digested as shown and hybridised with a 
gfp probe (left panel) or the homology arm “B” probe (right panel). In both panels, 
lanes containing the original PAC I, similarly digested, are shown for comparison. 
Lanes labelled M contain a lkb DNA ladder, with some bands and corresponding sizes 
indicated. The first three resolved PACs do not show hybridisation to gfp, whereas the 
last two (numbers 4 and 5) do. Fragment sizes are as expected (approximately a 5.9kb 
BamHl fragment and a lkb Spel fragment). The plasmid XLT-GFPlt-CS2+ is also 
shown as a positive control, which has been digested with Xbal and Notl to release the 
gfp gene. Upon using the homology arm “B” probe, the expected restriction fragment 
polymorphisms are obtained, such that the correctly resolved PACs have approximately 
3.8 and 7.5kb hybridising BamHl and Spel fragments respectively, whilst those which 
have reverted to the original form show 10 and 8.8kb bands using these restriction sites 
(compare to the PAC I control lane).
c. To check that the engineered PAC carried the modification desired, and not any gross 
rearrangements, RFLP analysis was performed to compare PACIGFP with the original 
PAC I. This was done using BamHl (B), EcoRl (E), Sail (S), Spel (Sp) and Xbal (X), as 
shown. It is clear that although some bands sizes are altered, many bands are common 
between the two PACs, suggesting no gross rearrangement has occurred.
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To ensure the transient presence of the recombinase in the PAC had not caused 
undesired rearrangements, restriction fingerprints of one of the modified PAC clones (#4) 
was compared to that of the original PAC. As can be seen in Figure 4.8c, although a 
number of bands are different between the original and modified PACs, as expected 
through modification, there are also a large number of bands in common, indicating that 
there has not been severe rearrangement of the PAC. It was thus concluded that the PAC 
represents a correctly modified construct, namely a GFP reporter flanked by approximately 
33kb upstream and 4 lkb downstream of the soxlO transcribed region. The modified PAC 
was named PACIGFP and a crude map, based on the known maps of PAC I and the 
recombination cassettes, is shown in Figure 4.9a.
To determine if the construct is functional as a sox 10 reporter, transient analysis was 
performed by injecting PACIGFP into 1-cell embryos and inspecting post-neurulation for 
expression. Figure 4.9b shows a 24hr embryo injected with approximately 30pg of 
PACIGFP, showing expression in head and trunk neural crest, as well as epithelium of the 
ear (enlarged inset; upper panel). In one embryo, expression was also noted in Schwann 
cells along the posterior lateral line nerve (Figure 4.9c). Note that expression is also 
evident in the ear (asterisk) and in migrating pigment cells such as a presumptive 
xanthophore (arrow). Expression was also noted in the CNS and jaw cartilage (not shown).
Surprisingly, expression in muscle was again apparent (Figure 4.9d). This was 
unexpected as it was assumed that the PAC construct would contain the muscle repressor 
element, which was missing in the smaller two constructs. Although it is feasible that such 
a repressor exists and lies outside the region included in the PACIGFP construct, it seems 
less likely with such a large construct. This ectopic expression might have other causes, 
other than lack of repressor elements. It is possible that repressor elements are present, but 
are unable to function effectively in an unintegrated state. This might be due to these 
repressors acting through a chromatin remodelling mechanism, and functioning only on 
chromosomal DNA. Alternatively, copy number cannot be controlled for in these 
experiments. The number of transgene copies inherited by each cell in these transient 
experiments might be beyond that which can be effectively silenced. With this in mind, it 
was hoped that germline transgenic embryos would not show this ectopic expression.
4.2.4.4. Linearising PACIGFP -  Generating PACIGFP2
To produce stable transgenic zebrafish carrying the PACIGFP construct, it was 
necessary to linearise the PAC. There are two rare cutting restriction sites reported in the 
backbone of the original PAC genomic library vector (pCYPAC6), Noil and l-Scel. The 
former site is present within both the soxlO gene sequence (see Fig. 3.3), and in the
Figure 4.9: Crude map and transient analysis of PACIGFP
a. A crude map of the engineered reporter PACIGFP is shown. This flanks the reporter 
gene (green box) with approximately 33kb of upstream and 4lkb of downstream 
sequence surrounding the sox 10 transcription region. Sites for Notl (N) and Sail (S) are 
shown, with those present on the vector sequence given in brackets. The approximate 
transcription start site is given as an arrow.
b. Images photographed under fluorescent light of transient assays performed using the 
PACIGFP construct to assess ability of the reporter to drive GFP expression, and the 
domains yielded.
An anterio-lateral image of an injected embryo at approximately 24hpf. Migrating 
neural crest cells are evident (arrowheads), as is expression in the otic placode 
(asterisk; magnified inset).
c. An example of an injected embryo at 2dpf. GFP is seen strongly in the ear (asterisk), as 
well as in migrating pigment cells in the head, over the eye and in the trunk. Striking 
expression is also seen in cells along the posterior lateral line. This was seen very rarely 
in transient analyses, but is consistent with the known expression of soxlO in this cell 
type. Fluorescent image is shown in the left panel, which is overlaid on a brightfield 
image in the right panel. The fluorescent image is magnified in the bottom panel, 
showing expression in cells with a morphological appearance of Schwann cells. 
Expression in a single xanthophore is also evident (arrow).
d. Surprisingly, muscle fibres were again GFP+. Fluorescent image is presented in the left 
panel of an embryo at 24hpf, with an overlay onto a brightfield image in the right 
panel.

transgene engineered into the PAC (Figure 4.5), and thus cannot be used to linearise the 
construct. The latter site is a 25bp recognition site for the intron-encoded meganuclease, I- 
SceI. Attempts to cut PACIGFP with this enzyme failed, despite the enzyme successfully 
cutting control DNA supplied by the manufacturer (not shown). It was decided to check 
the integrity of the site in the vector by sequencing. Primers PACF and PACR were 
designed to allow amplification of the region containing this site on the vector, and the 
resulting PCR product was sequenced directly (Figure 4.10a). There are clear discrepancies 
between the published sequence of pCYPAC6 and the derived sequence as shown by 
alignment in Figure 4.10a. The sequence boxed represents the l-Scel site and is clearly 
missing in the sequence obtained from direct sequencing of the vector. The likeliest 
explanation for this discrepancy is that the genomic library used was actually built in an 
earlier vector (such as pCYPAC2), which does not posses this meganuclease site (Figure 
4.10a).
To introduce restriction sites into the vector backbone of PACIGFP, the GPS™ -1 
Genome Priming System from NEB was employed. This is a transposon-based system 
which uses a transposase to transfer an engineered transposon from a donor plasmid 
randomly into a target plasmid, BAC or PAC. The transposon contains the 
chloramphenicol antibiotic resistance gene, allowing selection of product DNA molecules, 
as well as the meganuclease sites, I-*SceI and \-Ceu\, the introduction of which should 
allow easy linearisation of PACIGFP.
The reaction was performed as per manufacturers instructions using pGPS2.1 donor 
plasmid and the PACIGFP construct as a target, although with modification of product 
selection criteria. As insertion site is random, it was desirable to select for product 
molecules where the transposon integrated into the vector backbone of PACIGFP. 
Otherwise the transposon might disrupt a crucial regulatory region of the transgene and 
could affect the expression pattern. This directed approach was achieved by targeting the 
kanamycin resistance gene in the PAC vector. Thus, after transformation of the completed 
reaction into electrocompetent bacteria, selection for product molecules was performed 
solely on chloramphenicol, and not on dual selection of kanamycin plus chloramphenicol 
as recommended. The 115 colonies thus obtained were then tested for kanamycin 
sensitivity by replica plating on kanamycin plates. This identified any colonies which were 
chloramphenicol resistant but kanamycin sensitive due to insertion of the transposon into 
the KanR gene, thus disrupting its action and replacing it with CmR. As the kanamycin 
resistance gene is approximately 1 kb and PACIGFP is in total about 11 Okb, an insertion in 
the kanamycin gene was expected once approximately every 110 insertion events. This
Figure 4.10: Linearising PACIGFP via production of PACIGFP2
a. The integrity of the I-Scel site in the PAC vector was checked by PCR amplification of 
the region using primers PACF and PACR (Table 2.4), and subsequent sequence 
analysis of the product. Part of the sequence obtained is presented on the top line, and 
is compared to the corresponding sequence from the library vector (reported as 
pCYPAC6, lowest sequence) and an earlier version of the vector (pCYPAC2, middle 
sequence). It is clear that the PACIGFP vector lacks the l-Scel site as reported. It 
follows that the zebrafish PAC library was probably created in an earlier vector. To 
linearise the engineered PAC, a transposon-mediated introduction of unique sites was 
undertaken.
b. Following the re-engineering of PACIGFP to produce PACIGFP2, the ability to 
linearise the vector with l-Scel was tested. Shown is a PFG of single and double digests 
of PACIGFP2 cut with Xbal and/or l-Scel, along with uncut PACIGFP2 DNA.
Lane M: High Molecular Weight Markers; certain sizes shown.
Lane 1: Undigested PACIGFP2 
Lane 2: PACIGFP2 digested with l-Scel 
Lane 3: PACIGFP2 digested with l-Scel and Xbal 
Lane 4: PACIGFP2 digested WidnXbal
Whereas the undigested lane shows three bands, with additional bands due to 
supercoiled DNA species, the l-Scel cut DNA shows only one band of approximately 
correct size. Double digestion with Xbal showed a difference compared to the single 
Xbal digest lane, with a 38kb band (asterisk) present in the Xbal lane cut by l-Scel into 
24 and 14kb bands (arrows), further demonstrating successful digestion of the vector 
by l-Scel. No other Xbal bands were digested. Linearisation allowed attempts to 
generate a transgenic line carrying this construct.
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compares to the rate achieved experimentally as two of the 115 colonies tested were Kan 
sensitive.
The presence of the transposon in the vector of PACIGFP was confirmed by molecular 
techniques. PACIGFP2 DNA was digested singly with l-Sce\ and Xba and also doubly 
with both enzymes. These reactions were run on a PFG along with uncut PACIGFP2 DNA 
to check for the \-Sce\ site. This gel is shown in Figure 4.10b and clearly demonstrates 
both the presence of the site and that it can be used to linearise the construct successfully. 
This new construct was checked for functional ability to direct GFP expression in 
appropriate sites in the embryos. No difference in GFP expression pattern between 
PACIGFP and PACIGFP2 was evident in transient analyses (data not shown).
4.2.5. Production of transgenic zebrafish
As stated earlier, production of germline transgenics carrying a sox 10 GFP reporter 
would be of benefit to understanding the functions of sox 10 as well as a live label of neural 
crest cells. Towards this end, 3 reporter constructs have been produced and all show 
correct expression in a number of sox 10 domains in transient analyses. Unfortunately, they 
also drive expression ectopically in certain cell types such as skeletal muscle, and it was 
considered that this might be problematic for some of the experiments planned if this was 
still seen in the germline transgenics (e.g. GFP expression in all skeletal muscle might 
obscure visualisation of neural crest cells).
What could cause this expression in muscle? It could be argued that the muscle 
expression seen here is not in fact ectopic, but that the GFP reporter assay is more sensitive 
at detecting sites of low promoter activity than the sox 10 in situ. This would mean that 
promoter activity in muscle would be at far lower levels than that in neural crest, but there 
is no evidence for this from any of the transient GFP analyses, as expression in muscle 
cells is often just as bright as expression in neural crest cells. It might also be argued that 
the vector DNA could be influencing promoter expression, although transient analyses, 
where the vector is removed completely also produce muscle expression (not shown). If 
the muscle expression is truly ectopic, then lack of effective repression can be the only 
explanation. While it is possible that repressor elements necessary for silencing expression 
in ectopic cell types lie beyond the regions used in these reporters, it would mean they 
exist outside sequences found in PACIGFP (i.e. more than 37kb upstream and 40kb 
downstream of the soxlO gene). If true this would require the engineering of a much larger 
soxffl-containing genomic clone such as a YAC, an undertaking beyond the scope of this 
work. Another explanation for the ectopic expression seen could be that the normal 
repressor elements are present, but not able to function properly during the transient
transgenic assay. There may be two reasons for this. Firstly, repression might depend on 
some form of chromatin remodelling and thus need integration of the transgene into 
chromosomes for effective silencing. Secondly transgene copy number is variable in 
transient experiments due to mosaicism. It might be that the cells showing ectopic 
expression have, by chance, inherited a very large dose of the transgene, swamping or 
titrating out any repressor complexes needed for silencing. Whereas the endogenous sox 10 
promoter is present in two copies per cell, the reporter transgene might be present in 
thousands of copies, conceivably more than can be silenced. It was hoped that integration 
of a moderate number of transgene copies could allow repession to work correctly in 
germline transgenics.
Attempts to produce transgenic lines carrying the three reporters followed a simple 
procedure. Following linearisation by restriction digestion, the DNA was purified with 
Microcon™ filter units and diluted to approximately 6ng/pl. Embryos from wild-type 
incrosses were injected as early after fertilisation as possible, and no later than 2-cell stage. 
Injection amounts were such as to obtain about 70% deformity rates, generally around 50 
to 80 pg of DNA per embryo. A total of approximately 3000 embryos were injected for 
each construct and, after discarding malformed embryos, those with the best coverage of 
transgene as assayed under a fluorescent dissecting scope, were selected for rearing. These 
numbered approximately 100 to 150 embryos per construct and, allowing for some death 
of larvae during rearing, provided between 80 and 100 adult fish per construct. To identify 
transgenic founders, a batch of fish injected with each construct were crossed inter se and 
their progeny screened between 1 and 3 days under a fluorescent dissecting scope, ensuring 
at least 50 offspring per pair were screened. Positive founders have been identified for each 
construct mentioned above, however expression levels are quite divergent, and due to time 
constraints, not all lines have yet been firmly established or thoroughly analysed.
4.2.5.1.P4.9 :GFP
The p4.9:GFP construct, prepared as described above, was injected into one-cell stage 
embryos. Embryos with the best coverage of GFP positive cells were selected during later 
embryogenesis, and raised to adulthood. Almost all of the surviving adults were 
successfully screened for germline transmission. Out of 77 screened, one female founder 
produced offspring showing GFP expression in a sox 10 pattern. The average percentage of 
transgenic embryos this female founder produced per clutch was 6.5% indicative of the 
mosaic nature of the integration in the germ cells. All these FI embryos transmitted the 
transgene in Mendelian fashion when outcrossed, with an average of 47% transgenics in
the F2 generation. Mendelian ratios have been observed in all subsequent generations, and 
the line, now named soxlO-4.9:GFP, is now into its fourth generation.
All analysis reported for this line was conducted on hemizygous embryos produced by 
outcrossing F2 adults. First expression of GFP was detectable at approximately 1-2 somite 
stage (~10.5hpf), in anterior regions of the neural plate, identical to the first site of soxlO 
expression detected by in situ (Pauliny, 2002). This is shown in a lateral view of a 3 somite 
stage (~1 lhpf) embryo under both transmitted and fluorescent light in Figure 4.1 la. 
Viewing dorsally demonstrates that GFP+ cells lie in lateral positions of the neural plate, in 
a position consistent with nascent neural crest. These cells appear to be converging 
dorsally, into a more medial position (Figure 4.1 lb, left panel). Slightly later, at 
approximately 5 somite stage (~12hpf), this domain of GFP expression has extended 
posteriorly, following the anterior-posterior direction of neural crest generation. A 
magnified view of this domain is shown in Figure 4.1 lc showing these cells near to the 
neural tube. Viewed dorsally these cells can be seen almost covering the neural tube at this 
axial level (Figure 4.1 lb, right hand panel). Coverage is not complete however, and 
“holes” in GFP expression are apparent in this last panel. Whether this indicates an 
absence of a neural crest cell at this site, or a GFP' neural crest cell, remains to be 
determined.
As development proceeds, the premigratory neural crest expression domain broadens 
and extends more posteriorly (Figure 4.1 Id). Viewing dorsally at this stage, the GFP+ 
neural crest can be seen covering the neural tube, extending anteriorly to the axial level of 
the eye field (Figure 4.1 le). The expansion of GFP expression in the neural crest continues 
to extend further posteriorly during somitogenesis (Figures 4.1 I f  and g), until GFP+ 
premigratory neural crest can be seen the entire length of the embryo at approximately 
18hpf.
At approximately the 11 somite stage (~14.5hpf), cranial neural crest can be seen 
beginning to migrate ventrally away from this position (indicated on Figure 4.1 If). Trunk 
neural crest also begins to migrate not long afterwards (beginning at approximately 14 
somite stage (16hpf; not shown). This compares closely with the timing of migration in the 
trunk reported previously as approximately 15.5-16hpf (Raible et al., 1992). Due to its 
distribution throughout almost the entire cell, GFP allows visualisation of cellular 
processes and filopodia. An example of such a process in a premigratory neural crest cell 
from a 12 somite stage (~15hpf) embryo is indicated in Figure 4.12a. There have been 
some limited studies on the behaviour of these filopodia during neural crest migration in 
zebrafish (Jesuthasan, 1996); that they are readily visible in live embryos derived from this
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Figure 4.12: Expression of sox10-4.9:GFP from 15hpf to 22hpf
GFP expression pattern in the soxlO- 4.9:GFP line at certain stages between 12 somite 
stage (15hpf) and 22hpf. All figures are lateral views with dorsal up and anterior to the 
left. Parts a., b., and d. are projections of individual z-series taken by confocal 
microscopy. Parts c. and e. show images taken by both fluorescent microscopy and 
under Nomarski optics, and include overlays of the former onto the latter. In all parts, 
the stage of the embryo is given.
a. GFP expression in premigratory cranial neural crest cells at the 12 somite stage (15hpf) 
allows visualisation of filopodia (arrows), just as these cells begin to migrate.
b. Slightly later at 16hpf, GFP+ cranial neural crest cells can be seen migrating and 
dispersed in the head, and neural crest cells beginning to migrate in the anterior trunk, 
whilst the tail neural crest cells remain in a dorsal, premigratory position.
c. By 20hpf, GFP+ trunk neural crest can be clearly seen migrating on the medial pathway 
in the trunk (arrows), whilst GFP+ cranial neural crest can be seen both dispersed in the 
head, and present in the nascent branchial arches (arrowheads). Notable is the absence 
of expression in the ear, highlighted by an asterisk. An embryo photographed under 
fluorescence (top panel) and Nomarski optics (middle panel) is shown with the 
combined overlay (bottom panel).
d. Enlarged view of the GFP+ cranial neural crest cells in the head of a 20hpf embryo. 
Crest cells are starting to migrate over the eye, and can be seen populating the branchial 
arches (arrowhead).
e. Trunk and tail neural crest cells migrating medially follow well-defined paths 
alongside the somites, and generally do not cross over into the neighbouring somite 
axial level. Fluorescent (left panel), Nomarski (middle panel) and overlaid images of 
the posterior trunk neural crest cells of a 22hpf embryo are shown. GFP+ cells can be 
seen migrating ventrally in stripes aligned with the myotomes.
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GFP line suggests that it might prove a useful resource for future work in this area, and in 
detailed analysis of cellular behaviour in response to chemoattractive or repulsive stimuli.
By 20hpf, migrating cranial neural crest cells are clearly visible with GFP (Figure 
4.12b, c and d). It is also apparent that whilst the anterior neural crest is migrating, the tail 
neural crest cells remain GFP+ and in a premigratory position at this stage. Medially 
migrating crest cells in the trunk, do so at a specific rostro-caudal position relative to each 
somite as shown in Figures 4.12c and e, and as previously reported (Raible et al., 1992). At 
this stage there is also clear expression in neural crest migrating within the branchial arches 
(Figure 4.12d). This is surprising, as sox 10 message cannot be detected here by in situ 
hybridisation (Pauliny, 2002). Additionally, whilst there is apparent ectopic expression in 
branchial arches, there is no visible expression in the ear at this stage. This is also 
surprising as the ear represents the strongest site of sox 10 expression during this period 
when analysed by in situ (Pauliny, 2002), and the transient analysis showed strong 
expression at this site (see previously).
At 24hpf, the expression domains remain essentially the same as that of the 20hpf 
embryo. Anteriorly in the head and trunk, neural crest cells are labelled with GFP and 
migrating ventrally, whilst premigratory cells are still apparent in the tail (Figure 4.13a and 
b). As mentioned earlier, medially migrating neural crest cells follow well-defined paths 
alongside each somite, and can be seen in the anterior trunk (Figure 4.13b). Neural crest 
cells migrating on the lateral pathway can also be seen in the trunk, and unlike those 
migrating medially, these cross projected somite boundaries (Figure 4.13c). Meanwhile, 
premigratory neural crest in the tail is developing filopodia as it starts to migrate (Figure 
4.13e). Expression in neural crest migrating in the branchial arches is also clear at this time 
(Figure 4.13d). This image also displays GFP expression in other sites including migrating 
neural crest cells (including one beginning to melanise as indicated by the presence of 
melanin granules), and cells surrounding the forming posterior lateral line ganglion. The 
interior of this ganglion is populated by neurons and is GFP'. Expression in Schwann cells 
of the posterior lateral line nerve can be seen at this stage as well (not shown), providing an 
easy method for prim staging these embryos.
Low levels of GFP expression in epithelial cells of the otic vesicle are also evident 
(Figure 4.13d). Thus this promoter element appears to drive GFP expression strongly in the 
neural crest, but only weakly in the otic epithelium. This is in direct contrast to sox 10 
mRNA levels, which appear to be stronger in the otic vesicle than the neural crest (Pauliny, 
2002).
Putative neurons of the olfactory bulb also start to express GFP at about 24hpf, (Figure 
4.13f). This was first noted during transient reporter analyses (J. Dutton, pers. comm.).
Figure 4.13: Expression of sox10-4.9:GFP at 24hpf
GFP expression pattern in the soxlO- 4.9:GFP line at 24hpf. All figures are lateral 
views with dorsal up and anterior to the left. All images were taken by confocal 
microscopy except for those in a. and e.
a. Overview of the expression pattern in a 24hpf embryo, showing GFP expression 
viewed under fluorescence (left panel), a DIC image (middle panel) and an overlay of 
the two (right panel).
b. A confocal projection of GFP expression in a 24hpf embryo showing sites of 
expression, including streams of medially migrating neural crest cells in the anterior 
trunk (solid arrows), premigratory neural crest in the tail (open arrow) and neural crest 
cells in the branchial arches (solid arrowheads). Lack of expression in the ear (asterisk) 
and ectopic muscle expression (open arrowheads) was surprising and in contrast to in 
situ data.
c. Magnified image of the muscle expression seen in the anterior trunk at this stage (open 
arrowheads). Neural crest cells migrating on the lateral pathway can be seen (solid 
arrows).
d. Magnified image of the otic vesicle region in a soxlO-4.9:GFP embryo at 24hpf. 
Relatively faint expression in the otic vesicle (o) is apparent at this magnification, but 
in contrast to the abundant sox 10 signal obtained by in situ analysis. Cells (probably 
some form of glia) encapsulating the posterior lateral line ganglion (g) are also labelled, 
whilst the core of the ganglion (comprised of neurons) is GFP'. Migrating neural crest 
cells are also apparent with one labelled (me). Cells beginning to melanise (evident by 
melanin granules) are also labelled by GFP (m). Expression in the neural crest cells 
migrating through the branchial arches (a) is also clear in this image.
e. Image of the tail of a transgenic embryo at 24hpf in which GFP + tail neural crest cells 
are beginning to extend filopodia and migrate away fom the premigratory position.
f. Putative olfactory sensory neurons can be seen from approximately this stage in the 




Although this was not initially described by in situ analysis in zebrafish, olfactory bulb 
expression was reported in mice and humans. More thorough analysis of the zebrafish 
sox 10 in situ pattern has shown that soxlO is in fact expressed in the olfactory bulb (R.N.K. 
pers. com.) GFP expression in the ventral CNS (in particular the brain and anterior spinal 
cord) is visible at these stages as well (not shown). This is consistent with in situ data, 
which detected sox 10 in the ventricular layer upon transverse sectioning of the hindbrain 
(Pauliny, 2002). Transverse sections of the soxlO-4.9:GFP transgenics are required to 
demonstrate precise recapitulation of the sox 10 pattern at this site.
Strikingly, beginning at around this time, clear muscle fibre expression begins to be 
seen, restricted to the anterior trunk (Figure 4.13b). It is not known why this expression in 
this cell type is only present in this axial region, and not seen in more posterior muscle. A 
magnified image of muscle fibres labelled with GFP is shown in Figure 4.13c. Presence of 
GFP+ muscle in both transient and germline transgenics argues that lack of integration 
itself was not the sole cause of the ectopic expression in transient analyses.
Later, at 2dpf, almost all neural crest cells in the trunk and tail have begun to migrate. 
Figure 4 .14a shows two confocal planes of the tail region of a 2dpf embryo, with both 
laterally migrating (upper panel) and medially migrating (lower panel) neural crest cells. 
Cells remaining dorsally might later become pigment cells of the dorsal stripe. Figure 
4.14b shows a projected confocal stack of the head of a 2dpf embryo. Neural crest cells 
migrating through the branchial arches still show strong GFP expression at 2dpf. Unlike 
previously, when this expression was ectopic at this site, expression at this stage is 
consistent with in situ experiments in which sox 10 transcripts can be detected from 2dpf 
onwards (Pauliny, 2002). Neural crest cells in the head not associated with the branchial 
arches such as pigment cells have a much fainter GFP signal than earlier, possibly 
indicating cessation of promoter activity in these cell types. It must be remembered 
however, that xanthophores and iridophores are autofluorescent. Thus it is not clear that 
there is maintenance of promoter activity in these cell types, although it has been 
documented that soxlO transcripts are not detectable in pigment cells (Pauliny, 2002). 
Neural crest derived cells associated with the posterior lateral line ganglion and nerve 
(Schwann cells) remain GFP+.
In the CNS, GFP expression can be seen in cells in the ventral fore, mid and hindbrain 
(possibly oligodendrocyte precursors and neurons), consistent with reported sox 10 
expression at these sites (Pauliny, 2002). As at 24hpf, the transgene is also active in the 
olfactory bulb. Putative cartilage cells of the endoskeletal disc in the pectoral fin are also 
visibly expressing GFP at this stage (Figure 4.14b) and ectopic muscle expression can still 
be seen in the anterior trunk.
Figure 4.14: Expression of sox10-4.9:GFP at 2dpf
GFP expression pattern in the sox 10- 4.9:GFP line at 24hpf. All images were taken by 
confocal microscopy.
a. Two single plane confocal images of the tail region of a 2dpf transgenic embryo, 
showing a lateral plane (top panel) and a more medial plane (bottom panel) at the same 
axial level. By this stage, most of the tail neural crest has migrated or begun to migrate 
from its premigratory position, and does so in the same manner as trunk neural crest. 
Thus neural crest cells first embark upon the medial pathway, and migrate ventrally 
respecting somite boundaries as shown in the lower panel. Lateral pathway migrating 
neural crest cells lag behind and extend processes across somites.
b. A confocal projection of GFP expression in the head of a 2dpf embryo. Expression is 
maintained in a number of sites seen at 24hpf. These include the olfactory bulb (arrow), 
muscle (open arrowhead), branchial arches (a), posterior lateral line ganglion (g) and in 
Schwann cells along the posterior lateral line nerve (underscored with a brace). The 
otic vesicle (o) is indicated and does not show strong GFP presence. Expression is also 
seen in the cartilage cells of the forming pectoral fin (p). First visible from 
approximately 24hpf, expression in the CNS is prominent by 2dpf, sited in unidentified 
cells of the ventral fore- and midbrain (labelled by fb and mb respectively), and more 
extensively in the hindbrain (hb). Similarly, expression in the spinal cord (sc), first 
noticed at approximately 24hpf, is clear by this stage. Faint fluorescence is visible in 
some pigment cells, possibly due to perdurance of the GFP protein or autofluorescence 
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Slightly later at 56hpf, GFP+ cells are found arranged segmentally and medial to each 
somite, forming chains of cells running ventrally alongside the notochord (Figure 4.15a). 
These cells could be either cells still migrating on the medial pathway as seen earlier, or 
more likely, neural crest cells that have migrated to, and remained in, a medial position 
forming spinal nerve associated glial cells. GFP+ cells appear at the dorsal end of this chain 
of cells, and might be satellite glia surrounding the neurons of the DRGs (Figures 4.15a, b 
and d). Verification of the identity and differentiation status of these cells could be 
achieved through double labelling with other molecular markers such as foxD3, however 
there are few differentiated peripheral glial markers in zebrafish (see also Discussion). 
Schwann cells along the posterior lateral line nerve are GFP+ as soon as they form at 
around 24hpf, and continue to express GFP until at least 20dpf. Examples showing 
expression in this cell population at 2-3dpf (Figure 4.14b and Figure 4.15a) and 4dpf 
(Figure 4.15f) are presented.
A ventral view of the head of a 3dpf transgenic embryo is shown in Figure 4.15c. 
Expression in cartilage cells of the forming jaw elements and pectoral fin is evident. 
Previously it was shown by in situ that sox 10 was expressed strongly at this site from 
48hpf to at least 60hpf. Attempted in situ analysis beyond this timepoint has not been 
reported, possibly due to increased difficulty in the in situ protocol in older embryos. 
Analysis of this GFP line has no such restriction on age, and allows investigation of sox 10 
in later embryos.
Expression within the neural tube can be seen (Figure 4.15a and at higher 
magnification in b). Putative intemeurons, with axons projecting ventrally and laterally, 
express GFP, as do cells in a ventral position, consistent with their identity as 
oligodendrocyte precursors (also J. Dutton, pers. comm.). Olfactory bulb expression is also 
visible in Figure 4.15c, with a confocal projection of the olfactory bulbs at 3dpf showing 
cell bodies, most likely of olfactory sensory neurons, strongly expressing GFP. The axons 
of these cells can also be seen in a dorso-medial position in glomeruli, where they 
defasciculate and synapse with brain neuronal projections (Figure 4.15e). Labelling in this 
cell type is reminiscent of that derived from the ragl and rag2 GFP transgenics (Jessen et 
a/., 2001).
The 5dpf expression pattern remains essentially identical to that at three days, and the
only neural crest derivatives to have retained GFP expression are the cartilage cells of the
jaws and Schwann cells of the PNS (e.g. on the posterior lateral line, Figure 4.16a). A
confocal projection of a ventral view of the head shows the strong expression in the jaw
elements (Figure 4.16b). Although not neural crest derived, cartilage cells in the forming
fin also show GFP expression. For example, elements of the pectoral fin, including the
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Figure 4.15: Expression of sox10-4.9:GFP from 56hpf to 4dpf
GFP expression pattern in the soxlO- 4.9:GFP line between 56hpf and 4dpf. All images 
were taken by confocal microscopy, except c. and f. Ages of embryos are given in each 
image.
a. Low power lateral view of the trunk of a 56hpf, generated by projection of a confocal 
stack. Expression sites evident include the CNS, in particular in putative intemeurons 
(i) and more ventrally located cells, possibly oligodendrocyte precursors (ol). 
Fluorescence, possibly due to autofluorescence, is visible in certain pigment cells such 
as iridophores (ir) and xanthophores (x). Glial cells of the peripheral nervous system 
are also labelled with GFP such as Schwann cells of the posterior lateral line nerve 
(plln), DRG and spinal nerves (sn).
b. A higher magnification view of the trunk expression domains, also generated by 
projection of a confocal stack. Many features shown in a. are indicated.
c. Ventral fluorescent image of a 3dpf transgenic embryo showing expression in cartilage 
cells of jaw elements, pectoral fin (p) and olfactory bulbs (arrows). Expression in 
catilage cells of the scapulocoracoid supporting the pectoral fin is also highlighted 
(arrowhead).
d. Single confocal image of lateral view of putative DRG satellite glia in the trunk.
e. Confocal projection of an anterior view of the head of a 56hpf embryo, with dorsal up. 
Strong expression in sensory neurons of the olfactory bulbs is indicated with arrows. 
Associated axons visible dorso-medially to the bulb in the glomeruli are indicated with 
arrowheads. Ventro-medial positioned GFP+ cells (asterisks) are presumably cartilage 
cells in anterior jaw elements.
f. Expression in Schwann cells along the posterior lateral line nerve in a 4dpf embryo.
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Figure 4.16: Expression of sox10-4.9:GFP at 5dpf
GFP expression pattern in the sox 10- 4.9:GFP line at 5dpf.
a. Low power lateral views of a 5dpf soxlO- 4.9:GFP transgenic embryo under 
fluorescent light.
Top Panel: By this stage, GFP expression is restricted to pectoral fin and craniofacial 
cartilage elements, including the jaw and gill arch elements, as well as certain glia 
types of the CNS and PNS, including cells in the brain and spinal cord.
Bottom Panel: Magnified view of the spinal cord of the same embryo, showing 
expression in putative oligodendrocytes distributed throughout the spinal cord but 
predominant ventrally. Schwann cells along the posterior lateral line are also apparent 
in this image (arrow).
b. A ventral view of the head generated by projection of a confocal stack. Expression in 
cartilage cells in all jaw elements is evident, as is expression in the cartilage cells of the 
endoskeletal disk (arrowhead) and scapulacoracoid (arrow) of the pectoral fin.
c. Single confocal image of the pectoral fin showing the tessalated pattern of cartilage 
cells in the endoskeletal disk. The GFP expression in cartilage cells appears to be 
variable and patchy.
Double immunofluorescence was used to detect neurons in the PNS (red channel - 
using antibodies against the Hu epitope) and GFP+ cells (green channel - using and 
antibody against GFP). Both images are lateral views of 5dpf soxlO- 4.9:GFP 
transgenic embryo.
d. Two channel fluorescent image showing that GFP+ cells surround the DRG neurons 
(arrows) and line the nerves emanating from this ganglion (arrowheads). This 
localisation is further evidence that the sox 10 promoter is active in satellite glia and 
Schwann cells of the peripheral sensory nervous system.
e. Single confocal image showing the expression pattern in the DRGs, taken using two 
fluorescent channels. Again the GFP+ cells can be seen surrounding the Hu+ neurons. 
The distribution of signal is such that there is no overlap of expression in the two cell 
types. GFP expression in Schwann cells can be seen extending below the ganglion 
along the spinal nerve, until it ventures outside the confocal plane.

scapulocoracoid and endoskeletal disc show transgene activity (Figure 4.16b). Confocal 
images of the endoskeletal disc show the characteristic tessellated pattern of cartilage cells 
(Figure 4.16c). It is clear in this image that the expression level of the transgene in 
individual cartilage cells is highly variable. Expression in cartilage cells of the head and 
pectoral fin is still apparent at 20dpf, with large cartilage cells now also apparent in the 
hypurals of the forming tail fin (not shown). Thus this GFP analysis confirms the in situ 
analysis, which indicated expression in forming cartilage.
The low powered lateral views of a 5dpf embryo given in Figure 4.16a also show the 
strong expression in the CNS, including the ventral brain and neural tube. Nasal expression 
is still seen (not shown), whilst the majority of intemeuron expression appears to have 
disappeared by this stage. The expression remaining in the neural tube consists of GFP+ 
cells in a position consistent with oligodendrocytes. Maintenance of transgene activity in 
both these myelinating cells of the CNS, and the myelinating PNS cells (Schwann cells) 
has been noted until at least 20dpf (not shown). Muscle expression is still evident at this 
stage and can be seen in Figure 4.17a.
To better establish the relationship of the cell types expressing GFP to other cells, a 
double antibody labelling approach was commenced. Immunofluorescence using 
antibodies against the pan-neuronal epitope, Hu, was used to label neurons. This was done 
in conjunction with immunofluorescence to detect GFP, thus allowing assessment of the 
proximity or overlap of the GFP+ cells with neurons in 5dpf soxlO-4.9:GFP embryos.
Figure 4.16d shows DRG neuron expression (red fluorescence) with GFP expression in 
surrounding cells. GFP expression was also seen in putative Schwann cells along the spinal 
nerve projecting ventrally from the ganglion. At this low power, it appeared that GFP was 
not present in the neurons, but in cells immediately encapsulating the neurons, namely 
satellite glia. This non-overlapping expression is better shown by two channel confocal 
microscopy (Figure 4.16e). Here, close proximity of the GFP signal with the neuron of the 
DRG is clear, as is absence of GFP expression in the neuron itself.
Further analysis of these double labelled 5dpf embryos have shown that GFP+ cells 
were closely associated with neurons in other peripheral ganglia, including the posterior 
lateral line ganglion as shown in Figure 4.17a. Here GFP+ Schwann cells along the lateral 
line can be seen emanating from the Hu+ ganglion core. Although GFP is excluded from 
these neuronal cells, there appears to be GFP+ cells surrounding some cells within the 
ganglion.
GFP expression is additionally seen in cells along the sympathetic chain. Figure 4.17c 
shows Hu+ neurons positioned ventrally in the anterior trunk, and connecting these neurons 
is a chain of GFP+ cells, lying medially to the spinal nerves and running in an anterior-
Figure 4.17: PNS expression of sox10-4.9:GFP at 5dpf
Further double immunofluorescence images of 5dpf soxlO- 4.9:GFP transgenic 
embryos, again using an antibody against Hu to detect neurons in the PNS (red 
channel) and a GFP antibody (green channel).
a. Single plane confocal image taken using dual channel detection showing the posterior 
lateral line ganglion with the neurons in red (arrows), and GFP+ Schwann cells of the 
posterior lateral line branches (arrowheads). There appear to be some GFP signal 
surrounding, but not overlapping with, the neurons within the ganglion, most likely 
satellite glia (asterisk). Muscle fibres (m) can be seen in the top right of the figure.
b. Confocal slice through the eye, showing two neuronal layers to the retina. Image is a 
dorsal view with anterior up. Within the outer layer, GFP+ cells are apparent, with 
putative axons. The identity of these cells, and if they are true sites of sox 10 expression, 
remains to be determined.
c. Lateral view of the anterior trunk. Green (top panel) and red (middle panel) fluorescent 
images are shown with an overlay in the bottom panel.
GFP expression can be seen in cells linking the sympathetic chain. A chain of GFP+ 
cells can be seen in the ventral half of the anterior trunk (open arrowheads), underlying 
the Schwann cells of the segmentally arranged spinal nerves. This chain is closely 
associated with the location of the sympathetic neurons, as shown by Hu staining 
(filled arrowheads, middle panel). Comparison of these two images with a combined 
overlay image indicates that these neurons do not express GFP, but are closely 
surrounded by GFP+ cells. Additionally GFP expressing cells appear to connect these 
neurons, consistent with them surrounding axons of the chain.
d. Lateral views of the hindgut. Faint GFP expression is seen in the enteric nervous 
system at 5dpf. GFP+ cells can be seen in the gut (top panel), and comparing this to the 
neuron expression pattern (middle and bottom panels) indicates that there appears to be 
a large, but incomplete, overlap of expression. One example of a GFP+, Hu' cell is 
indicated with an open arrowhead. Apparent co-expression might indicate that GFP is 
present in neuronal cells, or that each neuron is surrounded by GFP+ cells and that 
microscopy at this level is unable to resolve the positional differences in fluorescent 
signals.
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posterior direction. Closer inspection of the expression pattern shows that the GFP is not 
expressed in the neurons, but in cells around each neuron (not shown). An overlay of the 
two fluorescent images highlights the connection between the sympathetic neurons and the 
GFP cells along the chain connecting them. Thus the transgene is probably active in 
Schwann cells associated with the sympathetic chain as well, consistent with a requirement 
for expression of sox 10 in myelinating cells.
Expression in the enteric nervous system was seen at 5dpf. Figure 4.17b shows 
fluorescent images of the hindgut of a soxlO-4.9:GFP transgenic embryo, immunostained 
for Hu and GFP. Faint GFP signal can be seen in cell bodies along the gut, and appear to 
mostly overlap with the Hu+ enteric neurons. However occasionally, GFP+, Hu' cells are 
evident (indicated with arrowhead).
Finally, a confocal slice through the eye of this embryo showed GFP+ expression in a 
subset of cells in the retina of the eye (Figure 4.17b). Although these cells, unlike most of 
their neighbours, do not appear to express Hu, axonal like projections can be seen 
associated. The identity of these cells remains to be determined.
The GFP expression pattern of this soxlO-4.9:GFP line has been described here in 
some detail, although there are some expression sites that require further investigation, and 
some apparently ectopic domains (see Section 4.3). This line should prove useful in a 
number of future experiments, some of which are also outlined in Section 4.3. One simple 
experiment already realised, has been to establish the state of promoter activity in 
melanophores during development. To achieve this, soxlO-4.9:GFP transgenic embryos 
were lightly treated with PTU to mildly inhibit melanin formation and then inspected 
between 26hpf to 4dpf. At each time point, an estimate of the percentage of GFP+ 
melanophores was made, with at least 20 melanophores assessed for GFP signal per 
embryos. The resulting counts were plotted (Figure 4.18), and a non-linear regression 
curve plotted using Prism statistical software version 5.1 (GraphPad software, San Diego, 
CA, USA). The model producing the best line of fit was an exponential decay curve, as 
expected for a drop off of GFP signal due to protein degredation (R2 value = 0.9415). 
Examples of melanophores both with and without GFP expression are shown at given 
timepoints (Figure 4.18).
Immediately obvious is that activity of the sox 10 promoter fragment present on the 
transgene is not maintained in melanophores throughout development. Although the 
promoter is active in melanophores at or just before the onset of neural crest melanogenesis 
(24hpf), it appears to be downregulated from this point onwards. Reported loss of sox 10 
transcript in all differentiating pigment cell types is consistent with this analysis (Pauliny, 
2002). This result has important implications for proposing a role for SoxlO in
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Figure 4.18: GFP signal is lost from melanophores over time
To determine whether the sox 10 promoter is active in melanophores throughout 
development, the percentage of GFP+ melanophores as assessed at various time points 
in embryos from the soxlO-4.9:GFP line. At their formation at around 25hpf, GFP is 
detectable in almost all melanophores. By 4dpf very few melanophores express GFP. 
Panels below show confocal images using a fluorescent and a white light channel at 
given stages. GFP expression can be seen through the melanin deposits in the 
melanophores early, but not later, indicating cessation o f promoter activity in this cell 
type.
melanophore development, and suggests that sox 10 plays only an early role and is 
dispensable at later stages. This further supports the theory that sox 10 is only essential very 
early in melanophore development to activate mitfa (Elworthy et al., 2003).
4.2.5.2. soxlO-6.1:GFP
In addition to those using p4.9:GFP, attempts to produce transgenic lines carrying the 
p6.1 :GFP construct were made. As before, the construct was linearised and injected into 1- 
cell stage embryos, with the best expressing embryos sorted and raised. Of the surviving 
adults, four out of a total of 33 screened to date gave embryos with GFP expression, and 
were named soxlO-6.1a:GFP, soxlO-6.1b:GFP, soxlO-6.1c:GFP and soxlO-6.1d:GFP. 
Presently, there are yet more potential founders to screen. The average percentage of 
transgenic embryos produced per founder was 12.9, 5.9, 4.6 and 15.4% respectively. All 
four lines are currently into the F3 generation and all have behaved in a Mendelian fashion. 
Curiously, all four identified so far express very weakly, much more weakly than the 
soxlO-4.9:GFP line. This low level of expression has made visualisation of the expression 
domains difficult, and due to time constraints, not all four lines have been examined or 
documented in detail. Brief analysis of two lines, soxlO-6.1c:GFP and soxlO-6.1d:GFP, is 
presented here, but all four lines are largely identical in expression domains.
The earliest time of expression has not yet been established, however expression in 
premigratory neural crest in the tail of a 28hpf embryo has been seen, as well as in neural 
crest cells that have commenced migration (Figure 4.19b). Viewing these embryos at 28hpf 
reveals a similar cranial neural crest expression pattern to that of the soxlO-4.9:GFP line, 
namely expression in the branchial arches. A hint of faint expression in migrating neural 
crest cells outside the branchial arches is also evident (Figure 4.19a and c). Strikingly, 
whereas otic vesicle expression was much weaker than branchial arch expression in the 
soxlO-4.9:GFP line, in all soxlO-6.1:GFP lines it is at a comparable level to the branchial 
arches (Figure 4.19a, c). This suggests that although the overall levels of expression in the 
soxlO-6.1:GFP lines are low, the comparative expression level in the forming ear is much 
stronger (Figure 4.19b). Transgene promoter activity is also evident in the olfactory bulb, 
as with the soxlO-4.9:GFP line (Figure 4.19a). Unlike transient analyses with the p6.1:GFP 
construct, no muscle cell expression is obvious in these lines.
Later, at 2dpf, GFP expression can be seen in cells associated with the posterior lateral 
line ganglion, Schwann cells (Figure 4.19d) and very faintly in cells surrounding the DRGs 
(Figure 4.19e). Detectable levels of GFP are also prominent in the ear, the hindbrain and in 
the nascent cartilage cells of the pectoral fin (Figure 4.19d). In the neural tube at this stage, 
the strongest expression is seen in putative oligodendrocytes, found predominantly
Figure 4.19: Expression pattern of sox10-6.1 :GFP lines
GFP expression in the sox 10- 6.1c:GFP and sox 10- 6.1d:GFP lines from 28hpf to 5dpf. 
Ages and genotype of embryos are given in each image.
a. Left Panel: Lateral image of the head of an approximately 28hpf sox 10- 6.1d:GFP 
transgenic embryo taken under fluorescent light. Expression is faint, compared to the 
sox 10- 4.7:GFP line, but evident in the branchial arches (a), the olfactory bulb (arrow) 
and clearly in the otic vesicle (o). A magnified image of the branchial arch and otic 
vesicle expression is shown in c. This image is overlaid onto a DIC image in the right 
panel.
b. Expression can also be seen in premigratory neural crest cells. Lateral image of the 
dorsal tail of a 28hpf sox 10- 6.1d:GFP transgenic embryo taken under fluorescent light, 
showing faint expression in neural crest cells positioned dorsally as well as in cells 
beginning to migrate (arrowheads).
c. Magnified fluorescent image of the otic region. GFP expression is present in the otic 
vesicle (o), migrating neural crest cells (arrowheads) and neural crest cells in the 
branchial arches (a).
d. Lateral confocal projection of a 2dpf soxlO- 6. lc:GFP transgenic embryo. Expression 
can be seen in the developing ear (e), cells in the hindbrain (hb), cartilage in the 
pectoral fin (p), cells associated with the posterior lateral line ganglion (g) and 
Schwann cells along the dorsal branch of the posterior lateral line (s).
e. Expression in the spinal cord at the same stage shows very low levels of GFP in 
putative intemeurons (i), whilst putative oligodendrocye precursors (ol), prominent 
ventrally, show strong expression. Diffuse expression is also detectable in DRG glia 
(arrows).
f. Lateral view of GFP expression in the ear of a 5dpf soxlO- 6.1d:GFP transgenic 
embryo viewed under fluorescent light.
g. The same embryo viewed ventrally under fluorescent light showing jaw cartilage 
expression
h. Lateral views of the heart of a 5dpf soxlO- 6.1c:GFP transgenic embryo, viewed under 
- fluorescent (left panel) and nomarski (centre panel) optics, with an overlay (right
panel). Expression in jaw elements can be seen (arrowheads). Unique to this line, 
expression in the heart is also evident (arrow).

ventrally and dispersed in more dorsal parts, but faint expression can be seen in other cells 
of the neural tube, probably intemeurons (Figure 4.19e). These expression sites, with the 
exception of the strong ear expression, are reminiscent of the soxlO-4.9:GFP expression 
pattern at this stage, although the levels are much lower.
Cartilage cells of the jaw elements and the ear retain GFP expression until at least 5dpf 
(Figure 4.19f, g).
Curiously, the soxlO-6.1c:GFP line has clear expression in the heart at 5dpf (Figure 
4.19h). This appears to be in cells surrounding the entire heart. Closer inspection is 
required to ascertain whether these cells are endo-, myo-, or epicardial in nature. A neural 
crest contribution to the heart outflow tract has been demonstrated in zebrafish (Li et al., 
2003). It is not yet known if these cells do, or ever did, express soxlO. Additionally sox 10 
in the chick has been shown to be expressed in glial cells of nerves innervating the heart as 
well as in septa and valves of the heart. The expression shown in Figure 4.19e appears to 
be too broad to correspond to any of these specific sites, although much more analysis is 
required. As this expression pattern is unique to this line, and not seen in any of the other 
sox 10-6.1 :GFP lines, it is possible that this is due to some form of enhancer trap. Analysis 
of the integration site might reveal proximity to a gene expressed in the heart.
4.2.5.3. PACIGFP2
The final construct used to produce a transgenic line was the PACIGFP2 reporter 
construct. Approximately 85 injected embryos have been successfully raised to adulthood, 
of which, 64 have been screened for transmission of the transgene. One founder male was 
identified that produced GFP+embryos. The transmission rate was approximately 6.3%, 
with the FI individuals nearing breeding age. As the identification of this line is only 
recent, detailed documentation of the expression sites of this line has not yet been 
performed. The line does however show strong GFP expression in a number of locations 
expected for a sox 10 reporter construct.
Thus expression is seen in nascent neural crest at around 1-2 somite stage (10.5hpf; not 
shown) and by 24hpf is seen in migrating neural crest cells in the head (Figure 4.20a) and 
trunk (Figure 4.20b). Expression in the branchial arches is also evident in 24hpf 
PACIGFP2 transgenic embryos. In the trunk, neural crest cells migrating on both the 
medial and lateral pathways are GFP+, and there appears to be some neural tube expression 
in a subset of neuronal cell bodies and their axons, possibly intemeurons or Rohon-Beards 
(Figure 4.20b). Interpretation and biological significance of this neuronal expression is 
under investigation. Clear in Figure 4.20a is the strong expression in the otic vesicle. 
Expression in the olfactory bulb is also apparent at this stage (not shown). No muscle
Figure 4.20: Expression pattern of the PACIGFP2 line
GFP expression in the PACIGFP2 line, from 24hpf to 5dpf. Ages of embryos are given 
in each image.
a. Confocal projections of a 24hpf embryo.
Left Panel: Lateral image of the head showing expression in migrating neural crest in 
the head and trunk (arrowheads) and in the branchial arches (a). The otic vesicle (o) is 
also strongly labelled.
Right Panel: The same image overlaid onto bright light image of the same embryo.
b. Images at higher magnification of the anterior trunk of a 24hpf PACIGFP2 embryo 
also generated by confocal projection. Medially and laterally migrating neural crest 
cells are GFP+, as are the cell bodies and axons of intemeurons or Rohon-Beards in the 
neural tube (arrowheards). Shown in the three panels are fluorescent (left panel), white 
light (middle panel) and an overlay (right panel).
c. Top Left Panel: Single confocal fluorescent image of a lateral view of the spinal cord 
of a 4dpf PACIGFP2 transgenic embryo, overlaid onto a brightfield image. Expression 
in putative oligodendrocytes can be seen predominantly in the ventral portion.
Neuronal expression is absent.
d. A lower powered fluorescent image of the same region of the embryo, at a more lateral 
plane. Satellite cells (arrowheads) in each DRG can be seen, as can the Schwann cells 
(arrows) of the ventrally and dorsally projecting spinal nerves.
e. A lateral confocal image of the ear of the same embryo showing that strong expression 
is maintained in this organ.
f. Ventral fluorescent image showing expression in the jaw elements of an 8dpf 
PACIGFP2 transgenic embryo.

expression is seen in this line. This is in contrast to the transient reporter assays performed 
with this construct, which did occasionally produce muscle expression. Thus integration of 
the reporter appears, in this case, to have permitted effective silencing in this cell type.
At 4dpf, PNS expression can be seen in posterior lateral line Schwann cells (not 
shown), and glia associated with DRGs and the spinal nerves. This is shown in Figure 
4.20d, with cells in a position and of a shape reminiscent of the satellite glia surrounding 
DRG neurons (shown for soxlO-4.9:GFP; Figure 4.17). In addition to the satellite glia, 
Schwann cells lining the nerves emanating from the DRG are also GFP+ (Figure 4.20d). At 
this stage, GFP expression in the neural tube is confined to putative oligodendrocytes 
(Figure 4.20c). Expression in the ear is still very strong (Figure 4.20e), as is expression in 
the craniofacial cartilage. An example of GFP+jaw cartilage at 8dpf is shown in Figure 
4.20f. The variable expression levels notable with the soxlO-4.9:GFP line at this site is not 
evident in the PACIGFP2 line.
4.3. S u m m a r y  a n d  D iscussion
This chapter describes the subcloning of the sox 10 genomic region, isolation of the 
upstream region including the promoter and generation of GFP reporter constructs. The 
targeted modification of a sox 10 PAC to produce a PAC reporter construct was also 
achieved. A scale diagram of the three constructs is shown in Figure 4.21, and clearly 
demonstrates the much larger amount of flanking DNA present in the PAC reporter. The 
number of transgenic lines generated for each construct, and a summary of the expression 
sites seen in both transient and transgenic analyses are presented, compared to known 
sox 10 expression sites.
Unfortunately the transient analysis of these promoters was limited due to time 
constraints, and presence or absence of GFP expression in all expected sites was not 
established for all constructs. Detailed transient analysis of these, and smaller promoter 
fragments, was initiated as part of a promoter dissection project by others in the lab. 
Subsequently, transient and transgenic GFP analyses in combination should allow 
identification of the regulatory elements controlling sox 10 expression. Full description of a 
reporter’s expression profile is difficult solely with transient analyses, due to associated 
mosaicism. As only a fraction of cells will inherit copies of the transgene, only a subset of 
the expression domains might be seen, even upon using a large sample size of injected 
embryos, and some cell types might be missed. Furthermore, it has been established here 
that a reporter can behave disparately in transient and transgenic environments (Figure
Figure 4.21: Summary of the reporter constructs produced and 
their expression patterns
The three soxlO.GFP reporter construct produced are depicted on the left side, with the 
amount of surrounding sox 10 promoter sequence shown as a horizontal line and to 
scale. The gfp gene and polyadenylation signal are presented as a green box. The 
approximate start of transcription for the sox 10 gene is presented as an arrow, and Notl 
(N) and Sail (S) sites are presented on the PAC reporter.
A table summarising the GFP expression analyses for each reporter is presented on the 
right. For each reporter, the top row represents a summary of results from transient 
analysis, whilst the bottom row represents results from germline transgenic analysis. 
The number of transgenic lines produced so far for each construct is also presented.
The major sites of expression are listed at the top of the table, be they endogenous or 
ectopic. They are listed in approximate chronological order of first appearance from 
left to right. The following key applies:
+: Expression is seen in this location.
Expression is not seen at this location.
?: presence or absence of GFP expression at this location has not been properly 
assessed.
Symbols are also colour coded such that:
Red: presence (or absence) of GFP expression is in contrast to the sox 10 in situ pattern. 
Green: presence (or absence) of GFP expression concurs with the sox 10 in situ pattern. 
Yellow: Presence of GFP in this cell contrasts with the in situ pattern, but may be due 
to perdurance from an earlier stage of correct expression.
Black: No conclusive in situ data is reported for this site yet.
Notes:
(1): Ear expression in this line is far weaker than expected from in situ analysis
(2): Schwann cells in all lines analysed have been seen on the PLL nerve and spinal 
nerves. Only in sox 10-4.9:GFP have they been searched for in the sympathetic 
chain as yet.
(3): Late expression in the ENS is seen in both in situs and in transgenics. It is unclear
in both analyses precisely which cell types (neuronal or glial) are labelled. Nor 
can an argument for GFP perdurance in the transgenic be discounted (see text).
(4): Premigratory neural crest has only been inspected in the tail of the sox 10-6.1 :GFP
lines at 28hpf. Earlier inspection has not been conducted.
(5): Ectopic heart epithelium expression is seen in only one of the four soxlO-6.1:GFP
lines.
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4.21). For example, the two larger constructs (p6.1 :GFP and PACIGFP2) show expression 
in muscle in transient analyses, but not in their respective transgenic lines. Thus it is 
possible that, in certain circumstances, transient analyses afford erroneous expression 
patterns. Thus identification of an expression site in transient transgenics requires 
substantiation through other means, including inspection of germline transgenics and in 
situ data.
The transient analyses performed were, however, crucial in quickly demonstrating that 
the reporter constructs produced could direct GFP expression in the neural crest and other 
sox 10 expressing sites. This information argued that if introduced into the germline, these 
constructs could produce useful and informative transgenic zebrafish lines. Of concern, 
however, was the presence of ectopic expression in the muscle. More detailed transient 
analyses with these and other promoters have uncovered other ectopic expression sites, 
namely notochord and skin (J. Dutton pers comm.). If present in the transgenic lines as 
well, this ectopic expression might obscure the neural crest expression, and interfere with 
further experiments aimed at observing or manipulating labelled cells. Fortunately the 
muscle expression was only found in the anterior muscle blocks of the soxlO-4.9:GFP line, 
and has not been seen in other lines. It has not hampered the analysis or use of this line so 
far. Others have reported ectopic expression in muscle and notochord in transient reporter 
analyses, including those made from the zebrafish tyrosinase promoter (Camp et al., 2003). 
Thus this phenomenon might not be uncommon in zebrafish transient transgenic studies.
A modification to a PAC recombinogenic targeting method was also used successfully, 
which invoked an alternate, NiCb, method for selecting against the tetR marker. This was 
necessary as the original method based on fusaric acid proved difficult. This modification 
is unlikely to have any serious use in further development of recombinogenic targeting 
methods as the new generation of Shuttle vectors employ better selectable markers. It 
should be remembered however, that the Building Vector might still be useful for future 
modification of sox 10 containing PACs or BACs. The GFP gene present between the 
homology arms is flanked by Xbal sites, which would allow easy replacement with other 
reporters or coding sequences. Subsequent transfer as a Sail fragment to the new 
generation of Shuttle vectors should allow for much easier PAC/BAC modification.
4.3.1. On the relative strength of GFP expression in the different 
transgenic lines
Generally, all the transgenics reproduced much of the zebrafish sox 10 in situ pattern 
and, as such, correlated well with the expression patterns known in other species. Of all
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constructs injected, the rate of successful germline transmission appears to vary, with the 
p6.1 :GFP construct being the most successful (4/33 injected fish screened so far are 
founders). Unfortunately all four lines appear to express only weakly. Meanwhile, only one 
founder has been identified for each of the other two constructs injected. These two lines 
both express GFP strongly, however. Why might all the soxlO-6.1:GFP lines express 
weakly? It is possible that the p6.1:GFP construct includes a general repressor element, 
absent in the p4.9:GFP construct and overridden in the PACIGFP2 construct by extra 
enhancers. Alternatively, integration of p6.1:GFP in all four soxlO-6.1:GFP transgenics 
may have been at a relatively low copy number, leading to weak GFP expression. The 
difference in copy number integrated could depend on the degree of concatemerisation of 
the transgene upon injection into the embryo. It has been reported that linear DNA, upon 
introduction into 1-cell stage zebrafish embryos, is both concatemerised and amplified up 
to 10-fold (Stuart et al., 1988). Estimation of the transgene copy number by Southern 
analysis remains an important goal in the characterisation of all the transgenic lines 
reported here.
As to why concatemerisation might have been lower upon injection of the p6.1 :GFP 
construct remains unknown, but might involve variations in DNA quality, age of embryos 
injected, amount and concentration of DNA injected or location of injection within the 
embryo (i.e. into the yolk or cell). Additionally, the lower degree of concatemerisation 
might also account for the increased rate of transgenesis. With less concatemerisation, it 
can be envisaged that mosaicism might be less problematic as DNA can be better 
distributed between cells. This might increase the probability that DNA is incorporated in 
primordial germ cells and thus able to integrate into the germline. Thus concatemerisation 
might be a critical factor in balancing the rate of transgenesis with the level of expression. 
This is the basis for the new transgenesis technique employing co-injection of a 
meganuclease. The authors proposed a mechanism in which the enzyme counteracts the 
natural ligase activity present in the cytoplasm, and thus provides more recombinogenic 
ends that facilitate integration events (Thermes et al., 2002).
Of all the lines, the PACIGFP2 line looks the most promising. Unlike the sox 10- 
4.9:GFP line, it expresses in the otic vesicle strongly and does not appear to have the 
highly variable expression levels, seen with the smaller plasmid construct. Furthermore, it 
is much brighter than the soxl0-6.1 :GFP lines. It might be that the PACIGFP2 line 
expresses well due to high copy number, but it could be that it has more enhancer elements 
present on it that direct much stronger expression.
4.3.2. High transgene copy number might result in ectopic muscle
expression
It appears strange that while all three reporters drive ectopic muscle expression in 
transient transgenic analysis, only the soxlO-4.9:GFP transgenic line expresses here. 
Although it might be that this construct lacks a repressor present on the others, and that this 
repressor requires germline integration for it to function efficiently, a simpler explanation 
involves copy number. As proposed earlier, if a cell inherits a very large dose of the 
transgene, any repressor complexes needed for silencing may be swamped or titrated out, 
leading to ineffective silencing in that cell. Other evidence supports this theory. Whereas 
linear DNA injected into embryos can be concatemerised and amplified, this is not possible 
in circular injected DNA. Thus it can be predicted that the transgene copy number in cells 
of embryos injected with linear DNA would be greater than in cells injected with the same 
amount of circular DNA. It follows that if the ectopic muscle expression is due to excess 
transgene copy number, then it should be more prevalent in embryos injected with 
linearised reporter constructs compared with circular DNA. This has been observed as 
indeed being the case (J. Dutton, pers. comm.).
This observation strengthens the proposal that the reason all constructs show ectopic 
muscle expression in transient analyses is due to excess copy number. It might be that only 
the soxlO-4.9:GFP transgenic line has a large enough copy number to swamp the repressor 
complexes and show muscle expression, and thus is the only transgenic line of all six 
produced to show this ectopic expression. Again, the crucial experiment to test this 
proposal is to obtain an estimate of the transgene copy number in each transgenic line 
using Southern analysis. The arguments outlined above predict that the soxlO-4.9:GFP line 
will show a much greater copy number than any of the other lines.
Finally, it is worth mentioning that the PACIGFP2 reporter construct contains loxP 
sites. This provides a means for resolving tandem arrays at integration sites to fewer copies 
via exposure of transgenic embryos to Cre recombinase, and thus avoiding any adverse 
effects of multiple tandem arrays on transgene expression sites. No such adverse effect has 
been seen in hemizygous PACIGFP2 embryos as yet.
4.3.3. GFP expression is seen in premigratorv neural crest
Aside from muscle, much of the expression pattern described for soxlO-4.9:GFP is in 
accordance with the soxlO in situ pattern. First, GFP expression is seen in premigratory 
neural crest, at the same time as the in situ signal is evident. No overt differences between 
the GFP and sox 10 in situ patterns are evident at this stage, and it is not obvious that the
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GFP is expressed in more or less neural crest cells than sox 10 itself. “Holes” in the GFP 
expression pattern are visible (see Figure 4.1 lb), but soxlO in situ analysis at the same 
stage also uncovered very occasional soxlO' neural crest cells (Pauliny, 2002), arguing that 
the “holes” could conceivably be due to promoter inactivity in some neural crest cells. It 
follows that the transgene might be faithfully reporting the status of the endogenous sox 10 
promoter. Currently, double labelling studies are being conducted to compare the sox 10 in 
situ pattern with the GFP pattern, using fluorescent in situ detection of sox 10 transcript and 
immunofluorescent detection of GFP protein in transgenic embryos. This is an important 
experiment for investigating how well the transgene mimics the expression of sox 10 in the 
premigratory neural crest, and whether it faithfully reports on the status of the sox 10 
promoter. It will also indicate whether all GFP+ cells at this stage are also soxl0+, and 
might help resolve the nature of such “holes” in the GFP pattern. It is also possible that 
they are artefactual and due to variegation in transgene activity rather than real variation in 
sox 10 promoter activity in the neural crest. The biological significance or fate of the sox 1 O' 
cells has not yet been established, but might be uncovered using the GFP line, by fate 
mapping the GFP' (and presumably sox 10') neural crest cells at an early stage with lineage 
tracing dyes.
Other double fluorescent analyses which might be informative, include use of other 
neural crest in situ markers such as crestin (Luo et a l, 2001),foxD3 (Odenthal and 
Nusslein-Volhard, 1998) and sox9b (Li et a l, 2002). Such experiments might reveal 
subsets of neural crest with divergent expression profiles, knowledge of which is important 
to the understanding of the mechanism and timing of neural crest specification. Double in 
situs using these markers combined with sox 10 have been performed previously, however 
this could not be performed with dual fluorescence (Pauliny, 2002). This hindered 
interpretation of the degree of overlap of signals. Using the GFP line in place of the soxlO 
in situ probe allows dual fluorescence to be used more readily which, combined with 
confocal microscopy, may improve visualisation of the overlap of expression of these 
markers with soxl0+ cells. As an alternative to the combination of fluorescent in situ 
detection and immunofluorescence against GFP, dual immunofluorescence could be 
attempted using antibodies against GFP in combination with antibodies against other 
neural crest proteins, such as foxD3.
In agreement with soxlO-4.9:GFP, there is evidence that the other lines reported here 
direct expression in premigratory neural crest. Firstly, the soxlO-6.1:GFP lines expresses 
GFP in premigratory neural crest in the tail at 28hpf, however this line has not yet been 
fully analysed. It seems highly likely that inspecting these embryos at an earlier stage 
would also reveal expression in premigratory neural crest from the 1 somite stage as seen
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in the sox 10-4.9:GFP line. Meanwhile, neural crest expression at an early stage (1-2 
somites) has been seen in the PACIGFP2 line.
4.3.4. GFP perdurance allows cell lineage analysis in transgenic lines
Later, GFP expression can be seen in migrating neural crest and, as shown previously, 
this allows processes and filopodia to be visualised. At 24hpf, medially migrating neural 
crest cells are GFP+, as are laterally migrating neural crest cells and those migrating 
through the branchial arches. Expression at these latter two sites is in contrast to the in situ 
data, which suggests that only neural crest cells on the medial pathway retain strong sox 10 
expression (Dutton et al., 2001). As with the muscle expression, this could represent 
ectopic promoter activity in this cell type, however a more attractive explanation is 
perdurance of the GFP protein after the promoter has been switched off. The stability of 
the GFP protein has been demonstrated experimentally in the lab by direct introduction of 
the protein into zebrafish embryos, with GFP fluorescence noted at least 48 hours after 
injection, indicating the high degree of stability of the protein (A. Jacoby, pers. comm.). 
Thus it is possible that the apparent ectopic expression in laterally migrating neural crest 
(pigment precursors) and neural crest migrating in the branchial arches (jaw precursors) at 
24hpf actually represents perdurance of the GFP protein expressed in premigratory neural 
crest. It appears that the sox 10 mRNA is present early on in premigratory neural crest fated 
to the cartilage lineage, is rapidly lost as they migrate through the branchial arches, and 
then is re-expressed in these cells at 48hpf as they begin chondrogenesis. Perdurance of 
GFP protein means that the phase of promoter inactivity is not seen in the transgenics.
As mRNA is generally turned over at a more rapid rate than protein, it follows that gfp 
transcripts might not be visible in GFP+ cells in these ectopic locations. Preliminary use of 
a gfp in situ as a more accurate read-out of promoter activity has indicated that at 24hpf 
there is no detectable gfp transcript in the branchial arches, despite the presence of GFP 
protein (see Appendix 2). This supports the argument for perdurance of the protein, rather 
than inappropriate expression. In this manner, the GFP protein acts as a lineage tracer, and 
allows fate mapping of cells in which the soxlO promoter has been active earlier (i.e. 
premigratory neural crest). One conclusion that can thus be drawn is that cells contributing 
to head ectomesenchyme (jaw cartilage) were soxlO+ at an earlier stage, along with other 
neural crest fated to become pigment and glial derivatives. This indicates that the cells 
forming all these fates are homogeneous with respect to sox 10 expression, a fact suggested 
but unproven by in situ analysis. This is despite there being no overt jaw phenotype in els, 
a fact previously used to argue that the neural crest undergoes a restriction of fate to either 
the ectomesenchymal or non-ectomesenchymal lineage (Weston, 1991). It is now evident
that sox 10 may be expressed in both, but not necessary for the ectomesenchymal lineage. 
Perhaps this can be accounted for by redundancy of function with other transcription 
factors such as sox9b, which is also expressed in premigratory neural crest. This GFP 
perdurance argues that SoxlO is expressed in both lineages, or prior to the fate restriction. 
In addition, there is currently some speculation as to the origin of ectomesenchymal fates, 
and whether they form from true neural crest or from mesodermally derived cells (R. N. 
Kelsh pers. comm). This result argues that ectomesenchymal fates are indeed descended 
from the same population of precursor cells as other neural crest fates.
It is well known that DRG neurons are neural crest derived, however there has not been 
any evidence that the neural crest cells fated to become DRG neurons express sox 10 at any 
point during their development. It has been argued that the DRG neuron phenotype in 
homozygous Dom mice is a secondary consequence of loss of trophic glial support (Britsch 
et al., 2001). Evidence that SoxlO plays a direct role in the development of DRG neurons 
requires demonstration that these cells expressed sox 10 at some stage in their history. Use 
of GFP perdurance in the soxlO-4.9:GFP line as a lineage tracer might allow this to be 
addressed. If, using dual immunofluorescence, cells co-expressing GFP and an early DRG 
neuron-specific marker are seen, then it would argue that these cells are specified to 
becoming sensory neurons, and at some stage expressed soxlO. This is crucial to any 
argument for the direct role of sox 10 in controlling DRG neuron specification, survival or 
differentiation. Early sensory neuron markers which could be used include the neuroD in 
situ probe, the Hu epitope, or perhaps the ngnlirfp transgenic line (Blader et al., 2003).
Perdurance might account for other unexpected sites of GFP expression, including 
pigment cells, putative intemeurons in the neural tube, and in enteric neurons. Reported 
sox 10 expression in the CNS is limited to the ventricular zone at 24hpf, and later in 
oligodendrocytes (Pauliny, 2002). The GFP expression seen in intemeurons is unexpected, 
as it has not been described for soxlO. Although expression in this cell type might have 
been undetected by in situ, it remains possible that the expression is either ectopic, or 
perdurance from earlier expression in the ventricular zone or the neural plate. Intemeuron 
expression is lost after approximately 3dpf. Ventricular zone expression in the sox 10 
transgenic lines has not yet been established, but will probably require the use of transverse 
sections to accurately determine GFP localisation. Further evaluation of the significance of 
GFP expression in this cell type is currently being undertaken. If perdurance is the cause of 
the intemeuron expression, it seems strange that more cell types in the CNS do not express 
GFP. Intemeurons share a common precursor with astrocytes in other vertebrates, whilst 
oligodendrocytes arise from the same precursor cell as motor neurons. Thus if this is true 
in zebrafish, and intemeuron expression is due to perdurance prior to specification, then it
might be expected that astrocytes are also GFP+, however this is not the case. That only 
oligodendrocytes, and not motor neurons have GFP expression supports the observation 
that soxlO is only activated in oligodendrocytes after they have specified from the bipotent 
precursor cell (Park et a l, 2002).
GFP expression is seen in cells of the enteric nervous system (possibly neurons) at 
5dpf. This expression pattern is surprising as it is known in mouse that enteric neurons do 
not express SoxlO once differentiated (Paratore et al, 2002). It cannot be ruled out that 
soxlO is not expressed in ENS neurons at 5dpf, as in situ analysis has not been performed 
this late. However the zebrafish gut is populated by soxl0+ precursor cells from 24hpf to 
60hpf at least (Dutton et a l, 2001). If sox 10 is not expressed at this later stage, then the 
GFP signal seen is erroneous. The cause of this could be that the expression here is ectopic. 
Alternatively, the GFP signal seen in the gut in these 5dpf embryos might represent 
perdurance of GFP from this earlier stage. Consistent with this, persistence of lacZ protein 
in differentiated neurons after cessation of promoter activity has been shown to occur in 
Soxl(facZl+ mice. If GFP expression in the enteric neurons at 5dpf is true perdurance then it 
should be dramatically reduced at later stages. Assessment of GFP in this location at mid- 
larval stages (14dpf onwards) should be relatively straightforward, and would ascertain if 
promoter activity is maintained. However presence or absence of GFP in enteric chain 
precursors prior to this stage has not been thoroughly assessed. It is interesting to note that 
although sox 10 mRNA can be readily detected in enteric chain precursors by in situ at 
30hpf, GFP expression here was strikingly absent (not shown), possibly indicating lack of 
an enhancer element in the reporter construct. It remains to be seen if the other transgenic 
lines express in this cell population. This lack of earlier expression argues against 
perdurance, and might support an alternative reason for the apparent expression of GFP in 
enteric neurons, but not in precursors, namely that the later expression is due to ectopic 
activity of the promoter. Finally the GFP might in fact not be expressed in neurons, but 
simply in cells closely associated with them, and the imaging used to analyse this did not 
have the resolution to distinguish the two fluorescent signals. Use of two-channel confocal 
microscopy would be a worthwhile approach towards resolving this issue. In support of 
this last theory it appears that the shape of the cells differs between the two different 
fluorescent images, with the GFP signal appearing in processes emanating from the cell 
bodies, whilst the Hu signal is seen in much more compact bodies (Figure 4.17d).
Although this might reflect differences in subcellular distribution of the two epitopes 
detected, it might also indicate that they are in fact present in two distinct, but closely 
associated, cell types.
Il l
Pigment cells represent a further cell type where GFP appears to perdure, with recent 
gfp in situ analysis showing that lateral pathway neural crest, which do show GFP protein, 
have no gfp transcript. Detection of presence or absence of GFP in differentiated 
xanthophores and iridophores is hampered by autofluorescence in these cell types. Often 
fixation of embryos can destroy autofluorescence. It might be possible to use this, 
combined with subsequent immunofluorescent detection of GFP to differentiate between 
autofluorescence and actual presence of GFP. Alternatively, xanthophore autofluorescence 
is rapidly quenched by exposure to fluorescent light. Thus a bleaching approach might 
indicate if the fluorescence is due to GFP protein or otherwise.
4.3.5. Further analysis of the GFP expression pattern in all transgenic 
lines is required
Due to time constraints, full analysis of GFP expression in all transgenic lines has not 
yet been performed. A summary of sites where expression might be seen, but has not yet 
been thoroughly evaluated is shown in Figure 4.21. Some of these sites, and others, are 
briefly discussed here.
sox 10 in situ analysis demonstrated expression in the pineal gland, however this has not 
been observed in any transgenic line as yet, and thus requires closer examination. 
Expression is also seen in all cranial ganglia, but GFP expression in cells associated with 
the posterior lateral line ganglion only has been identified so far. Expression pattern in 
other cranial ganglia and nerves has not yet been fully assessed. All lines have GFP 
expression in Schwann cells along the segmental nerves and posterior lateral line, however 
only the sox 10-4.9:GFP line has been examined for Schwann cells associated with the 
sympathetic ganglion. As this line clearly showed expression here, it will be interesting to 
see if the other lines do as well.
In situ analysis of SoxlO in mouse and chick also revealed sox 10 expression in septa 
and nerves of the heart, the pancreas and in oligodendrocytes along the optic nerve. These 
sites in the zebrafish transgenic lines also need to be checked for GFP and sox 10 
expression.
The identity of the cell types expressing GFP in the PNS and CNS is currently 
speculative, based on cell morphology, cell position and previously known expression 
patterns for soxlO. Confirmation of these cells’ identity could be achieved using molecular 
markers. For example, oligodendrocytes are labelled with the olig2 bHLH transcription 
factor and are known to co-express sox 10 (Park et al., 2002). Thin GFP+ strands seen in the 
CNS are intemeuron-derived axons. Double labelling experiment using an axon marker
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such as a-tubulin could be used to confirm this premise. Unfortunately there are very few 
markers for peripheral glia available in zebrafish. However much of this expression pattern 
confirms the previously reported in situ results, including expression in certain glial cells 
of the PNS and oligodendrocytes of the CNS. Use of dual immunofluorescence has shown 
that DRG and sympathetic neurons are surrounded closely by GFP+ cells. This proximity 
identifies these cells as satellite glia. Identification of soxlO expression in satellite glia 
surrounding DRGs had not previously been demonstrated in zebrafish, and is consistent 
with the expression of sox 10 in this cell type in other species (eg mouse; Britsch et a l ,
2001). Previous visualisation of satellite glia may have been difficult by in situ due to lack 
of mRNA distribution within the cell. The ability of GFP to label almost the entire cell aids 
visualisation and assessment of cell morphology and identification of cell type. In this 
respect, this GFP line might provide a complimentary method for analysing the expression 
pattern of the soxlO protein.
The GFP antibody might also allow staining of GFP+ cell type in adult sections. 
Assessment of the GFP expression pattern for these transgenic lines would be of interest in 
comparison with sites of maintenance of SoxlO expression in mouse and humans.
4.3.6. Downregulation of the promoter supports a model in which SoxlO 
has only an early role in melanophore development
As soxlO is required cell-autonomously in the melanophore lineage, and all neural crest 
cells lacking sox 10 (els mutants) fail to show early melanophore lineage markers (such as 
the master switch gene, mitfa), it is likely that the sox 10 promoter is active in neural crest 
cells before they melanise (Dutton et al., 2001; Kelsh and Eisen, 2000). Furthermore, 
recent rescue experiments have shown that forced expression of mitfa rescues 
melanophores in els mutant embryos equally as well as in nacre mutants (Elworthy et al., 
2003). This indicates that the essential role for sox 10 in melanophore development is the 
early induction of mitfa, and that sox 10 is not required in melanophores after this stage. As 
mitfa is expressed widely at 24hpf in melanoblasts, and is downregulated in differentiated 
melanophores (Lister et a l , 1999), it would appear that sox 10 would only be required in 
melanophores at this early stage, at around 24hpf. This is consistent with the GFP analysis 
presented here, as it appears that all melanophores express sox 10 at 24hpf, but a reduction 
in GFP signal occurs over time. It is likely that soxlO plays a similar early role in other 
pigment cells, and thus is not required (or expressed) at later stages.
That this reduction is not rapid (low level expression is still detectable at 4dpf) can be 
accounted for by stability of the GFP protein. The half-life of GFP protein in melanophores
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estimated by this analysis is approximately 14 hours. A better assessment of transgene 
promoter activity could be afforded through use of in situ detection of the GFP transcript, 
or by generation of a transgenic line carrying a destabilised GFP variant. Preliminary 
analysis of gfp transcripts in 24hpf embryos indeed shows absence of nascent transcript in 
laterally migrating neural crest cells (i.e. pigment precursors; not shown). It should be 
noted that similar conclusions were drawn from sox 10 in situ analysis. Most melanising 
melanophores did not express sox 10, and those that did only showed weak expression. 
However these in situs were not developed very far, nor was a detailed timecourse 
established.
4.3.7. SoxlO promoter activity is retained in cartilage cells and glia
Although, no sox 10 transcripts are present in the branchial arches at 24hpf, sox 10 does 
come on in these cells later at 48hpf. Analysis of these GFP lines indicates that the SoxlO 
promoter is active in cartilage cells until at least 20dpf. Thus, the later GFP expression in 
developing jaw cartilage cells most likely reflects the status of the endogenous sox 10 
promoter. It would be interesting to use this transgenic reporter line to ascertain when, if 
ever, the promoter is inactivated in this cell type.
Apparent in the soxlO-4.9:GFP line is the highly variable expression levels in 
individual cartilage cells, particularly evident in the pectoral fin at 5dpf. This is not 
apparent in other soxlO:GFP transgenic lines, and thus is most likely due to some form of 
instability of the DNA at the transgene integration site, or some form of position effect 
variegation. The PACIGFP2 line is just as bright as the soxlO-4.9:GFP line, but does not 
show variable expression levels in cartilage cells. This, combined with the knowledge that 
it is expressed correctly in the ear, and not in muscle cells, might make this a more reliable 
sox 10 reporter line, and thus more useful for future experiments
The role of sox 10 in chondrogenesis is currently poorly understood, despite known 
expression in the facial cartilage of humans and limb cartilage of mice and chicks. One 
possible role might be to confer competence to respond to BMP signals instructing the 
onset of chondrogenesis (Chimal-Monroy et al., 2003). Both the two other Group E Sox 
proteins have known roles in chondrogenesis, and the zebrafish sox9a mutant, jellyfish, 
displays severely disrupted chondrocyte morphogenesis and differentiation (Yan et al., 
2002). Possible functional redundancy between these closely related proteins might 
account for lack of an overt cartilage phenotype in els. Alternatively, the sox 10 phenotype 
might only present much later, beyond the time of embryo death. Transplantation of a few 
els neural crest cells into wild-type hosts would allow evaluation of a later cartilage neural
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crest cell phenotype, as the early death of the embryo would be circumvented, allowing 
any cartilage cells derived from the donor to be examined in vivo at a later stage.
Long-term maintenance of GFP expression is seen in various glial populations. For 
example satellite glia, oligodendrocytes and Schwann cells express GFP until at least 
20dpf. This corresponds to the known role of human and mouse SoxlO in the direct 
transcriptional control of a number of glial differentiation genes and myelin associated 
proteins. No such direct regulation of glial differentiation genes has yet been investigated 
in zebrafish, but it appears likely given that the soxlO promoter is active in these cells at 
mid-larval stages, and possibly throughout life. Thus these GFP transgenic lines strongly 
suggest that, as in the mouse, sox 10 is expressed in differentiated glial cells, probably with 
a conserved role. Use of dual immunofluorescence has demonstrated the relationship 
between GFP expressing cells and neurons of the peripheral nervous system. It would be 
worthwhile extending this approach to analyse other markers of the PNS, for example 
using an antibody against axons such as a-tubulin.
Expression of sox 10 in satellite cells had not previously been definitively shown, 
although it had been strongly suggested (Pauliny, 2002), and is consistent with known 
expression at this site in mice (Sonnenberg-Riethmacher et a l , 2001). The only other 
known zebrafish gene expressed in this cell type is foxD3 (fkd6\ Kelsh et al., 2000a), 
however expression in this cell type was not reported in the foxD3:GFP transgenic line 
(Gilmour et a l , 2002b). Thus the soxlO-4.9:GFP line might prove to be a unique tool for 
analysing development of satellite glia.
4.3.8. Identification of a possible ear enhancer?
Curiously, the soxlO-4.9:GFP line showed much weaker expression in the ear than in 
the neural crest cells or other sites (see Figure 4.13c). This is in contrast to all other 
transgenic lines and the in situ data, which all showed equally strong (or stronger) 
expression in the ear as in the neural crest. It is tempting to speculate that this latter 
construct lacks an ear-specific enhancer that directs higher-level expression in this tissue. 
Unfortunately there is only one sox 10-4.9:GFP line discovered so far, meaning that 
verification of this weak ear expression from this construct is not yet possible. It cannot be 
discounted that this expression is some form of unusual and specific repression in this site 
due to a position effect, or to integration near some repressor element. However, this seems 
unlikely to affect only the ear and it remains possible that an ear enhancer is missing or 
disrupted in the p4.9:GFP construct. By chance, the BamHl site at the 5* end of this 
construct and used for sub-cloning purposes, occurs in the middle of an extragenic region
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with high homology to an upstream region of the Fugu sox 10 gene (see Figure 3.6), which 
might represent a conserved enhancer. As faint ear expression is seen in the transgenic line 
carrying a reporter construct containing only half of this region, it is tempting to speculate 
that this site indeed represents an ear enhancer. Inclusion of the entire region as in the 
slightly larger 6.1:GFP construct, appears to produce much stronger absolute and relative 
levels of expression in the ear. A second independent soxlO-4.9:GFP line would be 
extremely useful in validating this observed decrease in ear expression, as would 
transgenic lines carrying smaller soxlO:GFP constructs, excluding this entire conserved 
domain. Attempts to produce these lines are currently underway (J. Dutton, pers. comm). 
Further complicating this observation is the strong ear expression of p4.9:GFP in transient 
assays, however, the strength of this expression may be misleading due to high transgene 
copy number in the cells.
4.3.9. Potential uses of these GFP reporter lines
A number of experiments using these lines have been proposed already (see above). 
These involve use of the transgenic lines to fate map GFP+ (and presumably soxlO+) 
premigratory neural crest cells, and to ascertain the sox 10 promoter status in various cell 
types. A series of other applications are envisaged. Foremost is a genome-wide analysis of 
neural crest cells’ expression profiles. This has recently been conducted in chick using 
induction of neural crest in explants in combination with subtractive array analysis. A 
number of gene expressed specifically in the neural crest were identified (Gammill and 
Bronner-Fraser, 2002). The transgenic lines described here are the first zebrafish GFP 
transgenic lines to strongly express GFP broadly in premigratory neural crest. This 
expression pattern should allow isolation of relatively pure neural crest from embryos 
using FACS. Analysis of the expression profile of these cells using microarrays will 
provide the first detailed evaluation of genes critical to proper neural crest development. 
Subtractive or differential screens using GFP labelled neural crest cells in various mutant 
contexts might further identify specific subsets of genes activated by certain signalling 
pathways or transcription factors. Such information will allow better understanding of the 
mechanisms involved in migration, specification and differentiation of neural crest.
At later stages, these transgenic lines appear to label PNS glia, oligodendrocytes and 
catilage cells. Use of FACS on older embryos, combined with similar microarray based 
expression profiling will also provide new markers of these cell types. Currently, markers 
of PNS glia are scarce, and mostly limited to transcription factors previously expressed at 
premigratory neural crest stages, which renders them unhelpful for establishing the 
differentiation status of the cells in various genetic contexts (Gilmour et al., 2002b). Thus
markers specific to the different glial cell types labelled in these lines would be of great 
benefit to the field. Similarly, the PACIGFP2 line labels the ear strongly, whereas the 
soxlO-4.9:GFP line does not. Some form of differential or subtractive screen of FAC 
sorted cells from both lines could exploit this to isolate ear specific transcripts at various 
stages.
Further uses of these lines include performing mutagenesis screens to isolate mutants 
affecting the various cell types labelled. Performing mutant screens using transgenic lines 
will become more prevalent in the future. The main advantage is that cell types of interest 
are labelled without the need for lengthy and laborious in situ or antibody stainings. Thus 
structures or cells not readily visible with DIC optics can be assessed. In this manner, use 
of these sox 10 :GFP reporter lines will allow the isolation of mutants specifically affecting 
PNS glia, cartilage cells, the otic vesicle, olfactory sensory neurons and/or 
oligodendrocytes. Additionally, this screen might reveal mutants in which GFP expression 
is diminished, and thus identify loci that regulate the sox 10 promoter. Knowledge of the 
regulation of sox 10 is also critical to understanding the mechanisms involved in neural 
crest specification. There has been no reported examination of the regulation of sox 10 in 
any species to date.
4.3.10. Analysis of soxlOiGFT* transgenic lines in mutant backgrounds
Finally, these soxlO.GFT1 transgenic lines will also allow further analysis of identified 
mutants. Firstly, the line provides a simple means for labelling a number of different cell 
types, the development of which can be scored in different genetic contexts. Further, as the 
transgenics label living cells, cellular behaviour can be followed with timelapse 
microscopy. One elegant example where GFP transgenics were employed to study 
previously described mutants used the foxd3:GFP line to label posterior lateral line 
Schwann cells, and to study their behaviour over time using timelapse microscopy in 
different genetic contexts, including wild-types, els and shh (Gilmour et al., 2002b).
Similar timelapse studies conducted in the jox70:GFP lines could include premigratory 
neural crest cell behaviour and migration in both wild-type and various mutants. This 
would constitute a novel and informative approach in the neural crest field. Previously 
unknown contributions of zebrafish neural crest cells to various organ systems, or better 
understanding of neural crest cell behaviour in specific mutants might ensue.
The first mutant strain it would be worthwhile analysing with the transgenics might be
els itself. One immediate question which could be answered by the transgenics is whether
satellite glia occur in els DRGs. This is an important question as some anterior DRG
neurons survive at 5dpf, whereas most die. Britsch et a l , (2001) has argued that in mice,
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loss of DRG neurons is secondary to loss of satellite cell-derived trophic support. The very 
early DRG neuron phenotype in zebrafish argues that this is not the sole cause of DRG 
neuron loss in els, but that there is a direct effect due to lack of sox 10 itself in a neuronal 
precursor. The extent of loss of satellite glia is not known in els. Use of the transgenic line 
to label these cells promises to answer this, although if present, no comment could be made 
as to their ability to provide trophic support. However, discovery of a surviving DRG 
neuron with absolutely no surrounding satellite cells would prove that DRG neurons can 
form in the absence of this trophic support, and therefore that their loss is not purely 
secondary to lack of glia.
Other analyses in els using the transgenic lines can be envisaged, and include detailed 
analysis of the migratory defect of the neural crest cells, and investigations into the 
sympathetic and enteric nervous system defects.
In summary, the production and characterisation of 5m70:GFP transgenic reporters has 
been achieved. These should provide a useful resource for the study of a number of cell- 
types labelled by the line. A number of labs have recently requested the line for such 
analyses.
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C h a p t e r  5 
C h a r a c t e r isa t io n  o f  t w o
COLOURLESS ALLELES
5 .1 . I n t r o d u c t i o n
5.1.1. Previous characterisation of colourless alleles
The first identified colourless allele, els13, arose spontaneously in a Tubingen stock 
(Kelsh et al., 1996). Subsequent large-scale zebrafish m utagenesis screens yielded 6 
further els alleles (K elsh et al., 1996; M alicki et al., 1996), o f  which 5 rem ain extant, 
namely clste275, elsty22^ , elstw2, elstwI1 and clsm618. The els locus has been shown to closely 
map to the sox 10 gene (Dutton et al., 2001). As the m utagenic agent used in the screens, 
ENU, m ostly  induces point m utations in DNA (M ullins et al., 1994), these alleles, 
therefore, were expected to display point m utations in the SoxlO protein, leading to non- 
synonym ous am ino acid substitutions or nonsense m utations. This has indeed been 
dem onstrated, w ith the latter three alleles being characterised as either a nonsense m utation 
leading to a prem ature stop codon {els™2 and els*™11) or as an am ino acid substitution 
(clsm618) (D utton et al., 2001).
Thus els'”2 and els'”11 both show the lesion K376X in the SoxlO protein, and probably 
represent independent isolations o f  the same original m utation event (Figure 5.1a). The 
introduced stop codon leads to truncation o f  the SoxlO protein, N-term inal to a domain 
showing conservation to a transactivation dom ain in hum an SOX 10 (Dutton et al., 2001). 
Accordingly, this loss dram atically disrupts the protein’s ability to transactivate a reporter 
construct in vitro (Pauliny, 2002).
M eanw hile, the clsm618 allele displays the lesion L142Q in the SoxlO protein (Figure 
5.1a). This substitutes a highly conserved leucine residue in the DNA binding dom ain with 
a glutam ine, and also disrupts protein transcriptional potency w hen assayed in vitro 
(Dutton et al., 2001; Pauliny, 2002). As this m utation occurs in the DNA binding domain, 
the reason for this reduced transactivation o f  a target prom oter w ould appear to be due to a 
com prom ised ability to bind to DNA. Indeed, com puter m odelling (done by M. Baker, 
University o f  Bath) o f  a DNA oligo representing a consensus Sox-binding site with the 
m618 protein  indicates that the substitution alters an am ino acid w ith close association to 
the DNA sequence, and consequently m ight significantly alter binding affinities. In vitro 
analysis has confirm ed that the same m utation in the hum an protein reduced its DNA 
binding activity (Rehberg et al., 2002). This contrasts w ith gel shift experim ents performed 
in our lab, w hich did not detect a reduced DNA binding ability com pared to wild-type 
protein (S. Elworthy, pers. comms.). Thus the m atter o f  the D N A binding capability o f  the 
SoxlC T ^5 protein requires further attention. Interestingly, Rehberg et al. (2002)
1 2 0Figure 5.1
Figure 5.1: Summary of characterised c/s alleles
a. Diagram showing the putative domains of the SoxlO protein including the HMG 
domain (red) and the transactivation domain (blue). The two described point mutations 
(clsm618 and els*™2 (=clstw11)) are indicated with arrowheads above. Two putative 
Nuclear Localisation Signals (NLS1 and NLS2) and the Nuclear Export Signal (NES) 
are shown below with sequences in brackets and the leucine disrupted in clsm618 is in 
bold. Adapted from Rehberg et al., 2002.
b. Reduced sox 10 expression levels in the clst3 allele as revealed by in situ hybridisation. 
Above panel shows a lateral view of a wild-type embryo (WT) at 18 somites with a 
clstS sibling at the same stage in the lower panel. Unlike other alleles at this stage, the 
amount of message is clearly reduced (indicated by arrows in the head and trunk), o, 












demonstrated that substituting the equivalent leucine with alanine in human Sox 10 
produced a protein that was able to bind a consensus Sox binding sequence strongly. 
However, they also showed that unlike wild-type Sox 10 protein, which shuttles between 
the nucleus and the cytoplasm, this protein could not be exported from the nucleus. The 
mutation deliberately targeted a consensus nuclear export sequence identified in the protein 
sequence (shown in Figure 5.1a), and largely abolished shuttling of the protein. This 
shuttling was shown to be critical for the transactivational potency of Sox 10 protein 
possibly due to post-translational modifications effected in the cytoplasm. The authors also 
substituted the leucine with glutamine as in the m618 mutation, and again noted defective 
shuttling, in addition to the compromised DNA-binding ability previously mentioned. 
Analysis of the sub-cellular localisation of the SoxlO"1575 protein in vivo is necessary to 
establish this in zebrafish, and further in vitro experiments are required to determine if lack 
of export contributes to its inability to transactivate. It is worth remembering that the HMG 
domain of Sox proteins also mediates protein-protein interactions, necessary for 
transactivation (see Section 1.2).
Of the remaining alleles, clste275 and els®22* are not characterised, however it was 
desirable to identify the clst3 mutation as it displayed unusual sox 10 in situ patterns 
compared with the other els alleles (Figure 5.1b; Pauliny, 2002). Whereas embryos 
homozygous for the characterised els alleles show a strong sox 10 in situ signal, clstS 
mutants show much lower levels of sox 10 mRNA, and RT-PCR attempts failed (Pauliny,
2002). Although this might be caused by a single point mutation disrupting transcription or 
transcript stability it is more likely due to some gross disruption at the locus such as a 
rearrangement, deletion or insertion event.
It should be noted that all alleles mentioned so far seem to show equally strong 
phenotypes, despite being due to different mutations in the gene. This might suggest that 
all are null alleles; otherwise it would require the unlikely event that all are hypomorphic 
to a similar degree (Dutton et a l , 2001). The validity of this claim is currently unresolved. 
A weak els allele (m241)  was discovered in the Boston screen (Malicki et al., 1996), 
however this has since been lost, and attempts to re-establish the stock from frozen sperm 
samples have failed. This is unfortunate as it displays an incomplete loss of dorsal 
melanophores, and a less severe ear phenotype, but was not fully analysed. Potentially this 
allele could uncover subtle functions of Sox 10 in the neural crest masked by the early 
apoptosis of these cells.
The aim of this area of work comprised the molecular characterisation of the t3 allele 
and also to assist in recovery and characterisation of novel els alleles with the hope of
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dom ain m apping the protein and/or better understanding the roles o f  Sox 10 during neural 
crest developm ent.
5.1.2. Repetitive elements and transposons in zebrafish
A  proportion o f  spontaneous m utations identified in various organism s can be 
attributed to transposons, which form a class o f mobile, repetitive elem ent found in higher 
eukaryotes. A summ ary o f  repetitive elements and transposons described to date in the 
zebrafish genome is presented as a tree diagram in Figure 5.2. Transposable elem ents fall 
into two groups, defined by the type o f  intermediate their transposition occurs through. 
RNA transposons (retroelem ents or retrotransposons) use an RN A interm ediate and thus 
require reverse transcriptase for their amplification in the genome, w hilst DNA transposons 
are m obilised or replicated through a DNA intermediate produced by the enzyme 
transposase using a “cut and paste” m echanism  (Ivies et al., 1999).
Apart from a small fam ily o f  M iniature inverted-repeat transposable elem ents 
(M ITES), DNA transposons identified in zebrafish so far are o f  the TcE superfamily, 
w hich can be divided into two subfam ilies, T drl and Tdr2 (Ivies et al., 1999). All DNA 
transposons identified so far are non-autonom ous in that they do not encode a functional 
transposase. A lthough there has not yet been direct dem onstration o f  a functional, 
endogenous reverse transcriptase or transposase in the zebrafish genome, the existence o f 
an active transposase has been inferred by Lam et a l  (1996) through a hybridisation 
strategy using a probe to Tdr2. A frequency o f  Tdr2 transposition per generation was 
estimated by the authors, which, after extrapolation, led them  to conclude that this forms a 
significant proportion o f  the background m utation rate. The validity o f  this claim  is 
questionable as a TcE induced spontaneous m utation is yet to be dem onstrated. Direct 
evidence at the sequence level, such as an induced m utation or identification o f  a DNA 
intermediate, is required for conclusive p roof o f  TcE transposition.
RNA transposons are characterised by either the presence or absence o f  long terminal 
repeats (LTRs). One LTR containing retrotransposon, bhikhari, is present at approxim ately 
100 copies in the genome and is actively transcribed (Vogel and Gerster, 1999), although 
there is no evidence that it has retained the ability to subsequently transpose. Both classes 
o f  non-LTR retrotransposons, namely LINEs (long interspersed nuclear elem ents) and 
SINEs (short interspersed nuclear elem ents), have been described in zebrafish. The first 
zebrafish SINE identified was named DANA (also called m erm aid; Shim oda et al. , 1996), 
which, like m ost SINEs, appears to be partially derived from  tRN A  species (Izsvak et al. , 
1996). DANA elem ents have been estim ated to comprise as m uch as 10% o f  the zebrafish 
genome, approxim ating 40 000 -  50 000 copies in a haploid genome. They contain a
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Figure 5.2 Tree diagram showing the Repetitive Elements found 
in zebrafish.
Repetitve elements fall into two main classes, namely Nonmobile, Tandemly repeated 
elements, which are comprised of high-copy transcribed genes and non-transcribed 
elements, including structural components of chromosomes (telomeres and 
centromeres), Variable number tandem repeats (VNTRs) and microsatellites. The other 
class of repetitive elements are the interspersed transposable elements assigned to two 
groups based on their method of transposition, namely DNA transposons or RNA 
transposons. The former include autonomous transposons, which encode their own 
transposase, and non-autonomous transposons, which rely on an external source of 
transposase for transposition. The former has not been conclusively demonstrated in 
zebrafish yet, but foreign transposases have been shown to be functional when 
introduced into zebrafish (in brackets and indicated with asterisks). Non-autonomous 
DNA transposons fall into two families: MITES (Minature Inverted-repeat 
Transposable Elements) and TcEs (Tcl-like transposable elements).
RNA transposons consist of those with long terminal repeats (LTRs) and those without 
(non-LTRs). The latter are divided into LINEs (Long Interspersed Nuclear Elements) 
and SINEs (Short Interspersed Nuclear Elements), to which the retroposon DANA 
belongs. A DANA-like element has inserted into some other transposable element to 
form the DANA„,/ composite transposon. The method of transposition of this 
composite transposon is unknown thus cannot strictly be allocated to one of the two 
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distinct structure of cassettes containing (up to) four constant (C) regions each separated by 
an associated variable (V) domain to produce Cv blocks. The number of Cv blocks found 
in DANA elements varies, and not all four are always present. Composite transposable 
elements have been formed by DANA elements inserting into other transposable elements, 
exemplified by a transposon found in a no tail allele (Izsvak et al., 1996).
5.1.3. Lateral inhibition functions during zebrafish development
Critical to organogenesis is the production of different cell types in appropriate 
numbers from a group of equivalent cells. During Drosophila neurogenesis, for example, 
only a subset of ventral neurectoderm cells are specified to form neuroblasts whilst 
adjacent cells form epidermoblasts (Technau and Campos-Ortega, 1987). Here, regulation 
of cell specification occurs through lateral inhibition and is mediated by interactions of the 
trans-membrane Delta ligand with its receptor Notch on neighbouring cells (reviewed in 
Muskavitch, 1994). Initially, expression of proneural genes acts to define an equivalence 
group, a group of cells all of which have equal potential to adopt a particular fate. In 
Drosophila neurogenesis, this is termed the proneural cluster, within which a lateral 
inhibition mechanism acts to select only single cells to become a neuroblast. This occurs 
through a regulatory feedback loop, with slight stochastic differences in amounts of Notch 
- Delta signalling amplified to result in a regular repeated pattern of cells expressing 
relatively high levels of Delta, surrounded by cells expressing Notch. Consequently, the 
initially equivalent cells are specified to two alternate fates. The Delta expressing cells 
adopt a primary fate whilst the surrounding Notch expressing cells are inhibited from 
adopting this primary fate, and later form a cell of alternate fate. Notch or Delta loss-of- 
fimction mutations, result in neurogenic phenotypes, with excess cells adopting the 
primary (neuroblast) fate at the expense of the later fates (reviewed in Chitnis, 1995). For 
example both Notch and Delta Drosophila mutants show overproduction of neuroblasts 
with concomitant loss of epidermoblasts (Muskavitch, 1994). It appears that this 
mechanism is widely used in animals, with Notch and Delta homologues identified in C. 
elegans (Seydoux and Greenwald, 1989) and numerous vertebrate model organisms, 
including zebrafish (Bierkamp and Campos-Ortega, 1993; Haddon et al., 1998; Westin and 
Lardelli, 1997).
There are a number of modulators and downstream effectors of this signalling system
in both vertebrates and invertebrates. Numb, for example, represses Notch function
(reviewed in Struhl and Greenwald, 1999), while cleavage of Notch by presenilins (Chan
and Jan, 1999) allows translocation of the Notch signal to the nucleus where, upon binding
to the Suppressor of Hairless (Su(H)) protein, activates transcription of bHLH transcription
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factors, namely the HES genes (homologues of the hairy and Enhancer of Split genes; Iso 
et a l,  2003). A large number of these components have been identified in zebrafish. In 
particular, the Notch and Delta genes of Drosophila both have four homologues in 
zebrafish, namely notchla, notchlb, notch2 and notch3 (Bierkamp and Campos-Ortega, 
1993; Westin and Lardelli, 1997), and deltaA, deltaB, deltaC and deltaD (Haddon et a l,  
1998; Smithers et al., 2000). Summaries of the expression domains and associated mutant 
loci of these genes are given in Tables 5.1 and 5.2.
Table 5.1: Expression domains and mutants of zebrafish delta genes
Process Structure deltaA deltaB deltaC deltaD
Gastrulation Epiblast y y
Hypoblast/margin y y y
Somitogenesis Tail bud y y y




Anterior of formed somites y
Posterior of formed somites y
1° neurogenesis Trigeminal ganglia y y y
Rohan-Beards y y  (subset) y
Motomeurons y y  (subset) y
Intemeurons y y  (subset) y
Later neurogenesis Cranial ganglia y
Ear y y y y
Spinal chord/hindbrain y y
Retina y









Summarised from: (Appel et al., 1998; Domseifer et a l,  1997; Haddon et a l,  1998; 
Holley et a l,  2000; Itoh and Chitnis, 2001; Riley et a l, 1999; Smithers et a l,  2000).
Table 5.2: Expression domains and mutants of zebrafish notch genes
Process Structure notch la notchlb notch2(notch6)
notch3
(notch5)
Cleavage Maternally derived mRNA y





Somitogenesis Tail bud y
Pre Somitic Mesoderm y y y
Tail fin primordium y y
Anterior of formed somites V
Posterior of formed somites y y
° neurogenesis Neural Rod y y
Late Notochord V y y
Late Hypochord y














Summarised from: (Bierkamp and Campos-Ortega, 1993; Holley et a l 2002; Itoh and 
Chitnis, 2001; Westin and Lardelli, 1997).
Although this is unlikely to represent the full expression pattern of these genes, it is 
apparent that expression patterns often overlap, and may indicate functional redundancy of 
these genes. Lateral inhibition in Drosophila sensory neurogenesis is required at two 
distinct stages, firstly to select sensory organ precursors and secondly to control cell 
specification of sibling cells within the developing sensory organ (Jan and Jan, 1994). 
Detailed analysis of expression of these genes in zebrafish secondary neurons, DRGs and 
during neural crest development is yet to be conducted, and is critical for understanding 
control of lineage specification in these domains.
Lateral inhibition has been shown to be critical in regulating both somitogenesis and 
various aspects of neurogenesis in zebrafish. For example, in both deadly seven and after 
eight mutants, only the first few (7-8) anterior somites form correctly (Gray et al., 2001; 
Holley et a l , 2000). Further, the importance of lateral inhibition in neurogenesis is
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conserved in zebrafish. Both delta mutants, dlA and aei, display hyperplasia of primary 
sensory neurons (Rohon-Beard cells) (Cornell and Eisen, 2000; Holley et al., 2000). It was 
shown for the dlA mutant that this is at the expense of neural crest, which was proposed to 
be the secondary fate of an equivalence group with Rohon-Beards. The inappropriate 
neurogenesis resulting in the dlA mutants is preceeded by an increase both in cells exiting 
the cell cycle and cells expressing the proneural bHLH gene, neurogeninl (ngnl), which is 
necessary and sufficient for sensory neuron development (Appel et al., 2001; Blader et al., 
1997; Cornell and Eisen, 2002). This is consistent with a role for Notch signalling in 
maintaining cells in a proliferative state and inhibiting differentiation of the primary fate.
Other phenotypes of the dlA mutant include an increase in primary motomeurons and 
certain intemeurons whilst late specified motomeurons were diminished (Appel et al., 
2001). dlA has an effect on midline structures, showing an excess of notochord cells 
concomitant with a deficit in hypochord and floorplate cells (also seen in the aei mutant 
and deltaC morphants) (Appel et al., 1999; Latimer et al., 2002). Finally, a five-fold 
increase in hair cells (sensory cells) of the inner ear has been reported for dlA mutants by 
Riley et al. (1999). Examination of hair cells in the lateral line system of these mutants has 
not been conducted, but is likely to reveal a similar over production, as deltaA is expressed 
here, and blocking Delta signalling genetically produces supernumerary hair cells (Itoh and 
Chitnis, 2001).
The zebrafish des/notchla mutant shows an intriguing neuron phenotype apart from the 
somite defect previously mentioned (Gray et al., 2001). Although des is similar to the dlA 
mutant in showing supernumerary primary motomeurons and early intemeurons (Mauthner 
Cells), it had an opposite effect on sensory neurons. While it displays a decrease in the 
number of Rohon-Beards, it has a measurable increase in secondary (DRG) neuron number 
(but not of other neural crest fates) (Gray et al., 2001). This strongly suggests a critical role 
for lateral inhibition in controlling cell number within DRGs. Due to a scarcity of markers 
for PNS glia, the authors could not test the relative numbers of these cells in des. If the 
increase in DRG neurons is at the expense of associated glia in the ganglia, it would be 
compelling evidence of these cell types belonging to an equivalence group, where Notchla 
activity is required to stop all cells adopting the neuron fate and instead form glia; failure 
in this signalling (as in des) leads to the inappropriate numbers of cells specifying as the 
primary fate (neurons). That only a mild neurogenic effect was seen might be due to 
retained partial function in the mutant or functional redundancy with another zebrafish 
Notch orthologue. Similar arguments for a Notch/Delta mediated neuron/glia fate choice 
within DRGs have been made following experimental evidence in chick (Wakamatsu et 
al, 2000; see below).
Note that replication of many of these mutant phenotypes by experimental 
manipulation of Delta-Notch signalling has confirmed that they occur through failure of 
the lateral inhibition mechanism. Injection of synthetic RNA encoding a dominant negative 
Delta protein phenocopies the primary neuron phenotype of dlA mutants (Appel and Eisen, 
1998; Cornell and Eisen, 2000), and artificial stimulation of the Notch pathway by 
introduction of RNA encoding wild-type Delta proteins or constitutively active Notch 
causes an opposite effect with respect to primary neurogenesis, as well as midline 
mesoderm and somite defects (Appel et al., 1999; Domseifer et al., 1997; Haddon et al., 
1998). Such an approach is useful when establishing a role for this system in a 
developmental context, in the absence of an identified mutant, and also in overcoming the 
effects of functional redundancy. The drawback to this is that it can be non-specific, and 
thus cause complicated phenotypes which are difficult to interpret, and will often only 
reveal early phenotypes, masking later roles for Notch-Delta signalling. Scheer et al.
(2001) have circumvented this by establishing a GAL4-UAS system in zebrafish to 
spatially and temporally control the misexpression of a constitutively active Notch 
receptor. They conclude that Notch signalling in the retina prevents neuronal 
differentiation and instructs cells to become glia and were able to establish a critical period 
in which Notch-Delta signalling dictated fate choice. Such a genetic system could have 
wider uses in elucidating the role of lateral inhibition in other domains such as secondary 
neurogenesis.
5.1.4. Notch and Delta activity directs cell fate choice in DRGs
It is apparent that Notch-Delta mediated lateral inhibition functions in many aspects of 
zebrafish development, including segregation of neural crest from the neural plate and 
possibly within developing DRG sensory neurons, and that disruption in this process can 
cause neurogenic phenotypes. There is growing evidence from other species that it does 
indeed control fate choice in DRGs and neural crest. Firstly, molecules involved in this 
signalling system are expressed in neural crest and nascent DRGs in rat, mouse and chick. 
For example, both Notchl and Deltal are expressed in mouse neural crest cells and DRGs 
(Bettenhausen et al., 1995; Morrison et al., 2000; Williams et al., 1995) as well as in 
NCSCs isolated from rodent spinal cords or nascent DRGs (Kubu et a l, 2002). The HES 
family transcription factor, hes6 can be seen in mouse DRGs (Pissarra et a l, 2000), where 
Numb is also expressed (Zilian et al., 2001). Finally, Wakamatsu et al. (2000) have shown 
that Deltal and Notchl are expressed in migratory neural crest cells in chick and later in 
nascent DRGs, where neurons within the core of the DRG express Deltal and are
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surrounded by proliferating Notchl positive cells. Interestingly, asymmetric localisation of 
NUMB protein was seen in some of the mitotic cells in the periphery of the DRG.
Strong evidence exists that Notch signalling is functional in these domains and has a 
role in determining neuronal versus glial fate choice in NCSCs. Activation of the Notch 
signalling pathway in chick and in cultured rat NCSCs promotes gliogenesis, possibly 
instructively, and concomitantly inhibits proliferation and neuronal differentiation 
(Morrison et al., 2000; Wakamatsu et al., 2000). As mentioned previously, a similar role 
for Notch signalling was reported in zebrafish retina by Scheer et al. (2001), but 
unfortunately the authors did not analyse the effect of activated notchl a in the PNS. Rat 
NCSCs become increasingly responsive to Delta signals during DRG development as 
Notch levels increase and levels of the Notch inhibitor Numb decrease, biasing 
differentiation from neurogenesis to gliogenesis (Kubu et al., 2002). Further evidence of a 
role for Numb in this process arises from the Numb knock-out mouse which has no DRG 
sensory neurons whilst presumptive glia were present (Zilian et al., 2001).
Hence control of relative numbers of cell types found in DRGs relies on Notch-Delta 
signalling. This is likely to also be true in zebrafish, but has not yet been directly 
demonstrated. In other vertebrates, this has been achieved through perturbing the notch 
signalling system artificially during DRG development. Use of appropriate promoters to 
drive constitutively active Notch, dominant negative Delta or other members of the 
signalling system in DRGs is feasible in zebrafish. An inducible constitutive Notchla 
transgenic line is available and chemical inhibitors of Notch signalling have been shown to 
be effective in zebrafish (Geling et al., 2002). If lateral inhibition regulated cell fate choice 
in zebrafish DRGs, downregulation of Notch signalling in wild-types would be predicted 
to produce a neurogenic effect, whilst its induction would lead to lack of neurogenesis.
Production of sensory neurons and glia also requires other factors and regulatory 
proteins, but understanding how these different influences on NCSCs are integrated into a 
developmental program is currently limited. Glial differentiation is promoted in vitro over 
neuronal differentiation through interaction of a neuregulinl (NRG1) isoform (glial growth 
factor2) with its co-receptors ErbB2/3 within NCSCs (Britsch et al., 2001; Leimeroth et 
al., 2002; Shah et al., 1994), an interaction that also appears crucial for neural crest cell 
survival (Paratore et al., 2001). In vivo, NRG1 and ErbB3 knock-out mice have no 
Schwann cells precursors or peripheral nerve associated Schwann cells, later resulting in 
peripheral nerve cell death (Riethmacher et al., 1997).
Meanwhile, as mentioned earlier, sensory neurons of the DRGs rely on the bHLH 
proteins, Neurogenin (ngn)-l and -2, which are necessary and sufficient for specification 
of sensory neurons. They are expressed in migrating neural crest cells and in early dorsal
root gangliogenesis in both chick and mouse (Ma et a l, 1999; Perez et al., 1999), with 
| ngn-2 expression slightly preceeding ngn-1. Mice lacking both neurogenins are devoid of
i any DRG sensory neurons, and forced expression of ngnl in migrating chick neural crest
cells directs them to migrate to DRGs and induces expression of sensory neuron markers. 
Zebrafish neurogeninl has similar expression patterns and behaves in the same way in 
functional studies, ngnl is expressed in the neural progenitors in the neural plate, including 
transiently in the neural crest cells and in nascent Rohon-Beards. Later expression is seen 
in nascent DRG neurons (Blader et al., 1997; Cornell and Eisen, 2002). Reduction of ngnl 
function by use of morpholino injection resulted in a severe reduction in both primary and 
secondary (DRG) sensory neurons (Cornell and Eisen, 2002), indicating a conservation of 
roles between higher and lower vertebrates. Additionally, overexpression of ngnl in 
zebrafish leads to ectopic formation of primary neurons (Blader et al., 1997). Neurogenins 
have also been shown to inhibit gliogenesis directly (Korzh and Strahle, 2002).
Regulatory interactions between proneural factors and Notch signalling have been 
demonstrated in Drosophila (Jan and Jan, 1994), with proneural bHLH transcription 
factors intimately involved with both the enhancment of lateral inhibition and the read-out 
through activation of downstream transcription factors responsible for neuronal 
differentiation (Kunisch et al., 1994). This appears to be conserved in vertebrates, as Notch 
ligands are co-expressed with neurogenins in mouse (Ma et a l , 1997). Further, 
experiments in lower vertebrates including zebrafish have demonstrated that the proneural 
gene, ngnl, is both a regulator of, and regulated by, lateral inhibition. Induction of ectopic 
Notch signalling by injection of Delta or her4 RNA leads to strong reduction of ngnl 
expression (Blader et a l , 1997; Takke et a l, 1999), and ablation of Notch signals through 
overexpression of a dominant negative form of Delta or in the dlA mutant leads to an 
increase in ngnl expression (Appel et a l, 2001; Blader et a l, 1997). Thus ngnl is 
negatively regulated by Notch activity and consistent with a role in negative feedback, it is 
also a positive regulator of neurogenic genes, ngnl injected embryos show increased levels 
of deltaA, deltaD and her4, and this activation, for deltaD at least, is probably due to direct 
binding of ngnl to the promoter (Hans and Campos-Ortega, 2002; Takke et a l, 1999).Thus 
a critical gene in sensory neuron specification is intimately involved with the lateral 
inhibition machinery, providing further evidence that this process is likely to be involved 
in specifying the correct number of neurons within DRGs.
The mechanisms involved in integrating lateral inhibition and other signalling systems 
in DRG neurogenesis are poorly understood. Analysis of zebrafish mutations where this 
process has been perturbed might elucidate how cells interpret these signals. With the els 
phenotype including severe disruption to DRGs, it is likely that Sox 10 plays some role in
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this integration of signals, and a more detailed evaluation of the cellular defects in forming 
DRGs in els embryos is required.
5.2 . R e s u l t s
5.2.1. The clst3 allele contains a transposable element
The spontaneous cls(3 allele displays a curious reduction in transcript levels in 
homozygotes. With the hypothesis that the cls‘3 allele was due to an insertion, deletion or 
rearrangement at the sox 10 locus, assessment of the integrity of the gene was required.
PCR was used to amplify sections in the 5’ and 3’ regions of the sox 10 gene from genomic 
DNA prepared from 5dpf clst3 homozygous embryos or sibling embryos. The position of 
PCR primer combinations are summarised in Figure 5.3a, and conditions used are 
summarised in Table 2.4. As can be seen in Figure 5.3b and c, PCR products from the 3’ 
region of the sox 10 gene, namely those amplified by SI 1-S13 and S26-S27 are identical in 
size between clst3/tS mutant embryos and their siblings. Thus no large insertions or 
deletions were evident in these regions in the els13 allele. However PCRs using Primers 
S15-S22 and S17-S22 failed for the els samples (but not siblings; Figure 5.3d) and using 
Primers S21-S22, there is an approximate 1.4kb increase in the size of the PCR product 
apparent in els13 homozygous embryos when compared to sibling embryos (Figure 5.3d). 
This implied that clst3 was due to an insertion or duplication event in this 5’ region of the 
sox 10 gene. It seems likely that this increased size of PCR product caused reactions with 
some of the primer pairs to fail. Additionally it is possible that some of the lanes labelled 
WT represent products obtained from heterozygous individuals. Although these should in 
theory show two different sized products with the S21-S22 PCR, it is likely that the shorter 
of the two products will be amplified with greater efficiency and might preclude 
amplification of the longer product. To identify the nature of the insertion/duplication via 
sequencing, the PCR product from the clst3/t3 S21-S22 reaction was cloned into pGEM-T 
Easy™ (Promega) to produce the plasmid pt3-GEMT.
A number of attempts to sequence the insert at the University of Bath sequencing 
facility failed, with the sequencing reactions prematurely ending a short way into a novel 
sequence found in the sox 10 gene. Thus it was decided to sequence the insert of pt3-GEMT 
commercially at Oswell Research Products Ltd. (Southhampton U.K.). The obtained 
sequence is given in Figure 5.4 and is available in Genbank (Accession Number: 
AF404490). The insert is 1397bp in size and occurs at position 631 of the cDNA. It shows
Figure 5.3: Assessment of the sox10t3 gene integrity by PCR
a. Schematic of the soxlO gene including positions of primers used to assess gene 
integrity by PCR. Boxes depict exons interrupted by lines (introns), and shaded boxes 
show coding region with translation start and stop codons marked. Arrowheads with 
primer names indicate position and direction of priming. Large arrow shows the start of 
transcription.
b. Agarose gel showing the products obtained from PCR using Primers pair S11 -S13.
Lane M: lOObp DNA ladder with selected fragment sizes indicated.
PCRs were performed on single embryo genomic DNA preparations from two els 
embryos (lanes labelled els) and on four siblings (lanes labelled WT). A negative 
control PCR was included in which template DNA was replaced with water. This 
reaction gave no product (lane labelled -ve).
It is clear that PCR products of the expected size (940bp) are present in all lanes 
corresponding to both mutant and sibling embryos, indicating no overt disruption to 
this part of the gene.
c. Agarose gel showing the products obtained from PCR using Primer pair S26-S27.
Lane M: lOObp DNA ladder with fragment sizes indicated PCR performed and labelled 
as in b., with negative control included. Again, PCR products of the expected size 
(546bp) are present in reactions of both mutant and sibling embryos.
d. Agarose gel showing the products obtained from PCR using Primer pairs S15-S22, 
S17-S22 and S21-S22. Lanes M: lOObp DNA ladder (left lane) and lkb DNA ladder 
(right lane), both with indicated fragment sizes. PCR performed and labelled as in b., 
each with negative control included.
PCR reactions using Primer pair S15-S22 amplifies across an intron to give an 
expected fragment size of 2825bp. Note this product is only obtained from WT 
embryos. Only reactions using clst3/t3 embryo template fail to produce a product.
PCR reactions using Primer pair S17-S22 behave similarly. Although a product of the 
expected size is obtained in WT embryos (597bp), this reaction fails for clst3/t3 genomic 
template.
PCR reactions using Primer pair S21-S22 identify an increased product size in clst3/t3 
genomic DNA in this region. The fragments obtained from WT embryos are 432bp as 
expected but those obtained from clst3/t3 embryos are approximately 1.8kb (indicated 
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Figure 5.4: Sequence and features of the clst3 insertion
Sequence of the 1397bp insertion found in the sox 10 gene in clstS (sequenced from the 
plasmid pt3-GEMT). Duplication of host sequence at both ends of the insertion are 
shown in bold, the two 9bp direct repeats are shown with a solid arrow ( ^  ),
and the six lObp inverted repeats are depicted by thin arrows (------------ B»-).
Additionally, the two Conserved boxes #3 and #4 are underlined and double underlined 
respectively, and both are shaded in grey. Variable regions #3 and #4 are underscored 
by asterisks (*) and circumflexes (A) respectively. Bracketing duplications surrounding 
these Conserved and Variable blocks are in italics and depicted with filled arrowheads 
above A conceptual translation in frame with that of the host sox 10
sequence is given above the corresponding sequence with the novel amino acids in 
bold and the introduced stop codon boxed.
1 GGTGCTGAAC AGTGGCGCCC CCAGAAAATT TTCT|TAG|GGG TGGCCAGAAG AGGCCGCACC 
6 1  AAATCTTGGG GTGGCACACA AAAAAAATTA TGAATTCAGT GTAATGTTAT ATTTTTGTTT
1 2 1  TTGGTAAATG TAATAATGTA GTTTTTAAAT AAAATTTATT TTATTTTATA ATGTATTTTT
1 8 1  ATTTTTATTT TCAATTTTAA CTAATTTATT TAAT T A G T T T  ATTAM TCCCG GAGATGGGTT
2 4 1 TGTGCTAGAT AAGTTGGCAG TTCA TTCCAC
3 0 1 IGACAAG AAAATGAATG AAAGAATAAT
3 6 1  G A G TTTA TTA  
4 2 1  CACTATACCT 
4 8 1  TTCTTCTATT  
5 4 1  AAGGTGTGTG 
6 0 1  ACACCCTGGG 
6 6 1  CAATAAATAT 
7 2 1  ATTATTCTGA  
7 8 1  TGATATGCCA 
8 4 1  GAATACAAAA 
9 0 1  TCATGTTATA  
9 6 1  CTTAGTGAAA 
1 0 2 1  ACTTTCACCT  
1 0 8 1  TTGTCGGCGT 
1 1 4 1  GCGCGCATGC 
1 2 0 1  AGACAATGAA 

















































































1 3 2 1  TGGGGTGGCC ACAGGGGTGG CCAGAGTTTA CTGAGGGGTC CGTGGCCACC CCCTGGCCAC
1 3 8 1  CCCTTGGGGG CGCCCCTGGT GCTGAAC
i / 2D
79% sequence homology to a type of transposon, first identified in the no tail allele ntl 
(Figure 5.5; Schulte-Merker et al., 1994). Features of this transposon include duplication of 
lObp of host sequence at both ends of the insertion site (Figure 5.4, in bold), a large 
number o f lObp inverted repeats (Figures 5.4 and 5.5, small arrows) and 9bp direct repeats 
at the termini (Figures 5.4 and 5.5, solid arrows).
The t3 and no tail insertions contain a region belonging to a family of retroposons 
called DANA (for Danio retroposon A, Izsvak et al., 1996), and must represent members 
of a family of composite transposable elements present in the genome. DANA elements are 
characterised by a consensus structure composed of (up to) four constant domains, each 
followed by a variable domain (Cv blocks). However not all DANA elements contain all 
four Cv blocks, and the no tail insertion contains only the C3v3 C4v4 blocks (Izsvak et al., 
1996). These are also present in the t3 insertion and are indicated in Figures 5.4 and 5.5 
(underlined and double underlined in both). Conserved direct repeats flanking this region 
of DANA blocks (termed bracketing duplications) are indicated in italics in both Figure 5.4 
and 5.5.
The t3 insert interrupts the sox 10 gene upstream of the HMG domain and adds eight 
novel amino acids before introducing an in-frame stop codon (shown in Figures 5.4 and 
5.5). This reduces the conceptual SoxlO protein from 485 amino acids in wild-type to only 
93 amino acids as represented in Figure 5.12c. A summary diagram of all the features of 
the insertion is presented in Figure 5.6.
5.2.2. A soxlO allele screen realizes two new alleles
5.2.2.1. Screen Methodology
The analysis of weak els alleles would be of great interest as such alleles often reveal a 
range of subtle or later roles of the protein, normally masked by early cell or embryo death. 
Further, generation of an allelic series for els, with mutations located throughout the 
protein would facilitate domain mapping. Finally, previously mentioned els alleles do not 
show any temperature sensitivity. Temperature sensitive alleles have proven enormously 
informative for enhancer screening and as inducible mutants to reveal adult phenotypes or 
to define temporal requirements of protein function. An inducible els allele would help to 
answer a number of questions about SoxlO such as highlighting when function was critical, 
if there were any later phenotypes and what other loci interact genetically. With this in 
mind a screen for novel els alleles was embarked on.
The allele screen methodology is depicted in Figure 5.7. Previously, 15 male fish 
founders (P generation) were mutagenized and mated to wild-type females of the AB
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Figure 5.5: Sequence alignment of the insertions in clst3 and
ntr95
Alignment of the transposon insertions found in the clstS and n t t195 alleles. These show 
79% homology overall, with the clstS being 148bp shorter than the n t t195 allele. 
Features of the transposon are depicted as in Figure 5.3, including Conserved blocks, 
variable regions, repeats (solid and line arrows), bracketing duplications (in italics) and 
amino acids introduced in the tS allele in bold above their respective codons.
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Figure 5.6: Summary diagram of features present on the clst3 
insertion
Schematic indicating the position and features of the insertion in the soxlO'3 gene. 
Lower portion depicts the sox 10 gene as per Figure 5.2, where exons are presented as 
boxes with coding region as black boxes and UTRs as open boxes. The HMG domain 
is presented as dark grey boxes, and the insertion has occurred in the second exon, 5’ to 
the HMG box. Upper portion depicts features of the insertion largely as per Figure 5.3. 
Position of the insertion site duplication is shown by line arrows with solid arrowheads 
( - ^ ) .  The 9bp direct repeats ( " ^ ) ,  lObp inverted repeats (—> ) and bracketing 
duplications (►) are also indicated. Cv blocks are numbered and shown as stippled 
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Figure 5.7: Crossing scheme for els allele screen
Males mutagenised with ENU were mated to wild-type females. FI offspring were thus 
heterozygous for any mutation, m. These fish were test crossed against known els 
heterozygotes. Any FI fish bearing a deleterious mutation (m) at the els locus would 
fail to complement and hence present 3:1 wild type:c/ 5  mutant larvae in F2. Such FI 
fish were thus considered “putants”, and then outcrossed to wild-type fish.
background. The resulting FI progeny were raised to adulthood and can be considered to 
be heterozygous for one mutagenized genome (this mutagenesis stock was produced by 
K.A. Dutton). To identity any carrying mutations in the sox 10 gene, these were then test- 
crossed by mating with known els heterozygotes. As els is recessive, any random mutation 
at this locus will fail to complement and hence present embryos at a 3:1 wild-type:c/s ratio. 
In addition to alleles at the els locus itself, it is also possible that a mutation acting as a 
dominant enhancer of the els mutant allele could also be isolated in this screen.
Using this method, approximately 1800 FI fish were test-crossed to screen for a els 
mutant phenotype in the F2 generation. We found 5 putative mutants (“putants”), named 
Jupiter, Mercury, Alpha, Zeta and Kappa. All these mutants appear to be as strong as els 
by appearance of the F2 generation, however this is possibly misleading as these mutants 
are transheterozygotes, and the weakness of any new allele may be masked by the strength 
of the established allele. The Mercury putant, it should be noted, originally did not shown 
Mendelian inheritance; only 2 mutants out of approximately 50 embryos showed the els 
mutant phenotype. Although this could be due to incomplete penetrance, it more likely 
represents contamination of embryos during collection. Failure to obtain els embryos from 
this individual when further test-crossed suggested that this latter explanation may be the 
case, and the Mercury putant was discarded. Of the remaining 4 putants, Zeta and Kappa 
were successfully outcrossed to wild-type fish, whilst Jupiter and Alpha were 
unfortunately lost either due to death, or inability to successfully outcross.
Of the remaining two putants, Kappa is yet to be incrossed and extensively examined, 
whilst Zeta has displayed some unique phenotypes.
5.2.2.2. sox!0bazl (Zeta) allele displays a weaker chromatophore phenotype
Having been established, the sox 10 allele Zeta was renamed bazl (for Bath Zeta /}. 
Incrosses of bazl hetereozygotes produced 25% of embryos with a els appearance as 
expected (Figure 5.8a). At 5dpf, bazl embryos showed no melanophores (Figure 5.8a), 
although some small melanophores were occasionally seen in the head at an earlier stage 
such as 3 days (Figure 5.8b), shown migrating behind the ear. However these died by 5 
days, and were never seen in other strong els alleles (Kelsh et al., 1996). Large stellate 
melanophores have been seen in the dorsal stripe of 5dpf bazl embryos very rarely (not 
shown).
Xanthophores were also severely reduced in bazl, as shown in Figure 5.8a by the lack 
of blue/yellow cast over the dorsal portion of the embryo (compare to the wild-type sibling 
above). Unlike stronger els alleles, a couple of xanthophores were occasionally seen in the 
anterior head at 5dpf (not shown).
Figure 5.8: bazl pigment phenotype
a. bazl shows a strong melanophore and xanthophore phenotype.
Top panel shows a lateral view of a 5dpf wild-type embryo viewed under transmitted 
light, with melanophores evident in all stripes.
Lower panel shows a cisbazl/bazl sibling, which clearly shows a complete absence of 
melanophores. Note also that the blue/yellow dorsal cast of xanthophores evident in the 
wild-type is also missing in the clsbazl/bazl embryo. Dark cells in the lateral patches, 
dorsal and ventral stripes (highlighted by arrowheads) are iridophores (see below). 
Compare with lateral view of a strong els allele at 5dpf shown in Introduction chapter.
b. Small melanophores (arrowhead) are sometimes seen in bazl migrating ventrally in the 
head. These have not been reported in other strong els alleles. These cells do not 
survive to 5dpf.
c. Iridophores are only weakly affected in bazl. Lateral view of 5dpf embryos viewed 
under incident light.
Top panel shows a wild-type embryo with iridophores apparent in the eye, lateral 
patches, dorsal and ventral stripes (arrowheads), whereas a strong els mutant (e.g. 
clst3/t3) is mostly devoid of these cells (one is highlighted, middle panel).
Lower panel shows a bazl mutant embryo at the same stage, with iridophores clearly 
present in the eye, lateral patches and both dorsal and ventral stripes, as well as the 
yolk sac stripe (indicated with arrowheads).
d. Semi-quantitative (see text) comparison of average iridophore score at different sites in 
bazl and t3 mutant embryos at 5dpf, indicating bazl has a generally better coverage of 
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A number of dark cells were seen in the dorsal stripe, lateral patch and often ventrally 
in bazl embryos. Looking at these with incident light revealed that they were in fact 
iridophores. Figure 5.8c shows a comparison of iridophores in bazl with wild-type and t3 
embryos. Clearly bazl has a less severe iridophore phenotype than that of t3. Note the 
almost wild-type coverage of iridophores in the bazl eye, and presence of iridophores in 
the lateral patch and dorsal stripe, as well as on the ventral stripe. These latter three regions 
show an intermediate number of iridophores, clearly being less than in wild-type embryos. 
Although iridophores are occasionally seen in stronger els alleles, they are limited to a very 
few on the dorsal stripe, a single patch in one eye or on the lateral patch (an example on the 
dorsal stripe is indicated with an arrowhead in Figure 5.8c).
The severity of the irdophore phenotype in bazl was quantified by assigning an 
iridophore score out of 6 for each iridophore location over 30 bazl and t3 embryos. This 
score comprised counts of iridophores on the dorsal and ventral stripes, as well as 
iridophore patch size in the eyes and lateral patches. Although slightly subjective, the 
counting criteria were consistent for all embryos. The results from these counts are 
displayed graphically in Figure 5.8d, and demonstrate the clear difference in iridophore 
phenotype, when compared to t3 or other strong els alleles (not shown).
Thus it can be seen that although bazl has a strong reduction in melanophore and 
xanthophore numbers approaching that for the strong els alleles, it displays only a clear 
weak iridophore phenotype in contrast to the strong alleles. To further examine the bazl 
phenotype it was decided to look at other neural crest fates affected in els.
52.2.3. soxW bazl has supernumerary peripheral sensory neurons
To analyse the effect of the bazl allele on peripheral nervous system neurons derived 
from the neural crest, immunofluorescence with an antibody to the Hu antigen was 
performed on 5dpf bazl embryos. An example is shown in Figure 5.9a with wild-type and 
tw2 embryos for comparison. It was seen that, as with the stronger allele, bazl has no 
enteric neurons were evident along the gut (arrowheads in all panels, compare with wild- 
type). However where other alleles showed a reduction, bazl displayed supernumerary 
dorsal root ganglia neurons (highlighted by arrows), above the numbers shown for wild- 
type embryos. Quantitation of this neurogenic effect showed an approximate doubling of 
DRG neurons compared to wild-type (K.A. Dutton pers. comm.). DRGs were seen in every 
somite block, with no gaps along the length of the embryo, and, as in other alleles, neurons 
were not always positioned correctly dorso-ventrally often being sited outside ganglia. 
Magnified images of adjacent DRGs from bazl and tw2 are shown in Figure 5.9b. Not only 
were supernumerary neurons seen, but ectopic neurons were prominent too, with Hu+ cells
Figure 5.9: bazl mutants show supernumerary DRG neurons
a. Lateral view of 5dpf embryos stained with the pan-neuronal marker Hu. DRGs are 
apparent as reiterated series of labelled cells situated in the middle of each somite in the 
wild-type (top panel; indicated with arrows). Enteric neurons along the gut are evident 
as well and indicated with an arrowhead.
Middle panel shows a tw2 embryo at the same stage, showing an absence of enteric 
neurons (arrowhead) and a severe, but incomplete, loss of DRG neurons (surviving 
neurons indicated with arrows). Note that these neurons are often abnormally 
positioned dorsoventrally, and sometimes occur in mega-ganglia or ectopically on the 
posterior lateral line (not shown).
Lower panel shows a bazl mutant at 5dpf stained with the Hu antibody. Lack of enteric 
neurons is also apparent as with the stronger alleles (arrowhead), but a greater number 
of trunk neurons is indicated (arrows). These are present in every somite, and also 
abnormally positioned.
b. Close up confocal images of posterior trunk DRGs from 5dpf embryos stained with the 
anti-Hu antibody.
Left panel shows neurons in three DRGs in a wild-type embryo.
Middle panel shows a tw2 embryo, with a clear reduction of neurons apparent 




positioned on the posterior lateral line of a 5dpf bazl homozygous embryo (not shown). 
Analysis at earlier stages indicated that the appearance of these neurons in the DRGs is 
precocious (K.A. Dutton pers. comm.).
The supernumerary neuron phenotype is not only in contrast to the other els mutant 
alleles, which all show a strong (but not complete) reduction in DRG neuron numbers, but 
is also in contrast to known mouse sox 10 homozygous mutants, which also display a 
severe loss of DRG neurons (Britsch et al., 2001; Kapur, 1999). Whether this reduction in 
neurons in the mouse mutants is due directly to lack of Sox 10 in neural precursors or is 
secondary to a lack of glial derived trophic support is an area of current debate 
(Sonnenberg-Riethmacher et al., 2001).
It is important to note that these phenotypes are all recessive, and all sibling embryos 
appear normal for both chromatophores and DRG neuron number and position. This 
indicates that the bazl mutation is less likely to be due to gain-of-function. This is 
important to consider when proposing an explanation for the bazl phenotypes.
5.2.2.4. The soxlObazl molecular lesion occurs in the DNA binding domain
Due to its unique hypermorphic nature with respect to DRG neurons, it was of interest 
to establish the molecular lesion of bazl. To achieve this, four RT-PCR reactions were 
performed on RNA extracted from 60 30hpf soxl0baz,/hazl embryos. Primer pairs used are 
indicated in Figure 5.10a and were designed to produce partially overlapping products 
corresponding to the entire sox 10 coding region (Pauliny, 2002). PCR products obtained 
can be seen in Figure 5.10b and are all of the expected size. These were purified using 
QIAquick columns, including a 35% Guanidine HC1 column wash and then sequenced at 
the University of Bath Automated DNA Sequencing Facility using appropriate PCR 
primers as a sequencing primer.
The sequences obtained were aligned using BioEdit software and compared to the wild 
type sox 10 cDNA sequence as shown in Figure 5.11. There are 17 nucleotide substitutions 
evident, 16 being present in the coding region. The reason for this large number of 
substitutions is probably that the mutagenesis was conducted in the leo background whilst 
all previous sequencing of sox 10 has been conducted on the AB background. Of these 
substitutions, only one is non-synonymous, namely a G to A conversion at position 724 of 
the full cDNA sequence (G—>A at 724), which is shown on a chromatogram section in 
Figure 5.12b. This gives a Valine to Methionine change at amino acid number 117 
(VI17M) (Figure 5.12a), which occurs in the DNA binding HMG box (underlined in 
Figure 5.12a), at a position fully conserved between human, mouse and chicken Sox 10 
protein sequences. This position is also within one of two nuclear localisation sequences in
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F ig u re  5.10: R T -PC R  o f  th e  bazl m u ta n t  a l le le
a. Schematic showing the position of primer pairs on the sox 10 cDNA used to PCR the 
coding region of soxl0bazI. Four overlapping primer pairs were used (arrowheads) and 
names of primers are given. Coding region is shown as an open box with the HMG box 
shaded, and the 5’ and 3’ UTR indicated. Following amplification, sequence of 
products were obtained and compared to the wild-type sequence (Pauliny, 2002; 
Genbank Accession number AF402677).
b. Agarose gel showing PCR products obtained from all four PCRs using bazl cDNA as 
template. Both gel images show lOObp DNA Ladder (lane M) with fragment sizes 
indicated.
Left hand gel image shows the PCR product obtained using Primer pair S19-S20, 
which yielded a fragment of 435bp as expected
Right hand gel image shows PCR products obtained using Primer pairs S21-S22, S24- 
S25 and S26-S27. Expected fragment sizes were obtained in each case, being 423bp, 
545bp and 550bp respectively.
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bazl  3 4 9   G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
v t  soxlO  4 2 9  GGACGATGGGCACTCCATGTCCCCTGGTCACTCGTCGGGCGCTCCCGGTGGCGCGGACTCCCCTCTGCCCGGTCAGCAGT  
bazl  4 2 9   A ..................................................................................................................
v t  soxlO  5 0 9  CTCAGATGTCCGGGATCGGGGATGATGGAGCCGGTGTCTCCGGCGGGGTCTCGGTGAAGTCCGACGAGGAAGATGACCGG  
bazl  5 0 9  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
v t  soxlO  5 8 9  TTCCCCATCGGCATCCGCGAGGCGGTCAGTCAGGTGCTGAACGGGTACGACTGGACGCTCGTGCCCATGCCCGTGCGCGT  
bazl  5 8 9  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
v t  soxlO  6 6 9  GAACTCGGGCAGCAAGAGCAAACCGCACGTCAAGCGGCCGATGAACGCGTTCATG§TGTGGGCGCAGGCCGCGCGCAGGA  
bazl  6 6 9  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
v t  soxlO  7 4 9  AACTGGCGGATCAATATCCGCACCTGCACAACGCCGAGCTCAGCAAAACACTGGGGAAGCTGTGGAGACTGCTGAACGAG  
bazl  7 4 9  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
v t  s o x l O  8 2 9  ACGGATAAGCGGCCGTTTATCGAGGAGGCCGAGCGCTTGAGGAAGCAGCATAAGAAAGATTATCCCGAGTACAAGTACCA  
bazl  8 2 9   T .........................................................................................................................................................................T ..............................................
v t  30x10  9 0 9  GCCACGTCGACGCAAGAACGGCAAACCGGGTTCCAGCTCAGAGGCCGACGCCCACTCTGAGGGTGAGGTCAGCCACAGCC  
bazl  9 0 9   C .....................................................
v t  soxl0 9 8 9  AATCGCATTACAAGAGCCTGCACCTGGAGGTGGCGCACGGCGGGGCTGCAGGGTCACCATTGGGTGATGGACACCACCCT  
bazl  9 8 9 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
v t  soxlO  1 0 6 9  CACGCTACAGGTCAGAGTCACAGCCCTCCAACGCCCCCTACCACCCCCAAGACGGAACTGCAGGGAGGAAAATCAGGCGA  
b a z l  1 0 6 9   G .........................................................................................................................................................................
v t  soxlO  1 1 4 9  GGGCAAGCGTGAGGGCGGAGCCTCTCGGAGTGGACTGGGGGTGGGAGCAGATGGAAGCTCCGCCTCATCGTCTGCCAGCG  
b a z l  1 1 4 9  ........................................................................................................................................................................... C ...............................................C .....................................T .
v t  soxlO  1 2 2 9  G G A A A C C G C A C A T C G A C T T C G G T A A C G T G G A C A T T G G C G A A A T C A G C C A T G A C G T G A T G G C C A A C A T G G A G C C G T T C G A C  
bazl  1 2 2 9  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T .  .  .
v t  soxlO  1 3 0 9  G T G A A C G A G T T C G A C C A G T A T C T C C C A C C C A A T G G C C A C C C G C A G G C G T C C G C C A C T G C C A G C G C A G G A T C T G C A G C G C C  
bazl  1 3 0 9  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
v t  30x10  1 3 8 9  A T C G T A T A C A T A C G G C A T C T C C A G C G C G C T A G C G G C C G C T A G T G G C C A C T C C A C C G C A T G G C T G T C C A A G C A G C A A C T G C  
b a z l  1 3 8 9  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G - - - - - - - - - -
v t  soxlO  1 4 6 9  C G T C C C A G C A G C A T T T G G G C G C A G A T G G C G G G A A A A C G C A G A T A A A G A G T G A A A C A C A C T T C C C T G G G G A T A C A G C G G C G  
bazl  1 4 6 9  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
v t  soxlO  1 5 4 9  A G C G G T T C A C A C G T C A C A T A C A C G C C G C T A A C A C T G C C G C A C T A C A G C T C C G C C T T C C C C T C G C T G G C G T C C C G C G C A C A  
b a z l  1 5 4 9   T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T . . . . . . . . . . . . . . . . .
v t  soxlO  1 6 2 9  A T T C G C C G A A T A C G C C G A G C A C C A G G C C T C G G G A T C C T A C T A C G C C C A C T C C A G C C A G A C C T C A G G C C T C T A C T C C G C C T  
bazl  1 6 2 9  G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
v t  soxlO  1 7 0 9  T C T C C T A C A T G G G C C C C T C A C A G C G G C C C C T G T A C A C C G C C A T T C C G G A T C C G G G A T C C G T G C C G C A G T C A C A C A G C C C T
bazl  1 7 0 9  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Stop
v t  soxlO  1 7 8 9  ACGCATTGGGAGCAGCCCGTATACACCACACTGTCTCGACCGfrGA|CACACTCTACCAAGATGACCAGTCAC  
bazl  1 7 8 9  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
F igu re  5.11: cDNA s e q u e n c e  of w ild -type  a n d  bazl soxlO c o d in g  
re g io n
Sequence of soxlO cDNA from bazl aligned to the wild-type soxlO cDNA sequence. 
Numbers on the left correspond to that of the full-length soxlO cDNA. Dots indicate 
identical nucleotides and the 17 substitutions found are shown. The non-synonymous 
substitution at position 724 leading to the amino acid substitution is highlighted. The start 
and stop codons are boxed and marked as M and Stop respectively.
Figure 5.12: Amino acid substitution in the bazl mutation
a. Alignment of wild-type and bazl SoxlO conceptual protein sequences. Numbers on the 
left correspond to amino acid position. The sole amino acid substitution (VI17M) in 
the bazl protein is highlighted. This occurs in the HMG box (underlined) and within 
one of two sequences with high homology to Nuclear Localisation Sequences described 
in human SRY and SOX9 (both boxed).
b. Chromatogram traces displaying the nucleotide change producing the amino acid 
substitution in the soxlC/3021 coding region. The G to A at position 724 is marked with 
arrows.
c. Summary of the changes to the SoxlO protein sequence induced by the mutations 
described in this chapter. The WT protein (top) is compared to the bazl mutant protein 
(middle) where the VI17M mutation is shown in the HMG box (red). The 1397bp t3 
insertion at position 631 of the cDNA sequence introduced 8 new amino acids (yellow 






























wt SoxlO 421 EYAEHQASGSYYAHSSQTSGLYSAFSYMGPSQRPLYTAIPDPGSVPQSHSPTHWEQPVYTTLSRP* 485 
bazl 421 .................................................................. * 485
WT







631insl397 (adds SGAPRKFS then Stop)
genome hybridisation display as used by Lam et al (1996) for Tdr2. RT-PCR experiments 
have shown that at least one actively transcribed LTR-retrotransposon, bhikhari, exists in 
zebrafish. It is not known if the transposon present in t3 is a retroposon or a DNA 
transposon. A similar RT-PCR approach could be used to detect any corresponding 
transcript from the t3 insertion family thus indicating that it transposes through an RNA 
intermediate and imply that the genome contains an active reverse transcriptase.
Attempting to sequence the clst3 insertion proved difficult, and this may be due to the
h  1nature of the sequence it contains. Sequencing the related insertion in the ntl allele also 
proved difficult (S. Schulte-Merker, pers. comm.), and it should be noted that the clstS 
sequence reactions failed exactly where the inverted lObp repeats are found. This could be 
due to induced secondary structure. Indeed the insert seemed refractory as a template for 
other polymerases. PCR of the region was problematic, and in vivo, levels of sox 10 
transcripts appeared to be reduced in clst3/t3 embryos compared to siblings or homozygous 
els embryos of other alleles when assayed by an in situ probe 3’ to the insertion site 
(Pauliny, 2002). This reduction could be due to either decreased processivity of the RNA 
polymerase complex leading to attenuation of transcription or reduced stability of the 
entire transcript due to the transposon. To differentiate between these two possibilities it 
was decided to attempt to detect transcripts using a 5’ sox 10 in situ probe, corresponding to 
the region upstream of the insertion site. It was hypothesised that if the insertion was 
destabilising the transcript, then both 5’ and 3’ ends of the sox 10 transcript would be 
equally affected. However if the insertion was causing attenuation of transcription, then 
only a short 5’ transcript would be produced, and differently positioned in situ probes 
might reveal relative differences in signal between clst3/t3 and sibling embryos. Although 
this was attempted, the 5* probe was short and did not give as strong a signal as the 3’ 
probe. Unfortunately this complicated interpretation of the relative in situ strengths and the 
experiment requires repeating, perhaps with more concentrated riboprobe.
Is the clst3 allele a null allele? This is an important question as such alleles reveal the 
effect of full loss of gene function, whereas alleles with partial protein function remaining 
are less informative about a genes full function. With the knowledge that the transposon 
present causes both a dramatic reduction of full-length sox 10 transcript, and also 
introduces a premature stop codon to give a severely truncated protein, it seems probable 
that it is a null. However the N-terminal protein-protein synergy domain of SoxlO remains 
unaffected (see Figure 5.12c), and conceivably might retain some function in the cell. 
Alternatively, cryptic splicing around the insertion might occur, similar to that seen in a 
viral insertional mutant of zebrafish sox9a (jellyfish; Yan et al., 2002), but this remains 
untested for clstS. As mentioned previously, the similarity of a number of strong els alleles
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argues they are all null; the genetic test would be to combine each allele with a strain 
carrying a deletion of the locus and assess if this displays a more severe els phenotype. A 
strain with an appropriate gamma-ray induced deletion in this region of LG3 exists 
(C1033) produced by the zebrafish deletion project (http://zfin.org).
Finally, use of DNA transposons in the production of zebrafish transgenics through the 
coordinate use of exogenous transposases and engineered TcE-type constructs are active 
fields of research. The transposase sources mostly used are Tol2 isolated from medaka 
(Kawakami et al., 2000), Mo s i  (from the mariner element of Drosophila mauritiana; 
(Fadool et al., 1998) or a phylogenetically reconstructed fish transposase called Sleeping 
Beauty (Ivies et al., 1997). Development of such a system in zebrafish will be extremely 
useful, providing a resource similar to the P-element system of Drosophila. This will 
facilitate transgenesis, insertional mutagenesis and enhancer/gene trapping strategies. It has 
been demonstrated here that there exists an active transposon in zebrafish capable of 
carrying a sizable amount of DNA (1.4kb), although its method of transposition remains 
unknown. Perhaps this transposon could also be exploited and modified to produce a 
potent system for transposition in zebrafish.
5.3.2. sox!0bazl has divergent effects on certain neural crest derivatives
The phenotype produced by the soxld*021 allele is unusual, as it appears to strongly 
affect some neural crest cell fates, but only weakly affects others. This suggests that the 
SoxlO protein it produces has an intermediate level of activity. For example, while 
melanophores and xanthophores are strongly reduced, iridophores are only weakly 
affected. In other els alleles all pigment cells are strongly affected, although occasional 
iridophores are seen. Underlying this might be that different levels of SoxlO activity are 
required by different pigment cell precursors for correct specification, survival or 
differentiation. In this case, it appears that the threshold of SoxlO activity required for a 
production of iridophores is less than that required for production of melanophores or 
xanthophores.
A similar situation occurs in the mouse SoxlO mutant, Dom. Haploinsufficiency 
promotes the loss of only some of the cell types disrupted in homozygous mutants (Kapur, 
1999). This indicates that certain cell types are disrupted to different extents than others, 
depending on the level of SoxlO present. The mechanisms underlying haploinsufficiency 
of SoxlO are not well understood. It has been proposed that altered transcriptional synergy 
due to insufficient amounts of protein is an underlying cause (Veitia, 2002). The resulting 
dominant phenotype can then be explained by insufficient occupancy of enhancers on 
target genes by transcription factor-complexes. If different promoters have differing
dosage sensitivities, then pleiotropic effects would be expected to present with different 
modes of inheritance. The author suggests that hypomorphic alleles in homozygosity might 
behave like an allele that displays haploinsufficiency, presumably also due to altered extent 
of enhancer occupation (Veitia, 2002).
What might cause different chromatophores to have different dependency on SoxlO 
activity? Conceivably, partial functional redundancy of SoxlO with another gene product 
might account for the increased tolerance of iridophores to loss of SoxlO. For example, the 
els DRG neuron phenotype can be strengthened by ablation of sox9b expression by use of 
morpholinos, suggesting that sox gene redundancy might cause incomplete sensory neuron 
loss in els (K.A.Dutton pers. comm.).
An alternative model proposes that different functions of SoxlO are dependent on 
different levels of SoxlO activity. As alluded to above, this might be realised at the level of 
the promoter, with different master switch genes triggered at different levels of SoxlO 
activity. If the affinity of a mutant SoxlO protein to different target gene promoters is not 
identical then they will be activated to different extents (rheostatic enhancers) or have 
altered probabilities of becoming active (binary enhancers). Extending this, the nature of 
the soxlObazl molecular lesion might cause differential effects on target promoters. The 
lesion is found in the DNA binding domain of the protein at a site fully conserved in 
human, mouse and chicken SoxlO (Cheng et al., 2000), as well as in the other murine E- 
group sox gene, sox9 and sox8 (Dutton et al., 2001). Computer modelling (done by M. 
Baker, University of Bath) of a DNA oligo representing a consensus sox-binding site with 
bazl protein has shown that the substituted amino acid does not have close associations 
with the DNA. Nevertheless, it is predicted to cause a slight conformational change in the 
protein-DNA complex and could conceivably alter the SoxlO binding affinities or DNA 
recognition ability. Consequently the Soxl06az7 protein might bind to its target promoters 
with altered affinity, and the differential effects on cell types might be due to differential 
binding to master gene promoters. This model predicts that bazl mutants would be 
expected to express target genes associated with promoting iridophore development to a 
more normal level than the t3 mutants, but like t3, would be mostly unable to activate 
melanophore switch genes. This proposed differential transcriptional activity of the SoxlO 
mutant proteins requires experimental demonstration in vivo through in situ analysis of 
candidate downstream genes and use of in vitro transcriptional assays of the associated 
target promoters. Pigment cell specification genes or other early markers are not well 
characterised in zebrafish and the only known direct target of zebrafish SoxlO so far is 
mitfa (Elworthy et al., 2003). Other candidates that have been identified include mbp, ngnl 
and notchla, but further targets must exist and need to be identified.
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The bazl mutation occurs in one of two consensus nuclear localisation motifs, which 
have been shown to direct the SRY and SOX9 proteins to the nucleus (Sudbeck and 
Scherer, 1997). In this work, the authors did not mutate the valine residue substituted in 
bazl, however mutation of both motifs was required to completely abolish transport into 
the nucleus. It is highly likely that SoxlO proteins use these conserved motifs to localise to 
the nucleus, however this remains to be experimentally demonstrated for SoxlO in any 
species including zebrafish. Whether the Soxl06az7 protein is able to nuclear localise also 
requires testing, although the work with SOX9 predicts it can. The intermediate activity of 
the Soxl06flz7 protein could thus be due to either compromised DNA binding ability, 
insufficient amounts of the protein entering the nucleus or a combination of both effects.
In contrast to the stronger alleles, soxl&azl/bazl displays a neurogenic phenotype with 
respect to DRG neurons. This divergent phenotype could be explained in four main ways. 
Extra neurons could be produced by increased proliferation, insufficient culling of neurons 
or neuroblasts, aberrant migration of other neurons to the DRG location or by inappropriate 
adoption of the neuronal fate by cells within the nascent DRG. Arguing against increased 
proliferation or decreased survival, is the detection of neurons in ectopic locations, namely 
on the posterior lateral line, which could not be produced purely by increased proliferation 
or enhanced survival. Furthermore, the precocious appearance of the DRG neurons cannot 
be accounted for by increased proliferation, which would be predicted to produce more 
neurons later, rather than earlier. A time course of BrdU incorporation in mutant and wild- 
type DRGs could be used to measure levels of proliferation. Conversely, the relative levels 
of apoptosis of cells in the ganglia could be analysed with a time course of TUNEL 
staining to assess if increased survival or lack of normal apoptosis led to the neurogenic 
phenotype.
As Hu is a marker for all neurons, the precise identity of these supernumerary neurons 
is yet to be established. Although their position along the entire embryo length and the time 
they arise is consistent with them being sensory in nature, it cannot be ruled out that they 
may be ectopic sympathetic neurons that have migrated inappropriately. Molecular 
markers specific to sensory and sympathetic neurons exist, namely ngnl and tyrosine 
hydroxylase (TH) respectively (An et al., 2002; Cornell and Eisen, 2002), and could be 
used to characterise these neurons in more detail. Use of an acetylated tubulin antibody 
could be used to ascertain if the neurons project axons correctly. Preliminary analysis with 
a TH in situ indicated that these supernumerary neurons do indeed express sensory markers 
(R. N. Kelsh pers.comm.), thus suggesting that these neurons are probably not abberently 
migrated neurons from other ganglia.
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All four hypotheses proposed above rely on different roles of SoxlO requiring different 
levels of activity, possibly through critical target genes of SoxlO being activated to 
different extents in bazl. This assumption predicts that in stronger els alleles, no critical 
genes are activated in almost all neural crest cells and all SoxlO functions fail including 
survival of neural crest stem cells. However, in bazl, subsets of genes and thus functions 
are activated, allowing some form of altered specification, proliferation, survival or 
migration of some progeny. Observations outlined above argue against a defect in survival, 
proliferation or migration as the cause of ectopic DRG neurons in bazl. It remains that 
specification of fate might be aberrant in bazl DRGs. As neurogenic phenotypes are 
classically associated with defects in the process of lateral inhibition, production of excess 
neurons might be brought about by an imbalance in this mechanism within the neural crest 
cells fated to the DRG lineage, leading to inappropriate neuronal fate adoption by some 
cells.
5.3.3. The bazl allele might indicate a role for SoxlO in establishing or 
interpreting lateral inhibition within DRGs
Given that there is strong evidence that lateral inhibition occurs in zebrafish and is 
critical for DRG patterning in vertebrates, it is tempting to speculate that the neurogenic 
DRG phenotype seen in Soxl06az7 mutants is due to disruption in Notch-Delta signalling. If 
true, this suggests a role for SoxlO in regulation of lateral inhibition, a function not 
previously attributed to this transcription factor. To determine how suitable this proposed 
role is, it is necessary to assess the known behaviour of SoxlO in neural crest. Importantly, 
it appears that SoxlO has multiple roles at different times in certain cell lineages, and that 
different roles require different doses of sox 10 function.
Firstly, sox 10 is expressed in migratory multipotent NCSCs in mouse and rat, when 
analysed both in vivo and in vitro (Kim et al., 2003; Kuhlbrodt et al., 1998b; Paratore et 
al., 2001), and is also expressed in undifferentiated neural crest cells isolated from mouse 
DRGs (Paratore et al., 2001). These multipotent DRG associated cells undergo increased 
apoptosis in SoxlO'A mice but not in heterozygous Soxl0+/' mice, suggesting a survival role 
for SoxlO in NCSCs. Survival of these cells appears to require only one copy of soxlO, and 
is NRG1 dependant, exerted through SoxlO’s ability to positively regulate levels of ErbB3 
(Britsch et al., 2001; Kim et al., 2003; Paratore et al., 2001). As mentioned in Section 1.2, 
recent work in rat has uncovered a role for SoxlO in maintenance of multipotency in 
NCSCs. Exposing NCSCs in vitro with neurogenic or smooth muscle promoting signals 
irreversibly blocked their potential to later become glia or neurons respectively. However
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forced expression of SoxlO protected them against this loss of potency, and additionally 
maintained their proliferative activity. Interestingly, SoxlO not only maintained NCSCs in 
a multipotent state, but also inhibited the differentiation of neuronal fates, leading to a 
delay in neurogenesis. Critically, this latter role requires a higher level of SoxlO than 
maintenance of neuronal capacity. NCSCs from homozygous Dom/Dom embryos display 
no neuronal capacity and never express neuron markers, whereas NCSCs derived from 
heterozygous Dom/+ embryos have neurogenic potency but display neural differentiation 
markers earlier than wild-type cells (Kim et al., 2003). This reflects the situation in the gut 
of soxlO heterozygous mice where distal gut aganglionosis can be attributed to 
inappropriate initiation of neural differentiation and concomitant depletion of neural 
progenitors from a proliferative, colonising state (Paratore et al., 2002). In contrast, in 
homozygous sox 10 mutants, neural crest derived enteric progenitor cells die very early 
leading to total gut aganglionosis. To summarise, SoxlO has two roles in undifferentiated 
neural crest cells, firstly a role in their survival and maintenance of potency, which requires 
a single gene dose and is thus unaffected in heterozygotes, and a role in inhibition of neural 
differentiation, which requires two copies of SoxlO gene and thus is aberrant in 
heterozygotes. It is important to note that most of the in vitro neural crest experiments use 
NCSC restricted to the autonomic or smooth muscle lineages. It is not known if these 
properties of SoxlO activity and function are general or lineage specific.
There is compelling evidence for a subsequent role for SoxlO in glial fate acquisition 
and differentiation. Upon differentiation, NCSCs downregulate soxlO in all cell types 
generated, except glia (Kim et al., 2003; Paratore et al., 2001). Analysis of soxl0'A NCSCs 
in culture demonstrate that not only do they have severely compromised survival, but also 
those cells that do survive are unable to differentiate as glia, in contrast to wild-type 
NCSCs (Paratore et al., 2001). This indicates a role for SoxlO in glial fate acquisition and 
is supported by evidence that surviving neural crest cells in soxlO'1' embryos also fail to 
differentiate to glia (Britsch et al., 2001). It is of interest to note that SoxlO is required for 
Notch expression in mice, which in turn is instructive for gliogenesis (see above). In 
addition SoxlO is also reported to directly regulate Po, a myelin gene expressed in 
differentiated Schwann cells (Peirano et al., 2000). It is yet to be determined whether 
SoxlO induces these genes in zebrafish, and if so, whether they are direct targets of SoxlO.
Finally, although neurons and glia of DRGs appear normal in soxl0+/' mice, 
undifferentiated DRG neural crest cells isolated from these mice behave differently to 
those isolated from wild-type mice in culture. SoxlO heterozygous NCSCs displayed 
different fate preference away from generation of glia, which was only corrected by both 
supply of NRG1 signals and allowing cell-cell interactions (Paratore et al., 2001). The
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authors concluded that SoxlO levels alter how a cell interprets a combination of external 
signals, but that there was a degree of redundancy within the integrated signalling networks 
in vivo. The mechanisms involved have not been elucidated, and it is not clear if the nature 
of the cell-cell interactions include Notch-Delta signalling. As mentioned earlier, dosage of 
a transcription factor such as SoxlO could alter levels of protein in such a way as to affect 
different promoters to different extents, and this effect might be indistinguishable from 
simply reduced ability to occupy enhancers (Veitia, 2002).
Thus SoxlO activity levels alter responsiveness to extracellular environments. Given 
the importance of Notch-Delta signalling in patterning DRGs and in gliogenesis, and given 
that SoxlO is necessary for Notchl expression in nascent DRGs of mice, it is conceivable 
that SoxlO levels alter the effectiveness of lateral inhibition. This may be through direct 
regulation of Notchl by SoxlO, or by SoxlO augmenting the activity of other transcription 
factors required for Notch expression. Alternatively SoxlO levels could alter a cell’s 
sensitivity to Notch signals by modulating other signalling systems integrated in the lateral 
inhibition process. Disruption of lateral inhibition within the DRG invoked by reduced 
SoxlO function might then lead to neurogenic phenotype as in bazl.
The production of a neurogenic phenotype through deficiency of a transcription factor 
implicated in regulating lateral inhibition has been seen previously in zebrafish. The no 
isthmus mutant is deficient for pax2.1 and displays a neurogenic inner ear hair cell 
phenotype, having twice the normal number (Riley et al., 1999), a phenotype similar to 
that of the dlA mutant. Expression of deltaA and deltaD are also perturbed in these mutants 
indicating pax2.1 is required for optimal expression of delta genes. Thus in this example of 
neurogenesis in zebrafish, proper lateral inhibition requires regulation by transcription 
factor activity.
A model explaining why bazl mutant embryos, uniquely for sox 10 alleles, produce a
neurogenic phenotype can be proposed, and relies on early and late roles for SoxlO in
neural crest, as well as the dependence on an integration and interpretation of lateral
inhibition signals for appropriate neurogenesis and gliogenesis within DRGs. Firstly,
SoxlO has an early role in vivo for the survival/maintenance of NCSCs restricted to a DRG
fate, requiring relatively low amounts of SoxlO activity. Stronger els alleles do not have
sufficient activity for this and so the stem cells fated to become neurons or glia of DRGs
apoptose, either before migration or once in a DRG position, bazl however has
intermediate activity sufficient for survival of these stem cells, but does not have sufficient
activity for the later role in gangliogenesis. Analysis of heterozygous stem cells in culture
reveals that SoxlO gene dose (and hence presumably amount of activity) alters a cells
interpretation of surrounding signals. So the undifferentiated neural crest stem cells in bazl
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might show less sensitivity to lateral inhibition, either due to a direct lack of SoxlO 
mediated Notch expression, or an indirect effect on a signal that somehow increases 
effectiveness of the Notch-Delta signalling system. It is failure of this late role for SoxlO 
that accounts for its neurogenic phenotype.
This model predicts that further reduction in the levels of SoxlO activity in bazl 
embryos to below a critical level should reverse the neurogenic effect due to increased 
early loss of NCSCs. Use of varying doses of morpholinos directed against SoxlO might 
reveal this, alternatively production of transheterozygotes achieved by crossing bazl 
heterozygous fish to heterozygotes of a stronger SoxlO allele would reduce effective levels 
of SoxlO, possibly to below the threshold required for NCSC survival. Furthermore, direct 
perturbation of Notch-Delta signalling using chemical inhibitors of Notch, or cell-specific 
promoters driving constitutively active Notch, dominant negative Delta or other members 
of the signalling system in bazl mutants, might enhance or rescue the bazl phenotype, and 
would provide strong evidence that the bazl phenotype is due to a defect in lateral 
inhibition.
The model presented above also predicts that any escaping NCSCs in strong SoxlO 
mutants might go on to produce supernumerary DRG neurons due to uncovering of the late 
role for SoxlO. This is indeed often the case, with “mega-ganglia” commonly seen in 
strong els embryos (K.A. Dutton pers. comm.). That they are not the rule for formed DRGs 
in els, might indicate that only a proportion of NCSCs that contribute to a normal ganglion 
ever survive, or that there is some additional level of apoptosis due to lack of glial derived 
trophic support associated with these DRGs.
It is also critical to ascertain if Schwann cells and satellite glia are associated with the 
supernumerary neurons. If the model is correct, and a failure in lateral inhibition causes 
supernumerary neurons to form at the expense of glia, then a reduction of glial cells would 
be evident.
To summarize, the 6az7mutant appears to have an intermediate level of SoxlO activity, 
giving divergent effects on neural crest fates. This might be due to different tolerance of 
critical target promoters to reduced occupation of enhancer sites by transcription factor 
complexes containing SoxlO. It is likely, but remains to be directly shown, that regulation 
of cell number in zebrafish DRGs is partially controlled by Notch-Delta mediated lateral 
inhibition. This remains unproven however. The neurogenic phenotype of bazl is 
consistant with this hypothesis and reveals a role for SoxlO in integrating and interpreting 
lateral inhibition signals during the developmental program of dorsal root gangliogenesis.
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C h a p t e r  6  
C o n c l u s i o n s
Many aspects of neural crest cell induction, specification, patterning and differentiation 
are poorly understood. It is evident from mutational studies in a number of vertebrate 
species that SoxlO is one of the many key factors in this process, although detailed 
investigation of its function and role during neural crest development is in its infancy. The 
zebrafish offers new approaches to elucidating the mechanisms involved in neural crest 
ontogeny. A number of mutants have already been identified, demonstrating that many 
genes and their functions are conserved between mammals and zebrafish. For example, 
homozygous SoxlO mutants in mouse, human and zebrafish all show a severe loss of non- 
ectomesenchymal neural crest derivatives. Evidence from zebrafish indicates that this is 
primarily due to a failure to specify neural crest progenitor cells to individual fates, most 
likely due to a failure to activate master switch genes in individual lineages, such as mitfa 
in the melanophore lineage. The complete array of SoxlO target genes is mostly unknown, 
and the identification of downstream effectors of SoxlO function, such as master 
transcription factors, remains a critical goal for determining its role in neural crest 
development. Furthermore, how crest cells integrate the environmental signals presented to 
them to effect a specific downstream transcription factor cascade is not known, but is 
crucial to understanding neural crest cell specification and commitment. There is in vitro 
evidence that SoxlO plays a further role in the interpretation of extrinsic signals, and 
alteration of SoxlO gene dose alters the response of neural crest cells to their environment, 
however this has not been well documented in vivo. Much of the work in this thesis has 
been directed towards generating tools to allow these questions, amongst others, to be 
addressed.
The zebrafish sox 10 genomic region has been cloned and is present on four 
overlapping PACs. From one of these PACs, high quality sequence of an 18.5kb contig 
containing the sox 10 gene has been obtained. The predicted amino acid sequence from the 
gene sequence was identical to that of the published zebrafish sox 10 cDNA. Intron-exon 
boundaries within the coding region appear conserved with humans and mouse arguing for 
orthology. Further, evidence that the gene isolated corresponded to the described sox 10 
zebrafish mutant, els, was obtained through rescue experiments. The ability of all four 
PACs to rescue the els pigment defect was demonstrated. Many aspects of the neuronal 
defects were also rescued but at a much lower frequency. For example, enteric neurons 
rescue was only identified upon injection of PAC N, although at a low success rate. This 
low rate of rescue probably means that no conclusions can yet be drawn from the fact that 
a larger PAC (PAC I) has so far not demonstrated enteric rescue. As the entire genomic 
region present on the smallest PAC is also present on all the larger PACs, it would be 
highly surprising if the latter could not rescue enterics. Sympathetic neurons are
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completely absent in els, and their presence in a mosaically rescued els embryo, 
demonstrates that rescue of this cell type is also possible. Less dramatic, nonetheless 
measurable, was the rescue of DRG neurons. That rescue of DRGs appeared less striking 
could be attributed to the fact that the DRG phenotype is much less severe in els mutants. 
Additionally, it is known from lineage analysis that the number of cells giving rise to the 
DRGs is relatively small, thus restricting the chances of a DRG fated neural crest cell 
inheriting the injected PAC. It has been proposed from mouse SoxlO mutant analysis that 
the DRG neuron phenotype is secondary to lack of differentiated glia. It cannot be ruled 
out by the injection experiments presented here that the DRG neuron rescue is not 
secondary to glial rescue. The extent of DRG-associated glia hypoplasia has not been fully 
addressed yet, but glia are not present on the posterior lateral line in els (Kelsh et al., 
2000a). Use of the soxlO-4.9:GFP transgenic line to visualise glia could be used to 
determine if any glial cells with normal morphology are present in rescued els embryos. 
However this would not determine if these cells express appropriate differentiation 
markers. Attempts to measure the ability of the PACs to fully rescue glia then also require 
use of the only PNS glial differentiation marker reported so far, namely myelin basic 
protein (MBP; Brosamle and Halpem, 2002). Similarly, a precise oligodendrocyte defect in 
els is yet to be established, but the increasing number of oligodendrocyte and myelin 
markers available could be used towards this end (Park et al., 2002). The mouse SoxldacZ 
mutants show a terminal differentiation defect in oligodendrocytes (Stolt et al., 2002), and 
a similar defect might be true in els. Molecular marker analysis could then be used to 
evaluate the ability of each PAC to rescue any uncovered oligodendrocyte defect.
These rescue experiments were important, not only for establishing that all four PACs 
map to the els/sox 10 locus, but also to demonstrate that all four PACs contained sufficient 
promoter elements to drive SoxlO expression in the neural crest to effect rescue. For the 
melanophore lineage, the earliest defect in els can be seen at 20hpf, namely loss of the 
essential melanophore lineage transcription factor, mitfa. Thus to rescue melanophores, the 
PACs must contain elements necessary for driving expression in this early stage of 
melanophore development. The presence or absence of elements controlling expression in 
other sites such as in the ear, oligodendrocytes, differentiated glia and cartilage could not 
be established by rescue experiments, due to a lack of known measurable molecular or 
morphological defect in els.
Potential sox 10 enhancer sites were identified by sequence comparison of the zebrafish 
sox 10 gene with a putative sox 10 orthologue from Fugu (obtained via the Fugu genome 
sequencing project). As expected the coding sequence and intron-exon boundaries are 
conserved, but the sequence comparison was also able to detect two conserved regions
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outside the transcribed region, one 5’ and one 3’ to both soxlO genes. It is not yet known if 
these conserved regions are significant, or if they are both involved in soxlO regulation. It 
would be worthwhile repeating the comparison using a greater amount of flanking 
sequence in an attempt to identify other conserved regions. Further it is important to scan 
the conserved regions for consensus transcription factor binding sites, which might reveal 
information about what might be upstream of SoxlO. Finally, a simple functional test 
demonstrating that the zebrafish and Fugu sox 10 genes are conserved would involve 
attempting to rescue els with a Fugu sox 10 containing genomic clone. This simple and 
quick assay would indicate that both gene regulation and protein function are conserved. 
Similar analysis using a mouse SoxlO genomic clone would also be of interest. 
Demonstrating an ability to rescue els with the mouse SoxlO gene would allow knowledge 
of the regulation and function of SoxlO to be transferred between the two species with 
more confidence.
Having established from the rescue experiments that functional regulatory sequence 
was present on all 4 PACs, a portion of promoter was subcloned upstream of the GFP 
reporter. This also included all of the first intron such that the ATG codon of GFP was 
positioned in an identical position with respect to that of the endogenous SoxlO protein. It 
has been reported previously that inclusion of the 5’UTR can be important for maximising 
gene expression, and that genes can contain regulatory regions upstream of the translation 
start site, but downstream of the transcription initiation site (Gilmour et al., 2002a; Long et 
al., 1997). Indeed, promoter dissection experiments have recently suggested that a 
necessary enhancer element is found within intron 1 of the zebrafish sox 10 gene (J. Dutton 
pers. comm.).
Three different sized reporter constructs were produced, two of which were plasmid 
based, whilst a recombinogenic technique was employed to engineer GFP into PAC I, 
creating a PAC based reporter. All the reporter constructs described in this work direct 
GFP expression in domains consistent with the in situ data, and which are also conserved 
with sites of SoxlO expression in other species, including neural crest cells, the ear, 
oligodendrocytes, cartilage cells and PNS glia. This supports the argument that SoxlO 
plays similar roles in these species. Some unexpected domains were also revealed for all 
constructs in transient analyses, namely muscle and intemeurons. Presence or absence of 
the latter has not been definitely demonstrated by in situ, and as such might not be ectopic, 
however the muscle expression was unexpected. Although all constructs showed muscle 
expression in transient transgenics, only the smallest 4.9:GFP construct consistently did so 
when integrated into the germline. It has been argued that this inappropriate expression 
could be due to a combination of copy number and/or insufficient repressor elements. With
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regard to the latter possibility, it is of interest that, by chance, the 5’ end of the promoter in 
this construct lies within the region showing sequence conservation with the Fugu 
sequence. Thus the 4.9:GFP reporter only contains half of this conserved region, whilst the 
larger two constructs contain the entire conserved region. This might have implications for 
the anomalous expression pattern seen in the soxlO-4.9:GFP line, possibly indicating that 
this region contains a muscle repressor element.
Furthermore, the 4.9:GFP reporter shows strong ear expression in transient analysis, 
but remarkably weak expression in the transgenic line, where the GFP expression in the ear 
is at a relatively much lower level than in the neural crest. There are a number of 
explanations for the faint ear expression, but one attractive explanation is that there are 
insufficient ear enhancer elements present to direct full GFP expression in the ear. The 
strong ear expression shown in transient analyses could thus be erroneous and might be 
due to extremely high copy numbers of transgene inherited by the cells, producing an 
additive effect and causing low levels of promoter activity to give a very high, but 
misleading, GFP signal.
Transgenic lines carrying the two larger constructs, p6.1 :GFP and PACIGFP2, both 
show increased absolute levels of GFP expression in the ear compared to the sox10- 
4.9:GFP. Additionally, in both lines, the relative levels of GFP expression in the ear and 
neural crest are approximately the same, supporting the notion that the smallest construct 
lacks an ear specific enhancer. Correlation of the presence of relatively strong ear 
expression with the conserved sequence region in the promoter mentioned above has been 
used to suggest the presence of an ear enhancer here.
It should be noted that all four 6.1 :GFP lines isolated show only weak GFP expression 
overall, whilst the 4.9:GFP and PACIGFP2 lines both express strongly. It is difficult at this 
stage to conclude anything about the strengths of the promoters. Establishing the copy 
number present in each of these lines is an important task for determining the relative 
strengths of each of the reporters, and for some of the arguments outlined above. This 
would easily be achieved through Southern analysis. Further characterisation of the 
spatiotemporal expression patterns of each of these lines is required, including better 
understanding of the PNS glial expression and the phases and sites of the CNS expression. 
It is important to better understand the nature of the ENS expression pattern in all GFP 
lines. Lack of detectable expression in migrating enteric precursors but later expression in 
presumptive enteric neurons, directly contrasts with the expression pattern predicted from 
in situ studies and SoxlO expression patterns in other species. It was documented by in situ 
analysis that sox 10 is expressed in cartilage and certain glial cells up to 60hpf. Inspection 
of the transgenic lines has indicated that this expression is maintained until much later,
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being evident in certain glial lineages and cartilage cells until at least 20dpf. The role of 
sox 10 in the latter site is not yet well understood, but studies in chick have suggested that it 
permits cells to remain competent to respond to BMP signals (Chimal-Monroy et al.,
2003). It is well documented that SoxlO is required for expression of myelin-associated 
proteins in differentiated glia, but this has not been demonstrated in zebrafish. Thus there is 
much to learn about the early and late roles for SoxlO during development.
The soxlO:GFP transgenic lines offer a valuable tool for better understanding these 
roles of SoxlO and the mechanism of neural crest ontogeny. They appear to be the first 
transgenic line in any species that allow live imaging of both premigratory and migratory 
neural crest, and thus should prove useful in a number of experiments. Firstly, if combined 
with cell lineage analysis, they offer a means of determining the fate specification of sox 10 
expressing cells from a very early stage. Thus it appears that SoxlO labels prospective 
neural crest cells before delamination from the neuroepithelium, and might mark these 
cells before they can be identified by DIC optics. If this is the case, it will allow lineage 
marking of neural crest precursors to occur at an earlier stage than previously, and thus 
could demonstrate a cell with less fate restriction than seen with later cells. For example, 
identification of a clone containing both ectomesenchymal and non-ectomesenchymal 
derivatives would prove the existence of a neural crest cell potent for both lineages. This 
has not yet been demonstrated in any organism in vivo. Additionally, there appeared to be a 
degree of heterogeneity present in the premigratory neural crest population with respect to 
GFP (and presumably sox 10) expression, with some GFP' ‘holes* present in the neural 
crest population. This was reminiscent of similar holes seen in the sox 10 in situ pattern 
(Pauliny, 2002). It is not known if the heterogeneity of soxlO expression reflects 
heterogeneity of fate specification. This is readily testable using the GFP line to allow 
labelling of GFP+ (=soxl0+) cells and comparing the resulting fates to those of GFP'
(=soxlO') cells, although it first needs to be established by dual labelling that the GFP'cells 
are also reliably soxlO'. This would prove a novel approach toward the correlation of 
marker heterogeneity with fate specification.
Due to protein perdurance, GFP itself proved a useful lineage marker, in that it was 
retained in cells that used to, but no longer, express GFP (=soxl0). For example, branchial 
arch expression was prominent in all transgenic lines, but not seen in the soxlO in situs. 
Furthermore, recent in situ analysis using a gfp in situ probe demonstrated that although 
the protein was present, the mRNA was not (see figure in Appendix 2). This strongly 
argued that the sox 10 promoter was not active in these cells at this stage, but had been at an 
earlier time point, namely at the premigratory stage. This was the first direct evidence that 
soxlO expressing premigratory neural crest cells in zebrafish are fated to give rise to jaw
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cartilage, and current cell labelling studies are attempting to conclusively demonstrate this. 
It is also important to identify other cell types which at one stage expressed sox 10 during 
their development. In particular, DRG neurons are known to be affected in SoxlO mutants 
in a number of species, but it has not been well documented if their precursors at any stage 
express SoxlO. It has been proposed that the DRG neuron defect is due to lack of glia, as 
opposed to a cell-autonomous defect caused by lack of SoxlO function. For the latter 
proposal, it is necessary to demonstrate SoxlO activity at some stage in the cells giving rise 
to DRG neurons. This could be done using the soxlO:GFP line, by lineage labelling GFP+
(=soxlO+) premigratory neural crest cells and showing they can contribute to DRG neurons 
or simply by showing co-expression of perduring GFP with early sensory neuron markers. 
Conversely, demonstrating that DRG neurons derive from cells that never express SoxlO 
would conclusively show that the latter proposal could not account for the DRG 
phenotype, and would support the alternative trophic model for DRG degeneration.
The observation that GFP expression is not maintained in the melanophore lineage is 
consistent with preliminary in situ analysis which also demonstrated that the sox 10 
promoter is inactivated in differentiated melanophores. This supports the recent 
demonstration that the essential role for sox 10 in the melanophore lineage is to activate 
mitfa (Elworthy et al., 2003). The status of the promoter in other pigment cell types is yet 
to be established. Fluorescence is seen in these cell types at later stages, but it cannot yet 
be ruled out that this is not autofluorescence. It is also conceivable that GFP might be more 
stable in some cell types, or might perdure to different extents in different cell lineages, 
thus meaning that although GFP signal is lost in melaonophores, it is maintained in 
xanthophores and iridophores for longer. Preliminary in situ analysis, however, hinted that 
soxlO was not maintained in any pigment cell type (Pauliny, 2002). Although sox 10 
appears to have only an early role in the melanophore lineage, it is likely that it does as 
well in xanthophores and/or iridophores; however it cannot yet be ruled out that it does not 
have a later function as well.
The perdurance of GFP in the embryo, exemplified by the expression in the branchial 
arches, makes the absence of signal in the migrating ENS progenitors even more curious. It 
would be predicted that even if promoter activity was not maintained in the ENS 
progenitors, GFP would be seen here as it would have perdured from the earlier expression 
in premigratory neural crest cells, as seen in the branchial arches. Two explanations can be 
proposed for this difference. Firstly, the premigratory neural crest cells fated to the ENS 
might never express GFP, however arguing against this is the observation that all neural 
crest cells in the vagal region appear to express GFP. There is growing evidence that neural 
crest cells fated to the ENS do express sox 10 at a premigratory stage, as there is a very
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early defect in ENS progenitors in els (Elworthy et al., in prep.). The second explanation 
might be that perdurance of GFP is different in different neural crest cell lineages. This 
might conceivably be a function of the number of cell divisions that occur within each 
lineage. Thus the ENS progenitors might undergo a much greater number of cell divisions, 
which would be expected to dilute the GFP signal much quicker.
Aside from lineage analysis, other uses for these lines are numerous. Firstly as they 
live-label a number of developmentally interesting cell types and tissues including 
premigratory neural crest, migrating neural crest, otic vesicle, cartilage and glial cells, 
these lines would prove extremely useful for following cell behaviour under wild-type and 
various mutant conditions. Combined with timelapse microscopy, this might yield a simple 
means for observing the morphogenesis of certain structures and cell types, such as 
condensation of jaw elements, migration of neural crest cells or wrapping of axons by 
myelinating glia. Investigating how these are affected by disruption of certain genes’ 
function would provide a crucial link between molecular and cellular processes. Extending 
this, these lines will also form the basis for more specific mutagenesis screening by 
permitting easy visualisation of cell types normally difficult to see. Screens aiming to 
isolate genes with essential function in these cell types could be readily performed.
Mutants that abolish GFP expression altogether might correspond to candidate upstream 
factors involved in the regulation oisoxlO. A current sox 10 promoter dissection is 
currently underway and offers a further means of investigating the regulation of soxlO.
One of the first mutants that needs to be analysed using this line is els itself. The 
soxlO-4.9:GFP line has already been crossed to a els allele, however analysis is only 
preliminary at this stage. One main hypothesis this might help to test is again the proposal 
that the DRG neuron defect in SoxlO mutants is due to loss of glia, and not a direct effect. 
This model would then predict that all surviving DRG neurons in els will have an 
associated glial cell adjacent to provide trophic support. Combined use of a neuronal 
marker and GFP signal in c/s'7';sox 10-4.9:GFP embryos allows investigation of the 
presence of GFP+ glial cells surrounding neurons. It is important to note however that this 
does not demonstrate that these glial cells function normally to provide trophic support.
Finally, these GFP lines also offer a powerful means of isolating pure populations of 
cell types by FACS analysis, as has been previously performed in zebrafish (Long et al, 
1997). This will allow expression profiling of specific cell populations at specific 
developmental stages and in different mutant backgrounds. Combined with microarray 
analysis, now emerging in the zebrafish field, this will allow identification of cell specific 
markers and downstream targets of transcription factors such as soxlO. Markers of certain 
cell types in zebrafish such as PNS Schwann cells and satellite glia are scarce, and remain
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a much needed resource in the neural crest field (Gilmour et al., 2002b). The full repertoire 
of signalling systems functioning in the neural crest is also not yet determined. Identifying 
the molecules present at different stages during neural crest specification will allow better 
understanding of how neural crest cells respond to different signals, and integrate these 
with intrinsic biases within each cell to achieve fate restriction. Furthermore, detailed 
understanding of the role of sox 10 in various cell lineages requires determination of its 
downstream targets. This could be achieved through comparison of the expression profiles 
of neural crest cells isolated from wild-type and els embryos via microarray analysis. 
Isolation of neural crest cells by FACS analysis might also facilitate cell biology 
experiments. One such experiment might involve neural crest heterochronic and 
heterotopic transplant experiments to be performed, to follow the degree of potency of 
neural crest cells closely over time. It would be interesting to establish if the soxlO 
expressing cells retain greater potency than other non-sox 10 expressing neural crest cells. 
This would provide an in vivo test of the proposals made by Kim et al (2003), who 
showed in vitro that SOX 10 maintains cells in a multipotent state.
Thus the generation of soxl0:GFP transgenic lines should prove a valuable tool to 
better understanding the ontogeny of various cell types, and the role of SoxlO, and only a 
handful of possible experiments have been outlined here. Of the six lines produced, the 
PACIGFP2 line appears to be the most promising as it expresses strongly and in sites 
appropriate for soxlO. A number of other labs are currently employing these lines for 
analysing different aspects of neural crest lineages.
The final part of this work involved characterising two unusual els alleles. Firstly, the 
original els allele, els , which arose spontaneously, has been shown to be due to a 
transposon insertion event. The transposon was closely related to one previously identified 
in a no tail allele, indicating that these are members of a family of composite transposons 
active in the zebrafish genome. Although similar, the two transposons were not identical. 
This might indicate that they are members of separate subfamilies. The number of copies 
of this family in the genome has been predicted to be around 100. Identification and 
sequencing of more members of these families might allow estimation of the time they 
arose in zebrafish. It is not yet known the mechanism of transposition, be it through a DNA 
or RNA intermediate. The insertion occurs 5’ to the HMG box, and appears to disrupt 
sox 10 transcription or message stability, leading to severe decrease in full length sox 10 
mRNA. Furthermore the transposon adds 8 novel amino acids before introducing a stop 
codon. This reduces the conceptual SoxlO protein to only 93 amino acids. It would thus 
appear that clstS represents a null allele, however this is disputed by morpholino
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experiments, which appeared to further enhance the clst3/t3 phenotype, arguing that it is not 
a null (K.A. Dutton pers. com.). The validity of this claim is currently unresolved.
A screen for novel sox 10 alleles yielded an unusual els allele, namely bazl. This 
displayed a strong defect in some neural crest derivatives, but only a weak effect in others. 
For example, no melanophores with wild-type morphology survived in bazl homozygous 
embryos, but iridophores were only weakly affected. In the PNS, no enteric neurons were 
evident, however there appeared a striking increase in the number of DRGs. With the 
knowledge that the molecular lesion in bazl is a substitution in the HMG domain, it has 
been proposed that the Soxl06az7 protein might have partially reduced ability to 
transactivate downstream targets, and might bind to different promoters with different 
affinities. The precise mechanism producing this difference in activity is not known. It 
might be that assembly of transcription factor complexes including Sox 10 occurs through a 
different mechanism on different target promoters. For example, if the DNA binding 
ability of the SoxlObazJ protein is compromised by the lesion, then transcription factor 
complexes that absolutely require Sox 10 binding to DNA for assembly will never attach to 
the DNA. Conversely, transcription factor complexes that only require protein-protein 
interactions mediated by Sox 10 could conceivably form as normal on a target promoter. A 
similar effect has been noticed previously for the human SOX 10 mutation S135T, also 
found in the HMG domain. Although this protein cannot form a transcription complex 
bound to the MITF promoter, it is able to transactivate the c-RET promoter, but only in the 
presence of the PAX3 protein, indicating that DNA binding in the latter, but not former 
case is mediated by PAX3 and not SOXIO. The identification of more direct target genes 
of Sox 10 will allow the status of the different downstream promoters in bazl to be 
established.
Thus it is conceivable that partial Soxl06az7 protein function could produce disparate 
effects on different pigment cell types. Similarly, activation of genes involved with DRG 
formation might also be affected to different extents. Could this produce a neurogenic 
phenotype? Firstly, DRG progenitors clearly survive in bazl, whereas in other stronger 
alleles they either fail to specify or die at an early stage. This might be because genes 
required early in progenitors for survival are transcribed in bazl, but not in other els 
alleles. Secondly, there is evidence that levels of Sox 10 alter a cell’s interpretation of the 
extrinsic signals in forming DRGs. Sox 10 haploinsufficiency has been shown to lead to an 
excess production of DRG neurons from cultures of neural crest cells in vitro. This appears 
to require cell-cell communication and the absence of NRG 1 signalling (Paratore et al., 
2001). Further, it has been shown that Notch-Delta signalling functions in both chick 
DRGs and the neural crest lineage of zebrafish (Cornell and Eisen, 2002; Wakamatsu et
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al.t 2000). A link between Sox 10 and Notch-Delta signalling is currently not well 
established. In Soxl(facZISoxlGfacZ mice, Notch expression is absent in the DRGs, and 
induction of ectopic Notch signalling in zebrafish leads to an increase in sox l(f cells 
(possibly glia) located on the medial pathway (Britsch et al., 2001; Park and Appel, 2003). 
Thus it might be that Sox 10 mediates the strength of lateral inhibition in ganglia, and that 
in bazl embryos, this does not occur due to an absence of Notch. DRG neurons thus form 
at the expense of glia. To test that the supernumerary DRG neurons are produced at the 
expense of glial fates, it is necessary to show that there is a reduction in the number of glia 
associated with these neurons. This could be achieved by using soxl0:GFP line crossed 
onto the bazl background to visualise glia, or alternatively the inspection of glial specific 
markers, such as mbp. Preliminary analysis using an mbp in situ has shown that this marker 
is absent from the PNS in bazl, consistent with a deficit of glia, however this result could 
simply mean that the glial cells simply do not express differentiation markers. Thus a 
detailed analysis using the soxl0:GFP lines might provide a better examination of the 
development over time of the two cell types. Perturbing Notch-Delta signalling in 
zebrafish DRGs will also be important to test the hypothesis that it plays a role in DRG 
formation. Attempting to rescue the bazl DRG phenotype by re-introduction of Notch 
signalling would strengthen an argument for a failure of lateral inhibition in bazl.
Although it would be best to perform these analyses in vivo, it might be that analysis of 
neural crest cells isolated from bazl and wild-type embryos in culture would permit a more 
detailed study.
Thus the bazl mutant phenotype might represent a unique in vivo demonstration of 
some of the roles of Sox 10 proposed by in vitro studies. A new idea in murine Sox 10 
studies is the concept that Sox 10 maintains neural crest cells in a “stem cell state”, in 
particular conferring multipotency and proliferative ability. Its levels appear to be critical 
to how a cell interprets its surroundings. Much of the mouse analysis has been confined to 
in vitro analysis, but the bazl mutant might offer an important in vivo confirmation of the 
models proposed by the mouse work, and also demonstration of the numerous roles Sox 10 
plays during neural crest development, including how it integrates a number of different 
signals presented to neural crest cells during development.
Both the soxl0:GFP transgenic lines and bazl represent useful means of dissecting the 
processes involved in zebrafish neural crest ontogeny, and the role of Sox 10 during 
development.
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A p p e n d i c e s
A p p e n d i x  1: Z e b r a f i s h  sox10 cDNA s e q u e n c e  a n d  f e a t u r e s
Nucleotide sequence of the full-length zebrafish sox 10 cDNA, as deposited in 
Genbank (Accession number AF402677; Dutton et al., 2001). Primers are indicated above 
the sequence as horizontal arrows, certain restriction sites present within the sequence are 
boxed and intron sites are indicated with vertical arrows. The conceptual translation is 
shown below the nucleotide sequence, with the start and stop codons underlined. The 
HMG box and HMG domain are both in bold. The mutant lesions are indicated with the 
nucleotide substitution written above the nucleotide sequence, and the incurred amino acid 
change in a bracket above the corresponding conceptual translation. Introduction or 
destruction of a restriction site in the cDNA sequence by the nucleotide substitution is also 
indicated. The sequence duplicated by the t3 insertion event is bracketed, and the novel 
amino acids presented in a text box.
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1 Spel M  S A E E  H S M  S E V  E M S P
4 2 1  G G G G T G T C G G  A C G A T G G G C A  C T C C A T G T C C  C C T G G T C A C T  C G T C G G G C G C  T C C C G G T G G C  G C G G A C T C C C  
1 6  G V S  D D G  H S M S  P G H  S S G  A P G G  A D S
4 9 1  C T C T G C C C G G  T C A G C A G T C T  C A G A T G T C C G  G G A T C G G G G A  T G A T G G A G C C  G G T G T C T C C G  G C G G G G T C T C
3 9 P L P  G Q Q S  Q M S  G I G  D D G A  G V S  G G V
^ ______ T33________ | t3 insertion site
5 6 1  G G T G A A G T C C  G A C G A G G A A G  A T G A C C G G T T  C C C C A T C G G C  A T C C G C G A G G  C G G T C A G T C A  [ g G T G C T G A A c ]  
6 2 S V K S  D E E  D D R  F P I G  I R E  A V S  Q V L N
S19
6 3 1  G G G T A C G A C T  G G A C G C T C G T  G C C C A T G C C C  G T G C G C G T G A  A C T C G G G C A G  C A A G A G C A A A  C C G C A C G T C A  
8 6  G Y D  W T L  V P M P  V R V  N S G  S K S K  P H V
S  G  A  P R K F  S
Extra t3 amino acids
156
A ------ >  BspH I (TCATGA)
7 0 1  AGCGGCCGAT GAACGCGTTC AT
bazl S22
GTGGG CGCAGGCCGC GCGCAGGAAA CTGGCGGATC AATATCCGCAW
(M)
1 0 9  K R P  M N A F  M V W  A Q A A R R K  L A D  Q Y P
A  >  T&R I (-CA % TG -)
m618 t
7 7 1  CCTGCACAAC GCCGAGCTCA GCAAAACA(fT| GGGGAAGCTG TGGAGACTGC TGAACGAGAC GGATAAGCGG
(Q)
1 3 2  H L H N  A E L  S K T  L G K L  W R L  L N E  T D K R
In tron  2
8 4 1  CCGTTTATCG AGGAGGCCGA GCGCTTGAGG AAGCAGCATA AGAAAGATTA TCCCGAGTAC AAGTACCAGC
1 5 6  P F I  E E A  E R L R  K Q H  K K D  Y P E Y K Y Q
San
9 1 1  c a c [g t c g a c |g  c a a g a a c g g c  a a a c c g g g t t  c c a g c t c a g a  g g c c g a c g c c  c a c t c t g a g g  g t g a g g t c a g
1 7 9  P R R  R K N G  K P G  S S S  E A D A  H S E  G E V
S24
9 8 1  C C A C A G C C A A  T C G C A T T A C A  A G A G C C T G C A  C C T G G A G G T G  G C G C A C G G C G  G G G C T G C A G G  G T C A C C A T T G  
2 0 2  S H S Q  S H Y  K S L  H L E V  A  H  G  G  A  A  G S P L
S23 <4 S20
1 0 5 1  G G T G A T G G A C  A C C A C C C T C A  C G C T A C A G G T  C A G A G T C A C A  G C C C T C C A A C  G C C C C C T A C C  A C C C C C A A G A
2 2 6  G D G  H H P  H A  T  G  Q S H  S P P  T P P T  T P K
Intron 3
►
1 1 2 1  C G G A A C T G C A  G G G A G G A A A A  T C A G G C G A G G  G C A A G C G T G A  G G G C G G A G C C  T C T C G G A G T G  G A C T G G G G G T
2 4 9  T E L  Q G G K  S G E  G K R  E G G A  S R S  G L G
1 1 9 1  G G G A G C A G A T  G G A A G C T C C G  C C T C A T C G T C  T G C C A G C G G G  A A A C C G C A C A  T C G A C T T C G G  T A A C G T G G A C
2 7 2  V G A D  G S S  A S S  S A S G  K P H  I D F  G N V D
1 2 6 1  A T T G G C G A A A  T C A G C C A T G A  C G T G A T G G C C  A A C A T G G A G C  C G T T C G A C G T  G A A C G A G T T C  G A C C A G T A T C
2 9 6  I  G  E  I S H  D V M A  N M E  P F D  V N E F  D Q Y
1 3 3 1  T C C C A C C C A A  T G G C C A C C C G  C A G G C G T C C G  C C A C T G C C A G  C G C A G G A T C T  G C A G C G C C A T  C G T A T A C A T A  
3 1 9  L P P  N G H P  Q  A  S  A T A  S A G S  A A P  S Y T
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S26 Not\
1 4 0 1  C G G C A T C T C C  A G C G C G C T A | G  C G G C C G ~ c [ t A G  T G G C C A C T C C  A C C G C A T G G C  T G T C C A A G C A  G C A A C T G C C G  
3 4 2  Y G I S  S A L  A A A  S G H S  T A W  L S K  Q Q L P
t tw2, twl 1 S25
1 4 7 1  T C C C A G C A G C  A T T T G G G C G C  A G A T G G C G G G  Q ^ A A C G C A G A  T A A A G A G T G A  A A C A C A C T T C  C C T G G G G A T A
(*)
3 6 6  S Q Q  H L G  A D G G  K T Q  I K S  E T H F  P G D
1 5 4 1  C A G C G G C G A G  C G G T T C A C A C  G T C A C A T A C A  C G C C G C T A A C  A C T G C C G C A C  T A C A G C T C C G  C C T T C C C C T C  
3 8 9  T  A  A  S G S H  V T Y  T P L  T L P H  Y S S  A F P
S9
1 6 1 1  G C T G G C G T C C  C G C G C A C A A T  T C G C C G A A T A  C G C C G A G C A C  C A G G C C T C G G  G A T C C T A C T A  C G C C C A C T C C  
4 1 2  S L A S  R  A  Q  F A E  Y A E H  Q  A  S  G S Y  Y A H S
1 6 8 1  A G C C A G A C C T  C A G G C C T C T A  C T C C G C C T T C  T C C T A C A T G G  G C C C C T C A C A  G C G G C C C C T G  T A C A C C G C C A  
4 3 6  S Q T  S G L  Y S A F  S Y M  G P S  Q R P L  Y  T  A
1 7 5 1  T T C C G G A T C C  G G G A T C C G T G  C C G C A G T C A C  A C A G C C C T A C  G C A T T G G G A G  C A G C C C G T A T  A C A C C A C A C T  
4 5 9  I  P  D  P G S V  P Q S  H S P  T H W E  Q P V  Y T T
1 8 2 1  G T C T C G A C C G  T G A C A C A C T C  T A C C A A G A T G  A C C A G T C A C T  A A A G G T C C A A  C C G T A A G G T G  T G T G T G T G T G  
4 8 2  L  S  R  P  *  ( S t o p )
1 8 9 1  T G C T A A A A A T  C A T C G A A A C A  C T C G C C T G C A  C C A C A A T C G A  C A C A A A C T G j f t  G A T C T | G A G A A  A C G A G T G T G T
Bgn i
1 9 6 1  G T G T G T G T G T  G | A G A T C T | G C A  G G G A A A T A T T  C T C A C G T G C C  T C A G A C G A C C  A C C G T C C A G A  C C T G C T C C C T
Bgn i
2 0 3 1  C A A C G C C A A T  T T G A C A C C A G  T A G T A T T T T C  G A A A A A G A C G  T A G T A C C A A A  G T A C C G A G A C  C A A A A C A T T A  
2 1 0 1  C A G A A A T A C G  A G A G T G C A T C  C A T C C T T C C T  G A A C T C C G | G A  T A T C | A G A T C A  C A C A C A G A C T  T C A A C A C A T G
EcoRV
2 1 7 1  A T G C T A G T A C  C A G T G C A T C C  G C A T T T T T T A  T C T G T A T T T G  T A T G A A T G A A  T A A T C T T T T T  A T T A A C C A A A
2 2 4 1  A T A A G G C C A T  A T T G T T T T T A  A A A A A A T A A T  G A G G T G T T T T  T C G T T G T T G T  A A T C T C T T G T  G T T G T C G T T A
2 3 1 1  C T G T T G T T A T  T T G T G T T G C C  A T A A C T A C A C  T G A A A A G T C T  T C A C C A C T G T  C T A G T G T T T G  T T A A T G A C A T
2 3 8 1  T T G T G T T T T A  T G A C T T T C A G  C G T G T G T A A A  T A T C A G T G C C  A G G A C G C C A T  A C A C A C A T G T  C T C C A C C C A A  
2 4 5 1  T T A A G G T G C G  C T C A C A G T G A  C G T T A A T T A A  A T T G A G j G A A T  T C | C C A A C C A T  G C A A A T T C C T  C T A G A A A T G G
EcoRI
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2 5 2 1
2 5 9 1
2 6 6 1
2 7 3 1
2 8 0 1
2 8 7 1
2 9 4 1
3 0 1 1
3 0 8 1
3 1 5 1
3 2 2 1
CTATATTTCG TGAAAGCAGT AAATGTGAGC GCACCTTTAT TTCACACAAG CAGTACTGTA AAGGTAATAT
A T T T T T G C C A  G A T T G G A A A T  G G T G G A C G T A  A T T A C G A A T T  T T T A A T A A T A  A A T G A C T A T T  T T T A G A G A A T
A C C G C T A G T G  C C T C A A G T C C  A T C A C A A A C G  A A T T G T C G T T  T C T G A T A A A T  T C A A T T T T G A  T G A T G T A A A A
T C C T T T T C A G  G G T G C A A A T T  T T A T C A T G C G  T T A A C C G A T G  T G A T T A T A C A  T C G A A T A T G C  A T A T G C A A A T
T A A T A A G T G C  C A T T T T T A T A  A T T A A A A A T A  C A T C A A C T A T  C T G A A G A C C T  T C C T A A C A T T  G G G T A A G T A A  
 1
A T A A A T A C A T  T T A T T T C A T T  G T A T T A T T T T  T G G T A A A T A C  A A T A T T T A G C  T A T T C T A T G T  T T T G T C T C C C
T T T G G T A C T T  T A T A G T T T T G  T T T T T G C C C T  C T T T A T T A T T  T A G T A T T A T T  C A G A A A C A A A  C A A A C T C T T T
T T A T A T A T T A  C A G A A T A T T A  T T T A T A T T T G  T T G T T G T T T T  T T T T T A T C A G  T A G C G T T T T A  T T C T G T T T G T
«  m 1 «--- si*-------- ,
T G T T G T G G T G  G G T T A A A G T G  C T G T T G T T T T  T C T C T G T C G G  T G T A A A T A G A
T T C C T C A C T C  T A A A T A A A G C  T G C A G T C T T T  A C T A A A A A A A  A A A A A A A A A A
A A A A A A A A A A
C G T A A A C C T C  T G T C G T G T G C
A C T G A G A G C A  G T G A C T A A C T
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Appendix 2: Perdurance of GFP protein in the Branchial Arches
GFP protein perdurance in the branchial arches as shown by comparison of GFP protein 
levels and GFP RNA levels. All figures are confocal images of lateral views of a 24hpf 
embryo. In both a. and b., the left-hand panels shows immunofluorescence using 
antibodies against the GFP protein (green channel), whilst the middle panels show 
detection of the gfpKNA  message (red channel), by in situ hybridisation using the 
fluorescence of the Fast Red stain (Roche, IN, USA) and according to Kelsh and Eisen
(2000). An overlay of the two fluorescent images is shown in the right hand panels.
a. At a lateral focal plane, strong GFP protein signal is evident in the branchial arches 
(arrow -  left panel). However there is no detectable transcript evident (arrows, middle 
panel and overlay in far right panel).
b. GFP promoter activity is detectable by in situ at a more medial focal plane, in neurons 
of the olfactory bulb (arrows) and ventral midbrain (red channel middle panel). GFP 
protein is also detectable at these sites, as shown in the first panel (again arrow 
indicates the olfactory neurons) and as an overlay in the right panel, detection of gfp 
mRNA acts as an internal positive control to show that the gfp in situ is capable of 
detecting gfp mRNA " and thus that the GFP protein present in the arches is not due to 
low active promoter activity, rather due to perdurance from an earlier phase of GFP 
expression. . . . -
C3
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SUMMARY
Waardenburg-Shah syndrome combines the reduced 
enteric nervous system characteristic of Hirschsprung’s 
disease with reduced pigment cell number, although the cell 
biological basis of the disease is unclear. We have analysed 
a zebrafish Waardenburg-Shah syndrome model. We show 
that the colourless gene encodes a soxlO homologue, 
identify soxlO lesions in mutant alleles and rescue the 
mutant phenotype by ectopic soxlO expression. Using 
iontophoretic labelling of neural crest cells, we demonstrate 
that colourless mutant neural crest cells form 
ectomesenchymal fates. By contrast, neural crest cells 
which in wild types form non-ectomesenchymal fates 
generally fail to migrate and do not overtly differentiate.
These cells die by apoptosis between 35 and 45 hours post 
fertilisation. We provide evidence that melanophore defects 
in colourless mutants can be largely explained by 
disruption of nacre/mitf expression. We propose that all 
defects of affected crest derivatives are consistent with a 
primary role for colourless/soxlO in specification of non- 
ectomesenchymal crest derivatives. This suggests a novel 
mechanism for the aetiology of Waardenburg-Shah 
syndrome in which affected neural crest derivatives fail to 
be generated from the neural crest.
Key words: Danio rerio, Waardenburg-Shah syndrome, 
Hirschsprung’s disease, Pigment cells, Melanophore, Apoptosis
INTRODUCTION
The neural crest is a vertebrate tissue of developmental and 
medical importance. Developmentally, neural crest is 
intriguing because the cells are initially multipotent and 
subsequently form a great diversity of derivative cell types, 
including ectomesenchymal fates, such as craniofacial skeleton 
and fin mesenchyme, and non-ectomesenchymal fates, such as 
neurones, glia and pigment cells (Le Douarin, 1982; Smith 
et al., 1994). Medically, neural crest is important because 
some diseases, known as neurocristopathies and including 
diverse conditions such as albinism, neurofibromatosis and 
Hirschsprung’s disease (aganglionic megacolon), affect cell 
types derived from this tissue (Bolande, 1974).
Understanding the genetic and embryological basis of 
neurocristopathies has depended on animal models. Thus, 
models for Hirschsprung’s disease, in which individuals have 
few or no enteric ganglia in the colon, or the related 
Waardenburg-Shah syndrome, in which individuals combine 
Hirschsprung’s disease with pigmentary anomalies of the skin, 
hair and irises, have been described in several species, 
including mouse and zebrafish (Hosoda et al., 1994; Kelsh and 
Eisen, 2000). Analysis of such models in mice has identified 
three loci that are crucial for Waardenburg-Shah syndrome
(Attie et al., 1995; Edery et al., 1996; Hofstra et al., 1996; 
Pingault et al., 1998; Puffenberger et al., 1994; Southard-Smith 
et al., 1999). Thus, mutations in loci encoding the G-protein- 
coupled transmembrane receptor protein endothelin receptor B 
(Ednrb) or its natural ligand endothelin 3 (Edn3) result in 
aganglionosis of terminal gut in homozygous mutants 
(Baynash et al., 1994; Hosoda et al., 1994), as do heterozygous 
mutations in the Sry-related transcription factor gene SoxlO 
(Herbarth et al., 1998; Southard-Smith et al., 1998). 
Homozygous SoxlO mutant animals show a more severe 
phenotype with aganglionosis of the whole gut (Herbarth et al., 
1998; Southard-Smith et al., 1998). Additionally, mutations in 
all these genes affect body pigmentation (Lane and Liu, 1984; 
Mayer, 1965; Mayer and Maltby, 1964), but only SoxlO 
mutations result in widespread peripheral nervous system 
defects (Herbarth et al., 1998; Kapur, 1999; Southard-Smith et 
al., 1998).
The Sox gene family encodes a large family of transcription 
factors, with vertebrates likely to have more than 20 Sox genes 
each (Wegner, 1999). Their precise roles are not well 
understood, although many are presumed to function in cell 
fate specification (Pevny and Lovell-Badge, 1997). For 
example, the founding family member, Sry, is likely to be 
responsible for Sertoli cell specification, and thus male sex
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determination, in mammals. While SoxlO is clearly an 
important transcriptional regulator in neural crest cell (NCC) 
development, the cellular basis of the SoxlO mutant phenotype 
remains unclear. It has been suggested that peripheral nervous 
I system and pigmentation defects result from loss of NCCs 
I (Southard-Smith et al., 1998; Kapur 1999), although the 
developmental status of these cells at the time of loss is 
unknown. Furthermore, roles in defining regional identity in 
the cranial neural crest and in glial cell differentiation have also 
been proposed (Bondurand et al., 1998; Herbarth et al., 1998; 
Kuhlbrodt et al., 1998a; Pusch et al., 1998; Southard-Smith et 
al., 1998; Britsch et al., 2001).
j  Mutations at the colourless (els) locus have been identified 
in zebrafish mutagenesis screens (Kelsh et al., 1996; Malicki 
et al., 1996). We have previously characterised the crest 
derivative defect displayed by els mutants (Kelsh et al., 2000a; 
Kelsh and Eisen, 2000), noting extensive loss of pigment cells 
and enteric nervous system, together with large reductions in 
sensory and sympathetic neurones and putative satellite glia 
and Schwann cells. By contrast, we found little effect on 
j ectomesenchymal derivatives, craniofacial skeleton and fin 
.mesenchyme. Based on the severity and details of the 
phenotype, we proposed that els functions in specification, 
proliferation or survival of a progenitors) for all non- 
ectomesenchymal crest derivatives.
The els phenotype, and the cell-autonomy of els gene action 
in pigment cell types (Kelsh and Eisen, 2000), suggested sox 10 
as a candidate gene. We provide an experimental test of this 
hypothesis. We report the mapping of the els locus and cloning 
of a zebrafish sox 10 homologue. We show linkage between els 
and soxlO, identify sox 10 lesions in four mutant alleles and show 
(rescue of the els phenotype by sox 10 expression. In addition, we 
describe iontophoretic labelling experiments to examine the 
precise cell-biological role of cls/soxlO gene function in neural 
I crest development. We show in live embryos that NCC clones in 
j els and wild-type embryos differentiated into ectomesenchymal 
I fates after migration to appropriate sites. Remaining NCC clones 
I adopted non-ectomesenchymal fates in wild-type embryos. By 
■ contrast, in els embryos differentiation to non-ectomesenchymal 
fates was rarely observed. Instead, most clones failed to migrate 
and underwent late cell death by an apoptotic mechanism.
; Finally, for the melanophore fate, we show disrupted expression 
in els mutants of genes vital for melanophore specification and 
migration. Together, these data demonstrate a complex phenotype 
in els embryos that can be explained by proposing that cls/soxlO 
has a primary role in specification of non-ectomesenchymal fates, 
j Defects in cell migration, survival and differentiation are 
therefore likely to be secondary consequences of an inability of 
these cells to adopt specific fates.
MATERIALS AND METHODS 
I Fish husbandry
j  Embryos were obtained through natural crosses and staged according 
I to Kimmel et al. (Kimmel et al., 1995). We used 4 els alleles (m618, 
j t3, tw2 and twll).
Mapping of els
| els'w11 heterozygous fish (Tubingen background), were crossed to 
wild-type strain WIK11 to produce a reference mapping cross.
Heterozygous Fi were incrossed and separate pools of F2 homozygous 
els fish and their wild-type siblings were used for simple sequence 
length polymorphism analysis (Knapik et al., 1996). Linkages from 
the pools were confirmed and refined by genotyping individual 
embryos, as described by Rauch et al. (Rauch et al., 1997).
Isolation, sequencing, phylogenetic analysis and radiation 
hybrid mapping of zebrafish soxlO
RT-PCR was performed using total RNA of 19 hpf stage wild-type 
embryos using published conditions and degenerate primers (Yuan et 
al., 1995). Sequencing of resulting clones identified a soxlO-like 
sequence. The soxlO clone was extended by RACE PCR using gene- 
specific primers (Clontech, SMART RACE kit) and sequenced on an 
ABI DNA sequencer. All primer sequences available on request. The 
full soxlO cDNA sequence is available in Genbank (Accession 
Number AF402677. The zebrafish soxlO homologue was mapped on 
the radiation hybrid panel LN54 (Hukriede et al., 1999) by PCR with 
primers 5'-ACCGTGACACACTCTACCAAGATGACC-3' and 5'- 
CATGATAAAATTTGCACCCTGAAAAGG-3', which generate a 
931 bp 3 'UTR fragment.
For phylogenetic analysis sequences were extracted from Genbank 
and coding sequences automatically extracted using Genetrans (within 
GCG9). These were translated and then aligned using ClustalX 
(Thompson et al., 1997). The nucleotide alignments were 
reconstructed from the protein alignments using MRTRANS 
(www.hgmp.mrc.ac.uk/Registered/Option/mrtrans.html). Tree-Puzzle 
(v 4.0.2) was used to construct an unrooted tree by maximum 
likelihood (Strimmer and von Haeseler, 1996). It automatically 
assigns estimations of support to each internal branch, figures for 
which are presented in the figure. To model the substitution process 
the Tamura and Nei (Tamura and Nei, 1993) model was employed and 
all sites were used. Gamma distributed variation in rates of evolution 
was permitted with eight variable sites and one invariable. Parameters 
were estimated using quartet sampling and the neighbour-joining tree.
Characterisation of mutant soxlO alleles
Total RNA from 27 hpf homozygous embryos of mutant alleles 
clsm6i8, d st* ’2  an(j cist*u was prepared using TRI reagent (Sigma). 
First strand cDNA was generated using random hexamers and 
Superscriptll RT (GibcoBRL). For each allele four overlapping RT- 
PCR fragments were sequenced to identify mutant lesions. For t3, 
genomic DNA was extracted from individual clst3 mutant embryos, a 
genomic fragment encoding the N-terminal of the SoxlO protein was 
amplified by PCR and sequenced commercially (Oswell, 
Southampton). The t3 insertion sequence is available in Genbank 
(Accession Number, AF404490).
Ectopic expression in zebrafish embryos
The full coding region of clsm618 was amplified by RT-PCR using 
primers CM-S21 (5'-CC ATCGATACCTACCG AAGTCACCTGT- 
GG-3') and S27-Xbal (5'-GCTCTAGAGTTTGTGTCGATTGTGG- 
TGC-3')- The 1615bp fragment was subcloned into the Clal/Xbal site 
of the heatshock vector pCSHSP (Halloran et al., 2000) to generate 
hs>soxlO(L142Q). The wild type sox 10 construct, hs>soxl0, was 
generated by site-directed mutagenesis of hs>soxlO(L142Q) using 
QuikChange Site Directed Mutagenesis Kit (Stratagene). Sequencing 
confirmed the successful generation of both clones. DNA purified for 
injection using Microcon Filter Devices (Millipore) was diluted to a 
concentration of 25 ng/fil, with 0.1% Phenol Red. clsm618 or their 
wild-type siblings were injected with 2 nl of either hs>sox/0 or 
hs>soxlO(L142Q) at the one- to two-cell stage and incubated at 
28.5°C. As appropriate, embryos were heatshocked twice (at 10-13 
hpf and 22-24 hpf), by incubation at 37°C for 1 hour, els embryos 
were scored for rescue at 48 hpf using a MZ12 dissecting microscope 
(Leica). Rescue was defined as the presence of at least one 
melanophore of wild-type morphology; these are never seen in 
uninjected mutant embryos.
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lontophoretic labelling and clonal analysis of single neural 
crest cells
lontophoretic labelling of individual neural crest cells was performed 
using essentially the method of Raible et al. (Raible et al., 1992), 
except that micropipette tips were filled with 3% lysinated rhodamine 
dextran and 3% biotinylated dextran (both lOxlO3 Mr\ Molecular 
Probes) mixture dissolved in 0.2 M KC1 and the needles backfilled 
with 0.2 M KC1. Embryos from heterozygotes for els alleles t3, tw2 
and tw ll were used; no phenotypic differences between these alleles 
were seen, so we do not distinguish them here. Individual NCCs were 
labelled by intracellular injection with dye. Premigratory cranial crest 
cells, between the posterior eye and the anterior boundary of somite 
1, were labelled in 4-14 somite (11-16 hours post fertilisation, hpf) 
embryos, while premigratory trunk NCCs at the level of somite 7 were 
labelled in 16-22 somite (18-20 hpf) embryos. Premigratory trunk 
NCCs at the level of somite 14 were labelled in 22-25 somite (20-22 
hpf) embryos. Embryos were recovered and raised for several hours 
at 28.5°C in embryo medium with 1% v/v penicillin/streptomycin 
solution (Gibco). Embryos were remounted and examined to identify 
those with only a single labelled NCC; only these embryos were 
analysed.
Labelled cells were monitored using Nomarski and fluorescence 
optics on a BX50WI microscope (Olympus), and documented on a 
Eclipse E800 microscope (Nikon) using low light level, video­
enhanced fluorescence microscopy. Labelled cells were monitored 
twice daily for up to 3 days until progeny could be identified using 
published morphological criteria (Raible and Eisen, 1994; Raible 
et al., 1992; Schilling and Kimmel, 1994). Thus, melanophores 
contained melanin granules; xanthophores were visibly yellow and 
autofluoresced at a wavelength near that of fluorescein; iridophores 
contained iridescent granules; dorsal root ganglial neurones were 
identified by position ventrolateral to the neural tube combined with 
a visible neurite; sympathetic neurones were positioned ventral and 
lateral to the notochord and showed neurites; Schwann cells were 
elongated and positioned along axonal processes, e.g. trigeminal 
nerve; satellite glia were associated with the ganglionic sheath or 
appeared to be wrapped around neuronal stomata; craniofacial 
cartilage formed characteristic stacks of vacuolated cells in the jaw or 
gill arches; fin mesenchyme occupied a position within the dorsal fin 
fold and showed characteristic asymmetric organisation of projections 
(Smith et al., 1994). Cells which could not be assigned to any of the 
described groups, owing to their position in regions of limited optical 
resolution or lack of distinctive morphologies, were classified as 
‘unidentified’. In cranial regions, these cells undoubtedly included 
cells of connective tissue fates (Schilling and Kimmel, 1994).
TUNEL
TUNEL (terminal deoxynucleotidyl transferase (TdT)-mediated 
deoxyuridinetriphosphate (dUTP) nick end-labelling) of double­
strand DNA fragmentation was used to confirm apoptosis in cells with 
apoptotic morphology. clst3 and their wild-type siblings were fixed 
overnight at 4°C in 4% paraformaldehyde and TUNEL performed 
using fluorescein dUTP and developed using 4-Nitroblue tetrazolium 
chloride and 5-Bromo-4-chloro-3-indolyl-phosphate (Boehringer 
Mannheim; Reyes, 1999).
Morpholino injections
AB wild-type embryos at 25, 30 and 35 hpf were injected with either 
a high (16.5 ng) or low (9 ng) dose of a morpholino designed to knock­
down sox 10, as described previously (Dutton et al., 2001). Effects on 
nadmitf expression in melanoblasts at 25 hpf were evaluated by 
counting nac/mitf-expressing cells in one half of the trunk in each of 
20 embryos at each dose.
Whole-mount in situ hybridisation and antibody staining
RNA in situ hybridisation was performed as described by Kelsh and 
Eisen (Kelsh and Eisen, 2000), on clsm618, elstwI1 and els'3, their wild-
type siblings and morphants. Probes for the following genes were 
used: nac/mitf (Lister et al., 1999), spa/kit (Parichy et al., 1999); 
dopachmme tautomerase (dct) (Kelsh et al., 2000b); dlx2 (Akimenko 
et al., 1994); forkhead 6 (fkd6) (Odenthal and Nuesslein-Volhard,
1998).
Antibody staining with anti-Hu, mAb 16A11 (Marusich et al., 1994), 
was performed using peroxidase-antiperoxidase (VECTASTAIN® 
Elite ABC kit) and DAB substrate.
RESULTS 
c/s and a zebrafish soxlO homologue map to the 
same region of Linkage Group 3
The strong phenotypic similarity between soxl0Dom mice and 
els mutants suggested a zebrafish sox 10 homologue as a 
candidate gene for els. We used RT-PCR to clone a partial 
soxl 0-like HMG box and RACE RT-PCR to clone 5' and 3' 
regions. Sequencing these clones revealed an open reading 
frame encoding a sox 10 homologue, which we refer to as sox 10 
(Fig. 1A,B).
Genetic mapping of 274 meioses placed els on LG 3 within 
a 3.9 cM interval between markers z872 and zl3387 (Fig. 1C). 
Two oligonucleotide primers amplified a 931 bp fragment 
from zebrafish, but not from control mouse genomic DNA. 
Amplification from the DNAs in the LN54 radiation hybrid 
mapping panel (Hukriede et al., 1999) with these primers 
mapped sox 10 to LG 3, OcR from the marker z8492 (LOD 
score=17.6; Fig. 1C). The striking linkage of els and soxlO, 
together with in situ hybridisation experiments showing sox 10 
expression in neural crest (see below), strongly supported our 
hypothesis that els might encode sox 10.
soxlO is disrupted in els mutants
We used RT-PCR to amplify the so x l0-coding region from 27 
hpf homozygous mutants of 3 els alleles. Sequencing these 
PCR products identified sequence differences from wild-type 
consistent with them causing the mutant phenotype (Fig. 
1D,E). Two alleles show an A—»T transversion, resulting in 
a premature Stop codon; the third is a non-conservative 
substitution (L142Q) of a fully-conserved residue in the HMG 
domain. A fourth allele, t3, showed highly reduced RNA 
expression using a 3' probe for whole-mount RNA in situ 
hybridisation. PCR from genomic DNA identified a 1.5 kb 
insertion in all t3 mutants that was not present in wild types. 
Sequencing genomic DNA from t3 homozygotes identified a 
1397 bp insertion with sequence homology to a transposon 
first identified in a mutant no tail allele (data not shown; 
Schulte-Merker et al., 1994). The insertion interrupts the 
soxl 0-coding sequence upstream of the HMG domain and 
adds eight novel amino acids before prematurely truncating 
the protein (Fig. ID).
To test further whether els encodes soxlO, we attempted to 
rescue the els phenotype with ectopic sox 10 expression under 
heat shock control. We took advantage of the consistent 
absence of large, stellate melanophores in every els embryo. 
Ectopic expression of wild-type sox 10 rescued 1-40 
melanophores to a wild-type morphology in 48% of clsm618 
mutants, while ectopic mutant soxlO(L142Q) failed to do so 
(Table 1; Fig. 2). Furthermore, while els melanophores always 
remain dorsal to the neural tube, rescued melanophores 
frequently migrated, even to very distal positions (Fig. 2).
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Zebrafish soxlO  mutant 4117
Fig. 1. A zebrafish sox 10 homologue maps to the region of the els 
locus. (A) Sequence comparison o f predicted zebrafish SoxlO 
homologue (44,45 and 60% identity to mouse Sox8, Sox9 and 
SoxlO, respectively). Blocks o f identity corresponding to all 
proposed functional domains can be seen, including the HMG 
domain (red underline; 95% amino acid identity), N-terminal 
synergy domain (1-105; 48% identity), dimerisation domain (66-105; 
78% identity), C-terminal transcriptional activation domain (395- 
485; 76% identity) and a domain C-terminal to the HMG domain 
corresponding to a putative protein-protein interaction domain (234- 
325; 64% identity; Bondurand et al., 2000; Kuhlbrodt et al., 1998a; 
Kuhlbrodt et al., 1998b; Liu et al., 1999; Peirano and Wegner, 2000).
(B) Maximum likelihood phylogenetic tree of subgroup E Sox genes. 
Zebrafish soxlO clusters within the SoxlO clade of vertebrate Sox 
genes. The Accession Numbers for the sequences are as follows: 
chicken Sox8 (AF228664); trout SoxPl (D83256); mouse Sox8 
(AF191325); human SOX8 (AF226675); frog Sox9a (AB035887); 
alligator Sox9 (AF 106572); trout Sox9 (AB006448); zebrafish sox9a 
(AF277096); zebrafish sox9b (AF277097); chicken Sox9 
(AB012236); pig Sox9 (AF029696); human SOX9 (Z46629); 
zebrafish soxlO (AF402677); chicken SoxlO (AF 152356); mouse 
SoxlO (AF047389); rat SoxlO (AJ001029); human SOXIO 
(NM_006941). (C) Mapping using the LN54 panel placed sox 10 on 
LG 3 in the region of the els locus identified using microsatellite 
markers (we found four recombinants between els and z 13387 in 274 
meioses). Note that z8492 was not polymorphic and could not be 
analysed in the mapping cross. (D) Schematic to illustrate changes in 
SoxlO mutant proteins. In clsm618 a T425A substitution results in a 
non-conservative change (Leul42Gln) within the HMG domain 
(red). In clstw2 and elstwl/, a A l 126T substitution introduced a Stop 
codon truncating the protein just N-terminal to the transactivation 
domain (blue). Insertion o f a 1.4 kb transposon at the site indicated 
by the arrow in A disrupts soxlO in els13 and introduces a C-terminal 
extension o f eight novel amino acids before premature truncation N- 
terminal to the HMG domain (yellow). (E) Chromatogram traces to 
show nucleotide changes affecting soxlO-coding regions in clsm618 
and clstw2.
s o x  10 expression is disrupted in e ls  mutants
We used in situ hybridisation to examine sox 10 expression in 
wild-type and els embryos. In w ild types, expression was first 
detected at the one-som ite stage in cells in the lateral neural 
plate (data not shown). Throughout som itogenesis stages, 
strong sox 10 expression was seen in premigratory N CC s and 
extended progressively more caudally in older stages (Fig. 3A- 
C,F). Double RNA in situ hybridisation studies show that there 
is extensive, but incom plete, overlap o f  sox 10 and Jkd6, a 
marker expressed w idely in premigratory NCCs (Fig. 3 0 ,P) 
(Odenthal and Nuesslein-Volhard, 1998). sox 10 expression  
was maintained in som e migrating NCCs on the medial 
migration pathway (Fig. 3C,F). By 30-40 hpf soxlO expression
Table 1. Rescue of els phenotype using ectopic soxlO 
expression
Construct
Mean number o f
Heat Injected els Rescued cls~ melanophores per
shock that survived (% rescued) rescued embryo
hs>soxl0  + 92 44 (48)
hs>soxl0 -  48 17 (35)1*




*A similar degree o f  leakiness with this promoter has been reported by 
Lister et al. (Lister et al., 1999); note that the degree o f rescue is much less in 
the absence o f heat shock.
on the medial pathway is organised in segmentally arranged 
clusters adjacent to the notochord, presumably developing  
Schwann cells associated with the segmental nerves (Fig. 3Q); 
soxlO expression is lost from this site by 48 hpf. Although  
N CC s are found extensively on the lateral pathway from 24 hpf 
(Raible et al., 1992), counts o f  sax70-expressing cells show  
that expression was essentially absent from cells on this 
pathway (Fig. 3M ,N). This demonstrates the rapid 
downregulation o f  sox 10 from pigm ent cell precursors, as 
N CC s on this pathway form only pigment cells (Raible and 
Eisen, 1994). Consistent with this, xanthophores and most 
pigm ented melanophores show no detectable sox 10 expression  
(Fig. 3L), although som e weakly expressing melanophores 
were noted at earlier stages (Fig. 3K). Expression was not seen  
in fin m esenchym e nor in dlx2-expressing craniofacial cartilage 
precursors (Fig. 3D,E), although differentiating jaw cartilage 
show s weak expression by 60 hpf (data not shown). C ells 
expressing sox 10 accumulated in clusters corresponding to the 
forming cranial ganglia and extending along the posterior 
lateral line nerve by 24 hpf (Fig. 3F,H), in a pattern reminiscent 
o f  Jkd6 expression (Kelsh et al., 2000a), suggesting that sox 10 
is expressed in satellite glial and Schwann cells. Consistent 
with this interpretation, double labelling with anti-Hu antibody 
confirmed the non-overlapping expression o f  sox 10 and this 
neuronal marker (Fig. 3J). soxlO is maintained in developing  
Schwann cells on the posterior lateral line nerve up to 60 hpf 
(data not shown). soxlO expression was prominent in enteric 
nervous system  precursors at 60 hpf (Fig. 3S).
At early stages, premigratory crest showed equivalent 
patterns o f  soxl 0-positive cells in w ild-type and els1"’11 and 
clsm618 mutant embryos. Counts at 24, 30 and 35 hpf revealed 
that although in w ild type soxl  ^ -expressing cells were rapidly 
lost from the premigratory position, they remained here in 
elsm6,8 mutants; by contrast, sox 10 expression in migrating 
trunk NCC was broadly comparable between wild type and 
elsm6,8 mutants (Fig. 3M ,N). Additionally, els mutants were
Fig. 2. els phenotype is rescued by ectopic 
soxlO expression. Wild-type embryos show 
many large, strongly pigmented 
melanophores at 48 hpf (A; close-up o f anal 
region in D), while hs>sox!0(L142Q)- 
injected clsm618 mutants (B) show only tiny 
melanised spots in position o f premigratory 
NCCs (arrowheads). (C,E,F) By contrast, 
elsm618 embryos injected with hs>sax/0  and 
heat-shocked, show mosaic rescue of melanophores. This embryo showed one rescued melanophore in the dorsal stripe (* in C), two in the 
ventral stripe (arrows in C; close-up in E) and one on the yolk sac (F). Scale bar: 125 pm in A-C; 70 pm in D-F.
*
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Fig. 3. Embryonic soxlO expression in 
wild-type and els embryos.
(A,B) soxlO is expressed in most 
cranial (A; five-somite stage) and trunk 
(B; 14-somite stage) premigratory 
NCCs; double mRNA in situ 
hybridisation with Jkd6 (O, purple) and 
soxlO (P, green) in a six-somite stage 
embryo reveals extensive overlap, 
although some individual NCCs lack 
soxlO (arrowheads). (C) 18-somite 
stage embryo shows strong expression 
in premigratory (black arrow) and 
migrating (asterisk) NCCs and otic 
vesicle (o). (D,E) Double mRNA in 
situ hybridisation with dlx2 (D, purple) 
and sox 10 (E, green) in 29 hpf stage 
embryos shows absence o f sox 10 
expression in developing branchial 
arches (1 -5). (F) By 24 hpf in wild 
types, strong expression is associated 
with cranial ganglia (white 
arrowheads) and posterior lateral line 
nerve (black arrowhead; enlarged in 
inset), otic vesicle (o), migrating NCCs 
throughout trunk (asterisks) and in 
premigratory crest (arrow). (G) At 24 
hpf in els mutants, expression in the 
head is clustered (white asterisks) and 
cranial ganglia have reduced labelling 
(white arrowheads). Cells expressing 
sox 10 extend along the posterior lateral 
line nerve (arrowhead and inset).
Rostral trunk shows some migrating 
cells (black asterisk), but soxlO- 
positive cells are clustered dorsal to the 
neural tube (arrows) in trunk and tail.
(H,I) Combined soxlO in situ 
hybridisation (purple) and anti-Hu 
antibody labelling (orange) shows 
strong soxlO expression associated 
with wild-type (H) posterior lateral line 
ganglion (g), much reduced in els 
mutant (I). (J) In transverse section o f
wild-type ganglion (approximate pre mp LP pre w> LP
position indicated by white line in H), 
sox 10 expression is strong peripherally (non-neuronal cells), but absent centrally (neurones). (K,L) 36 hpf wild-type embryos show weak 
expression in some melanophores, but not all. Thus, weak expression (arrowhead) is seen in some cells of the dorsal stripe (K), but not in cells 
on the yolk sac (L). (M,N) Number of soxlO-expressing NCCs in different locations (premigratory, pre; migrating on medial pathway, MP; 
migrating on lateral pathway, LP) o f trunk and anterior tail (somites 1-20) at 24 (M) and 30 hpf (N) in WT and els mutants. (Q,R) Segmentally 
arranged lines o f soxl0-positive cells lying adjacent to the notochord (no), presumably glia, are abundant in wild type (Q) and only weakly 
affected in els mutants (R) at 40 hpf. (S,T) Transverse section o f trunk of 60 hpf wild-type embryo (S) shows enteric nervous system expression 
(arrowheads) lateral to the gut (g), absent in els mutant (T). e, eye; m, muscle; s, somite; vs, ventral stripe melanophores. All images are lateral 
views, rostral towards the left, dorsal upwards, except dorsal views of A,K,0,P. Scale bar; 200 pm in A; 50 pm in B,H-I,K-L; 120 pm in C;
75 pm in D,E; 150 pm in F,G; 35 pm in J; 65 pm in 0,P; 55 pm in Q,R; 45 pm in S,T.
distinguishable from 24 hpf by the clustered, not scattered, 
distribution of sox 70-positive cells in the head (Fig. 3F,G) and 
a variable reduction in the number of soxl0-positive cells in 
cranial ganglia and on cranial nerves (Fig. 3H,I). By 35 hpf, 
els mutants were readily distinguished from wild types by their 
reduced number o f soxl0-positive cells, concentrated in a 
premigratory position dorsal to the neural tube or clustered 
near the posterior lateral line ganglia; putative Schwann cells 
[were missing from the posterior lateral line nerve, els mutants
showed reduced expression in the putative Schwann cells 
found as segmental clusters of soxl 0-positive cells (Fig. 3Q,R). 
Enteric nervous system precursors were absent at 60 hpf (Fig. 
3T) in els mutants.
In contrast to the other mutant alleles examined, clst3 
mutants consistently show highly reduced sox 10 transcripts 
when examined using the 3' soxlO probe at all stages. When 
examined using a probe lying 5' to the insertion site, soxlO 
expression levels were comparable with those in other mutant
Zebrafish soxlO mutant 4119  
Table 2. Fates of single neural crest cells injected with lineage tracer
Trunk (somite 14) Cranial"
Fate*
Wild type colourless Wild type colourless























































*A11 progeny within a single clone adopted the same fate in every case, as shown previously (Schilling and K.immel, 1994).
♦Only single injected cells that survived and were identified as NCCs in the afternoon on the day of labelling are included. The numbers represent the number 
of clones whose cells adopted the indicated fates, using the criteria outlined in the Materials and Methods.
$A11 xanthophores identified in els embryos subsequently died; hence in total, 23 (92%) and 22 (66%) cells died in the somite 14 and cranial samples.
^Mixed neural fates include clones with both neuronal and glial derivatives.
alleles, suggesting that insertion of the transposon does not 
disrupt transcription of 5' sequences (data not shown).
Outside neural crest, sox 10 expression was particularly 
strong in otic placode and otic vesicle, and from 11-somite 
stage onwards (Fig. 3C,F,H), was detected in pectoral fin and 
in some spinal cord cells from 36 hpf. Expression in the ear 
was significantly weaker in els mutants by 40 hpf (data not 
shown).
els non-ectomesenchymal neural crest cells die 
prior to differentiation
Previous characterisation of els embryos catalogued a strong 
reduction in non-ectomesenchymal neural crest derivatives 
(Kelsh and Eisen, 2000). To analyse the cell biological basis 
for loss of these neural crest derivatives, we used iontophoretic 
labelling of single NCCs. We labelled premigratory NCCs in 
els mutants and their wild-type siblings in two regions that 
generate ectomesenchymal fates, and scored them for the 
fate(s) adopted by their progeny (Table 2). In wild-type 
embryos, almost all (148/160; 93%) labelled cells survived 
throughout the experiment, and all major derivatives, both 
ectomesenchymal and non-ectomesenchymal, were identified 
among the clones. Consistent with our previous analyses, 
labelled cells generated a similar proportion of 
ectomesenchymal fates in els mutants (4/58; 7%) and wild-type 
siblings (11/160; 7%). Furthermore, even in els mutants, cells 
in these clones migrated and differentiated normally. In wild- 
type embryos, most cells where fates were identifiable 
(111/122; 91%) differentiated into recognisable non-
ectomesenchymal derivatives. By contrast, most identifiable
clones in els embryos (45/49; 92%) died late on the second day 
(~35-45 hpf). Most showed no sign of morphological 
differentiation or pigmentation (34/49; 69%). The only 
exception, clones that developed some xanthophore 
pigmentation (11/49; 22%), always had abnormal morphology, 
being rather rounded and blebbed, and died soon after 
differentiation (Fig. 4N). A series of single cell injections in 
NCCs at the axial level of somite 7 gave similar results, with 
92% of els cells dying by around 48 hpf, in contrast to only 
2% in wild-type siblings (data not shown); note that at this 
axial position no ectomesenchymal fates have been reported 
(Raible and Eisen, 1994). Our results are consistent with the 
severe reduction in differentiated non-ectomesenchymal fates 
in els embryos and suggest that extensive NCC death is 
associated with the els phenotype.
Non-ectomesenchymal crest derivatives die by 
apoptosis during a discrete time-window
The morphological appearance of dying cells in our clonal 
analyses suggested an apoptotic mechanism of death. We 
combined TUNEL with biotin-detection of the labelled clone 
in each of five els embryos and showed that the dying cells had 
fragmented DNA (Fig. 4A-C). We conclude that many non- 
ectomesenchymal clones in els embryos die by an apoptotic 
mechanism.
Analysis o f cell survival in our cranial NCC data set shows 
that death o f labelled NCCs occurs within a relatively discrete 
time-window (Fig. 4L). In both els and wild-type embryos, 
around 10% of labelled clones had died by the morning after 
injection. In wild-type embryos, the number of surviving
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Fig. 4. MCC death in els embryos.
(A-C) NCC clones die by an apoptotic 
mechanism in els embryos. Lateral 
views of 40 hpf els embryo in which 
two daughters of a single labelled 
[NCC contributed to the posterior 
lateral line ganglion, lying just 
posterior to the otic vesicle (o). In the 
jive embryo, both cells show blebbed 
morphology typical of apoptotic cells 
when viewed with Nomarski optics 
(A). After fixation and processing for 
TUNEL (B) and detection o f the 
biotinylated-dextran lineage-tracer
(C), visible TUNEL signal o f these H I * J  K
clonal cells indicates DNA 
fragmentation characteristic of 
apoptotic cells. (D-K) Whole-mount 
TUNEL shows NCC apoptosis in els 
embryos. Lateral views o f dorsal BMI
spinal cord (sc) in tail of 30 (D,H), 35 ion M . * N ClS
(E,I), 40 (F,J) and 45 (G,K) hpf 
embryos show apoptotic NCCs
immediately dorsal to the spinal cord « ■ ■  m  ■  ■  ■  gwi
from 35 hpf in els (arrowheads, D-G), ■ ■  ■  ■  bcis
but not wild-type (H-K), embryos.
Scattered TUNEL-positive cells are 
prominent in dorsal spinal cord (*) of 
Ids embryos (E-G); these are 
occasionally seen in wild-type 
siblings at these stages (data not 
shown), df, dorsal fin. (L) Time-
course o f labelled single cranial NCC clone survival in els mutants and their wild-type siblings. Percentage o f surviving clones is given at each 
of the five standard time points when embryos were examined. The time points correspond to approximately 16, 32,40, 56 and 64 hpf, 
respectively. The first time point includes only single labelled NCCs based on examination within a few hours after labelling. See text for 
further details. (M,N) Wild-type xanthophores (arrows) at 48 hpf have a very flattened, thin morphology and are only weakly coloured (M), 
while a dying els xanthophore (arrow) shows characteristic apoptotic morphology and concentrated yellow coloration, which was usually 
visible by 35 hpf (N). Scale bar: 100 pm in A-C; 50 pm in D-K; 75 pm in M,N.
clones was essentially unchanged at later times. However, 
in els mutants, the number of surviving clones dropped 
precipitously to only 40% within the period of around 5-10 
hours between the two observational time-points on the second 
day after labelling (equivalent to -40 hpf), but then remained 
constant. We interpret the early (overnight after injection) loss 
of wild-type and els clones as representing death due to 
damage during labelling. The subsequent late loss of clones in 
els embryos corresponds to the time of appearance of apoptotic 
cells and we attribute this to the els phenotype.
To examine the extent to which apoptosis contributes to the 
els phenotype, we used whole-mount TUNEL to examine 
apoptosis of NCCs (Fig. 4D-K). We saw a notable 
concentration of apoptotic cells dorsal or dorsolateral to the 
neural tube in els embryos, but not in wild-type control 
embryos. A timecourse of TUNEL between 20 and 60 hpf 
indicated that cell death in NCCs becomes apparent by 35 hpf 
and continues to approximately 45 hpf.
c/s neural crest cells fail to migrate before 
undergoing apoptosis
Our in vivo clonal studies revealed that, while wild-type NCCs 
migrated extensively on both medial and lateral pathways, 
most els NCCs failed to leave the premigratory crest area. 
Thus, excluding ectomesenchymal derivatives (which always
migrated normally), only 2/31 (6%) of cranial NCCs appeared 
to migrate away from their initial positions. At the level of 
somite 14, all wild-type labelled cells left the premigratory 
area, and more than 75% migrated at least 50 pm from their 
original position. Only fin mesenchyme clones migrated 
normally in els mutants. Of the remaining clones, only 4/23 
(17%) migrated away from the premigratory crest; another cell 
extended towards the horizontal myoseptum, but maintained 
contact with the premigratory area. Of these five cells, two 
migrated on the lateral pathway, but underwent apoptosis after 
moving about half way to the horizontal myoseptum. The other 
three cells migrated on the medial path. In one case, the cell 
did not divide, migrated to a position appropriate for a dorsal 
root ganglion, then died before overt differentiation. The other 
two cells divided once; in each clone, one sister cell remained 
dorsal to the neural tube, and may have been an extramedullary 
cell (Kelsh and Eisen, 2000), while the other migrated to 
a dorsal root ganglial position, but failed to undergo 
axonogenesis, consistent with the impaired touch response of 
5 dpf larvae. We obtained similar results for labelled NCCs 
from the region of somite 7 (data not shown). This direct 
observation o f failed NCC migration in els embryos is 
consistent with our observation of </c/-expressing melanoblasts 
and sox I (/-expressing NCCs concentrated dorsal to the neural 
tube in mutant embryos (Kelsh et al., 2000b) (this work).
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els mutants and soxlO morphants fail to express 
genes critical for melanophore specification and 
migration
els mutants combine an extensive failure of NCC migration 
with late apoptotic death of non-ectomesenchymal derivatives. 
Three recent studies suggested a possible molecular genetic 
mechanism for these aspects of the phenotype, sparse (spa), a 
kit homologue, is crucial for survival and migration of 
melanophores and melanoblasts (Parichy et al., 1999; Kelsh et 
al., 2000b) and nacre (nac), a microphthalmia transcription 
factor (mitf) homologue, is crucial for melanophore 
specification and required for spa expression (Lister et al., 
1999). We used in situ hybridisation at 20-35 hpf to ask 
whether spa or nac expression was disrupted in els embryos 
(Fig. 5). We found that both spa and nac expression were 
absent from NCCs, even at a time when many dc/-positive cells 
are present, suggesting that the els melanophore phenotype 
might result from loss of nac expression. By contrast, spa 
expression in intermediate cell mass and nac expression in the 
pigmented retinal epithelium are unaffected in els mutants.
We have recently shown that injection of soxlO morpholino 
oligonucleotides phenocopies the els mutant phenotype 
(Dutton et al., 2001). The morphant phenotype varies 
depending upon the amount of morpholino injected, with high 
doses phenocopying all aspects of the phenotype of the strong 
els alleles. Injection o f lower doses results in a phenocopy of 
the weak els allele phenotype, with embryos showing some 
melanophores, concentrated in dorsal positions (Dutton et al., 
2001; Malicki et al., 1996). The number of nac/mitf-expressing 
cells in embryos injected with a low dose of sox 10 morpholino 
(median number=78; n=20) is significantly higher than in 
embryos injected with a high dose (median number=20; w=20; 
Mann-Whitney U-test, P<0.05; Fig. 5C,D), consistent with the 
differences in melanophore phenotype.
DISCUSSION
Studies in mice have led to identification of SoxlO as a key 
gene in human Waardenburg-Shah syndrome. We have shown 
that the zebrafish els locus is a sox 10 homologue predicted to 
encode a protein with all the major domains identified in 
mammals (Fig. 1). We have identified the molecular lesion 
likely to cause the mutant phenotype in 4 els alleles. In two 
cases, tw2 and tw ll ,  both originating from the same 
mutagenised male (Haffter et al., 1996; Kelsh et al., 1996), the 
lesions are identical and are presumably independent isolations 
of the same allele. The zebrafish Lys376Stop lesions resemble 
the human 059 allele (delGA) in lacking the transactivation 
domain, although they lack the C-terminal extension present in 
the human allele. In transient transfection assays human 059 
mutant protein has been shown to have no transcriptional 
activation (Bondurand et al., 2000; Kuhlbrodt et al., 1998b; Liu 
et al., 1999). The m618 allele substitutes Leu 142 in the second 
alpha helix of the HMG domain and there is no similar 
mammalian mutation. The t3 allele results in a severely 
truncated protein that lacks both the DNA-binding and 
transcriptional activation domains. It is thus reminiscent of the 
human Y83X allele which has been proposed to be a functional 
null (Kuhlbrodt et al., 1998b; Potterf et al., 2000). All four 
mutant alleles described here show similar, strong phenotypes
A B
Fig. 5. els mutants lack nac and spa expression. Lateral views of 
caudal trunk o f 25 hpf wild-type and els embryos after in situ 
hybridisation with nac (A,B), spa (E,F) and dct (G,H) probes. 
(C,D) nac/mitf expression is decreased weakly (C) or strongly (D) 
after injection with either a low or high dose, respectively, o f soxlO 
morpholino. n, neural tube; y, yolk sac. Scale bar: 75 pm.
(Kelsh et al., 1996; Malicki et al., 1996) (data not shown). 
These considerations, combined with the similarity of these 
phenotypes with the maximal morphant phenocopy generated 
with a sox 10 morpholino, lead us to suggest that these alleles 
are all likely null alleles. Analysis of the activities of these 
mutant proteins will be interesting to test this proposal.
Zebrafish sox 10 expression is consistent with cell types 
affected in els mutants and strongly reminiscent of that in 
mammals. We have taken advantage of the higher resolution of 
such studies in zebrafish, to define more precisely the extent of 
sox 10 expression throughout the neural crest at different stages. 
In wild type, expression is extensive in premigratory neural 
crest, but comparison with fkd6 expression shows that a 
minority of premigratory NCCs lack soxlO expression. 
Expression persists in some migrating cells on the medial 
migration pathway, but is rapidly downregulated in 
differentiating pigment cells. Glia of the developing peripheral 
nervous system show strong expression, as has also been 
described in mice (Kuhlbrodt et al., 1998a; Britsch et al., 
2001). Crest cells in forming branchial arches and fin 
mesenchyme do not show expression, in agreement with 
mouse, but not human, expression studies (Bondurand et al., 
1998; Kuhlbrodt et al., 1998a; Southard-Smith et al., 1998). 
Late expression in cranial cartilages is intriguing, but will 
require further study to evaluate its role. In els mutants, sox 10- 
expression in premigratory NCCs is initially unaffected but, 
unlike in wild-type siblings, soxlO-expressing cells soon 
accumulate in this position. In the trunk sox 10-expressing cells 
migrating on the medial pathway are seen and presumably 
contribute to the neurones and glia of the dorsal root ganglia, 
which are detectable in mutants (Kelsh and Eisen, 2000) (this
4122 K. A. Dutton and others
study). NCCs tend to become clustered in premigratory 
positions in els mutants, consistent with the observed defect in 
NCC migration revealed by our single-cell labelling studies.
Outside the neural crest, sox 10 expression is also largely 
conserved. Thus, expression in the developing inner ear 
epithelium is seen in zebrafish as well as in mammals 
(Bondurand et al., 1998; Southard-Smith et al., 1998). In 
zebrafish, this expression is remarkably strong and persistent 
in wild type, but is downregulated in els mutants by 40 hpf. As 
pronounced otic defects are morphologically detectable in els 
mutants by 48 hpf (R. N. K., unpublished), we suggest that 
sox 10 is crucial for development of otic epithelium. Limited 
expression in embryonic central nervous system is seen in 
zebrafish and mice (Kuhlbrodt et al., 1998a), although detailed 
studies will be required to establish the cell types involved in 
each case.
Our single cell labelling studies at three rostrocaudal 
positions make clear that defects in els mutants are not limited 
to one axial position, but instead affect non-ectomesenchymal 
rather than ectomesenchymal crest derivatives. Most NCCs 
in els mutants show restricted migration and poor or no 
differentiation before dying by an apoptotic mechanism within 
a discrete time-window. We interpret the dying cells as 
being those that would in wild-type siblings form non- 
ectomesenchymal fates. Thus, in els embryos, NCCs that 
would normally yield these missing neural crest derivatives are 
present in premigratory neural crest in normal numbers, but 
then die before differentiating, usually without migrating. This 
confirms and extends reports that putative NCCs apoptose 
during migration in mouse soxlO mutants (Kapur, 1999; 
Southard-Smith et al., 1998).
The sox 10 expression pattern in els mutants may appear 
contradictory to our single cell label results, as the expression 
studies show normal numbers of soxl 0-positive NCCs 
migrating on the medial pathway, while the single cell labelling 
studies show a strong migration defect in the neural crest. 
However, our data suggest that soxlO is expressed in almost all 
premigratory cells, but is rapidly downregulated in 
ectomesenchymal and pigment cell precursors as they start to 
migrate. Thus, sox 10 expression in migrating cells reflects just 
the neural precursors. Our studies show that these cells are 
much less defective in migration in els mutants. Consistent 
with this, the labelled cells in els mutants that did migrate 
normally all took the medial migration pathway and, if they 
survived, adopted a position consistent with a dorsal root 
ganglial fate. By contrast, most labelled NCC clones generated 
pigment cells, consistent with former studies in zebrafish. 
These pigment cells are severely defective in migration, as 
shown by molecular markers for xanthophore (gdh; Parichy et 
al., 2000) and melanophore (dct.; Fig. 5) cell fates (M. Hawkins 
and R. N. K., unpublished) (Kelsh and Eisen, 2000). Further 
work will be required to investigate the specification status of 
the migrating neural precursors in wild-type and mutant 
embryos.
; We have demonstrated the complexity of NCC defects in els 
embryos, with survival, migration and differentiation of non- 
ectomesenchymal cell types all affected. Further, a small 
decrease in clone size suggests that proliferation may also be 
somewhat affected (K. A. D. and R. N. K., unpublished). This 
spectrum of defects is not readily consistent with a primary 
function for wild-type cls/soxlO in NCC survival, proliferation
or differentiation. Although a dying cell might show abnormal 
migration and proliferation, the timing of appearance of defects 
in els mutants conflicts with cell survival being the primary 
defect. We can first distinguish els mutants at 20 hpf (by lack 
of ncic/mitf expression), but do not see NCC apoptosis by 
TUNEL until around 35 hpf; previous work in zebrafish has 
suggested that the delay between induction of apoptosis and 
detectable morphological changes and DNA fragmentation is 
at most 3-4 hours (Ikegami et al., 1999). Likewise the els 
mutant phenotype cannot be explained as primarily a failure of 
migration, with subsequent failure of exposure to required 
trophic factors, because for three subsets of affected cells (three 
pigment cell types in the stripe dorsal to the neural tube), the 
premigratory position is also a final location and hence the 
necessary trophic factors must be available. Despite this, in els 
mutants all pigment cells, including those of the dorsal stripe, 
fail to develop properly. Instead, we propose that the primary 
role of els gene function is in specification of non- 
ectomesenchymal cell fates; all other defects in els mutants 
would then be secondary effects of a failure to become properly 
specified. Thus, in els mutants NCCs are unable to adopt non- 
ectomesenchymal fates and so fail to differentiate. This 
differentiation process would include expression of growth and 
trophic factor receptors, and hence secondary defects might 
include impaired proliferation and later apoptosis. Our 
identification of the els gene as a sox 10 transcription factor 
gene is consistent with this interpretation.
Indeed, for the specific case of melanophore fate, data 
presented here and elsewhere permit us to propose a molecular 
model consistent with this interpretation (Fig. 6). In both 
zebrafish and mammals, Nac/Mitf homologues have been 
shown to be important transcription factors for specifying 
melanophore fate (Lister et al., 1999; Opdecamp et al., 1997; 
Tachibana et al., 1996). We show here that els mutants lack 
expression of nac (indeed it is the earliest defect we have 
identified). Thus, sox 10 is required for nac expression and thus 
for melanophore lineage specification. In addition, in nac 
mutants, «ac-positive cells show a failure to migrate highly 
reminiscent of the els melanoblast phenotype (Lister et al., 
1999). Likewise, in both els and nac mutants, spa/kit 
expression is lost in melanoblasts. spa function is necessary for 
both melanoblast migration and melanoblast and melanophore 
survival (Kelsh et al., 2000b; Parichy et al., 1999). 
Furthermore, the timing of loss of melanoblasts in spa mutants, 
beginning between 30 and 36 hpf, is consistent with the timing 
of decrease in melanoblast numbers and with the timing of 
NCC apoptosis in els mutants (Kelsh et al., 2000b; this study). 
Hence, a simple model can largely explain the els melanophore 
phenotype. cls/soxlO has a key role, by direct or indirect 
activation of nac/mitf, in melanophore specification and 
consequently els mutants lack expression of genes activated by 
nac, including spa/kit, mediating survival and migration, and 
melanogenic enzymes, mediating pigmentation. In support of 
this model, injection of soxlO mRNA into early embryos 
results in ectopic nac/mitf expression and expression of nac in 
els embryos is sufficient to rescue melanophores (S. E. and R. 
N. K., unpublished). It will be of interest to expand this model 
to include other targets of sox 10 and nac, as well as to extend 
this model to other non-ectomesenchymal neural crest 
derivatives affected in els mutants. Our model predicts that the 
immediate targets of sox 10 will be either master regulators of
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Fig. 6. Model of role o f cls/sox 10 in melanophore specification. 
Formal genetic interactions between selected genes known to 
function in zebrafish melanophore development are schematised. In 
els mutants, failure to activate nac expression (and thus to specify 
melanophore fate) results in absence o f gene products critical for 
melanophore survival, migration and differentiation. For details, see 
main text.
neural crest fate (e.g. nac) or a multitude of diverse gene 
products required within specific crest derivatives for the 
cellular functions of trophic support, migration and 
differentiation. Thus, it will be important to identify the direct 
targets of Sox 10 transcriptional regulation.
This specific model is likely to be applicable to mammalian 
neural crest too. Thus, Sox 10 directly regulates M itf expression 
in mouse (Bondurand et al., 2000; Lee et al., 2000; Potterf et 
al., 2000; Verastegui et al., 2000). Although Dcf-positive 
melanoblasts are not detectable in SoxlODom mice, some 
evidence of impaired or delayed migration of some NCCs has 
been presented (Southard-Smith et al., 1998). Similarly, Kit 
function is critically involved in promoting melanoblast 
migration and survival, is rapidly lost from melanoblasts in 
A////mutants and is known to be a direct target of Mitf, at least 
in cultured mast cells (Opdecamp et al., 1997; Wehrle-Haller 
and Weston, 1995; Wehrle-Haller and Weston, 1997). In Sox 10 
mutant mice, Kit expression in melanoblasts may be absent, 
although the presence of unaffected cells in the skin, suggested 
to be mast cells, means that this result needs to be confirmed 
(Bondurand et al., 2000).
sox 10 alone cannot be sufficient to specify each of the non- 
ectomesenchymal fates. We believe that soxlO, while crucial 
for each of them, is not sufficient; instead, we propose that 
sox 10 is one of a combination of genes that together specify 
non-ectomesenchymal fates from neural crest. This model 
helps explain why cells that express molecular markers for 
affected cell types can be identified in els mutants (Kelsh and 
Eisen, 2000). For example, although melanophores barely 
express melanin, xanthophores show much pigment in els 
mutants. If a combination o f transcription factors together 
specify a cell type, each factor might regulate only partially 
overlapping subsets of the characteristics of individual fates. In 
the absence of sox 10 gene function, those aspects of 
melanophore and xanthophore fate requiring sox 10 function 
would be affected (e.g. synthesis of melanin and trophic 
machinery, respectively), while others would remain at least 
partly unaffected (e.g. dct expression and pteridine pigment 
synthesis, respectively). A directly analogous mechanism has 
been proposed for autonomic neurone specification from the 
neural crest, with different genes regulating pan-neuronal and 
subtype specific cell properties (Anderson et al., 1997). Factors 
that interact with SoxlO to regulate target genes have been
described, including the paired box transcription factor Pax3 
and the POU-domain protein Tst-l/Oct6/SCIP (Bondurand et 
al., 2000; Kuhlbrodt et al., 1998a). However, it remains to be 
seen whether these co-factors have any role in distinguishing 
non-ectomesenchymal fates. Identification of combinations of 
transcription factors required to specify each fate will be a 
promising line o f future research.
Our specification model predicts that sox 10 function is 
required only in NCCs fated to non-ectomesenchymal 
derivatives. Jkd6 is expressed very broadly in premigratory 
NCCs (Odenthal and Nuesslein-Volhard, 1998) and shows 
extensive, but incomplete, overlap with sox 10. Further studies 
will be required to test whether sox!0-;Jkd6+  NCCs represent 
ectomesenchymal precursors. However, our results do show 
that, consistent with our model, expression is, at least, rapidly 
downregulated in cells that adopt ectomesenchymal fates. In 
mammals, SoxlO has sometimes been assumed to be a generic 
NCC marker (Pattyn et al., 1999), but our results show that, in 
fish, overlap with other NC markers is incomplete, even at 
premigratory stages.
In many respects, zebrafish neural crest development is 
typical of neural crest development in all vertebrates (Raible et 
al., 1992). In contrast to mouse and human SoxlO mutations, 
none of the fish sox 10 mutations show dominant effects on 
melanophore number or pattern (R. N. K.., unpublished). In 
mice, expressivity of the sox 10 haploinsufficiency phenotype 
is dependent on the genetic background (Lane and Liu, 1984). 
Presumably, in the AB background in zebrafish heterozygotes 
have sufficient SoxlO for normal melanophore development. 
Nevertheless, the conserved expression pattern and 
homozygous phenotypes in the two species suggest that the 
detailed cell-biological basis for the els phenotype proposed 
here illuminates a possible mechanism behind Waardenburg- 
Shah syndrome and Hirschsprung’s disease, in which reduced 
SOX 10 function may reduce the number of melanoblasts and 
enteric precursors specified.
We thank J. James for fish husbandry, L. D. Hurst for generation 
of Fig. IB, D. Raible for pCSHSP, and C. Miller, D. Parichy and D. 
Raible for cDNA clones. We also gratefully acknowledge J. Eisen, D. 
Raible, J. M. W. Slack, R. Adams, W. Bennett, A. Ward and J. R. 
Dutton for helpful criticism and discussion of the manuscript. R. G. 
thanks S. Rudolph-Geiger for technical assistance. This work was 
supported by a Praxis XXI PhD Studentship (S. S. L.), a University 
of Bath studentship and ORS award (T. J. C.), a Royal Society 
Research Grant, Wellcome Trust Project Grant 050602/Z, a MRC Co­
operative Group Component Grant G9810985, and MRC Co­
operative Group Grant G9721903. R. G. and P. H. were supported by 
the German Human Genome Project (DHGP Grant 01 KW 9919).
REFERENCES
Akimenko, M. A., Ekker, M., Wegner, J., Lin, W. and Westerfield, M.
(1994). Combinatorial expression of three zebrafish genes related to distal- 
less: part of a homeobox gene code for the head. J. Neurosci. 14, 3475- 
3486.
Anderson, D. J., Groves, A., Lo, L., Rao, M., Shah, N. M. and Sommer, L.
(1997). Cell lineage determination and the control of neuronal identity in 
the crest. Cold Spring Harbor Symp. Quant. Biol. LXII, 493-504.
Attie, T., Till, M., Pelet, A., Amiel, J., Edery, P., Boutrand, L., Munnich, 
A. and Lyonnet, S. (1995). Mutation of the endothelin-receptor B gene in 
Waardenburg-Hirschsprung disease. Hum. Mol. Genet. 4, 2407-2409. 
Baynash, A. G., Hosoda, K., Giaid, A., Richardson, J. A., Emoto, N.,
H24 K. A. Dutton and others
Hammer, R. E. and Yanagisawa, M. (1994). Interaction of endothelin-3 
with endothelin-B receptor is essential for development of epidermal 
melanocytes and enteric neurons. Cell 79, 1277-1285.
Bolande, R. P. (1974). The neurocristopathies: a unifying concept of disease 
arising in neural crest maldevelopment. Hum. Pathol. 5, 409-429. 
pondurand, N., Kobetz, A., Pingault, V., Lemort, N., EnchaRazavi, F.,
! Couly, G., Goerich, D. E., Wegner, M., Abitbol, M. and Goossens, M.
(1998). Expression of the SOX 10 gene during human development. FEBS 
' Lett. 432, 168-172.
Bondurand, N., Pingault, V., Goerich, D. E., Lemort, N., Sock, E., Caignec, 
C. L., Wegner, M. and Goossens, M. (2000). Interaction among SOX10, 
PAX3 and MITF, three genes altered in Waardenburg syndrome. Hum. Mol. 
Genet. 9, 1907-1917.
Britsch, S., Goerich, D. E., Riethmacher, D., Peirano, R. I., Rossner, M., 
Nave, K. A., Birchmeier, C. and Wegner, M. (2001). The transcription 
factor SoxlO is a key regulator of peripheral glial development. Genes Dev. 
15, 66-78.
Dutton, IG, Dutton, J. R., Pauliny, A. and Kelsh, R. N. (2001). A morpholino 
phenocopy of the colourless mutant. Genesis 30, 188-189.
Edery, P., Atti’e, T., Amiel, J., Pelet, A., Eng, C., Hofstra, R. M., Martelli,
H., Bidaud, C., Munnich, A. and Lyonnet, S. (1996). Mutation of the 
endothelin-3 gene in the Waardenburg-Hirschsprung disease (Shah- 
Waardenburg syndrome). Nat. Genet. 12, 442-444.
Haffter, P., Granato, M., Brand, M., Mullins, M., Hammerschmldt, M., 
Kane, D., Odenthal, J., van Eeden, F., Jiang, Y., Heisenberg, C. et al. 
(1996). The identification of genes with unique and essential functions in 
the development of the zebrafish, Danio rerio. Development 123, 1-36. 
Halloran, M., Sato-Maeda, M., Warren, J., Su, F., Lele, Z., Krone, P., 
Kuwada, J. and Shoji, W. (2000). Laser-induced gene expression in 
specific cells of transgenic zebrafish. Development 127, 1953-1960. 
Herbarth, B., Pingault, V., Bondurand, N., Kuhlbrodt, K., Hermans- 
Borgmeyer, I., Pullti, A., Lemort, N., Goossens, M. and Wegner, M. 
(1998). Mutation of the Sry-related SoxlO gene in Dominant megacolon, a 
mouse model for human Hirschsprung disease. Proc. Natl. Acad. Sci. USA 
95, 5161-5165.
Hofstra, R. M., Osinga, J., Tan Sindhunata, G., Wu, Y., Kamsteeg, E. J., 
Stulp, R. P., van Ravenswaaij Arts, C., Majoor Krakauer, D., Angrist, 
M., Chakravarti, A. et al. (1996). A homozygous mutation in the 
endothelin-3 gene associated with a combined Waardenburg type 2 and 
Hirschsprung phenotype (Shah-Waardenburg syndrome). Nat. Genet. 12, 
445-447.
Hosoda, K., Hammer, R. E., Richardson, J. A., Baynash, A. G., Cheung, 
J. C., Giaid, A. and Yanagisawa, M. (1994). Targeted and natural (piebald- 
lethal) mutations of endothelin-B receptor gene produce megacolon 
? associated with spotted coat color in mice. Cell 79, 1267-1276.
Hukriede, N. A., Joly, L., Tsang, M., Miles, J., Tellis, P., Epstein, J. A., 
Barbazuk, W. B., Li, F. N., Paw, B., Postlethwait, J. H. et al. (1999). 
Radiation hybrid mapping of the zebrafish genome. Proc. Natl. Acad. Sci. 
USA 96, 9745-9750.
Jkegami, IL, Hunter, P. and Yager, T. D. (1999). Developmental activation 
J of the capability to undergo checkpoint-induced apoptosis in the early 
\ zebrafish embryo. Dev. Biol. 209, 409-433.
Kapur, R. P. (1999). Early death of neural crest cells is responsible for total 
enteric aganglionosis in Soxl0(Dom)/Soxl0(Dom) mouse embryos. Pediatr. 
Dev. Pathol. 2, 559-569.
Kelsh, R. N., Brand, M., Jiang, Y.-J., Heisenberg, C. P., Lin, S., Haffter, 
P., Odenthal, J., Mullins, M. C., van Eeden, F. J., Furutani-Seiki, M. et 
al. (1996). Zebrafish pigmentation mutations and the processes of neural 
crest development. Development 123, 369-389.
Kelsh, R. N. and Eisen, J. S. (2000). The zebrafish colourless gene regulates 
development of non-ectomesenchymal neural crest derivatives. 
Development 127, 515-525.
Kelsh, R. N., Dutton, IC, Medlin, J. and Eisen, J. S. (2000a). Expression of 
zebrafish Jkd6 in neural crest-derived glia. Mech. Dev. 93, 161-164.
Kelsh, R. N., Schmid, B. and Eisen, J. S. (2000b). Genetic analysis of 
1 melanophore development in zebrafish embryos. Dev. Biol. 225, 277-293. 
Kimmel, C. B., Ballard, W. W., Kimmel, S. R., Ullmann, B. and Schilling, 
j T. F. (1995). Stages of embryonic development of the zebrafish. Dev. Dyn.
\ 203,253-310.
Knapik, E., Goodman, A., Atkinson, O., Roberts, C., Shiozawa, M., Sim, 
C., Weksler-Zangen, S., Trolliet, M., Futrell, C., Innes, B. et al. (1996). 
A reference cross DNA panel for zebrafish (Danio rerio) anchored with 
simple sequence length polymorphisms. Development 123, 451-460. 
Kuhlbrodt, 1C, Herbarth, B., Sock, E., Hermans-Borgmeyer, I. and
Wegner, M. (1998a). SoxlO, a novel transcriptional modulator in glial cells. 
J. Neurosci. 18, 237-250.
Kuhlbrodt, K., Schmidt, C., Sock, E., Pingault, V., Bondurand, N., 
Goossens, M. and Wegner, M. (1998b). Functional analysis of SoxlO 
mutations found in human Waardenburg-Hirschsprung patients. J. Biol. 
Chem. 273, 23033-23038.
Lane, P. W. and Liu, H. M. (1984). Association of megacolon with a new 
dominant spotting gene (Dom) in the mouse. J. Hered. 75, 435-439.
Le Douarin, N. M. (1982). The Neural Crest. Cambridge: Cambridge 
University Press.
Lee, M., Goodall, J., Verastegui, C., Ballotti, R. and Goding, C. R. (2000). 
Direct regulation of the microphthalmia promoter by SoxlO links 
Waardenburg-Shah syndrome (WS4)-associated hypopigmentation and 
deafness to WS2. J. Biol. Chem. 275, 37978-37983.
Lister, J. A., Robertson, C. P., Lepage, T., Johnson, S. L. and Raible, D. 
W. (1999). nacre encodes a zebrafish microphthalmia-related protein that 
regulates neural-crest-derived pigment cell fate. Development 126, 3757- 
3767.
Liu, Q., Melnikova, I. N., Hu, M. and Gardner, P. D. (1999). Cell type- 
specific activation of neuronal nicotinic acetylcholine receptor subunit genes 
by SoxlO. J. Neurosci. 19, 9747-9755.
Malicki, J., Schier, A. F., Solnica-Krezel, L., Stemple, D. L., Neuhauss, S.
C. F., Stainier, D. Y. 1L, Abdelilah, S., Rangini, Z., Zwartkruis, F. and 
Driever, W. (1996). Mutations affecting development of the zebrafish ear. 
Development 123, 275-283.
Marusich, M. F., Furneaux, H. M., Henion, P. D. and Weston, J. A. (1994). 
Hu neuronal proteins are expressed in proliferating neurogenic cells. J. 
Neurobiol. 25, 143-155.
Mayer, T. C. (1965). The development of piebald spotting in mice. Dev. Biol. 
11,319-334.
Mayer, T. C. and Maltby, E. L. (1964). An experimental investigation of 
pattern development in lethal spotting and belted mouse embryos. Dev. Biol. 
9, 269-286.
Odenthal, J. and Nuesslein-Volhard, C. (\998). fork head domain genes in 
zebrafish. Dev. Genes Evol. 208, 245-258.
Opdecamp, K., Nakayama, A., Nguyen, M. T. T., Hodgkinson, C. A., 
Pavan, W. J. and Amheiter, H. (1997). Melanocyte development in vivo 
and in neural crest cell cultures: Crucial dependence on the Mitf basic-helix- 
loop-helix-zipper transcription. Development 124, 2377-2386.
Parichy, D. M., Rawls, J. F., Pratt, S. J., Whitfield, T. T. and Johnson, S. 
L. (1999). Zebrafish sparse corresponds to an orthologue of c-kit and is 
required for the morphogenesis of a subpopulation of melanocytes, but is 
not essential for hematopoiesis or primordial germ cell development. 
Development 126, 3425-3436.
Parichy, D. M., Ransom, D. G., Paw, B., Zon, L. I. and Johnson, S. L. 
(2000). An orthologue of the kit-related gene fins is required for 
development of neural crest-derived xanthophores and a subpopulation of 
adult melanocytes in the zebrafish, Danio rerio. Development 127, 3031- 
3044.
Pattyn, A., Morin, X., Cremer, H., Goridis, C. and Brunet, J.-F. (1999). 
The homeobox gene Phox2b is essential for the development of autonomic 
neural crest derivatives. Nature 399, 366-370.
Peirano, R. I. and Wegner, M. (2000). The glial transcription factor SoxlO 
binds to DNA both as monomer and dimer with different functional 
consequences. Nucleic Acids Res. 28, 3047-3055.
Pevny, L. H. and Lovell-Badge, R. (1997). Sox genes find their feet. Curr. 
Opin. Genet Dev. 7, 338-44.
Pingault, V., Bondurand, N., Kuhlbrodt, K., Goerich, D. E., Prehu, M. O., 
Puliti, A., Herbarth, B., Hermans-Borgmeyer, L, Legius, E., Matthijs, 
G. et al. (1998). SOX 10 mutations in patients with Waardenburg- 
Hirschsprung disease. Nat. Genet. 18, 171-173.
Potterf, S. B., Furumura, M., Dunn, K. J., Arnheiter, H. and Pavan, W. J. 
(2000). Transcription factor hierarchy in Waardenburg syndrome: regulation 
of MITF expression by SOX10 and PAX3. Hum. Genet. 107, 1-6.
PufTenberger, E. G., Hosoda, K., Washington, S. S., Nakao, K., deWit, D., 
Yanagisawa, M. and Chakravarti, A. (1994). A missense mutation of the 
endothelin-B receptor gene in multigenic Hirschsprung’s disease. Cell 79, 
1257-1266.
Pusch, C., Hustert, E., Pfeifer, D., Sudbeck, P., Kist, R., Roe, B., Wang, Z., 
Balling, R., Blin, N. and Scherer, G. (1998). The SOXlO/SoxlO gene from 
human and mouse: sequence, expression, and transactivation by the encoded 
HMG domain transcription factor. Hum. Genet. 103, 115-123.
Raible, D. W. and Eisen, J. S. (1994). Restriction of neural crest cell fate in 
the trunk of the embryonic zebrafish. Development 120, 495-503.
Zebrafish soxlO mutant 4125
Raible, D. W., Wood, A., Hodsdon, W., Henion, P. D., Weston, J. A. and 
Eisen, J. S. (1992). Segregation and early dispersal of neural crest cells in 
the embryonic zebrafish. Dev. Dyn. 195, 29-42.
Rauch, G. J., Hammerschmidt, M., Blader, P., Schauerte, H. E., Strahle, 
U., Ingham, P. W., McMahon, A. P. and Haffter, P. (1997). Wnt5 is 
required for tail formation in the zebrafish embryo. Cold Spring Harbor 
Symp. Quant. Biol. 62, 227-234.
Reyes, R. (1999). Development and Death of Zebrafish Rohon-Beard Spinal 
Sensory Neurons. In Institute of Neuroscience, pp. 1-99. Eugene, OR: 
University of Oregon.
Schilling, T. F. and Kimmel, C. B. (1994). Segment and cell type lineage 
restrictions during pharyngeal arch development in the zebrafish embryo. 
Development 120, 483-494.
Schulte-Merker, S., Van Eeden, F. J. M., Halpem, M. E., Kimmel, C. B. 
and Niisslein-Volhard, C. (1994). no tail (ntl) is the zebrafish homologue 
of the mouse T (Brachyury) gene. Development 120, 1009-1015.
Smith, M., Hickman, A., Amanze, D., Lumsden, A. and Thorogood, P. 
(1994). Trunk neural crest origin of caudal fin mesenchyme in the 
zebrafish Brachydanio rerio. Proc. R. Soc. London B Biol. Sci. 256, 137- 
MS.
Southard-Smith, E. M., Kos, L. and Pavan, W. J. (1998). SoxlO mutation 
disrupts neural crest development in DOM Hirschsprung mouse model. Nat. 
Genet. 18, 60-64.
Southard-Smith, E. M., Angrist, M., Ellison, J. S., Agarwala, R., 
Baxevanis, A. D., Chakravarti, A. and Pavan, W. J. (1999). The 
SoxlO(Dom) mouse: modeling the genetic variation of Waardenburg-Shah 
(WS4) syndrome. Genome Res. 9, 215-225.
Strimmer, K. and von Haeseier, A. (1996). Quartet puzzling: A quartet
maximum-likelihood method for reconstructing tree topologies. Mol. Biol. 
Evol. 13, 964-969.
Tachibana, M., Takeda, K., Nobukuni, Y., Urabe, K., Long, J. E.,.Meyers, 
K, A., Aaronson, S. A. and Miki, T. (1996). Ectopic expression of MITF, 
a gene for Waardenburg syndrome type 2, converts fibroblasts to cells with 
melanocyte characteristics. Nature Genet. 14, 50-54.
Tamura, K. and Nei, M. (1993). Estimation of the number of nucleotide 
substitutions in the control region of mitochondrial-DNA in humans and 
chimpanzees. Mol. Biol. Evol. 10, 512-526.
Thompson, J. D., Gibson, T. J., Piewniak, F., Jeanmougin, F. and Higgins,
D. G. (1997). The CLUSTAL_X windows interface: flexible strategies for 
multiple sequence alignment aided by quality analysis tools. Nucleic Acids 
Res. 25, 4876-4882.
Verastegu), C., Bille, K., Ortonne, J. P. and BaUotti, R. (2000). Regulation 
of microphthalmia-associated transcription factor gene by the waardenburg 
syndrome type 4 Gene, SoxlO. J. Biol. Chem. 275, 30757-60.
Wegner, M. (1999). From head to toes: the multiple facets of Sox proteins. 
Nucleic Acids Res. 27, 1409-1420.
Wehrle-Haller, B. and Weston, J. A. (1995). Soluble and cell-bound forms 
of steel factor activity play distinct roles in melanocyte precursor dispersal 
and survival on the lateral neural crest migration pathway. Development 121, 
731-742.
Wehrle-Haller, B. and Weston, J. A. (1997). Receptor tyrosine kinase- 
dependent neural crest migration in response to differentially localized 
growth factors. BioEssays 19, 337-345.
Yuan, H., Corbi, N., Basilico, C. and Dailey, L. (1995). Developmental- 
specific activity of the FGF-4 enhancer requires the synergistic action of 
Sox2 and Oct-3. Genes Dev. 9, 2635-2645.
Development 130, 2809-2818 








Stone Elworthy1-*-*, James A. Lister2-*, Tom J. Carney1, David W. Raible2-* and Robert N. Kelsh1-*
department of Biology and Biochemistry, University of Bath, Bath BA2 7AY, UK 
department of Biological Structure, University of Washington, Seattle, WA 98195-7420, USA
‘P resen t add ress : Centre for Developm ental G enetics, D epartm ent of Biomedical Science, University of Sheffield, Sheffield S10 2TN, UK
fT h ese  au thors contributed equally to this work and  a re  joint first authors
^Authors for co rrespondence (e-mail: bssm k@ bath .ac .uk  and  draible@ u.w ashington.edu)
Accepted 26 February 2003
SUMMARY
The transcription factor SoxlO is required for the 
specification, migration and survival of all 
nonectomesenchymal neural crest derivatives including 
melanophores. soxlfH~ zebrafish lack expression of the 
transcription factor mitfa, which itself is required for 
melanophore development. We demonstrate that the 
zebrafish mitfa promoter has soxlO binding sites necessary 
for activity in vitro, consistent with studies using 
mammalian cell cultures that have shown that SoxlO 
directly regulates M itf expression. In addition, we 
demonstrate that these sites are necessary for promoter 
activity in vivo. We show that reintroduction of mitfa 
expression in neural crest cells can rescue melanophore 
development in s o x l O embryos. This rescue of
melanophores in s o x l O embryos is quantitatively 
indistinguishable from rescue in mitftr/_ embryos. These 
findings show that the essential function of soxlO in 
melanophore development is limited to transcriptional 
regulation of mitfa. We propose that the dominant 
melanophore phenotype in Waardenburg syndrome IV 
individuals with SOX10 mutations is likely to result from 
failure to activate MITF in the normal number of 
melanoblasts.
Key words: Zebrafish, Danio rerio, Neural crest, Fate specification, 
Melanocyte, sox 10, colourless, mitf, nacre, Survival, Transcriptional 
regulation
INTRODUCTION
During vertebrate embryogenesis neural crest cells delaminate 
from the dorsal neural tube, migrate throughout the body and 
differentiate into a remarkably diverse array o f cell types (Le 
Douarin and Kalcheim, 1999; Smith et al., 1994). These neural 
crest fates can be broadly categorized as ectomesenchymal and 
nonectomesenchymal. The ectomesenchymal neural crest fates 
include cranial cartilage and fin mesenchyme (in fish) whereas 
the nonectomesenchymal fates include neurons and glia of the 
peripheral nervous system and pigment cells. Defects in neural 
crest development are a significant cause o f human disease and 
the resulting syndromes are termed neurocristopathies (Le 
Douarin and Kalcheim, 1999). One such neurocristopathy is 
Waardenburg’s Syndrome, in which individuals have dominant 
pigmentation defects. Waardenburg’s Syndrome types Ila and 
IV are associated with haploinsufficiency for the transcription 
factor genes MITF and SOX10, respectively (Pingault et al., 
1998; Tachibana et al., 1994; Tassabehji et al., 1994).
Zebrafish or mice homozygous for mutations in the sox 10 
transcription factor gene [previously called colourless (els) in 
zebrafish] have severe defects in all the nonectomesenchymal
neural crest cell fates (Dutton et al., 2001; Herbarth et al., 1998; 
Kelsh and Eisen, 2000; Southard-Smith et al., 1998). In 
cls/soxlO~^ zebrafish many neural crest cells undergo 
apotoptic cell death near the neural tube. They do so after 
failing to become specified or migrate (Dutton et al., 2001). 
Apoptotic death o f cells on the neural crest migration pathways 
has also been reported in S o x l O mouse embryos (Kapur,
1999). In cls/soxlO~l~ zebrafish and in S o x l O mouse embryos 
some o f the nonectomesenchymal neural crest cell fates such 
as melanocytes (also called melanophores in zebrafish) and 
peripheral glia are essentially absent whereas others such as 
the dorsal root ganglia sensory neurons do form but with fewer 
and disorganized cells (Britsch et al., 2001; Kelsh and Eisen, 
2000; Sonnenberg-Riethmacheretal., 2001; Southard-Smith et 
al., 1998).
In mammalian systems it has been shown that in the case of 
the peripheral glia a major requirement o f SoxlO is to directly 
regulate expression o f terminal differentiation genes such as Po 
and Cx32 (Gjbl -  Mouse Genome Informatics) (Bondurand et 
al., 2001; Peirano et al., 2000). SoxlO also regulates expression 
o f the neuregulin receptor gene, Erbb3 (Britsch et al., 2001). 
Signaling through Erbb3 promotes acquisition o f the glial fate
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by neural crest cells and is required for peripheral glial cell 
migration and survival (Paratore et al., 2001). However it is not 
known whether this Erbb3 regulation by SoxlO is direct.
In the case of melanocytes it is not clear to what extent SoxlO 
is required for direct transcriptional regulation of terminal 
differentiation genes. One plausible hypothesis is that in the 
melanocyte lineage SoxlO is simply required for direct 
activation of the M itf transcription factor gene, which then acts 
as a master regulator of melanocyte cell fate. Evidence for the 
pivotal role of Mitf in melanocyte development has come from 
studies with both mammals and zebrafish. In mammalian 
systems Mitf transactivates expression of melanogenic enzyme 
genes such as Tyr and Trpl as well as the receptor tyrosine 
kinase gene Kit. Kit signaling potentiates Mitf activity in turn 
and is also required for melanocyte proliferation and survival 
in both zebrafish and mice (Goding, 2000; Hemesath et al., 
1998; Hou et al., 2000; Opdecamp et al., 1997; Parichy et al., 
1999; Steel et al., 1992; Yasumoto et al., 1997). In mammalian 
systems Mitf also directly regulates expression of the 
antiapoptotic factor gene Bcl2 required for melanocyte survival 
(McGill et al., 2002). Similarly, ectopic mitfa (previously 
known as nac) expression in zebrafish embryos causes ectopic 
expression of the melanogenic enzyme gene dct (Lister et al.,
1999). Forced expression of M itf in cultured mouse fibroblasts 
can induce some aspects of melanocyte differentiation and 
ectopic nac/mitfa expression in zebrafish embryos causes 
ectopic abnormal melanized cells (Lister et al., 1999; 
Tachibana et al., 1996).
| In cultured mammalian cells, SoxlO can directly activate 
expression from the mouse or human M itf promoter 
(Bondurand et al., 2000; Lee et al., 2000; Potterf et al., 2000; 
i Verastegui et al., 2000). SoxlO-1'  zebrafish or mouse embryos 
lack M itf expression and nac/mitfcr/_ zebrafish or M itf1'
, mouse embryos have melanocyte defects at least as severe as 
those in SoxlO'1- mutant embryos (Dutton et al., 2001; 
Hodgkinson et al., 1993; Lister et al., 1999; Potterf et al., 
.2001). Thus loss of m itf expression would be sufficient to 
account for the melanocyte defect in sox 1 0 mutant embryos.
| Although regulation of M itf expression is clearly part of the 
SoxlO requirement in the melanocyte lineage it is also possible 
that there are other essential SoxlO functions in this lineage. 
Unlike zebrafish, mice show a haploinsufficiency phenotype 
when heterozygous for SoxlO mutations (Britsch et al., 2001). 
This phenotype includes a mild melanocyte deficiency. 
Melanocytes from these mice show little reduction in M itf 
expression and yet transiently have a severe reduction in 
expression of the melanogenic enzyme gene Dct (Potterf et al.,
2001). In addition, SoxlO can transactivate expression from a 
Dct promoter construct in cultured cells (Britsch et al., 2001; 
Potterf et al., 2001). These findings could suggest a 
requirement for SoxlO in regulating Dct expression that is not 
mediated via Mitf. A critical question is whether any such non- 
AfrT/'-mediated effects of SoxlO have a significant role in 
melanocyte development.
We show here that the direct regulation of M itf expression 
by SoxlO reported in cultured mammalian cells also occurs in 
developing melanophores in zebrafish embryos. We extend 
these studies by showing that forced expression of nac/mitfa in 
the neural crest of cls/sox 1O'1'  mutant zebrafish embryos is 
sufficient to rescue melanophore development. Furthermore, 
we show that rescue of melanophores in cls/sox 1 O'1'  embryos
is quantitatively indistinguishable from rescue in nac/mitfcr1'  
embryos. Together, these data suggest that regulation of 
nac/mitfa by cls/soxlO can fully account for the cls/soxlO 
requirement in the zebrafish melanophore lineage.
MATERIALS AND METHODS 
Fish
Embryos were obtained through natural crosses and staged according 
to Kimmel et al. (Kimmel et al., 1995). We used three els alleles 
(m618, t3 and tw2) which all have equally strong phenotypes (Dutton 
et al., 2001). We used the nac*'2 allele (Lister et al., 1999) except 
where it is stated that we used the nacb692 allele (Lister et al., 2001).
PCR genotyping
Embryos were tested for heterozygosity or homozygosity of the nac 
mutations by PCR on genomic DNA. The nacw2 test used PCR 
primers cattcttgggttcatggatgcaggac and ggcaggcttgaggggcaggag 
followed by digestion with Dral which cleaves the mutant allele 
(Lister et al., 1999). The natf692 test used PCR primers 
gcagaagtaagagccctggc and acggatcatttgacttgggaattaaag followed by 
digestion with BsrDl which cleaves the mutant allele.
Whole-mount in situ hybridization
Embryos were processed for whole-mount in situ hybridization with 
nac/mitfa digoxigenin-labeled riboprobe as in Dutton et al. (Dutton et 
al., 2001).
Cell culture and iuciferase assays
Promoter truncations were made from plasmid nac>luc (Dorsky et al.,
2000) using the restriction sites indicated in Fig. 3. Mutation to 
the Ml sequence (see Table 1) was made by replacing the Spe 1- 
Age 1 region with the annealed oligonucleotides ctagtaaccc- 
atcgtcggcggtaggcttttgtcgaatcgga and ccggtccgattcgacaaaagcctacc- 
gccgacgatgggtta. The QuickChange kit (Stratagene) was used for 
mutation to the M2, M3 or M4 sequences (see Table 1). pCS2soxl0 
and pCS2soxlOL142Q were constructed by cloning the ClaVXbal 
fragments from hs>5oxi0 or hs>sox!0L142Q (Dutton et al., 2001) 
into pCS2+.
Transfection of NIH3T3 cells and Iuciferase assays were performed 
essentially as described previously (Lister et al., 2001). Transfections 
were performed on cells in 24-well dishes, with each well receiving 
300 ng soxlO expression vector, 100 ng m/(/h-promoter>luciferase 
reporter, and 50 ng pCMV-|3gal as internal control.
Electrophoretic mobility shift assays
The pCls/Sox 10-GST expression plasmid was constructed by cloning 
a PCR product amplified from hs>soxl0 (Dutton et al., 2001) (using 
primers cgggatcccgatgtcggcggaggagcacag and gcgaattcaggaaccc- 
ggtttgeegtt) between the BamHl and EcoRl sites of pGEX-3X 
(Amersham Pharmacia). Cls/Sox 10-GST fusion protein was 
expressed in E. coli BL21(RIL) (Stratagene) and affinity purified 
using glutathione agarose following the manufacturer’s instructions 
(Amersham Pharmacia). Approximate relative concentrations of 
Cls/Sox 10-GST protein were estimated by comparison to a dilution 
series of bovine serum albumin (BSA) standard using Coomassie- 
stained polyacrylamide gel electrophoresis (PAGE). The SpeAge 
DNA probe was oligonucleotides ctagtaacccatcgtcaaaga- 
ggcttttgtcgaatcgga and ccgattcgacaaaagcctctttgagacgacgatgggttact 
annealed together, end labeled with [y_32P] ATP using T4 
polynucleotide kinase and native PAGE purified. For electrophoretic 
mobility shift assays (EMSA), a 20 jil reaction mixture (containing 
Cls/Sox 10-GST protein, 2000 c.p.m. of [32P]DNA, 330 ng poly(dG- 
dC)»poly(dG-dC) (Amersham Pharmacia), 50 mM NaCl, 3% (w/v) 
Ficol (Amersham Pharmacia), 10 mM HEPES (pH 7.9), 5 mM MgCh,
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Fig. 1. Pigment cell defects in cls/soxlO~'-, nac/mitfcr1 ~ and 
cls/sox 10~'-,nac/mitfa1- mutant embryos. Lateral views of the 
dorsal trunk o f 3 dpf wild type (A), nac/mitfab692/h692 (B), 
cls/soxlO13/(3 (C) and cls/sox 10 ,3/,3\nac/mitfa h692/h692 (D) 
embryos. Wild-type embryos have large flat melanophores 
(black arrow), cls/sox 10~'- and cls/sox 10-'—,nac/mitfcr1 - 
embryos have a few tiny rounded melanophores (black 
arrows), but n ac/m itfa embryos lack melanophores. 
Iridophores (white arrows) are not reduced in nac/mitfcr 
embryos but are severely reduced in cls/sox 10~!~ and 
cls/sox 10~l~\nac/mitfa~l~. Double mutant embryos were 
identified by PCR genotyping.
A B
f v > ' S 'S *.
nac/mitfa-/-
D
cls/sox 10-/- cls/sox 10-/-;nac/mitfa-/-
0.5 mM EDTA, O.l mM dithiothreitol, 1 mg/ml BSA and sometimes 
specific competitor oligonucleotide) was incubated on ice for 20 
minutes then electrophoresed on a gel (5% (w/v) polyacrylamide 
(37:1), 0.5% TBE) at 120 V, at 4°C, for 3 hours. Dried gels were 
exposed to Biomax MS film (Kodak) for autoradiography.
Embryo injections
One- or two-cell stage embryos were injected with plasmids and/or 
RNA using standard methods as in Dutton et al. (Dutton et al., 2001). 
RNA was produced using the mMESSAGE mMACHINE kit 
(Ambion) from hs>5o;c/0  or hs>sox!0(L142Q) templates (Dutton et 
al., 2001) linearized with Asp718.
Plasmids nac>GFP and nac>nac were generated as follows: the 
SV40 promoter o f pGL3-Promoter (Promega) was replaced by a 
fragment of the mitfa promoter from the plasmid pNP-P+ (Lister et 
al., 2001) via Sail and Hindlll sites to make pGL3-NP. The Iuciferase 
gene of pGL3-NP was then excised with HindUl and Xbal and 
replaced with GFP (from pCS2-BE-GFP) or mitfa (from pHS- 
MT3A.1) (Lister et al., 1999). Plasmids nac>GFP and nac>nac were 
mutated to the M l, M2, M3, M4, Ml M3 and M3M4 sequences by 
replacing the appropriate nac promoter fragments with those from the 
corresponding Fspnac>luc constructs (see above). cls>nac was 
constructed by PCR amplifying the nac/mitfa coding sequence with 
N-terminal myc tags from pHS-MT3A.l (Lister et al., 1999) and 
cloning the PCR fragment into the Xbal site of CS26.8. CS26.8 has 
the Sall-Xba CMV promoter fragment o f pCS2+ replaced by 6.8 kb 
of sequence extending upstream from the cls/soxlO translational start 
site.
GFP fluorescence was scored in gastrulas using an MZ12 dissecting 
microscope (Leica). GFP fluorescence was scored in 24 hours-post- 
fertilization (hpf) embryos using an Axioplan 2 microscope (Zeiss) 
with the embryos anesthetized using 0.003% MS222 (Sigma) and 
mounted between bridged coverslips. Melanophore rescue was scored 
at 48 hpf or at 72 hpf in the case when the cls/soxlO~'~ iridophore 
phenotype was also being scored. Melanophores were only scored as 
rescued if they had wild-type morphology.
Photography
Live embryos were anesthetized with 0.003% MS222 (Sigma), 
mounted in methylcellulose or between bridged coverslips and 
photographed using a Spot digital camera mounted on an Eclipse 
E800 microscope (Nikon) or Axioplan 2 microscope (Zeiss) with DIC 
optics. Embryo whole-mount in situ hybridization specimens were 
photographed using a Spot digital camera mounted on a MZ12 
microscope (Leica) with epi-illumination. The GFP fluorescent 
gastrula image was captured using a LSM510 confocal microscope 
(Zeiss) with DIC and confocal fluorescence images superimposed.
RESULTS
nac/mitfa-'-;cls/sox10-'- double mutant embryos 
have minute melanophores
cls/soxlO-'- embryos show no nac/mitfa expression detectable by 
in situ hybridization and nac/mitfa~!~ embryos have a complete 
absence of melanophores (Dutton et al., 2001; Lister et al.,
1999). Although cls/sox!0~'~ embryos never have any normal 
melanophores, they do have a small number of tiny rounded cells 
expressing melanin (Kelsh et al., 1996; Kelsh et al., 2000). To 
determine whether these melanized cells result from residual 
mitfa expression below the sensitivity of in situ hybridization, we 
examined nac/mitfa1 ;cls/sox 1 ( t  double mutant embryos.
Intercrossing nac/mitfa+/b692; cls/sox 10w,s parents gave 
embryos with three different phenotypes: wild-type (Fig. 1A), 
embryos with the typical n a c /m i t f a phenotype of complete 
loss of all melanophores but no reduction in iridophores (Fig. 
1B), and embryos with the typical cls/sox 10~' phenotype of a 
severe reduction in all pigment types including iridophores but 
a persistence of tiny melanized spots (Fig. 1C,D). All embryos 
classified as having a els phenotype were similar, having at least 
five tiny melanophores, and importantly we did not observe any 
embryos with both a complete absence of these tiny melanized 
cells and loss of iridophores. The numbers o f embryos with 
these specific phenotypes, 168 wild type: 59 nac\ 67 els, fits 
the ratio of 9:3:4 expected if embryos with the genotype 
c l s - ' - ; n a c exhibit the els phenotype (p=0.64 by chi-square 
analysis). We confirmed that some o f these embryos were 
indeed n a c /m i t f a homozygotes by PCR genotyping. Of the 
27 such embryos we tested, four were nac/mitfa-'-; cls/sox 10~'~ 
(Fig. ID), 14 were nac/mitfaf'-;cls/sox 10~'- and nine were 
nac/mitfa+,+;cls/soxlO-'-.
To test whether this surprising result was also observed 
with other nac/mitfa and cls/soxlO alleles we crossed 
nac/mitfaw2/w2;cls/soxl0+/tw2 and nac/mitfa+/w2;cls/soxJ0+/tw2 
parents. This gave 36 wild-type embryos, 39 embryos with the 
typical nac/mitfa-'- phenotype and 18 embryos with a severe 
reduction in all pigment types. These 18 embryos each had at 
least five tiny melanophores and PCR genotyping showed 
that of the 17 such embryos we tested, 12 were 
nac/mitfar'-;cls/sox 10~'- and five were nac/mitfa"'-;cls/sox 10~'-.
These results suggest that the less severe melanophore defect 
observed in cls/sox!0~'~ embryos as compared to nac/mitfar'-
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nac/mitfa ISH
Fig. 2 . Precocious nac/mitfa expression in 6 h.p.f embryos following 
injection with cls/soxlO RNA. Lateral views o f uninjected (A), 
cls/sox 10L142Q RNA injected (250 pg per embryo; B) and cls/soxlO 
RNA injected (250 pg per embryo; C) 6 hpf embryos following in 
situ hybridization with a nac/mitfa probe. Spots and/or patches of 
nac/mitfa expression were detected in 39% of cls/soxlO RNA 
injected embryos (n=136) but not in any of the uninjected embryos 
(n=58) nor in any of the cls/soxlOL142Q RNA injected embryos 
(«=92). (D) Superimposed fluorescent confocal and DIC images of 
an animal/lateral view of a 6 hpf embryo coinjected with cls/soxlO 
RNA (250 pg per embryo) and nac>GFP reporter plasmid (150 pg 
per embryo) show cells with GFP fluorescence. GFP fluorescence 
was observed in 75% (n=224) of embryos coinjected with cls/soxlO 
RNA and nac>GFP.
embryos cannot be attributed to residual nac/mitfa expression 
in cls/soxlO ~mutant embryos.
Ectopic cls/sox10 expression in the embryo can 
induce ectopic nac/mitfa expression
In zebrafish embryos cls/soxlO has been shown to be 
necessary for nac/mitfa expression (Dutton et al., 2001). In 
mammalian cells SoxlO has also been reported to directly 
activate Mitf expression (Bondurand et al., 2000; Lee et al., 
2000; Potterf et al., 2000; Verastegui et al., 2000). We used 
forced ectopic expression o f cls/soxlO to test whether 
cls/soxlO was also sufficient to induce nac/mitfa expression 
in the zebrafish embryo. Embryos injected with cls/soxlO 
RNA were probed for nac/mitfa expression by in situ 
hybridization. cls/soxlO RNA injection induced nac/mitfa 
transcription at 6 hpf (Fig. 2C), 12 hours before the onset of  
endogenous nac/mitfa expression (Lister et al., 1999). The 
induced nac/mitfa expression was unevenly distributed as 
patches or spots, with the pattern o f expression varying 
greatly from embryo to embryo. Ectopic nac/mitfa expression 
was not seen when embryos were injected with point mutant 
cls/soxlOL142Q RNA (Fig. 2B), the mutation in the clsm6,s 
allele (Dutton et al., 2001). These results show that cls/soxlO 
can induce nac/mitfa expression in embryonic contexts other 
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Fig. 3. Distribution of cls/sox 10 response elements in the nac/mitfa 
promoter. Schematic diagram represents the 836 b.p. nac/mitfa 
promoter Iuciferase reporter construct (nac>luc) and derivative 
constructs with truncations of the nac/mitfa promoter. Co­
transfection of the cls/soxlO expression plasmid pCS2soxlO into 
NIH3T3 cells with these constructs led to higher levels o f induction 
with the full length promoter and incrementally lower levels with 
incremental 5' truncations of the promoter. SoxlO induction was 
measured as: (Iuciferase activity with co-transfected 
pCS2soxlO)/(luciferase activity with co-transfected 
pCS2soxlOL142Q). The values shown are means+s.e.m. from at 
least four repetitions o f each experiment.
nac/mitfa upstream sequence responds to cls/sox10
To establish whether cls/soxlO acts directly or indirectly on 
nac/mitfa transcription it was necessary to identify sequence 
elements in the nac/mitfa promoter mediating cls/soxlO 
responsiveness. Dorsky et al. (Dorsky et al., 2000) showed that 
an 836 b.p. nac/mitfa promoter (extending from -753 to +83 b.p. 
relative to the transcriptional start site) was able to direct 
expression from a GFP reporter plasmid (nac>GFP) to 
melanophores. We found that this reporter responded to cls/soxlO 
RNA coinjection (Fig. 2D), but not cls/sox 10L142Q RNA 
coinjection (n=146 embryos), in gastrula embryos, recapitulating 
the ectopic expression of nac/mitfa. This indicates that this 836 
b.p. region of the nac/mitfa promoter contains sequence elements 
responsible for the cls/soxlO response in zebrafish embryos. We 
used a cell line transfection assay to further localize sequence 
elements in the nac/mitfa promoter responsible for cls/soxlO 
responsiveness. In transfected NIH3T3 cells a Iuciferase reporter 
construct with the 836 b.p. nac/mitfa promoter (nac>luc) was 
activated by a co-transfected zebrafish cls/soxlO expression 
construct (pCS2soxlO). All cls/soxlO transfections were 
compared with the baseline value obtained by co-transfection 
with the point mutant construct pCS2soxlOL142Q. Successive 5' 
truncations of the nac/mitfa promoter resulted in incremental 
decreases in the level of induction in response to cls/soxlO (Fig. 
3). Thus elements conferring response to cls/soxlO appeared to 
be widely distributed throughout the 836 b.p. nac/mitfa promoter. 
We chose to focus on the most proximal regions that conferred 
cls/soxlO response. A promoter with a 5' truncation to the Spe l 
site (at - l  73 b.p.) could still respond to cls/soxlO, and was 
significantly different than control transfection (p=0.01), but 
further truncation to the Age 1 site (at -134 b.p.) prevented 
significant response (indistinguishable from control, P>0.1). 
These results tentatively localized a sequence element(s) 
responsible for some of the response to cls/soxlO to this 41 b.p. 
region of the nac/mitfa promoter.
Cls/Sox10 binds nac/mitfa promoter sequences in 
vitro
The 41 b.p. critical region of the nac/mitfa promoter between 
the Spe 1 and Age I sites contains a sequence element (site SI)
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Fig. 5. cls/soxlO response of nac/mitfa 
promoter Iuciferase reporter constructs with 
mutated Cls/Sox 10 binding sites (see Table 1). 
cls/soxlO response is measured as: (Iuciferase 
activity in NIH3T3 cells co-transfected with 
reporter and pCS2SoxlO)/(activity with reporter 
and pCS2Soxl0L142Q). Mean values from five 
or more repetitions of each experiment are 
shown for Fspnac>luc (Fsp), FspMl nac>luc 
(FspMl), FspM2nac>luc (FspM2), 
FspM3nac>luc (FspM3), FspM4nac>luc 
(FspM4), FspMlM3nac>luc (FspMlM3) and 
|FspM3M4nac>luc. Bars indicate s.e.m. Fsp FspMl FspM2 FspM3 FspM4 FspMlM3 FspM3M4
(making Mlnac>nac) greatly reduced the plasmid’s 
effectiveness at melanophore rescue (Table 2). Mutation of sox 
binding site S3 (making M3nac>nac) caused a less dramatic 
reduction in effectiveness, whereas mutations of sites S2 or 
S4 (making M2nac>nac and M4nac>nac) had little effect 
(Table 2). We combined the SI and S3 mutations (making 
M 1 M3nac>nac) which had more effect than mutating S 1 alone 
(P<0.0001 by chi-square analysis). Combining the S3 and S4 
mutations (making M3M4nac>nac) had no more effect than 
mutating S3 alone (P>0.5). These results show that the ability 
o f a binding site to act as a response element in vivo is not 
accurately reflected by binding affinity in vitro, because sites 
S2 and S4 compete effectively for Cls/Sox 10-GST protein 
binding in vitro (Fig. 4C) and yet show little evidence of being 
cls/soxlO response elements in vivo (Table 2). Presumably 
other characteristics such as the context of the binding site in 
the promoter are just as important in defining a site as active 
in vivo.
We used the GFP reporter plasmid nac>GFP to further test 
the effect o f mutating sox binding sites SI and S3. As shown 
by Dorsky et al. (Dorsky et al., 2000), the 836 b.p. nac/mitfa 
promoter in nac>GFP directs expression of GFP to prospective 
pigment cells in injected embryos at 24 hpf. This assay differs 
from the nac>nac melanophore rescue assay in that it assesses 
promoter function in melanoblasts at an earlier developmental 
stage. Mutation of sox binding site SI in nac>GFP (making 
Mlnac>GFP) markedly reduced GFP reporter expression 
(Table 3). Mutation of site S3 (making M3>GFP) also reduced 
GFP reporter expression and combining the two mutations 
(making MlM3nac>GFP) had more effect than mutating SI 
alone. The mutant rescue and GFP expression assays are 
different and so it is not prudent to compare the magnitude of 
the effects observed with each. However, both assays show 
similar trends in which mutating site SI has a major effect, 
mutating site S3 has less of an effect, and mutating both sites 
has more effect than mutating S 1 alone.
These results demonstrate that the nac/mitfa promoter 
contains a Cls/Sox 10 protein binding site (site SI) that acts as 
a cls/soxlO response element and that is necessary for adequate 
nac/mitfa expression in developing melanophores in the 
zebrafish embryo. The Cls/SoxlO protein binding site S3 also
Table 2. Melanophore rescue at 48 hpf from nac/mitfa 






Number of embryos 
with one or more 
rescued melanophores
(%)
nac>nac 658 373 (57)
M 1nac>nac 568 50(8.8)
M2nac>nac 429 235 (55)
M3nac>nac 405 94(23)
M4nac>nac 371 163 (44)
M3M4nac>nac 338 75 (22)
M 1 M3nac>nac 485 10(2.1)
*50 pg plasmid injected per embryo.
Table 3. GFP expression in wild type embryos from a 
nac/mitfa promoter construct is reduced by mutating a 
Cls/SoxlO-binding site in the promoter of the plasmid
Number of 






cells at 24 hpf 
(%)
nac>nac 132 87(66)
M 1nac>nac 179 29(16)
M3nac>nac 139 55 (40)
M 1 M3nac>nac 153 10(6.5)
*25 pg plasmid injected per embryo.
contributes to activation of nac/mitfa expression but to a lesser 
extent. These results suggest that in zebrafish neural crest cells 
in the embryo, Cls/Sox 10 activates nac/mitfa expression by 
directly binding to the nac/mitfa promoter.
Forced nac/mitfa expression rescues the 
cls/soxlO-1- melanophore phenotype
cls/sox 10~f mutant embryos lack nac/mitfa expression and 
nac/mitfar1 mutant embryos lack melanophores (Dutton et al., 
2001; Lister et al., 1999). This prompted us to investigate 
whether activation of nac/mitfa transcription could account for




Table 4. Melanophore rescue from forced nac/mitfa 
expression in embryos from intercrossed 
cls/soxlO+l~,nac/mitfa+l~ double heterozygous parent fish
Number of 
mutant embryos 
Number of with one or more
embryos injected* rescued melanophores 
with cls>nac (%)
Wild-type embryos 450 Not applicable
Embryos with melanophore and 210 68(32)
iridophore defects
Embryos with melanophore but 161 48(30)
not iridophore defects
* 15 pg plasmid injected per embryo.
Fig. 6. In vivo melanophore rescue by forced nac/mitfa expression in 
the premigratory neural crest. Lateral views of the posterior trunk of 
2 dpf, cls/sox 10~^ ~ (A) and nac/mitfa~ ~ (B) embryos that had been 
injected with cls>nac (15 pg per embryo). Rescued melanophores 
(arrows) have normal position and morphology.
the required role o f cls/soxlO in the melanophore lineage. We 
tested this by forcing nac/mitfa expression in cls/soxlO~'~ 
embryos, thus bypassing the role of cls/soxlO in activating 
nac/mitfa expression. Because ectopic expression of mitf can 
confer some melanophore characteristics upon other cell types 
(Lister et al., 1999; Tachibana et al., 1996), we wanted to 
express nac/mitfa specifically in neural crest cells. We 
constructed a plasmid with the nac/mitfa cDNA under control 
of a cls/soxlO promoter (cls>nac). The cls/soxlO promoter 
used had previously been shown to target expression of a GFP 
reporter plasmid to the endogenous sites of cls/soxlO 
expression such as neural crest and otic vesicle (T.J.C., J. 
Dutton and R.N.K., unpublished). Injected cls>nac was able to 
rescue melanophores with normal morphology and migratory 
ability in cls/sox 10~'~ mutant embryos and in nac/mitfar/_ 
mutant embryos (Fig. 6). In both genotypes, and in agreement 
with previous rescue studies o f mitf/nac~'~ (Lister et al., 1999), 
only a few melanophores were rescued in each embryo, 
presumably because of the highly mosaic distribution of 
injected DNA typical for zebrafish injection experiments. 
These results show that reintroduction of nac/mitfa expression 
rescues the differentiation, migration and survival deficiencies 
of c ls / s o x lO neural crest cells in the melanophore lineage. 
We were also able to rescue melanophores by expression of 
nac/mitfa using a hsp70 promoter construct (Lister et al., 1999) 
(data not shown).
We tested whether forced expression of nac/mitfa was as 
effective at rescuing melanophores in cls/soxlO~'~ embryos 
as in n a c / m i t f a embryos. We injected cls>nac into 
embryos from intercrossed cls/sox 1 Of1 ;nac/mitfa+l~ double 
heterozygous parent fish to compare rescue in cls/sox 10~j~ and 
nac/mitfar/_ siblings that were laid, injected and raised 
together. Because both cls/soxlO~l~ and nac/mitfar/_ embryos 
have melanophore defects, we used the iridophore phenotype 
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Fig. 7. Melanophore rescue by forced nac/mitfa expression in the 
neural crest of embryos from intercrossed cls/sox70+/_,nac/mitfa" 
double heterozygous parent fish. The plot shows what number of 
melanophores were rescued in what percentage of cls/soxIO~/~ 
embryos (white squares) and embryos mutant for nac/mitfa but not 
cls/soxlO (black squares). The numbers of each class of embryo are 
shown in Table 4. A Mann-Whitney rank sum test shows no 
significant difference in the extent o f rescue of these two classes of 
mutant (P=0.876).
mutant for nac/mitfa alone (see Fig. 1). As mentioned above, 
double homozygous cls/sox 10~'~; nac/mitfar1 embryos have 
melanophore and iridophore defects as in cls/sox 10~ ~ embryos 
and this is reflected in the ratio of phenotypes (Table 4). The 
c ls / s o x lO embryos were rescued to the same extent as the 
embryos mutant for n a c /m i t fa alone, both in terms of the 
proportion of embryos showing any rescued melanophores and 
in terms of the number of rescued melanophores per embryo 
(Table 4, Fig. 7). This result indicates that in the melanophore 
lineage, cls/soxlO is required only to induce nac/mitfa 
expression.
DISCUSSION 
cls/sox10~'~; nac/mitfa~'~ embryos have a less severe 
melanophore phenotype than nac/mitfar'-
Previous reports indicated that n a c /m i t fa embryos lack all 
melanophores whereas c ls / s o x lO embryos still have a few 
tiny, rounded, melanized cells that fail to migrate (Kelsh and 
Eisen, 2000; Kelsh et al., 2000; Lister et al., 1999). We report
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here that the presence o f these melanized cells cannot be 
attributed to putative residual nac/mitfa expression in 
cls/sox 1 O'1'  embryos because they are also found in 
cls/soxlft1';  nac/mitfar1'  embryos. The stronger phenotype of 
nac/mitfar1'  embryos may, therefore, imply the presence of  
a cls/sox 10-dependent activity that inhibits melanophore 
development. Obviously, in normal development any such 
effect must be greatly outweighed by the positive activation of  
melanophore development mediated by cls/soxlO. The source 
o f any such inhibitory activity is completely unknown. 
However, nac/mitfa'1'  embryos have an increased number of 
iridophores (Lister et al., 1999) and so it is conceivable that 
there might be some mechanism for mutual repression between 
pigment cell types. SoxlO is expressed in neural crest lineages 
other than that giving rise to melanophores, and perhaps 
the inhibitory activity functions to prevent expression o f  
melanogenic genes in these cell types.
Role of soxlO in nonectomesenchymal crest fate 
specification
Several groups have shown that SoxlO can directly activate M itf 
expression in cultured mammalian cells (Bondurand et al., 
2000; Lee et al., 2000; Potterf et al., 2000; Verastegui et al.,
2000). We found that the zebrafish nac/mitfa promoter is also 
directly activated by zebrafish Cls/Sox 10 and that this direct 
regulation is necessary for expression from the zebrafish 
nac/mitfa promoter in neural crest cells in the developing 
embryo. Most significantly we found that this activation o f  
nac/mitfa expression can account quantitatively for all o f the 
cls/soxlO requirement in the melanophore lineage. Studies in 
zebrafish and in mice have revealed defects in neural crest cell 
fate specification, migration, survival and differentiation in 
sox 10 mutants. We have previously proposed that the complex 
phenotype of cls/soxlO mutants might be explained by a 
primary defect in specification o f nonectomesenchymal crest 
fates, with defects in migration, survival and differentiation 
being secondary consequences o f this (Dutton et al., 2001; 
Kelsh and Raible, 2002). Our demonstration here that cls/soxlO 
directly activates nac/mitfa, a key gene in melanophore fate 
specification, and that this is vital for melanophore rescue in 
nac/mitfa mutants, is clearly consistent with our model.
Although not usually interpreted in the same way, the mouse 
SoxlO mutant phenotype is plainly consistent with the model 
proposed. For example, the recent demonstration that M itf 
regulates the antiapoptotic gene Bcl2 provides a molecular 
explanation for the apoptosis o f melanoblast progenitors in 
SoxlO mutants (McGill et al., 2002). Furthermore, in mice the 
regulation of Erbb3 (directly or indirectly) by SoxlO (Britsch 
et al., 2001) provides evidence that SoxlO regulates glial fate 
specification, because neuregulin signaling has been shown to 
direct neural crest stem cells to a glial fate (Shah and Anderson, 
1997; Shah et al., 1994).
At first glance, our findings with the melanophore lineage 
contrast with the body o f work establishing that SoxlO directly 
activates a variety of differentiation genes in developing glia. 
However, these findings are consistent with the observation 
that cls/soxlO expression is downregulated in melanoblasts but 
retained in developing peripheral glia (Dutton et al., 2001), and 
suggests that in addition to its roles in nonectomesenchymal 
fate specification, sox 10 is also required for glial cell 
differentiation.
Only a subset o f soxl  ^ -expressing neural crest cells express 
mitfa and become melanophores. Dorsky et al. (Dorsky et al.,
2000) showed that wnt signaling also directly activated 
nac/mitfa expression. These findings are consistent with a 
model for cls/soxlO function in the melanophore lineage in 
which sox 10 is required in conjunction with Wnt signaling to 
activate nac/mitfa expression in neural crest cells (Kelsh and 
Raible, 2002). nac/mitfa then in turn specifies the melanophore 
fate by activating expression o f differentiation genes such as 
dct and genes such as spa/kit required for survival and 
migration. The NIH3T3 cell transfection work described here 
was conducted in the absence o f any known Wnt signaling. 
Furthermore, eliminating the Tcf/Lef binding sites as described 
by Dorsky et al. (Dorsky et al., 2000) from the nac/mitfa 
promoter reporter construct did not prevent the observed 
cls/soxlO response in NIH3T3 cells (data not shown). Recently, 
Saito et al. (Saito et al., 2002) have shown that LEF-1 activates 
transcription from the MITF promoter in Hela cells much more 
effectively when bound together as a complex with the MITF- 
M protein itself. Future studies using coexpression o f soxlO, 
mitfa and Wnt signaling components could help to reveal how 
Wnt signaling and sox 10 interact to establish mitfa expression. 
Work by others using mammalian systems has also shown that 
the transcription factors Pax3, OC-2 and CREB transactivate 
M itf transcription (Bertolotto et al., 1998; Jacquemin et al., 
2001; Potterf et al., 2000; Watanabe et al., 1998).
SOX10, MITF and human disease
Our demonstration that soxlO function in melanophores may 
be limited to regulation o f mitfa helps to explain the similar 
pigmentation defects o f the Waardenburg Syndromes Ila and 
IV. Waardenburg Syndromes Ila and IV are associated with 
human haploinsufficiency for MITF and SOX10, respectively 
(Pingault et al., 1998; Tachibana et al., 1994; Tassabehji et al., 
1994). Although zebrafish cls/soxlO mutants have no dominant 
phenotype, our results suggest a model for the aetiology of 
Waardenburg Syndrome IV. We propose that in heterozygous 
SOX10 mutant humans, activation o f MITF by SOX 10 is less 
efficient, resulting in specification o f fewer melanoblasts. 
Consistent with this, in heterozygous SoxlO mutant mice, 
which share the dominant pigment defects o f human 
individuals, KzY-positive melanoblasts are reduced in number 
(Potterf et al., 2001); although not reported in these studies, we 
predict that the number o f Mitf-expressing cells would be 
reduced in these mice compared to wild-types.
That we can, in zebrafish, account quantitatively for the role 
o f sox 10 in the melanophore lineage by its activation o f mitfa 
is perhaps surprising in view o f the reports that the mouse Dct 
promoter can be directly regulated by SoxlO (Britsch et al., 
2001; Potterf et al., 2001). However, these studies used co­
transfection assays in cultured cells and thus leave open the 
question o f whether Dct is regulated directly by SoxlO in the 
developing neural crest. Our findings strongly suggest that 
even if  SoxlO does directly regulate dct expression in vivo, 
this requirement may be dispensable for melanophore 
development. Such an interpretation is consistent with the 
phenotype in heterozygous SoxlO mutant mice. Thus, a 
transient reduction in Dct expression seen in developing 
melanoblasts was attributed to an effect o f the reduced levels 
o f SoxlO (Potterf et al., 2001), although an alternative 
explanation that sub-wild-type levels o f M itf expression result
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in lowered Dct expression cannot be ruled out; indeed, more 
recent studies in culture show that MITF interacts with LEF-1 
to directly coactivate the DCT promoter (Yasumoto et al.,
2002). However, regardless o f the mechanism mediating this 
reduction in detectable Dct expression, the Dct phenotype 
rapidly recovers, suggesting that in melanophores in which 
M itf expression is above a threshold level, the requirement for 
SoxlO is only transient and non-essential. The alternative 
explanation, that the precise contributions o f SoxlO and M itf in 
melanocyte development may not be fully conserved between 
zebrafish and mice, is less attractive because o f the striking 
similarities in the genetic control o f melanocyte development 
already demonstrated between mouse and zebrafish (Rawls et 
al., 2001).
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